<SEC-DOCUMENT>0001493152-21-023153.txt : 20210920
<SEC-HEADER>0001493152-21-023153.hdr.sgml : 20210920
<ACCEPTANCE-DATETIME>20210920160545
ACCESSION NUMBER:		0001493152-21-023153
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20210920
DATE AS OF CHANGE:		20210920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Integrity Applications, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-259664
		FILM NUMBER:		211263307

	BUSINESS ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>forms-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
filed with the Securities and Exchange Commission on September 20, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
No. 333-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>INTEGRITY
APPLICATIONS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>46-0820877</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</FONT></P>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</FONT></P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></P>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">area
code, of registrant&rsquo;s principal executive offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8
Ariel Sharon Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Or
Yehuda 6037607</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone:
</B><FONT STYLE="background-color: white">972 (8) 675-7878</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Address,
including zip code, and telephone number,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>including
area code, of principal executive offices)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jolie
Kahn, Esq.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12
E. 49<SUP>th</SUP> Street, 11<SUP>th</SUP> floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, NY 10017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone:
(516) 217-6379</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Facsimile:
(866) 705-3071</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Address,
including zip code, and telephone number,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>including
area code, of agent for service)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Copy
to:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jolie
Kahn, Esq.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12
E. 49<SUP>th</SUP> Street, 11<SUP>th</SUP> floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, NY 10017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone:
(516) 217-6379</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Facsimile:
(866) 705-3071</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public:</B> From time to time after the effective date of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following
box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer &#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company &#9746;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company &#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Title of each class of securities to be registered</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount to be registered / </B></FONT></P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>proposed maximum offering </B></FONT></P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>price per unit / proposed </B></FONT></P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>maximum aggregate offering </B></FONT></P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>price (1)(2) </B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount of </B></FONT></P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration</B></FONT></P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>fee </B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%">Common Stock, par value $0.0001 per share</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 24%; text-align: right">(3</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 24%; text-align: right">(3</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Preferred stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Debt securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Warrants (4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Units (5)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; padding-bottom: 2.5pt; font-weight: bold">Total: </TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">100,000,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,910.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    registration statement pertains to $100,000,000 of securities that may be issued by the registrant from time to time in indeterminate
    amounts and at indeterminate times. Securities registered hereunder may be sold separately or together with other securities registered
    hereunder. The securities registered hereunder also include such indeterminate number of shares of common stock of the registrant
    as may be issued upon conversion, exchange or exercise of other securities registered hereunder. Separate consideration may or may
    not be received for the shares of common stock issuable upon such conversion, exchange or exercise.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the
    &ldquo;Securities Act&rdquo;), which permits the registration fee to be calculated on the basis of the maximum aggregate offering
    price of all securities being registered.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    required to be included as to each class in accordance with General Instruction II.D. of Form S-3 under the Securities Act.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    will represent rights to purchase securities registered hereby. Because the warrants will provide a right only to purchase the securities
    offered hereunder, no additional registration fee is required for the warrants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    registered securities may be sold separately or as units with other registered securities. Units may consist of two or more securities
    in any combination, which may or may not be separable from one another. Each unit will be issued under a unit agreement. Because
    units will consist of securities registered hereunder, no additional registration fee is required for the units.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the
Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. WE MAY NOT SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT
FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IS NOT SOLICITING
AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBJECT
TO COMPLETION, DATED SEPTEMBER 20, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$100,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Integrity
Applications, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Debt
Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer and sell up to $100 million in the aggregate of the securities identified above from time to time in one or more offerings.
This prospectus provides a general description of the securities that may be offered. We will provide specific information and the amounts,
prices and terms of the securities being offered in supplements to this prospectus. The supplements may also add, update or change information
in this prospectus. Please read this prospectus and any prospectus supplements and term sheets, together with any documents incorporated
by reference, carefully before investing. This prospectus may not be used to sell securities unless accompanied by a prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer these securities directly to investors, through agents, underwriters or dealers to be designated by us at a future date, on
a continuous or delayed basis. For additional information on the methods of sale, you should refer to the section titled &ldquo;Plan
of Distribution&rdquo; in this prospectus. Each prospectus supplement will provide the terms of the plan of distribution relating to
each series of securities, including the names of any underwriters, dealers or agents involved and any applicable purchase price, fee,
commission or discount arrangement between or among them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTING
IN OUR SECURITIES INVOLVES RISKS. SEE &ldquo;RISK FACTORS&rdquo; ON PAGE 5 OF THIS PROSPECTUS AND ANY SIMILAR SECTION CONTAINED IN THE
APPLICABLE PROSPECTUS SUPPLEMENT CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the OTCQB Market under the symbol &ldquo;IGAP.&rdquo; On September 13, 2021, the last reported sale price of
our common stock on the OTCQB was $6.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPLANATORY
NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
registration statement contains a base prospectus. The specific terms of the securities offered pursuant to the base prospectus will
be specified in a prospectus supplement to be filed subsequent to the filing of this base prospectus. The issuer&rsquo;s unaffiliated
market float of its common stock as of July 23, 2021 was approximately $79.3 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with its application to list its shares on NASDAQ, on August 13, 2021, the Company effected a reverse split of its Ordinary
Shares in a ratio&nbsp;of 1 for 13 (the &ldquo;Reverse Share Split&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THE U.S. SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED
IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#GK_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#GK_002">PROSPECTUS SUMMARY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>2</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#GK_003">RISK FACTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#pa_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION INCORPORATED BY REFERENCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>23</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">32<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">34<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ma_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">35<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="GK_001"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is a part of a registration statement that we filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;), utilizing
a &ldquo;shelf&rdquo; registration process. Under this shelf registration process, we may offer to sell the common stock, preferred stock,
debt securities, warrants and units described in this prospectus in one or more offerings up to a total aggregate offering price of $100,000,000.
In this prospectus, we refer to the common stock, preferred stock, debt securities, warrants and units collectively as the &ldquo;securities&rdquo;.
This prospectus provides you with a general description of the securities we may offer. Each time we offer securities under this shelf
registration, we will provide a prospectus supplement that will contain specific information about the terms of that offering. The prospectus
supplement may also add, update or change information contained in this prospectus. To the extent that any statement that we make in
a prospectus supplement is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed
modified or superseded by those made in the prospectus supplement. You should read both this prospectus and any prospectus supplement,
including all documents incorporated herein or therein by reference, together with additional information described under &ldquo;Where
You Can Find More Information&rdquo; and &ldquo;Information Incorporated by Reference.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not authorized any dealer, salesperson or other person to give any information or to make any representation other than those contained
or incorporated by reference in this prospectus and the accompanying prospectus supplement. You must not rely upon any information or
representation not contained or incorporated by reference in this prospectus or the accompanying prospectus supplement. This prospectus
and the accompanying prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities other
than the registered securities to which they relate, nor do this prospectus and the accompanying prospectus supplement constitute an
offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such
offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus and the accompanying
prospectus supplement is accurate on any date subsequent to the date set forth on the front of the document or that any information we
have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference even though this
prospectus and any accompanying prospectus supplement is delivered or securities are sold on a later date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated in the applicable prospectus supplement or pricing supplement, neither we nor any applicable underwriters have taken
any action that would permit us to publicly sell these securities in any jurisdiction outside the United States. If you are an investor
outside the United States, you should inform yourself about and comply with any restrictions as to the offering and sale of the securities
and the distribution of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context otherwise requires, the terms &ldquo;Integrity Applications,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo;
and &ldquo;our&rdquo; refer to Integrity Applications, Inc. and not to any of its existing or future subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="GK_002"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information contained elsewhere, or incorporated by reference, in this prospectus. As a result, it does not contain
all the information that may be important to you. To understand this offering fully, you should read this entire prospectus carefully,
including the risk factors under the section entitled &ldquo;Risk Factors&rdquo; and the documents incorporated by reference into this
prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>References
in this section to the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Integrity Applications,
Inc. and our consolidated subsidiaries.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
in Delaware in May 2010, we are a medical device company focused on the design, development and commercialization of non-invasive glucose
monitoring devices for use by people with diabetes and pre-diabetics. On July 15, 2010, we completed a reverse triangular merger with
Integrity Israel and Integrity Acquisition Corp. Ltd., an Israeli corporation and a wholly owned subsidiary of ours, pursuant to which
Integrity Acquisition Corp. Ltd. merged with and into Integrity Israel and all of the stockholders and option holders of Integrity Israel
became entitled to receive shares and options in us in exchange for their shares and options in Integrity Israel (the &ldquo;Reorganization&rdquo;).
Following the Reorganization, the former equity holders of Integrity Israel were entitled to the same proportional ownership in us as
they had in Integrity Israel prior to the Reorganization. As a result of the Reorganization, Integrity Israel became a wholly owned subsidiary
of ours. We operate primarily through Integrity Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integrity
Israel was founded in 2001 with a mission to develop, produce and market non-invasive glucose monitors for home use by diabetics. We
have developed a non-invasive glucose monitor, the GlucoTrack&reg; glucose monitoring device, which is designed to help people with diabetes
and pre-diabetics obtain glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot
finger stick devices. The first generation GlucoTrack&reg; (&ldquo;GlucoTrack 1.0&rdquo;) utilizes a patented combination of ultrasound,
electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto
one&rsquo;s earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently developing our own companion applications and a cloud-based solution, as well as conducting ongoing discussions with potential
partners, to offer an effective platform to provide real time, data driven personalized tools to effectively help a user manage their
diabetes. In addition to being a critical and effective management tool for the end user, we believe that third parties such as insurers,
pharmaceutical companies and advertisers would be willing to pay for the de-identified data that we will obtain through our platform,
and that this is an opportunity for us to develop an additional revenue source.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
a short calibration process of approximately thirty minutes and consisting of three invasive reference measurements, GlucoTrack 1.0 can
be used to non-invasively measure glucose levels for six months before a user is required to repeat the calibration process. The entire
calibration process can be performed by the user themselves without the need for a trained calibrator. We believe the simple-to-perform
calibration, as well as the infrequency of the required re-calibration are significant advantages over our competition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GlucoTrack
1.0 has received the initial Conformit&eacute; Europ&eacute;ene (CE) Mark (indicating the conformity of the Company&rsquo;s product with
health, safety, and environmental protection standards for products sold within the European Economic Area) approval for the GlucoTrack&reg;
1.0 from DEKRA Certification B.V., our European notified body (the &ldquo;Notified Body&rdquo;), which is an entity that has been accredited
by a member state of the European Union (&ldquo;EU&rdquo;) to assess whether a product to be placed on the market meets certain preordained
standards. The intended use for GlucoTrack 1.0 received by the Notified Body is for both those with Type 2 diabetes as well as those
suffering from pre-diabetes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; text-indent: 33.9pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receipt
of the CE Mark allows us to market and sell GlucoTrack&reg; 1.0 glucose monitoring device in EU member countries that have adopted the
European Medical Device Directive (the &ldquo;MDD&rdquo;) without being subject to additional national regulations with regard to demonstration
of performance and safety. However, although the MDD is applicable throughout the EU, in practice it does not ensure uniform regulation
throughout the EU. Accordingly, member countries may apply and enforce the MDD&rsquo;s terms differently, and certain EU member countries
may request or require performance and/or safety data in addition to the MDD&rsquo;s requirements from time to time, on a case-by-case
basis. The CE Mark also permits the sale in countries that have an MDD Mutual Recognition Agreement with the EU. This would include some
countries in South East Asia as well as in Latin America, opening new potential markets for Integrity on a global basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Safety
and quality are non-negotiables in the medical devices industry. Regulatory requirements are increasingly stringent throughout every
step of a product&rsquo;s life cycle, including service and delivery. More and more, organizations in the industry are expected to demonstrate
their quality management processes and ensure best practice in everything they do. ISO 13485, is an internationally agreed standard that
sets out the requirements for a quality management system specific to the medical devices industry. On February 19, 2016, we received
an extension of our ISO 13485:2003 certificate and Annex II certification from the EU. The ISO 13485:2003 certification signifies that
we have met the standards required for company-wide implementation of device quality management system(s). The scope of the certification
is design, development, manufacture and service of non-invasive glucose monitoring systems for home use. Annex II also addresses quality
control systems. The certification allows us to self-certify certain modifications and changes and simplifies some of the reporting to
and review by the relevant Notified Body. This can shorten the CE-mark review process of future GlucoTrack&reg; enhancements or revisions,
including software updates and other improvements of the device that do not affect the intended use and/or safety performance. The ISO
13485:2003 and Annex II certifications enable us to potentially reduce the time to market for product sales on new, enhanced or modified
GlucoTrack&reg; devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials conducted in Germany by Pfutzner Science &amp; Health Institute, GmbH, headed by Prof. Dr. Andreas Pfutzner, on subjects with
Type 2 diabetes and pre-diabetes, as well as at Soroka University Medical Center, Beer-Sheva, Israel, demonstrated favorable results.
Results from the trials show 99.7% of the study data points within the clinically accepted A and B zones of the Consensus Error Grid
(which is a new tool for evaluating the accuracy of a blood glucose meter) (Type 2), 99.3% of the study data points were within the clinically
accepted A and B zones of the Clarke Error Grid (which is a tool used to quantify the clinical accuracy of blood glucose estimates generated
by meters as compared to a reference value), 17.0% Mean Absolute Relative Difference, and 12.9% Median Absolute Relative Difference.
In addition, the German trial concluded that the data confirms the performance of the GlucoTrack&reg; among its intended users, including
pre-diabetic patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has demonstrated (1) the GlucoTrack&reg; algorithm, which compensates for the tissue-lagging effect relative to
blood glucose changes post-meal intake, significantly improves GlucoTrack&reg; accuracy at different post-prandial (post- meal) states,
and equalizes accuracy for pre- and post-meal glucose readings; (2) GlucoTrack&reg; clinical accuracy as measured by Consensus Error
Grid (CEG) showed 100% of the pre-prandial readings in the A+B zones, and 98.2% of the post-prandial readings in the A+B zones; (3) GlucoTrack&reg;
1.0 demonstrates consistent glucose measurement repeatability between different GlucoTrack&reg; devices and on each earlobe of the same
subject; (4) the repeatability of different GlucoTrack&reg; devices is similar at all tested glucose ranges and post-prandial time periods;
and (5) the GlucoTrack&reg; mean precision absolute relative difference (PARD) of 8.2% is equivalent or better than the independently
reported PARD values of commercially available continuous glucose monitoring systems.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company conducted a study that evaluated GlucoTracker accuracy in 172 adults with type 2 diabetes who were prescribed one or more medications
for major medical conditions associated with diabetes and presented key findings of this study at the European Association for the Study
of Diabetes Congress (EASD) in Lisbon, Portugal. The experiment stratified participants into five medication groups, focusing on anti-cholesterolemia,
anti-hypertension, anti-thrombotic, and anti-diabetic (prolonged duration and short and mixed duration) medications. The study demonstrated
that the use of these common concomitant medications in diabetes had no effect on the performance of GlucoTrack&reg;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2018, the Company presented at the 11th International Conference on Advanced Technologies &amp; Treatments for Diabetes (ATTD 2018) in
Vienna, Austria. The Company presented data on the performance of a non-invasive glucose monitoring device (GlucoTrack&reg;) with regard
to accuracy and precision. Device accuracy data was presented for 37 people with type 2 diabetes using the consensus error grid analysis
for type 2 diabetes and measuring the median absolute relative difference (ARD). The results showed that 99.6% of 257 measurements were
in zones A and B of the Consensus error grid, with 90.3% of the measurements in zone A, the mean and median ARD were 17.2% and 12.9%,
respectively, and at various glucose levels, mean PARD ranged from 7.7%-8.7%. Data was also presented on sensor to sensor precision in
20 people with type 2 diabetes where ~19 simultaneous measurements using two GlucoTrack&reg; devices, one on each earlobe. The results
show that GlucoTrack&reg; is highly accurate with sensor-to-sensor precision is comparable to that of CGMs (GlucoTrack: 8.1%, Dexcom
G6: 9.0%, Freestyle Navigator: 9.6%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had begun the implementation of a proof of concept pilot program for GlucoTrack 1.0 in the Netherlands, a country chosen based
on the relatively smaller size of the marketplace to allow us to be able to rapidly assess our performance and make adjustments as necessary.
We have been working closely with our exclusive distributor in the Netherlands, Medireva B.V., and have accomplished product and disease
area training across the organization and segmentation of the local target audiences including key opinion leaders, treating physicians,
and diabetes nurses. The most important aspect of our pilot program in the Netherlands are the discussions held with many health insurance
companies. Approval of full or partial reimbursement by the health insurance companies will be a key factor in enabling us to achieve
significant sales volume. The Company has made progress with several of these companies on initial programs with GlucoTrack 1.0 as an
important step towards reimbursement approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Talent
development, recruiting and organizational health have been a critical focus of the Company over the last 12 months. A number of high-quality
individuals have joined the Company, each of whom bring extensive experience in their respective fields. We have bolstered our Senior
Management with the recruitment of Erez Ben-Zvi, a highly experienced MedTech development professional who joined us last year as Vice
President of Product, and recently took on the additional role of General Manager, and Shalom Shushan, a seasoned executive who joined
us as Chief Technology Officer. We added two new independent directors; Paul V. Goode PhD, who has a decorated career developing innovative
medical technologies, including at DexCom and MiniMed, and Luis J. Malav&eacute;, formerly of Insulet Corp, Medtronic and MiniMed. Several
highly talented and accomplished executives joined the Company as senior advisors to the Board. These include Yair Briman, the former
CEO of Philips Healthcare Informatics, Daniel McCaffrey MBA MA, a world-renowned behavioral scientist and digital health expert currently
at Samsung Health and formerly of Dexcom, Dr. Alexander Raykhman PhD, a measurement and artificial intelligence expert and Dr. David
C. Klonoff, world renowned endocrinologist and diabetes technology thought leader. We intend to continue to invest in our talent and
to expand and strengthen all areas within the company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently,
the Company performed a top-down analysis of the GlucoTrack 1.0 model to identify areas of potential enhancement, as it relates to the
platform, integrations, sensor technologies, accuracy as well as costs to manufacture. The result of this comprehensive review is an
accelerated development plan for GlucoTrack 2.0. GlucoTrack 2.0 will be a completely wireless and rechargeable earclip to be paired with
a smartphone, with more capabilities and features, increased accuracy, significantly greater margins for the Company and lower cost to
the end-user as compared to GlucoTrack 1.0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported, the Company has made significant progress towards receiving insurance reimbursement in the Netherlands. With the
new accelerated development plan for GlucoTrack 2.0, with all of the expected advantages over GlucoTrack 1.0, it made clear to the Company
that introducing GlucoTrack 2.0 rather than the GlucoTrack 1.0 would serve the diabetes market and the Company more effectively. We are
currently working with our European partners on the roadmap for distribution of GlucoTrack 2.0 when completed and ready to market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the European markets, the Company is now focused on the U.S. market as well, including building out its U.S. go-to-market
strategy and planning the required FDA clinical trials and field testing to support its entrance into the market. The Company is currently
in the process of identifying clinical sites in the U.S., interviewing Contract Research Organizations (CRO&rsquo;s), and forming its
Scientific and Medical Advisory Boards. We intend to build out a team to support the U.S. activities, while continuing our technology
development in our R&amp;D facility located in Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
may be at risk as a result of the current COVID-19 pandemic. Risks that could affect our business include the duration and scope of the
COVID-19 pandemic and the impact on the demand for our products; actions by governments, businesses and individuals taken in response
to the pandemic; the length of time of the COVID-19 pandemic and the possibility of its reoccurrence; the timing required to develop
effective treatments and a vaccine in the event of future outbreaks; the eventual impact of the pandemic and actions taken in response
to the pandemic on global and regional economies; and the pace of recovery when the COVID-19 pandemic subsides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integrity
    Applications, Inc. (the &ldquo;Company&rdquo;) was incorporated on May 18, 2010 under the laws of the State of Delaware. On July
    15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter: &ldquo;Integrity Acquisition&rdquo;), a wholly owned Israeli subsidiary
    of the Company, which was established on May 23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter: &ldquo;Integrity
    Israel&rdquo;), an Israeli corporation that was previously held by the stockholders of the Company. Pursuant to the merger, all equity
    holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the
    merger. Following the merger, Integrity Israel became a wholly-owned subsidiary of the Company. As the merger transaction constituted
    a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.
    Integrity Israel was incorporated in 2001 and commenced its operations in 2002. Integrity Israel, a medical device company, focuses
    on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and prediabetes.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate website is <U>www.integrity-app.com</U>. Our website and the information contained in, or accessible through, our website will
not be deemed to be incorporated by reference into this prospectus and does not constitute part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Securities offered pursuant to this prospectus</I></FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 11pt Calibri, Helvetica, Sans-Serif; width: 62%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may offer and sell from time to time up to an aggregate of $100 million of any of, or units comprised of, or other combinations of, the following securities:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Common
    Stock</I>. We may issue shares of our common stock. Subject to the prior rights of any class or series of preferred stock which may
    from time to time be outstanding, if any, holders of our common stock are entitled to receive dividends ratably when, as, and if
    declared by our Board of Directors. Holders of common stock are entitled to one vote per share, and do not have cumulative voting
    rights in the election of directors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Preferred
    Stock</I>. We may issue shares of our preferred stock in one or more series. Our Board of Directors will determine the dividend,
    voting, conversion and other rights of the series of preferred stock being offered.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Debt
    Securities</I>. We may offer debt securities, which may be secured or unsecured, senior, senior subordinated or subordinated, may
    be guaranteed by our subsidiaries, and may be convertible into shares of our common stock. We may issue debt securities either separately
    or together with, upon conversion of or in exchange for other securities.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Warrants</I>.
    We may issue warrants to purchase shares of common stock, preferred stock and/or debt securities of the Company. We may issue warrants
    independently or together with other securities.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Units</I>.
    We may also issue units comprised of one or more of the other securities described in this prospectus in any combination. Each unit
    will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit
    will have the rights and obligations of a holder of each included security.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Use
    of proceeds</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 62%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    anticipate that the net proceeds from the sale of the securities that we may offer under this prospectus and any accompanying prospectus
    supplement will be used primarily for working capital and general corporate purposes. Please see &ldquo;Use of Proceeds&rdquo; below.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risk
    factors</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our common stock involves substantial risk. For a discussion of risks relating to us, our business and an investment in our common
    stock that you should consider before investing in our common stock, see &ldquo;Risk Factors&rdquo; below and all other information
    set forth in this prospectus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OTCQB
    symbol</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IGAP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="GK_003"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
investment in our securities involves a high degree of risk. You should carefully consider the risks described below, together with all
of the other information included in this prospectus, before making an investment decision. If any of the following risks actually occurs,
our business, financial condition or results of operations could suffer. In that case, the trading price of our shares of common stock
could decline and you may lose all or part of your investment. See &ldquo;Cautionary Note Regarding Forward-Looking Statements&rdquo;
below for a discussion of forward-looking statements and the significance of such statements in the context of this prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have a history of operating losses, and there is no assurance that we will generate material revenues or become profitable in the near
future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a medical device company with a limited operating history. We are not profitable and have incurred losses since our inception. To
date we have not generated material revenue from the sale of products, and we do not anticipate that we will report operating income
in the near future. Our initial product, GlucoTrack&reg; 1.0, has not been approved for marketing in the United States and may not be
sold or marketed without FDA clearance or approval in the United States. Our next generation product, GlucoTrack&reg; 2.0 is currently
under development. While our GlucoTrack&reg; 1.0 received CE Mark approval in 2013, there is no assurance that we will be able to generate
any material revenues from sales of such model in the EU or any other jurisdictions. We continue to incur research and development and
selling, marketing and general and administrative expenses related to our operations, development and commercialization of our first
product. Our operating losses for the years ended December 31, 2020 and 2019 were approximately $3.1 million and $3.5 million, respectively,
and we had an accumulated deficit of approximately $93.4 million as of December 31, 2020. We expect to continue to incur losses for the
foreseeable future, and these losses will likely increase as we develop and prepare to commercialize GlucoTrack&reg; 2.0. If we are not
successful in developing, manufacturing and distributing GlucoTrack&reg; 2.0, or if GlucoTrack&reg; 2.0 does not achieve market acceptance,
we may never become profitable. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent
periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have never declared or paid any cash dividends on our Common Stock and do not anticipate paying any dividends on our Common Stock in
the foreseeable future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our Common Stock and do not anticipate paying any dividends on our Common Stock in
the foreseeable future. Any cash that might be available for payment of dividends will be used to expand our business. Payments of any
cash dividends in the future will depend on our financial condition, results of operation and capital requirements, as well as other
factors deemed relevant to our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Economic
crises and market instability may materially and adversely affect the demand for our products, as well as our ability to obtain credit
or secure funds through sales of our stock, which may materially and adversely affect our business, financial condition and ability to
fund our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Economic
crises may reduce the demand for new and innovative medical devices, resulting in delayed market acceptance of our products, if and when
they are approved. Such a delay could have a material adverse impact on our business, expected cash flows, results of operations and
financial condition. Additionally, we have funded our operations to date primarily through private sales of securities, including common
stock and other securities convertible into or exercisable for shares of our common stock. Economic turmoil and instability in the world&rsquo;s
equity and credit markets and in the unstable world may materially adversely affect our ability to sell additional securities and/or
borrow cash. There can be no assurance that we will be able to raise additional working capital on acceptable terms or at all, and any
failure to do so may materially adversely affect our ability to continue operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>GlucoTrack&reg;
may not be approved for sale in the United States or other (non-CE Mark) jurisdictions.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will likely be required to undertake significant clinical trials to demonstrate to the FDA that GlucoTrack&reg; is either safe and effective
for its intended use or is substantially equivalent in terms of safety and effectiveness to an existing, lawfully marketed non-Section
515 premarket approval (PMA) device (refer to &ldquo;<I>Management Discussion and Analysis - Government Regulatory</I>&rdquo;). We may
also be required to undertake clinical trials by non-U.S. regulatory agencies in non-CE Mark jurisdictions. Clinical trials are expensive
and uncertain processes that may take years to complete. Failure can occur at any point in the process and early positive results do
not ensure that the entire clinical trial will be successful. Product candidates in clinical trials may fail to show desired efficacy
and safety traits despite early promising results. A number of companies in the medical device industry have suffered significant setbacks
in advanced clinical trials, even after their product candidates demonstrated promising results at earlier points.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Positive
results from the limited pre-clinical trials and safety and performance clinical trial that we have conducted should not be relied upon
as evidence that later-stage or large-scale clinical trials will succeed. These trials involved limited patient populations and there
is no assurance that the experimental protocol or protocols, as the case may be, used in these informal trials will be methodologically
similar to ones submitted to the FDA or any other regulatory body for its approval. Because of the sample size, possible variation in
methodology, differences in exclusion/inclusion criteria, or differences in endpoints, the results of these pre-clinical trials may not
be indicative of future results. We will likely be required to demonstrate through well-controlled clinical trials that GlucoTrack&reg;
or future product candidates, if any, are safe and effective for their intended uses. In the event that the FDA deems GlucoTrack&reg;
to be a Class II device, which we do not believe is likely at this point, then we would be required to demonstrate that it is substantially
equivalent in terms of safety and effectiveness to a device lawfully marketed either through a premarket notification or prior to May
28, 1976.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
although we have received our CE Mark approval for GlucoTrack&reg; 1.0, EU member countries may request or require additional performance
and/or safety data from time to time, on a case-by-case basis. GlucoTrack&reg; 2.0 is currently under development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
GlucoTrack&reg; or our future product candidates, if any, may not be cleared or approved, as the case may be, even if the clinical data
are satisfactory and support, in our view, its or their clearance or approval. The FDA or other non-U.S. regulatory authorities may disagree
with our trial design or interpretation of the clinical data. In addition, any of these regulatory authorities may change requirements
for the clearance or approval of a product candidate even after reviewing and providing comment on a protocol for a pivotal clinical
trial that has the potential to result in FDA approval. In addition, any of these regulatory authorities may also clear or approve a
product candidate for fewer or more limited uses than we request or may grant clearance or approval contingent on the performance of
costly post-marketing clinical trials. In addition, the FDA or other non-regulatory authorities may not approve the labeling claims necessary
or desirable for the successful commercialization of GlucoTrack&reg; or our future product candidates, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are highly dependent on the success of our next generation product candidate, GlucoTrack&reg; 2.0, and cannot give any assurance that
it will receive regulatory approval or clearance or be successfully commercialized.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are highly dependent on the success of our next generation product candidate, GlucoTrack&reg; model 2.0. We cannot give any assurance
that the FDA will permit us to clinically test the device, nor can we give any assurance that the clinical trials will be successful
or that GlucoTrack&reg; 2.0 will receive regulatory clearance or approval or be successfully commercialized, for a number of reasons,
including, without limitation, the potential introduction by our competitors of more clinically-effective or cost-effective alternatives,
failure in our sales and marketing efforts, or the failure to obtain positive coverage determinations or reimbursement. Any failure to
obtain approval to conduct clinical trials, favorable clinical data, clearance or approval of or to successfully commercialize GlucoTrack&reg;
2.0 would have a material adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our competitors develop and market products that are more effective, safer or less expensive than GlucoTrack&reg; or our future product
candidates, if any, our commercial opportunities will be adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
life sciences industry is highly competitive and we face significant competition from many medical device companies that are researching
and marketing products designed to address the needs of persons suffering from diabetes. We are currently developing medical devices
that will compete with other medical devices that currently exist or are being developed. Some of our competitors have significantly
greater financial, manufacturing, marketing and product development resources than we do. Large medical device companies, in particular,
have extensive experience in clinical testing and in obtaining regulatory clearances or approvals for medical devices. These companies
also have significantly greater research and marketing capabilities than us. Some of the medical device companies that we expect to compete
with include Roche; LifeScan, Inc., a division of Johnson &amp; Johnson; the MediSense and TheraSense divisions of Abbott Laboratories;
Ascensia, a spin off from Bayer Corporation; Dexcom, Inc. and Medtronic, Inc. In addition, many other universities and private and public
research institutions are or may become active in research involving blood glucose measurement devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our ability to successfully compete will depend on, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to have partners manufacture and sell commercial quantities of any approved products to the market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
    of product candidates by physicians and other health care providers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    results of our clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to recruit and enroll patients for our clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    efficacy, safety, performance and reliability of our product candidates;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    speed at which we develop product candidates;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain prompt and favorable IRB review and approval at each of our clinical sites;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to commercialize and market any of our product candidates that may receive regulatory clearance or approval;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to design and successfully execute appropriate clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing and scope of regulatory clearances or approvals;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appropriate
    coverage and adequate levels of reimbursement under private and governmental health insurance plans, including Medicare; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to protect intellectual property rights related to our products.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our competitors market products that are more effective, safer, easier to use or less expensive than GlucoTrack&reg; or our future product
candidates, if any, or that reach the market sooner than GlucoTrack&reg; or our future product candidates, if any, we may not achieve
commercial success. In addition, the medical device industry is characterized by rapid technological change. It may be difficult for
us to stay abreast of the rapid changes in each technology. If we fail to stay at the forefront of technological change, we may be unable
to compete effectively. Technological advances or products developed by our competitors may render our technologies or product candidates
obsolete or less competitive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
product development activities could be delayed or stopped.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not know whether our future clinical trials will begin on time, or at all, and whether ongoing and/or future clinical trials will
be completed on schedule, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
commencement of future clinical trials could be substantially delayed or prevented by several factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    failure to obtain sufficient funding to pay for all necessary clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    number of, and competition for, suitable patients that meet the protocol&rsquo;s inclusion criteria and do not meet any of the exclusion
    criteria;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    number of, and competition for, suitable sites to conduct the clinical trials, and delay or failure to obtain FDA approval, if necessary,
    to commence a clinical trial;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
    or failure to obtain sufficient supplies of the product candidate for clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">requirements
    to provide the medical device required in clinical trials at cost, which may require significant expenditures that we are unable
    or unwilling to make;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
    or failure to reach agreement on acceptable clinical trial agreement terms or clinical trial protocols with prospective sites or
    investigators; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
    or failure to obtain IRB approval or renewal of such approval to conduct a clinical trial at a prospective or accruing site, respectively.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
completion of clinical trials in connection with our application for FDA approval could also be substantially delayed or prevented by
several factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">slower
    than expected rates of patient recruitment and enrollment;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of patients to complete the clinical trial;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unforeseen
    safety issues;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
    of efficacy evidenced during clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">termination
    of clinical trials by one or more clinical trial sites;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    or unwillingness of patients or medical investigators to follow clinical trial protocols; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to monitor patients adequately during or after treatment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
clinical trials may be suspended or terminated at any time by the FDA, other regulatory authorities, the IRB for any given site, or us.
Any failure or significant delay in completing clinical trials for GlucoTrack&reg; or future product candidates, if any, could materially
harm our financial results and the commercial prospects for our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
regulatory approval process is expensive, time-consuming and uncertain and may prevent us from obtaining approvals for the commercialization
of GlucoTrack&reg; or our future product candidates, if any.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
research, testing, manufacturing, labeling, approval, selling, marketing and distribution of medical devices are subject to extensive
regulation by the FDA and other non-U.S. regulatory authorities, which regulations differ from country to country. We are not permitted
to market our product candidates in the United States until we receive a clearance letter under the 510(k)-premarket notification process
or approval of a Section 515 premarket approval, from the FDA, depending on the nature of the device. We have not submitted an application
or premarket notification for or received marketing clearance or approval for any of our product candidates. Obtaining approval of any
premarket approval can be a lengthy, expensive and uncertain process. While the FDA normally reviews, and clears a premarket notification
in three months, there is no guarantee that our products will qualify for this more expeditious regulatory process, which is reserved
for Class I and II devices, nor is there any assurance that, even if a device is reviewed under the 510(k)-premarket notification process,
the FDA will review it expeditiously or determine that the device is substantially equivalent to a lawfully marketed non-premarket approval
device. If the FDA fails to make this finding, then we cannot market the device. In lieu of acting on a premarket notification, the FDA
may seek additional information or additional data which would further delay our ability to market the product. In addition, failure
to comply with FDA, non-U.S. regulatory authorities or other applicable U.S. and non-U.S. regulatory requirements may, either before
or after product clearance or approval, if any, subject us to administrative or judicially imposed sanctions, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the products, manufacturers or manufacturing process;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    inspectional observations (Form 483), warning letters or non-warning letters incorporating inspectional observations, i.e., so-called
    &ldquo;untitled letter&rdquo;;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">civil
    and criminal penalties;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
    or withdrawal of regulatory clearances or approvals;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizures, detentions or import bans;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voluntary
    or mandatory product recalls and publicity requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">total
    or partial suspension of production;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">imposition
    of restrictions on operations, including costly new manufacturing requirements; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    to clear or approve pending applications or premarket notifications.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
approval of a PMA or PMA supplement or clearance pursuant to a 510(k)-premarket notification is not guaranteed, and the approval or clearance
process, as the case may be, is expensive and may, especially in the case of the PMA, take several years. The FDA also has substantial
discretion in the medical device clearance or approval processes. Despite the time and expense exerted, failure can occur at any stage
and we could encounter problems that cause us to abandon clinical trials or to repeat or perform additional pre-clinical studies and
clinical trials. The number of pre-clinical studies and clinical trials that will be required for FDA clearance or approval varies depending
on the medical device candidate, the disease or condition that the medical device candidate is designed to address, and the regulations
applicable to any particular medical device candidate. The FDA can delay, limit or deny clearance or approval of a medical device candidate
for many reasons, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    medical device candidate may not be deemed safe or effective, in the case of a PMA;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    medical device candidate may not be deemed to be substantially equivalent to a lawfully marketed non-premarket approval device in
    the case of a 510(k)-premarket notification;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
    officials may not find the data from the clinical trials sufficient;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA might not approve our third-party manufacturer&rsquo;s processes or facilities; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA may change its clearance or approval policies or adopt new regulations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
while we have received CE Mark approval for GlucoTrack&reg; 1.0, the MDD requires only minimum harmonization. In practice, uniform regulation
throughout the EU is not ensured. Rather, member countries may apply and enforce the MDD&rsquo;s terms differently, and certain EU member
countries may request or require performance and/or safety data additional to the MDD&rsquo;s requirements from time to time, on a case-by-case
basis. Therefore, we cannot predict whether we will be able to successfully commercialize GlucoTrack&reg; or our future product candidates,
if any, in the EU.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to recruit and enroll patients for clinical trials may cause the development of our product candidates to be delayed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may encounter delays if we are unable to recruit and enroll and retain enough patients to complete clinical trials. Patient enrollment
depends on many factors, including the size of the patient population, the nature of the protocol, the proximity of patients to clinical
sites and the eligibility criteria for the trial. Delays in patient enrollment are not unusual. Any such delays in planned patient enrollment
may result in increased costs, which could harm our ability to develop products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
terms of clearances or approvals and ongoing regulation of our products may limit how we manufacture and market our product candidates,
which could materially impair our ability to generate anticipated revenues.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
regulatory clearance or approval has been granted, the cleared or approved product and its manufacturer are subject to continual review.
Any cleared or approved product may only be promoted for its indicated uses. In addition, if the FDA or other non-U.S. regulatory authorities
clear or approve GlucoTrack&reg; or our future product candidates, if any, the labeling, packaging, adverse event reporting, storage,
advertising and promotion for the product will be subject to extensive regulatory requirements. We, and the manufacturers of our products,
if other than us, also will be required to comply with the FDA&rsquo;s Quality System Regulation, which includes requirements relating
to quality control and quality assurance, as well as the corresponding maintenance of records and documentation. Moreover, device manufacturers
are required to report adverse events by filing Medical Device Reports with the FDA, which are publicly available. Further, regulatory
agencies must approve our manufacturing facilities before they can be used to manufacture products, and these facilities are subject
to ongoing regulatory inspection. If we fail to comply with the regulatory requirements of the FDA and other non-U.S. regulatory authorities,
or if previously unknown problems with our products, manufacturers or manufacturing processes are discovered, we could be subject to
administrative or judicially imposed sanctions, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the products, manufacturers or manufacturing process;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    inspectional observations (Form 483), warning letters, or non-warning letters incorporating inspectional observations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">civil
    or criminal penalties or fines;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizures, detentions or import bans;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voluntary
    or mandatory product recalls and publicity requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
    or withdrawal of regulatory clearances or approvals;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">total
    or partial suspension of production;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">imposition
    of restrictions on operations, including costly new manufacturing requirements; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    to clear or approve pending applications or premarket notifications.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the FDA and other non-U.S. regulatory authorities, including the EU and each of the EU member countries individually, may change
their policies and additional regulations may be enacted that could prevent or delay regulatory clearance or approval of our product
candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative
action, either in the United States or abroad. If we are not able to maintain regulatory compliance, we will likely not be permitted
to market future product candidates and may not achieve or sustain profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if we receive regulatory clearance or approval to market GlucoTrack&reg; or our future product candidates, if any, the market may not
be receptive to our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if GlucoTrack&reg; or our future product candidates, if any, obtain regulatory clearance or approval, resulting products may not gain
market acceptance among physicians, patients, health care payors or the medical community. We believe that the degree of market acceptance
will depend on a number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">timing
    of market introduction of competitive products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">safety
    and efficacy of our product;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prevalence
    and severity of any side effects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    advantages or disadvantages over alternative treatments;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">strength
    of marketing and distribution support;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
    of our product candidates, both in absolute terms and relative to alternative treatments; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">availability
    of coverage and reimbursement from government and other third-party payors.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the GlucoTrack&reg; or our future product candidates, if any, fail to achieve market acceptance, we may not be able to generate significant
revenue or achieve or sustain profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
coverage and reimbursement status of newly cleared or approved medical devices is uncertain, and failure to obtain adequate coverage
and adequate reimbursement could limit our ability to market GlucoTrack&reg; or future product candidates, if any, and may inhibit our
ability to generate revenue from GlucoTrack&reg; or our future product candidates, if any, that may be cleared or approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is significant uncertainty related to the third-party coverage and reimbursement of newly cleared or approved medical devices. The commercial
success of GlucoTrack&reg; or our future product candidates, if any, in both domestic and international markets will depend in part on
the availability of coverage and adequate reimbursement from third-party payors, including government payors, such as the Medicare and
Medicaid programs, managed care organizations and other third-party payors. Government and other third-party payors are increasingly
attempting to contain health care costs by limiting both coverage and the level of reimbursement for new products and, as a result, they
may not cover or provide adequate payment for GlucoTrack&reg; or our future product candidates, if any. These payors may conclude that
our products are not as safe or effective as existing devices or that the overall cost of using one of our devices exceeds the overall
cost of the competing device, and third-party payors may not approve GlucoTrack&reg; or our future product candidates, if any, for coverage
and adequate reimbursement. Furthermore, deficit reduction and austerity measures in the United States and abroad may put further pressure
on governments to limit coverage of, and reimbursement for, our products. The failure to obtain coverage and adequate reimbursement for
GlucoTrack&reg; or our future product candidates, if any, or health care cost containment initiatives that limit or restrict reimbursement
for such products may reduce any future product revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not obtain insurance coverage to adequately cover all significant risk exposures.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be exposed to liabilities that are unique to the products we provide. We currently maintain premises insurance and there can be
no assurance that we will acquire or maintain insurance for certain risks, that the amount of our insurance coverage will be adequate
to cover all claims or liabilities, or that we will not be forced to bear substantial costs resulting from risks and uncertainties of
business. It is also not possible to obtain insurance to protect against all operational risks and liabilities. The failure to obtain
adequate insurance coverage on terms favorable to us, or at all, could have a material adverse effect on our business, financial condition
and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
product liability lawsuits are brought against us, we may incur substantial liabilities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face a potential risk of product liability as a result of any of the products that we offer for sale. For example, we may be sued if
any product we sell allegedly causes injury or is found to be otherwise unsuitable during product testing, manufacturing, marketing or
sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of
dangers inherent in the product, negligence, strict liability and a breach of warranties. Claims could also be asserted under state consumer
protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities. Even
successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability
claims may result in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreased
    demand for products that we may offer for sale;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury
    to our reputation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    to defend the related litigation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    diversion of management&rsquo;s time and our resources;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
    monetary awards to trial participants or patients;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    recalls, withdrawals or labeling, marketing or promotional restrictions; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decline in our stock price.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
inability to obtain and retain sufficient product liability insurance at an acceptable cost to protect against potential product liability
claims could prevent or inhibit the commercialization of products we develop. We currently maintain product liability insurance up to
$5,000 thousand per claim and in the aggregate. Although we have product liability coverage, we may have to pay amounts awarded by a
court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have,
or be able to obtain, sufficient capital to pay such amounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to attract and retain key management and scientific personnel, we may be unable to successfully develop or commercialize GlucoTrack&reg;
or our future product candidates, if any.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will need to expand and effectively manage our managerial, operational, financial, development and other resources in order to successfully
pursue our research, development and commercialization efforts for GlucoTrack&reg; or our future product candidates, if any. Our success
depends on our continued ability to attract, retain and motivate highly qualified management and pre-clinical and clinical personnel.
The loss of the services of any of our senior management could delay or prevent the development or commercialization of GlucoTrack&reg;
or our future product candidates, if any. At present, we do not have key man insurance policies with respect to any of our employees.
We will need to hire additional personnel as we continue to expand our research and development activities and build a sales and marketing
function.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to attract or retain qualified management and scientific personnel in the future due to the intense competition for qualified
personnel among medical device and other businesses. If we are not able to attract and retain the necessary personnel to accomplish our
business objectives, we may experience constraints that will significantly impede the achievement of our research and development objectives,
our ability to raise additional capital and our ability to implement our business strategy. In particular, if we lose any members of
our senior management team, we may not be able to find suitable replacements in a timely fashion or at all and our business may be harmed
as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
we continue to evolve from a company primarily involved in development to a company also involved in commercialization, we may encounter
difficulties in managing our growth and expanding our operations successfully.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that, as our operations expand, we will need to expand our manufacturing, marketing and sales capabilities by contracting
with third parties. Maintaining these relationships and managing our future growth will impose significant added responsibilities on
members of our management. We must be able to manage our development efforts effectively; manage our clinical trials effectively; hire,
train and integrate additional management, development, administrative and sales and marketing personnel; improve managerial, development,
operational and finance systems; and expand our facilities, all of which may impose a strain on our administrative and operational infrastructure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
rely on third parties to manufacture and supply our product.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not own or operate manufacturing facilities for clinical or commercial production of GlucoTrack&reg;, other than a prototype lab.
We have no experience in medical device manufacturing and lack the resources and the capability to manufacture the GlucoTrack&reg; on
a commercial scale. To date we have manufactured GlucoTrack&reg; with a third-party manufacturer in Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our manufacturing partners are unable to produce our products in the amounts, timing or pricing that we require, we may not be able to
establish a contract and obtain a sufficient alternative supply from another supplier on a timely basis and in the quantities or pricing
we require. We expect to depend on third-party contract manufacturers for the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GlucoTrack&reg;
does, and our future product candidates, if any, likely will require precise, high quality manufacturing. Any of our contract manufacturers
will be subject to ongoing periodic unannounced inspections by the FDA and other non-U.S. regulatory authorities to ensure strict compliance
with quality system regulations, including current good manufacturing practices and other applicable government regulations and corresponding
standards. If our contract manufacturers fail to achieve and maintain high manufacturing standards in compliance with quality system
regulations, we may experience manufacturing errors resulting in patient injury or death, product recalls or withdrawals, delays or interruptions
of production or failures in product testing or delivery, delay or prevention of filing or approval of marketing applications for our
products, cost overruns or other problems that could seriously harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
performance failure on the part of our contract manufacturers could delay clinical development or regulatory clearance or approval of
our product candidates or commercialization of our future product candidates, depriving us of potential product revenue and resulting
in additional losses. In addition, our dependence on a third-party for manufacturing may adversely affect our future profit margins.
Our ability to replace an existing manufacturer may be difficult because the number of potential manufacturers is limited and the FDA
must approve any replacement manufacturer before it can begin manufacturing our product candidates. Such approval would require additional
non-clinical testing and compliance inspections. It may be difficult or impossible for us to identify and engage a replacement manufacturer
on acceptable terms in a timely manner, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are dependent on third-party distributors to market and sell our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited internal marketing, sales or distribution capabilities and currently we do not intend to develop extensive internal marketing,
sales or distribution capabilities in the future. Rather, we intend to utilize third-party distributors to market our products, and have
entered into exclusive distribution agreements with respect to certain territories. There is no assurance that third party distributors
will achieve acceptable levels of sales or that, if any of our existing arrangements expire or terminate, we will be able to replace
any distributors on terms advantageous to us, or at all. Further, there is no assurance that we will be able to expand our distribution
network by adding additional distributors. If third party distributors cease to promote our products, or if we are unable to make acceptable
arrangements with distributors or sales personnel in other markets, our business prospects, operating results or financial condition
could be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Independent
clinical investigators and contract research organizations that we engage to conduct our clinical trials may not be diligent, careful
or timely.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will depend on independent clinical investigators to conduct our clinical trials. Contract research organizations may also assist us
in the collection and analysis of data. These investigators and contract research organizations will not be our employees and we will
not be able to control, other than by contract, the amount of resources, including time that they devote to products that we develop.
If independent investigators fail to devote sufficient resources to the clinical trials, or if their performance is substandard, it will
delay the approval or clearance and commercialization of any products that we develop. Further, the FDA requires that we comply with
standards, commonly referred to as good clinical practice, for conducting, recording and reporting clinical trials to assure that data
and reported results are credible and accurate and that the rights, integrity and confidentiality of trial subjects are protected. If
our independent clinical investigators and contract research organizations fail to comply with good clinical practice, the results of
our clinical trials could be called into question and the clinical development of our product candidates could be delayed. Failure of
clinical investigators or contract research organizations to meet their obligations to us or comply with federal regulations could adversely
affect the clinical development of our product candidates and harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to obtain and enforce patent protection for our products, our business could be materially harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends, among other things, on our ability to protect proprietary methods and technologies that we develop under the patent
and other intellectual property laws of the United States and other countries, so that we can prevent others from unlawfully using our
inventions and proprietary information. However, we may not hold proprietary rights to some patents required for us to commercialize
proposed products. For this and other reasons, we may be unable to secure desired patent rights, thereby losing desired exclusivity.
Although we do not believe that we need any licenses for GlucoTrack&reg;, we may need to obtain licenses in the future for other products
or in certain circumstances, such as if one of our patents were declared invalid in the future. If such licenses are not available to
us on acceptable terms, we will not be able to market the affected products or conduct the desired activities, unless we successfully
challenge the validity, enforceability or infringement of the third-party patent or otherwise circumvent the third-party patent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy depends on our ability to rapidly identify and seek patent protection for our discoveries. The process of obtaining patent protection
is expensive and time-consuming. Despite our efforts to protect our proprietary rights, unauthorized parties may be able to obtain and
use information that we regard as proprietary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of a patent does not guarantee that it is valid or enforceable. Any patents we have obtained, or which we may obtain in the
future, may be challenged, invalidated, unenforceable or circumvented. Moreover, the United States Patent and Trademark Office (the &ldquo;USPTO&rdquo;)
may commence interference proceedings involving our patents or patent applications. Any challenge to, finding of unenforceability or
invalidation or circumvention of our patents or patent applications would be costly, would require significant time and attention of
our management and could have a material adverse effect on our business. In addition, court decisions may introduce uncertainty in the
enforceability or scope of patents owned by medical device companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pending patent applications may not result in issued patents. The patent position of medical device companies, including us, is generally
uncertain and involves complex legal and factual considerations. The standards that the USPTO and its foreign counterparts use to grant
patents are not always applied predictably or uniformly and can change. There is also no uniform, worldwide policy regarding the subject
matter and scope of claims granted or allowable in medical device patents. Accordingly, we do not know the degree of future protection
for our proprietary rights or the breadth of claims that will be allowed in any patents issued to us or to others. The legal systems
of certain countries do not favor the aggressive enforcement of patents, and the laws of foreign countries may not protect our rights
to the same extent as the laws of the United States. Therefore, the enforceability or scope of our patents in the United States or in
foreign countries cannot be predicted with certainty, and, as a result, any patents that we own may not provide sufficient protection
against competitors. We may not be able to obtain or maintain patent protection for our pending patent applications or those we may file
in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that any patents that will issue, that may issue or that may be licensed to us will be enforceable or valid or will
not expire prior to the commercialization of our product candidates, thus allowing others to more effectively compete with us. Therefore,
any patents that we own may not adequately protect our product candidates or our future products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to protect the confidentiality of our proprietary information and know-how, the value of our technology and products could
be adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to patent protection, we also rely on other proprietary rights, including protection of trade secrets, know-how and confidential
and proprietary information. To maintain the confidentiality of trade secrets and proprietary information, we will seek to enter into
confidentiality and non- disclosure agreements with our employees, consultants and collaborators upon the commencement of their relationships
with us. These agreements generally require that all confidential information developed by the individual or made known to the individual
by us during the course of the individual&rsquo;s relationship with us be kept confidential and not disclosed to third parties. Our agreements
with employees also generally provide and will generally provide that any inventions conceived by the individual in the course of rendering
services to us shall be our exclusive property. However, we may not obtain these agreements in all circumstances, and individuals with
whom we have these agreements may not comply with their terms. In the event of unauthorized use or disclosure of our trade secrets or
proprietary information, these agreements, even if obtained, may not provide meaningful protection, particularly for trade secrets or
other confidential information. To the extent that our employees, consultants or contractors use technology or know-how owned by third
parties in their work for us, disputes may arise between us and those third parties as to the rights in related inventions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adequate
remedies may not exist in the event of unauthorized use or disclosure of our confidential information. The disclosure of trade secrets
would impair our competitive position and may materially harm our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Some
jurisdictions may require us to grant licenses to third parties. Such compulsory licenses could be extended to include some of our product
candidates, which may limit potential revenue opportunities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
countries, including certain countries in Europe, have compulsory licensing laws under which a patent owner may be compelled to grant
licenses to third parties. In addition, most countries limit the enforceability of patents against government agencies or government
contractors. In these countries, the patent owner may be limited to monetary relief and may be unable to enjoin infringement, which could
materially diminish the value of the patent. Compulsory licensing of life-saving products is also becoming increasingly popular in developing
countries, either through direct legislation or international initiatives. Such compulsory licenses could be extended to include some
of our product candidates, which may limit our potential revenue opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
commercial success depends significantly on our ability to operate without infringing the patents and other proprietary rights of third
parties.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
entities may have or obtain patents or proprietary rights that could limit our ability to manufacture, use, sell, offer for sale or import
products or impair our competitive position. In addition, to the extent that a third party develops new technology that covers our products,
we may be required to obtain licenses to that technology, which licenses may not be available on commercially reasonable terms, if at
all. If licenses are not available on acceptable terms, we will not be able to market the affected products or conduct the desired activities
unless we successfully challenge the validity, enforceability or infringement of the third-party patent or circumvent the third-party
patent, which would be costly and would require significant time and attention of our management. Third parties may have or obtain valid
and enforceable patents or proprietary rights that could block us from developing products using our technology. Our failure to obtain
a license to any technology that we require may materially harm our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we become involved in patent litigation or other proceedings related to a determination of rights, we could incur substantial costs and
expenses, substantial liability for damages or be required to stop our product development and commercialization efforts.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties may sue us for infringing their patent rights. Likewise, we may need to resort to litigation to enforce a patent issued or licensed
to us or to determine the scope and validity of proprietary rights of others. In addition, a third party may claim that we have improperly
obtained or used our confidential or proprietary information. The cost to us of any litigation or other proceeding relating to intellectual
property rights, even if resolved in our favor, could be substantial, and the litigation would divert management&rsquo;s efforts. Some
of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially
greater resources. Uncertainties resulting from the initiation and continuation of any litigation could limit our ability to continue
our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any parties successfully claim that our creation or use of proprietary technologies infringes upon their intellectual property rights,
we might be forced to pay damages, potentially including treble damages, if we are found to have willfully infringed on such parties&rsquo;
patent rights. In addition to any damages we might have to pay, a court could require us to stop the infringing activity or obtain a
license. Any license required under any patent may not be made available on commercially acceptable terms, if at all. In addition, such
licenses are likely to be non-exclusive and, therefore, our competitors may have access to the same technology. If we fail to obtain
a required license and are unable to design around a patent, we may be unable to effectively market some of our technology and products,
which could limit our ability to generate revenues or achieve profitability and possibly prevent us from generating revenue sufficient
to sustain operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to obtain additional regulatory approvals outside the United States will prevent or limit us from marketing our product candidates abroad.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to market our product candidates in non-U.S. markets. In order to market product candidates in the EU and many other non-U.S.
jurisdictions, we must obtain separate regulatory approvals. In December 2012, we submitted our technical file to the Notified Body in
connection with our application to obtain CE Mark approval for GlucoTrack&reg; 1.0. On June 4, 2013, we received CE Mark approval for
the GlucoTrack&reg; 1.0 from the Notified Body. Receipt of the CE Mark allows us to market and sell the GlucoTrack&reg; 1.0 in EU member
countries that have adopted the MDD without being subject to additional national regulations with regard to demonstration of performance
and safety. The CE Mark also permits the sale in countries that have an MDD Mutual Recognition Agreement with the EU. However, member
countries may apply and enforce the MDD&rsquo;s terms differently, and certain EU member countries may request or require that we provide
performance and/or safety data additional to the MDD&rsquo;s requirements from time to time, on a case-by-case basis, in order to be
cleared to market and sale GlucoTrack&reg; in such countries. Receipt of FDA approval does not ensure approval by regulatory authorities
in countries, and approval by one or more non-U.S. regulatory authorities (including receipt of the CE Mark) does not ensure approval
by regulatory authorities in other countries or by the FDA. The non-U.S. regulatory approval process may include all of the risks associated
with obtaining FDA approval or clearance. We may not obtain additional non-U.S. regulatory approvals on a timely basis, if at all. We
may not be able to file for additional non-U.S. regulatory approvals and may not receive necessary approvals to commercialize our product
candidates in any market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Non-U.S.
governments often impose strict price controls, which may adversely affect our future profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to seek approval to market GlucoTrack&reg; and our future product candidates, if any, in both the U.S. and in non-U.S. jurisdictions.
If we obtain approval in one or more non-U.S. jurisdictions, we will be subject to rules and regulations in those jurisdictions relating
to our products. In some countries, particularly countries of the EU, each of which has developed its own rules and regulations, pricing
may be subject to governmental control under certain circumstances. In these countries, pricing negotiations with governmental authorities
can take considerable time after the receipt of marketing approval for a medical device candidate. Each of the EU member states has its
own unique legal system and thus it is difficult to predict the particular requirements to which we may be subject. To obtain reimbursement
or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product
to other available products. If reimbursement of our product candidates is unavailable or limited in scope or amount, or if pricing is
set at unsatisfactory levels, we may be unable to achieve or sustain profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business may become subject to economic, political, regulatory and other risks associated with international operations, which could
harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to risks associated with conducting business internationally. Accordingly, our future results could be harmed by
a variety of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in compliance with non-U.S. laws and regulations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in non-U.S. regulations and customs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in non-U.S. currency exchange rates and currency controls;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in a specific country&rsquo;s or region&rsquo;s political or economic environment;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">trade
    protection measures, import or export licensing requirements or other restrictive actions by U.S. or non-U.S. governments;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">negative
    consequences from changes in tax laws; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    associated with staffing and managing foreign operations, including differing labor relations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to enforce covenants not-to-compete under current Israeli law, which might result in added competition for our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have non-competition agreements or provisions with all of our employees and executive officers, all of which are governed by Israeli
law. These agreements or provisions prohibit our employees from competing with us or working for our competitors, generally during, and
for up to nine months after termination of, their employment with us. However, Israeli courts are reluctant to enforce non-compete undertakings
of former employees and tend, if at all, to enforce those provisions for only relatively brief periods of time or in restricted geographical
areas. In addition, Israeli courts typically require the presence of additional circumstances, such as a demonstration of an employer&rsquo;s
legitimate interest which was damaged; breach of fiduciary duties, loyalty and acting not in good faith; a payment of a special consideration
for employee&rsquo;s non-compete obligation; material concern for disclosing employer&rsquo;s trade secrets; or a demonstration that
an employee has unique value to the employer specific to that employer&rsquo;s business, before enforcing a non-competition undertaking
against such employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
funding that we received through the Office of the Chief Scientist (the &ldquo;OCS&rdquo;) for research and development activities restricts
our ability to manufacture products or to transfer technology outside of Israel.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 4, 2004, the OCS agreed to provide us with a grant of 420 thousand New Israeli Shekels (&ldquo;NIS&rdquo;), or approximately $93
thousand at an exchange rate of 4.502 NIS/dollar (the exchange rate in effect on such date), for our plan to develop a non-invasive blood
glucose monitor (the &ldquo;development plan&rdquo;). This grant constituted 60% of our research and development budget for the development
plan at that time. Due to our acceptance of this grant, we are subject to the provisions of the Israeli Law for the Encouragement of
Industrial Research and Development, 1984 (the &ldquo;R&amp;D Law&rdquo;). Among other things, the R&amp;D Law restricts our ability
to sell or transfer rights in technology or know-how developed with OCS funding or transfer any Means of Control (as defined in the R&amp;D
Law) of us to non-Israeli entities. The Industrial Research and Development Committee at the OCS (the &ldquo;research committee&rdquo;)
may, under special circumstances, approve the transfer outside of Israel of rights in technology or know-how developed with OCS funding
subject to certain conditions, including the condition that certain payments be made to the OCS. Additionally, we may not manufacture
products developed with OCS funding outside of Israel without the approval of the research committee. The restrictions regarding the
sale or transfer of technology or manufacturing rights out of Israel could have a material adverse effect on our ability to enter into
strategic alliances or enter into merger or acquisition transactions in the future that provide for the sale or transfer of our technology
or manufacturing rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to certain employee severance obligations, which may result in an increase in our expenditures.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Israeli law, employers are required to make severance payments to dismissed employees and employees leaving employment in certain other
circumstances, on the basis of the latest monthly salary for each year of service. This obligation results in an increase in our expenses,
including accrued expenses. Integrity Israel currently makes monthly deposits to insurance policies and severance pay funds in order
to provide for this liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s and its Israeli subsidiary&rsquo;s agreements with all of their Israeli employees are in accordance with Section 14 of
the Israeli Severance Pay Law -1963 (&ldquo;Section 14&rdquo;). Payments in accordance with Section 14 release the Company from any other
future severance payments in respect of those employees. Deposits under Section 14 are not recorded as an asset in the Company&rsquo;s
balance sheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be at risk for delay in product development and other economic repercussions as a result of the COVID-19 pandemic.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #1D2228"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
may be at risk as a result of the current COVID-19 pandemic. Risks that could affect our business include the duration and scope of the
COVID-19 pandemic and the impact on the demand for our products; actions by governments, businesses and individuals taken in response
to the pandemic; the length of time of the COVID-19 pandemic and the possibility of its reoccurrence; the timing required to develop
effective treatments and a vaccine in the event of future outbreaks; the eventual impact of the pandemic and actions taken in response
to the pandemic on global and regional economies; and the pace of recovery when the COVID-19 pandemic subsides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is a limited trading market for our common stock, which may make it difficult for our stockholders to sell their shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
our stock is quoted on the OTCQB, few trades in our stock have taken place, to-date, and an active trading market in our securities may
not develop, or if developed, may not be sustained. If no active market is ever developed for our Common Stock, it will be difficult
for you to sell any shares you purchase in our Company at the time you wish to sell them or at a price that you consider reasonable or
at all. In such a case, you may find that you are unable to achieve any benefit from your investment or liquidate your shares without
considerable delay, if at all. In the absence of an active public trading market, an investor may be unable to liquidate an investment
in our Common Stock. As a result, investors: (i) may be precluded from transferring their shares of Common Stock; (ii) may have to hold
their shares of Common Stock for an indefinite period of time; and (iii) must be able to bear the complete economic risk of losing their
investment in us. In the event a market should develop for the Common Stock, there can be no assurance that the market price will equal
or exceed the price paid for such share by any of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
may be limitations on the effectiveness of our internal controls, and a failure of our control systems to prevent error or fraud may
materially harm our company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proper
systems of internal controls over financial accounting and disclosure are critical to the operation of a public company. If we are unable
to effectively establish such systems, this would leave us without the ability to reliably assimilate and compile financial information
about our company and significantly impair our ability to prevent error and detect fraud, all of which would have a negative impact on
our company from many perspectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
we do not expect that disclosure controls or internal control over financial reporting will prevent all error and all fraud. A control
system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&rsquo;s
objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits
of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of
controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Failure of our control
systems to prevent error or fraud could materially adversely impact us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price of our common stock may fluctuate significantly.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of the common stock may fluctuate significantly in response to numerous factors, some of which are beyond our control, such
as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    announcement of new products or product enhancements by us or our competitors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    concerning intellectual property rights and regulatory approvals;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
    in our and our competitors&rsquo; results of operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in earnings estimates or recommendations by securities analysts, if the common stock is covered by analysts;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    in the medical device industry;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    results of product liability or intellectual property lawsuits;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
    issuances of common stock or other securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    addition or departure of key personnel;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of acquisitions, investments or strategic alliances; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    market conditions and other factors, including factors unrelated to our operating performance.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
in recent years, the stock market in general, and the market for medical device companies in particular, have experienced extreme price
and volume fluctuations. Continued or renewed market fluctuations could result in extreme volatility in the price of our common stock,
which could cause a decline in the value of the common stock. Price volatility of our common stock might be significant if the trading
volume of the common stock is low, which often occurs with respect to newly traded securities on the OTCQB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
our common stock is a &ldquo;penny stock,&rdquo; it may be more difficult for investors to sell shares of the common stock, and the market
price of the common stock may be adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock may be a penny stock if, among other things, the stock price is below $5.00 per share, it is not listed on a national securities
exchange or approved for quotation on the Nasdaq Stock Market or any other national securities exchange or it has not met certain net
tangible asset or average revenue requirements. Broker-dealers who sell penny stocks must provide purchasers of these stocks with a standardized
risk- disclosure document prepared by the SEC. This document provides information about penny stocks and the nature and level of risks
involved in investing in the penny-stock market. A broker must also give a purchaser, orally or in writing, bid and offer quotations
and information regarding broker and salesperson compensation, make a written determination that the penny stock is a suitable investment
for the purchaser and obtain the purchaser&rsquo;s written agreement to the purchase. Broker-dealers must also provide customers that
hold penny stock in their accounts with such broker-dealer a monthly statement containing price and market information relating to the
penny stock. If a penny stock is sold to an investor in violation of the penny stock rules, the investor may be able to cancel its purchase
and get its money back.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
applicable, the penny stock rules may make it difficult for investors to sell their shares of common stock. Because of the rules and
restrictions applicable to a penny stock, there is less trading in penny stocks and the market price of the common stock may be adversely
affected. Also, many brokers choose not to participate in penny stock transactions. Accordingly, investors may not always be able to
resell their shares of common stock publicly at times and prices that they feel are appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compliance
with changing regulations concerning corporate governance and public disclosure may result in additional expenses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been changing laws, regulations and standards relating to corporate governance and public disclosure, including the Sarbanes-Oxley
Act of 2002, new regulations promulgated by the SEC and rules promulgated by the national securities exchanges. These new or changed
laws, regulations and standards are subject to varying interpretations in many cases due to their lack of specificity, and, as a result,
their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies, which could result
in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance
practices. As a result, our efforts to comply with evolving laws, regulations and standards are likely to continue to result in increased
general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance
activities. Our directors, Chief Executive Officer and Chief Financial Officer could face an increased risk of personal liability in
connection with the performance of their duties. As a result, we may have difficulty attracting and retaining qualified directors and
executive officers, which could harm our business. If our efforts to comply with new or changed laws, regulations and standards differ
from the activities intended by regulatory or governing bodies, we could be subject to liability under applicable laws or our reputation
may be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
a certain portion of our expenses is incurred in currencies other than the NIS, our results of operations may be harmed by currency fluctuations
and inflation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of Integrity Israel is the NIS, and we pay a substantial portion of our expenses in NIS. However, we expect a portion
of our future revenues to be denominated in U.S. dollars or in Euros. As a result, we will be exposed to the currency fluctuation risks
relating to the recording of our revenues in NIS. For example, if the NIS strengthens against either the U.S. dollar or the Euro, our
reported expenses in NIS may be higher than anticipated. The Israeli rate of inflation has not offset or compounded the effects caused
by fluctuations between the NIS and the U.S. dollar or the Euro. To date, we have not engaged in hedging transactions. Although the Israeli
rate of inflation has not had a material adverse effect on our financial condition to date, we may, in the future, decide to enter into
currency hedging transactions to decrease the risk of financial exposure from fluctuations in the exchange rates of the currencies mentioned
above in relation to the NIS. These measures, however, may not adequately protect us from material adverse effects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
adoption of the &ldquo;Conflict Minerals&rdquo; regulations may adversely affect the manufacturing of our current and future products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
requirements regarding the use of &ldquo;conflict minerals&rdquo; could affect the sourcing and availability of the raw materials used
by our third-party manufacturers. We may be subject to costs associated with the new regulations, including for the diligence pertaining
to the presence of any conflict minerals used in our products and the cost of remediation and other changes to products, processes, or
sources of supply as a consequence of such verification activities. The impact of the regulations may result in a limited pool of suppliers
who provide conflict free minerals, and we cannot assure that we will be able to obtain products in sufficient quantities or at competitive
prices. We may face reputational challenges with our customers and other stakeholders if we are unable to sufficiently verify the origins
for the metals used in the products we sell. As a result, we may not be able to obtain the materials necessary to manufacture our products,
which could force us to cease production or search for alternative supply sources, possibly at a higher cost. Such disruptions may have
a material adverse effect on our business, financial condition, results of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="pa_002"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains &ldquo;forward-looking statements,&rdquo; which include information relating to future events, future financial performance,
financial projections, strategies, expectations, competitive environment and regulation. Words such as &ldquo;may&rdquo;, &ldquo;should&rdquo;,
&ldquo;could&rdquo;, &ldquo;would&rdquo;, &ldquo;predicts&rdquo;, &ldquo;potential&rdquo;, &ldquo;continue&rdquo;, &ldquo;expects&rdquo;,
&ldquo;anticipates&rdquo;, &ldquo;future&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;, &ldquo;believes&rdquo;, &ldquo;estimates&rdquo;,
&ldquo;will&rdquo;, and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking
statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance
or results will be achieved. Forward-looking statements are based on information we have when those statements are made or management&rsquo;s
good faith belief as of that time with respect to future events and are subject to significant risks and uncertainties that could cause
actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important
factors that could cause such differences include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    limited operating history;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to manufacture, market and sell our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain or protect the validity of our U.S. and other patents and other intellectual property;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to launch and penetrate markets;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to retain key executive members;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to internally develop new inventions and intellectual property;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interpretations
    of current laws and the passages of future laws; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
    of our business model by investors.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or
risk factors that we are faced with that may cause our actual results to differ from those anticipate in our forward-looking statements.
Please see &ldquo;<I>Risk Factors</I>&rdquo; for additional risks which could adversely impact our business and financial performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
new risks regularly emerge and it is not possible for our management to predict or articulate all risks we face, nor can we assess the
impact of all risks on our business or the extent to which any risk, or combination of risks, may cause actual results to differ from
those contained in any forward-looking statements. All forward-looking statements included in this prospectus are based on information
available to us on the date of this prospectus. Except to the extent required by applicable laws or rules, we undertake no obligation
to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent
written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety
by the cautionary statements contained above and throughout this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Risks
that could affect our business include the duration and scope of the COVID-19 pandemic and the impact on the demand for our products;
actions by governments, businesses and individuals taken in response to the pandemic; the length of time of the COVID-19 pandemic and
the possibility of its reoccurrence; the timing required to develop effective treatments and a vaccine in the event of future outbreaks;
the eventual impact of the pandemic and actions taken in response to the pandemic on global and regional economies; and the pace of recovery
when the COVID-19 pandemic subsides.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><A NAME="ma_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and other reports, proxy statements and other information with the SEC. Our SEC filings are available to the public
over the Internet at the SEC&rsquo;s website at http://www.sec.gov. Please call the SEC at 1-800-SEC-0330 for further information on
the Public Reference Room. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, including
any amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section 13(a) or 15(d) of
the Exchange Act can also be accessed free of charge through the Internet. These filings will be available as soon as reasonably practicable
after we electronically file such material with, or furnish it to, the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement under the Securities Act of 1933 relating to the offering of these securities. The registration
statement, including the attached exhibits, contains additional relevant information about us and the securities. This prospectus does
not contain all of the information set forth in the registration statement. You can obtain a copy of the registration statement, at prescribed
rates, from the SEC at the address listed above. The registration statement and the documents referred to below under &ldquo;Information
Incorporated by Reference&rdquo; are also available on our Internet website, www.cutera.com. We have not incorporated by reference into
this prospectus the information on our website, and you should not consider it to be a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="ma_002"></A>INFORMATION
INCORPORATED BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to &ldquo;incorporate by reference&rdquo; the information we file with it, which means that we can disclose important information
to you by referring you to other documents that we have filed separately with the SEC. The information incorporated by reference is considered
to be part of this prospectus, except for any information superseded by information contained directly in this prospectus, and information
we file later with the SEC will automatically be deemed to update and supersede this information. We incorporate by reference the documents
listed below and any future filings made with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934,
as amended (the &ldquo;Exchange Act&rdquo;) (excluding, in each case, any portions of such documents that have been &ldquo;furnished&rdquo;
but not &ldquo;filed&rdquo; for purposes of the Exchange Act). The documents we are incorporating by reference as of their respective
dates of filing are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1506983/000149315221008654/form10-k.htm" STYLE="-sec-extract: exhibit">Form 10-K</A> for the year ended December 31, 2020, filed with the SEC on April 13, 2021, and our Amendment No. 1 to
    <A HREF="https://www.sec.gov/Archives/edgar/data/1506983/000149315221010161/form10-ka.htm" STYLE="-sec-extract: exhibit">Form 10-K</A>, filed on April 30, 2021.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Quarterly Report on Form 10-Q for the quarters ended March 31, 2021 and June 30, 2021, filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1506983/000149315221012443/form10-q.htm" STYLE="-sec-extract: exhibit">May 21, 2021</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1506983/000149315221020191/form10-q.htm" STYLE="-sec-extract: exhibit">August 16, 2021</A>, respectively.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Current Reports on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1506983/000149315221002928/form8-k.htm" STYLE="-sec-extract: exhibit">February
    8, 2021</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1506983/000149315221015482/form8-k.htm" STYLE="-sec-extract: exhibit">June
    29, 2021</A>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    description of our common stock contained in our Registration Statement on Form S-1 filed under the Exchange Act, as filed on August
    (File No. 333-176415), including any amendment or report filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we also incorporate by reference all documents we file under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after
the initial filing date of the registration statement of which this prospectus is a part and before the effectiveness of the registration
statement and (ii) after the effectiveness of the registration statement and before the termination of the offering, with the exception
of any information furnished under Item 2.02 and Item 7.01 of any Current Report on Form 8-K, which is not deemed filed and which is
not incorporated by reference herein. The information contained in these future filings will automatically update and supersede the information
contained in this prospectus or incorporated by reference to any previously filed document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for all purposes to the
extent that a statement contained in this prospectus, or in any other subsequently filed document which is also incorporated or deemed
to be incorporated by reference, modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement we filed with the SEC under the Securities Act. As permitted by the rules and regulations
of the SEC, this prospectus does not contain all of the information set forth in the registration statement and the exhibits and schedules
that were filed with it. The statements contained in this prospectus as to the contents of any contract or any other document are not
necessarily complete. We qualify any statement by reference to the copy of the contract or document filed as an exhibit to the registration
statement. If you would like a copy of any document incorporated in this prospectus by reference (other than exhibits unless these exhibits
are specifically incorporated by reference in a document), you may request, orally or in writing, a copy of these filings, which will
be provided to you at no cost, by contacting our investor relations department at our principal executive offices, which are located
at 8 Ariel Sharon Street, Or Yehuda 6037607 Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not authorized any dealer, salesperson or other individual to give any information or to make any representation not contained or
incorporated by reference in this prospectus. If you receive any of that kind of information or if any of those types of representations
are made to you, you must not rely on the information or representations as having been authorized by the Company. Also, you must not
consider that the delivery of this prospectus or any sale made under it implies that the affairs of the Company have remained unchanged
since the date of this prospectus, or that the information contained in this prospectus is correct or complete as of any time after the
date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and any supplement to this prospectus do not constitute an offer to sell or a solicitation of an offer to buy any securities
covered by this prospectus to any person in any jurisdiction in which this offer or solicitation is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="ma_003"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated in the applicable prospectus supplement, we anticipate that the net proceeds from the sale of the securities that
we may offer under this prospectus and any accompanying prospectus supplement will be used primarily for working capital and general
corporate purposes, which may include, without limitation, engaging in acquisitions or other business combinations or investments, sales
and marketing activities, general and administrative matters and capital expenditures. Pending use of the net proceeds, we may invest
them in capital preservation instruments, including interest-bearing securities. Additional information relating to the use of net proceeds
from the sale of securities covered by this prospectus will be set forth in prospectus supplements relating to specific offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><A NAME="ma_004"></A><B>DESCRIPTION
OF CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue two classes of stock. The total number of shares of stock that we are authorized to issue is five hundred ten
million (510,000,000) shares, consisting of five hundred million (500,000,000) shares of common stock, $0.0001 par value and ten million
(10,000,000) shares of preferred stock, $0.0001 par value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2021, there were 15,444,738 shares of our common stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders, including
the election of directors, and do not have cumulative voting rights. Our directors are elected by a plurality of the votes cast by the
stockholders entitled to vote at our annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the prior rights of any class or series of preferred stock which may from time to time be outstanding, if any, holders of our common
stock are entitled to receive dividends ratably when, as and if declared by our Board of Directors, out of funds legally available for
that purpose and, upon our liquidation, dissolution or winding up, are entitled to share ratably in all assets remaining after payment
of liabilities and payment of accrued dividends and liquidation preferences on the preferred stock, if any. We have not paid any dividends
on our common stock and none are contemplated in the foreseeable future. We anticipate that all earnings that may be generated from our
operations will be used to finance our growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock have no preemptive, subscription or redemption rights pertaining to the common stock and have no rights to convert
their common stock into any other securities. The absence of preemptive rights could result in a dilution of the interest of the existing
stockholders should additional shares of common stock be issued. In addition, the rights of holders of our common stock are subject to,
and may be adversely affected by, the rights of holders of shares of any series of preferred stock that we may designate and issue in
the future. See &ldquo;Risk Factors&rdquo; for a further description of risks related to the common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
outstanding shares of common stock are fully paid and non-assessable. Our common stock is traded on the OTCQB under the symbol &ldquo;IGAP.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, the Company had zero (0) shares of Preferred Stock issued and outstanding. Our board of directors, without
stockholder approval, has the authority under our certificate of incorporation to issue preferred stock with rights superior to the rights
of the holders of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Effects of Delaware Law and Our Charter and Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certificate
of Incorporation and Bylaws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Blank
Check Preferred Stock</I>. Our board of directors, without stockholder approval, has the authority under our certificate of incorporation
to issue preferred stock with rights superior to the rights of the holders of Common Stock. As a result, preferred stock could be issued
quickly and easily, could impair the rights of holders of Common Stock and could be issued with terms calculated to delay or prevent
a change of control or make removal of management more difficult.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Election
of Directors</I>. Our certificate of incorporation provides that a majority of directors then in office may fill any vacancy occurring
on the board of directors, even though less than a quorum may then be in office. These provisions may discourage a third-party from voting
to remove incumbent directors and simultaneously gaining control of the board of directors by filling the vacancies created by that removal
with its own nominees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stockholder
Action</I>. Our certificate of incorporation provides that stockholders may act at meetings of stockholders or by written consent in
lieu of a stockholders&rsquo; meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stockholder
Meetings</I>. Our bylaws provide that the only business that may be conducted at a special meeting of stockholders is such business as
was specified in the notice of the meeting. These provisions may discourage another person or entity from making a tender offer, even
if it acquired a majority of our outstanding voting stock, because the person or entity could only take action at a duly called stockholders&rsquo;
meeting relating to the business specified in the notice of meeting and not by written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Requirements
for Advance Notification of Stockholder Nominations and Proposals</I>. Our bylaws provide that a stockholder seeking to bring business
before an annual meeting of stockholders, or to nominate candidates for election as directors at an annual meeting of stockholders, must
provide timely notice of this intention in writing. To be timely, a stockholder must deliver or mail the notice and we must receive the
notice at our principal executive offices not less than five days prior to the date our directors determine for proposals to be received.
The bylaws also include a similar requirement for making director nominations and specify requirements as to the form and content of
the stockholder&rsquo;s notice. These provisions could delay stockholder actions that are favored by the holders of a majority of our
outstanding stock until the next stockholders&rsquo; meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delaware
Anti-Takeover Statute</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a Delaware corporation subject to Section 203 of the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;). Under Section 203,
some business combinations between a Delaware corporation whose stock generally is publicly-traded or held of record by more than 2,000
stockholders and an interested stockholder are prohibited for a three-year period following the date that the stockholder became an interested
stockholder, unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    corporation has elected in its certificate of incorporation not to be governed by Section 203;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    board of directors of the corporation approved the transaction which resulted in the stockholder becoming an interested stockholder
    before the stockholder became an interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder
    owned at least 85% of the voting stock of the corporation outstanding at the commencement of the transaction, excluding voting stock
    owned by directors who are also officers or held in employee benefit plans in which the employees do not have a confidential right
    to tender stock held by the plan in a tender or exchange offer; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    board of directors approves the business combination and holders of two-thirds of the voting stock which the interested stockholder
    did not own authorize the business combination at a meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not made an election in our certificate of incorporation to opt out of Section 203. In addition to the above exceptions to Section
203, the three-year prohibition does not apply to some business combinations proposed by an interested stockholder following the announcement
or notification of an extraordinary transaction involving the corporation and a person who was not an interested stockholder during the
previous three years or who became an interested stockholder with the approval of a majority of the corporation&rsquo;s directors. For
the purposes of Section 203, a business combination generally includes mergers or consolidations, transactions involving the assets or
stock of the corporation or its majority-owned subsidiaries and transactions which increase an interested stockholder&rsquo;s percentage
ownership of stock. Also, an interested stockholder generally includes a stockholder who becomes beneficial owner of 15% or more of a
Delaware corporation&rsquo;s voting stock, together with the affiliates or associates of that stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock is American Stock Transfer &amp; Trust Company, LLC, with an address of <FONT STYLE="background-color: white">6201
15th Ave, Brooklyn, NY 11219 and a telephone number of <U>(800) 937-5449</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="ma_005"></A>DESCRIPTION
OF DEBT SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description summarizes the material terms and provisions of the debt securities that we may offer under this prospectus. While
the terms we have summarized below will apply generally to any future debt securities we may offer, we will describe the particular terms
of any debt securities that we may offer in more detail in the applicable prospectus supplement. If we so indicate in a prospectus supplement,
the terms of any debt securities we offer thereunder may differ from the terms we describe below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
debt securities will be issued under an indenture (the &ldquo;Indenture&rdquo;) between us and a trustee named in the prospectus supplement
(the &ldquo;Trustee&rdquo;). We may issue debt securities either separately, or together with, or upon the conversion or exercise of
or in exchange for, other securities described in this prospectus. Debt securities may be our senior, senior subordinated or subordinated
obligations and, unless otherwise specified in a prospectus supplement, the debt securities will be our direct, unsecured obligations
and may be issued in one or more series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of selected provisions of the Indenture is not complete and is qualified in its entirety by reference to the provisions
of the Indenture, which provisions are incorporated by reference in this prospectus. You should review the form of Indenture, which has
been filed as an exhibit to the registration statement of which this prospectus is a part. The terms of the debt securities include those
stated under the Indenture and those made part of the Indenture by reference to Trust Indenture Act of 1939, as amended (the &ldquo;TIA&rdquo;).
Capitalized terms used in the summary and not defined herein have the meanings specified in the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Indenture does not limit the amount of debt securities we may issue, and we may issue debt securities up to an aggregate principal amount
as we may authorize from time to time. The debt securities will be our unsecured obligations and will rank equally with all of our other
unsecured and unsubordinated debt from time to time outstanding. Our secured debt, if any, will be effectively senior to the debt securities
to the extent of the value of the assets securing such debt. As of the date of this prospectus, we have no debt securities issued and
outstanding. The debt securities will be exclusively our obligations and not of our subsidiaries, and, therefore, the debt securities
will be structurally subordinate to the debt and liabilities of our subsidiaries. The prospectus supplement will describe the terms of
any debt securities being offered, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    limit upon the aggregate principal amount;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date or dates on which the principal is payable;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    rate or rates (which may be fixed or variable) at which the debt securities shall bear interest, if any, or the method by which such
    rate shall be determined;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date or dates from which interest shall accrue;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date or dates on which interest shall be payable;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    record dates for the determination of holders to whom interest is payable;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    right, if any, to extend the interest payment periods and the duration of such extension;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    place or places where the principal and any interest shall be payable;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    price or prices at which, the period or periods within which and the terms and conditions upon which debt securities may be redeemed;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    obligation, if any, to redeem, purchase or repay the debt securities pursuant to any sinking fund or otherwise or at the option of
    a holder thereof;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    applicable, the price or prices at which and the period or periods within which and the terms and conditions upon which the debt
    securities shall be redeemed, purchased or repaid, in whole or in part;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    other than denominations of $2,000 and any multiple of $1,000 in excess thereof, the denominations in which the debt securities of
    the series shall be issuable;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    percentage of the principal amount at which the debt securities will be issued and, if other than the principal amount thereof, the
    portion of such principal amount which shall be payable upon declaration of acceleration of the maturity thereof or provable in bankruptcy;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the debt securities are issuable as global securities and, in such case, the identity for the depositary;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    deletion from, modification of or addition to the Events of Default (as defined below) or covenants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    provisions granting special rights to holders when a specified event occurs;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    and under what circumstances we will pay additional amounts on the debt securities held by a person who is not a U.S. person in respect
    of any tax, assessment or governmental charge withheld or deducted;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    special tax implications of the debt securities;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    trustees, authenticating or paying agents, transfer agents or registrars or any other agents with respect to the debt securities;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    guarantor or co-issuer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    special interest premium or other premium;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the debt securities are convertible or exchangeable into common stock or other of our equity securities and the terms and conditions
    upon which such conversion or exchange shall be effected; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    currency in which payments shall be made, if other than U.S. dollars.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
on Mergers and Other Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Indenture provides that we may not merge or consolidate with any other person or persons (whether or not affiliated with us), and we
may not sell, convey, transfer, lease or otherwise dispose of all or substantially all of our property or assets to any other person
or persons (whether or not affiliated with us), unless the following conditions are satisfied:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">either
    (a) the transaction is a merger or consolidation, and we are the surviving entity; or (b) the successor person (or the person which
    acquires by sale, conveyance, transfer or lease all or substantially all of our property or assets) is organized under the laws of
    the United States, any state thereof or the District of Columbia and expressly assumes, by a supplemental indenture satisfactory
    to the Trustee, all of our obligations under the debt securities and the Indenture;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately
    after giving effect to the transaction and treating our obligations in connection with or as a result of such transaction as having
    been incurred as of the time of such transaction, no Event of Default shall have occurred and be continuing under the Indenture;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    officer&rsquo;s certificate and an opinion of counsel are delivered to the Trustee to the effect that the conditions set forth above
    have been satisfied.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
restrictions in the second and third bullets above shall not be applicable to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    merger or consolidation with an affiliate of ours if our Board of Directors determines in good faith that the purpose of such transaction
    is principally to change our state of incorporation or convert our form of organization to another form; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    merger with or into a single one of our direct or indirect wholly-owned subsidiaries pursuant to Section 251(g) (or any successor
    provision) of the NBCL.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of any such consolidation, merger, sale, transfer or other conveyance, but not a lease, in a transaction in which there is a
successor entity, the successor entity will succeed to, and be substituted for, us under the Indenture and, subject to the terms of the
Indenture, we will be released from the obligation to pay principal and interest on the debt securities and all obligations under the
Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the foregoing, if we consummate a Holding Company Reorganization (as defined below), the newly formed holding company (New
HoldCo, as defined below) shall be treated as the &ldquo;successor person,&rdquo; and the Holding Company Reorganization shall constitute
the transfer to New HoldCo of substantially all of our assets; as such, we will be discharged from all obligations and covenants under
the Indenture, and New HoldCo will be the sole obligor on the debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Holding
Company Reorganization&rdquo; shall mean our merger with and into our newly formed wholly-owned, indirect subsidiary (&ldquo;MergerCo&rdquo;),
all of the equity interests of which shall be held by our newly formed wholly-owned, direct subsidiary (&ldquo;New HoldCo&rdquo;), all
of the equity interest of which shall be initially be held by us. Such merger shall be effected pursuant to Section 251(g) (or any successor
provision) of the NBCL and shall not require the vote of our stockholders. Each of our shares of common stock shall be converted into
a right to receive one share of New HoldCo common stock, with identical terms and rights as our common stock immediately prior to such
conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reports
to Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Indenture provides that any document or report that we are required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange
Act will be furnished to the Trustee within 15 days after we file such document or report with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Events
of Default</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following events are defined in the Indenture as &ldquo;Events of Default&rdquo; with respect to debt securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
the failure to pay interest on any debt securities when the same becomes due and payable and the Default continues for a period of 60
days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
the failure to pay the principal (or premium, if any) of any debt securities, when such principal becomes due and payable, at maturity,
upon acceleration, upon redemption or otherwise;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
a default in the performance, or breach, of our obligations under the &ldquo;Limitation on Mergers and Other Transactions&rdquo; covenant
described above;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
a default in the observance or performance of any other covenant or agreement contained in the Indenture which default continues for
a period of 60 days after we receive written notice specifying the default (and demanding that such default be remedied) from the Trustee
or the Holders of at least a majority of the outstanding principal amount of each series of debt securities affected, voting together
as a single class;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
(a) a failure to make any payment at maturity on any of our Indebtedness (other than Indebtedness owing to any of our Subsidiaries) outstanding
in an amount in excess of $50.0 million or its foreign currency equivalent at the time and continuance of such failure to pay after any
applicable grace period, or (b) a default on any of our Indebtedness (other than Indebtedness owing to any of our Subsidiaries), which
default results in the acceleration of such Indebtedness in an amount in excess of $50.0 million or its foreign currency equivalent at
the time, without such Indebtedness having been discharged or the acceleration having been cured, waived, rescinded or annulled, in the
case of clause (a) or (b) above; provided, however, that if any failure, default or acceleration referred to in clauses (a) or (b) ceases
or is cured, waived, rescinded or annulled, then the Event of Default under the Indenture will be deemed cured; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
certain events of bankruptcy or insolvency affecting us or any of our Significant Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Event of Default (other than an Event of Default specified in clause (6) above), shall occur and be continuing, the Trustee or the
Holders of at least 25% of the principal amount of each series of debt securities affected, voting together as a single class, may declare
the principal of and accrued interest on all such debt securities to be due and payable by notice in writing to us and the Trustee specifying
the respective Event of Default and that it is a &ldquo;notice of acceleration&rdquo;, and the same shall become immediately due and
payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Event of Default specified in clause (6) above occurs and is continuing, then all unpaid principal of and premium, if any, and accrued
and unpaid interest on all debt securities shall automatically become due immediately and payable without any declaration or other act
on the part of the Trustee or any Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the Indenture provides that, at any time after a declaration of acceleration with respect to one or more series of debt
securities as described above, the Holders of a majority in principal amount of each series of debt securities affected, voting together
as a single class, may rescind and cancel such declaration of acceleration and its consequences if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
the rescission would not conflict with any judgment or decree;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
all existing Events of Default have been cured or waived except nonpayment of principal or interest that has become due solely because
of the acceleration;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
to the extent the payment of such interest is lawful, interest on overdue installments of interest and overdue principal, which has become
due otherwise than by such declaration of acceleration, has been paid;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
we have paid the Trustee its reasonable compensation and reimbursed the Trustee for its expenses, disbursements and advances; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
in the event of the cure or waiver of an Event of Default of the type described in clause (6) of the description of Events of Default
above, the Trustee shall have received an officer&rsquo;s certificate and an opinion of counsel that such Event of Default has been cured
or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
such rescission shall affect any subsequent Event of Default or impair any right consequent thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holders of a majority in principal amount of the debt securities of each series affected, voting together as a single class, may waive
any existing default or Event of Default under the Indenture, and its consequences, except a default in the payment of the principal
of or interest on any debt securities of a series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holders may not enforce the Indenture except as provided in the Indenture and under the TIA. Subject to the provisions of the Indenture
relating to the duties of the Trustee, the Trustee is under no obligation to exercise any of its rights or powers under the Indenture
at the request, order or direction of any of the Holders, unless such Holders have offered to the Trustee reasonable security or indemnity.
Subject to all provisions of the Indenture and applicable law, the Holders of a majority in aggregate principal amount of each series
of debt securities affected that is then outstanding, voting together as a single class, will have the right to direct the time, method
and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee.
Nothing in the Indenture shall impair the right of a Holder to institute suit for the enforcement of any payment of principal, premium,
if any, and interest on or with respect to the debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be required to provide a certificate to the Trustee, from our principal executive, financial or accounting officer or our treasurer,
promptly upon any such officer obtaining knowledge of any default or Event of Default (provided that such officers shall provide such
certification at least annually whether or not they know of any default or Event of Default) that has occurred and, if applicable, describe
such default or Event of Default and the status thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Personal Liability of Directors, Officers, Employees, Incorporator and Stockholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
director, officer, employee, incorporator, agent, stockholder or affiliate of us or any of our Subsidiaries, as applicable, shall have
any liability for any of our or our Subsidiaries&rsquo; obligations under the debt securities or the Indenture or for any claim based
on, in respect of, or by reason of, such obligations or their creation. Each Holder of the debt securities, by accepting such security,
waives and releases all such liability. This waiver and release are part of the consideration for issuance of the debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Defeasance and Covenant Defeasance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may, at our option and at any time, elect to have our obligations discharged with respect to the outstanding debt securities of a series
(&ldquo;Legal Defeasance&rdquo;). Such Legal Defeasance means that we shall be deemed to have paid and discharged the entire indebtedness
represented by the outstanding debt securities of a series, except for:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
the rights of Holders to receive payments in respect of the principal of, premium, if any, and interest on the debt securities when such
payments are due;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
our obligations with respect to the debt securities concerning issuing temporary debt securities, registration of debt securities, mutilated,
destroyed, lost or stolen debt securities and the maintenance of an office or agency for payments;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
the rights, powers, trust, duties and immunities of the Trustee and our obligations in connection therewith; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
the Legal Defeasance provisions of the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may, at our option and at any time, elect to have our obligations released with respect to certain covenants that are described
in the Indenture (&ldquo;Covenant Defeasance&rdquo;) and, thereafter, any omission to comply with such obligations shall not constitute
a default or Event of Default with respect to the applicable series of debt securities. In the event Covenant Defeasance occurs, certain
events (not including non-payment, bankruptcy, receivership, reorganization and insolvency events) described under &ldquo;&mdash;Events
of Default&rdquo; will no longer constitute an Event of Default with respect to the debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to exercise either Legal Defeasance or Covenant Defeasance with respect to the debt securities of a series:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
we must irrevocably deposit with the Trustee, in trust, for the benefit of the Holders, cash in U.S. dollars, non-callable U.S. government
obligations or a combination thereof, in such amounts as will be sufficient, in the opinion of a nationally recognized investment bank,
appraisal firm or firm of independent public accountants, to pay the principal of, premium, if any, and interest on the debt securities
on the stated date for payment thereof or on the applicable redemption date, as the case may be;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
in the case of Legal Defeasance, we must deliver to the Trustee an opinion of counsel reasonably acceptable to the Trustee confirming
that, as a result of an Internal Revenue Service ruling or a change in applicable federal income tax law, to the effect that the Holders
of the applicable debt securities will not recognize gain or loss for federal income tax purposes as a result of such Legal Defeasance
and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if
such Legal Defeasance had not occurred;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
in the case of Covenant Defeasance, we must deliver to the Trustee an opinion of counsel reasonably acceptable to the Trustee confirming
that the Holders will not recognize gain or loss for federal income tax purposes as a result of such Covenant Defeasance and will be
subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant
Defeasance had not occurred;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
no default or Event of Default shall have occurred and be continuing with respect to the applicable debt securities then-outstanding
on the date of such deposit (other than a default or an Event of Default resulting from the borrowing of funds to be applied to such
deposit and the grant of any lien securing such borrowings);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
such Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of, or constitute a default under the Indenture
(other than an Event of Default resulting from the borrowing of funds to be applied to such deposit and the grant of any lien securing
such borrowings) or any other material agreement or instrument to which we or any of our Subsidiaries is a party or by which we or any
our Subsidiaries is bound;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
we must deliver to the Trustee an officer&rsquo;s certificate and an opinion of counsel, each stating that all conditions precedent provided
for or relating to the Legal Defeasance or the Covenant Defeasance have been complied with; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
certain other customary conditions precedent are satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Satisfaction
and Discharge</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Indenture will be discharged and will cease to be of further effect (except as to surviving rights or registration of transfer or exchange
of the applicable series of the debt securities, as expressly provided for in the Indenture) as to all outstanding debt securities of
a series, when:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
all of the applicable series of the debt securities theretofore authenticated and delivered (except lost, stolen or destroyed debt securities
which have been replaced or paid and debt securities for whose payment money has theretofore been deposited in trust or segregated and
held in trust by us and thereafter repaid to us or discharged from such trust) have been delivered to the Trustee for cancellation; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
all of the applicable series of debt securities not theretofore delivered to the Trustee for cancellation (1) have become due and payable,
or (2) will become due and payable within one year, or are to be called for redemption within one year, under arrangements satisfactory
to the Trustee for the giving of notice of redemption by the Trustee in our name and at our expense, and we have irrevocably deposited
or caused to be deposited with the Trustee funds in an amount sufficient to pay and discharge the entire indebtedness on the applicable
series of debt securities not theretofore delivered to the Trustee for cancellation, for principal of, premium, if any, and interest
on the applicable series of debt securities to the date of deposit, together with irrevocable instructions from us directing the Trustee
to apply such funds to the payment thereof at the applicable maturity or redemption date, as the case may be;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
we have paid all other sums then due and payable under the Indenture; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
we have delivered to the Trustee an officer&rsquo;s certificate and an opinion of counsel stating that all conditions precedent under
the Indenture relating to the satisfaction and discharge of the Indenture have been complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Modification
of the Indenture</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we and the Trustee, without the consent of the Holders, may amend the Indenture or the applicable series of debt securities
for certain specified purposes, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
to cure any ambiguity, defect or inconsistency;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
to provide for uncertificated debt securities in addition to or in place of certificated debt securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
to comply with the provisions described under &ldquo;Consolidation, Merger, Sale or Conveyance&rdquo; in the Indenture in the case of
a merger or consolidation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
to maintain the qualification of the Indenture under the TIA;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
to evidence and provide for the acceptance of appointment by a successor Trustee;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
to conform the text of the Indenture or the terms of the debt securities to any provision of this &ldquo;Description of Debt Securities&rdquo;
or other description of the debt securities contained in the applicable prospectus supplement relating to the offer and sale of such
debt securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
to establish the form or terms of the debt securities of any series as permitted by the terms of the Indenture;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
to provide for the assumption by a successor corporation, partnership, trust or limited liability company of our obligations under the
Indenture, in each case in compliance with the provisions thereof; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
to make any change that would provide any additional rights or benefits to the Holders of the debt securities (including to secure the
debt securities, add guarantees with respect thereto, to add to our covenants for the benefit of the Holders or to surrender any right
or power conferred upon us) or that does not adversely affect the legal rights under the Indenture of any Holder of the debt securities
in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
formulating its opinion on such matters, the Trustee will be entitled to rely on such evidence as it deems appropriate, including, without
limitation, solely on an opinion of counsel. Other modifications and amendments of the Indenture may be made with the consent of the
Holders of a majority in aggregate principal amount of all then-outstanding debt securities affected by such modification or amendment,
voting together as a single class, except that, without the consent of each Holder affected thereby, no amendment may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
reduce the aggregate principal amount of debt securities of any series at maturity whose Holders must consent to an amendment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
reduce the rate of or change or have the effect of changing the time for payment of interest, including defaulted interest, on any debt
securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
reduce the principal of or change or have the effect of changing the fixed maturity of any debt securities, or change the date on which
any debt securities may be subject to redemption or repurchase or reduce the redemption price therefor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
make any debt securities payable in currency other than that stated in the debt securities or change the place of payment of the debt
securities from that stated in the debt securities or in the Indenture;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
make any change in provisions of the Indenture protecting the right of each Holder to receive payment of principal of and interest on
such Holder&rsquo;s debt securities on or after the due date thereof or to bring suit to enforce such payment, or permitting Holders
of a majority in aggregate principal amount of each series of debt securities affected to waive defaults or Events of Default;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
make any change in these amendment and waiver provisions; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
make any change to or modify the ranking of the debt securities that would adversely affect the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Trustee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Indenture provides that, except during the continuance of an Event of Default, the Trustee will perform only such duties as are specifically
set forth in the Indenture. During the existence of an Event of Default, the Trustee will exercise such rights and powers vested in it
by the Indenture, and use the same degree of care and skill in their exercise, as a prudent person would exercise or use under the circumstances
in the conduct of its own affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Indenture and the provisions of the TIA contain certain limitations on the rights of the Trustee, should it become a creditor of us,
to obtain payments of claims in certain cases or to realize on certain property received in respect of any such claim as security or
otherwise. Subject to the TIA, the Trustee will be permitted to engage in other transactions; provided that if the Trustee acquires any
conflicting interest as described in the TIA, it must eliminate such conflict or resign.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unclaimed
Funds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
funds deposited with the Trustee or any paying agent for the payment of principal, interest, premium or additional amounts in respect
of the debt securities that remain unclaimed for two years after the date upon which such amount became due and payable will be repaid
to us upon our request. Thereafter, any right of any Holder to such funds shall be enforceable only against us, and the Trustee and paying
agents will have no liability therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Indenture and the debt securities for all purposes shall be governed by and construed in accordance with the laws of the State of New
York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="ma_006"></A>DESCRIPTION
OF WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue warrants for the purchase of shares of common stock or preferred stock or of debt securities in one or more series. We may
issue warrants independently or together with other securities and the warrants may be attached to or separate from any offered securities.
While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any
series of warrants in more detail in the applicable prospectus supplement. The terms of any warrants offered trust under a prospectus
supplement may differ from the terms described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports
that we file with the SEC, the form of warrant agreement, including a form of warrant certificate, that describes the terms of the particular
series of warrants we are offering before the issuance of the related series of warrants. The following summary of material provisions
of the warrants and the warrant agreements is subject to, and qualified in its entirety by reference to, all the provisions of the warrant
agreement and warrant certificate applicable to the particular series of warrants that we may offer under this prospectus. We urge you
to read the applicable prospectus supplements related to the particular series of warrants that we may offer under this prospectus and
the complete warrant agreements and warrant certificates that contain the terms of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will describe in the applicable prospectus supplement the terms of the series of warrants being offered, including, but not limited to,
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    offering price and aggregate number of warrants offered;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    currency for which the warrants may be purchased;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with
    each such security or each principal amount of such security;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock purchasable
    upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant
    and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    applicable, the date on and after which the warrants and the related securities will be separately transferable;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    terms of our rights to redeem the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dates on which the right to exercise the warrants will commence and expire;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    manner in which the warrant agreements and warrants may be modified;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    discussion of any material U.S. federal income tax consequences of holding or exercising the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    terms of the securities issuable upon exercise of the warrants; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other specific terms, preferences, rights or limitations of or restrictions on the warrants.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the warrants that we offer may or may not have the same material terms as our currently outstanding warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise,
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the case of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or, payments upon our liquidation,
    dissolution or winding up or to exercise voting rights, if any; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium, if any, or interest
    on, the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
warrant will entitle the holder to purchase the common stock, preferred stock and/or debt securities that we specify in the applicable
prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Holders of the warrants may exercise
the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After
such time on the expiration date, unexercised warrants will become void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the warrants may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with
specified information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable
prospectus supplement. We will set forth in the warrant certificate and in the applicable prospectus supplement the information that
the holder of the warrant will be required to deliver to the warrant agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
receipt of the required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the
warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable
upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new
warrant certificate for the remaining amount of warrants. Additional information about the exercise of the warrants will be specified
in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
we provide otherwise in the applicable prospectus supplement, the warrants and warrant agreements will be governed by and construed in
accordance with the laws of the State of Delaware and the federal laws of the United States applicable therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="ma_007"></A>DESCRIPTION
OF UNITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may, from time to time, issue units comprised of one or more of the other securities that may be offered under this prospectus, in any
combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus,
the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit
is issued will contain additional important terms and provisions of the units being offered, and may provide that the securities included
in the unit may not be held or transferred separately at any time, or at any time before a specified date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description, together with the additional information included in any applicable prospectus supplement, summarizes the general
features of the units that we may offer under this prospectus. You should read any applicable prospectus supplement and any free writing
prospectus we may authorize to be provided to you related to the series of units being offered, in addition to the complete unit agreements
that contain the terms of the units. Specific unit agreements will contain additional important terms and provisions, and we will file
as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we
file with the SEC, the form of each unit agreement relating to units offered under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
applicable prospectus supplement will describe:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    material terms of the units and of the securities comprising the units, including whether and under what circumstances those securities
    may be held or transferred separately;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    material provisions relating to the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising
    the units; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    material provisions of the governing unit agreement that differ from those described above.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="ma_008"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell the securities offered by this prospectus in any one or more of the following ways from time to time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    any national securities exchange or quotation service on which our securities may be listed at the time of sale, including the OTCQB;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directly
    to investors in privately negotiated transactions or through a specific bidding, auction, other process or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    investors through agents, or directly to agents;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    or through brokers or dealers, including through ordinary brokerage transactions and transactions in which the broker-dealer solicits
    purchasers and through purchases by a broker-dealer as a principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
    underwriters, broker-dealers, agents, in privately negotiated transactions or any combination of these methods;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the public through underwriting syndicates led by one or more managing underwriters;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    one or more underwriters acting alone for resale to investors or to the public;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
    short sales;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
    a combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
distribution of the securities may be effected from time to time, in one or more transactions, at a fixed price or prices, which may
be changed, at market prices prevailing at the time or sale or at prices related to such prevailing market prices, or at negotiated prices,
as determined at the time of sale, or at prices determined as the applicable prospectus supplement specifies. The securities may be sold
through a rights offering, forward contracts or similar arrangements. In any distribution of subscription rights to stockholders, if
all of the underlying securities are not subscribed for, we may then sell the unsubscribed securities directly to third parties or may
engage the services of one or more underwriters, dealers or agents, including standby underwriters, to sell the unsubscribed securities
to third parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
prospectus supplement will set forth the terms of the offering and the method of distribution and will identify any firms acting as underwriters,
dealers or agents in connection with the offering, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    name or names of any underwriters, dealers or agents;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    purchase price of the securities and the proceeds to us from the sale;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    arrangements under which the underwriters have the option to purchase additional securities from us;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    underwriting discounts and other items constituting compensation to underwriters, dealers or agents;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    public offering price;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    discounts or concessions allowed or reallowed or paid to dealers; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    securities exchange or market on which the securities offered by the prospectus supplement may be listed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
underwritten offering may be on a best efforts or a firm commitment basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities, underwriters, dealers or agents may be deemed to have received compensation from us in the
form of underwriting discounts or commissions and also may receive commissions from securities purchasers for whom they may act as agent.
Underwriters may sell the securities to or through dealers, and the dealers may receive compensation in the form of discounts, concessions
or commissions from the underwriters or commissions from the purchasers for whom they may act as agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide in the applicable prospectus supplement information regarding any underwriting discounts or other compensation that we pay
to underwriters or agents in connection with the securities offering, and any discounts, concessions or commissions that underwriters
allow to dealers. Underwriters, dealers and agents participating in the securities distribution may be deemed to be underwriters, and
any discounts and commissions they receive and any profit they realize on the resale of the securities may be deemed to be underwriting
discounts and commissions under the Securities Act. Underwriters and their controlling persons, dealers and agents may be entitled, under
agreements entered into with us, to indemnification against and contribution toward specific civil liabilities, including liabilities
under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no market for any of the offered securities other than the common stock, which is listed on the OTCQB. Any common stock
sold pursuant to a prospectus supplement will be listed on the OTCQB. It is possible that one or more underwriters may make a market
in the securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice.
No assurance can be given as to the liquidity of, or the trading market for, any offered securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with an offering, the underwriters may purchase and sell securities in the open market. These transactions may include short
sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters
of a greater number of securities than they are required to purchase in an offering. Stabilizing transactions consist of bids or purchases
made for the purpose of preventing or retarding a decline in the market price of the securities while an offering is in progress. The
underwriters also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting
discount received by it because the underwriters have repurchased securities sold by or for the account of that underwriter in stabilizing
or short-covering transactions. These activities by the underwriters may stabilize, maintain or otherwise affect the market price of
the securities. As a result, the price of the securities may be higher than the price that otherwise might exist in the open market.
If these activities are commenced, they may be discontinued by the underwriters at any time. Underwriters may engage in over-allotment.
If any underwriters create a short position in the securities in an offering in which they sell more securities than are set forth on
the cover page of the applicable prospectus supplement, the underwriters may reduce that short position by purchasing the securities
in the open market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also sell the securities offered by this prospectus in &ldquo;at the market offerings&rdquo; within the meaning of Rule 415(a)(4)
of the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise. In addition, we
may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately
negotiated transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties
may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so,
the third party may use securities pledged by us or others to settle those sales or to close out any related open borrowings of common
stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of our common
stock. In addition, we may loan or pledge securities to a financial institution or other third party that in turn may sell the securities
using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic
short position to investors in our securities or in connection with a concurrent offering of other securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters,
dealers or agents that participate in the offer of securities, or their affiliates or associates, may have engaged or engage in transactions
with and perform services for, us or our affiliates in the ordinary course of business for which they may have received or receive customary
fees and reimbursement of expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated in the applicable prospectus supplement, the legality of the issuance of the shares offered in this prospectus will
be passed upon for us by Jolie Kahn, Esq., New York, New York. If legal matters in connection with offerings made pursuant to this prospectus
are passed upon by counsel to underwriters, dealers or agents, such counsel will be named in the prospectus supplement related to such
offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="ma_009"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The audited financial statements
incorporated by reference in this prospectus and elsewhere in the registration statement have been so incorporated by reference in reliance
upon the report of Fahn Kanne &amp; Co, independent registered public accountants, upon the authority of said firm as experts in accounting
and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14. Other Expenses of Issuance and Distribution.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table itemizes the fees and expenses incurred, or expected to be incurred, by the registrant in connection with the registration
of the securities being registered, other than underwriting discounts and commissions. All amounts are estimates, except the SEC registration
fee. Estimated expenses only include information that is known at the time of filing this registration statement and are subject to future
contingencies, including additional expenses for future offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    registration fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">10,910</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,000</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
fees to be determined upon filing of prospectus supplements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
15. Indemnification of Directors and Officers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL empowers a Delaware corporation to indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than
an action by or in the right of such corporation) by reason of the fact that such person is or was a director, officer, employee or agent
of such corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation
or enterprise. A corporation may, in advance of the final action of any civil, criminal, administrative or investigative action, suit
or proceeding, pay the expenses (including attorneys&rsquo; fees) incurred by any officer, director, employee or agent in defending such
action, provided that the director or officer undertakes to repay such amount if it shall ultimately be determined that he or she is
not entitled to be indemnified by the corporation. A corporation may indemnify such person against expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action,
suit or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best
interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct
was unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Delaware corporation may indemnify officers and directors in an action by or in the right of the corporation to procure a judgment in
its favor under the same conditions, except that no indemnification is permitted without judicial approval if the officer or director
is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of
any action referred to above, the corporation must indemnify him or her against the expenses (including attorneys&rsquo; fees) which
he or she actually and reasonably incurred in connection therewith. The indemnification provided is not deemed to be exclusive of any
other rights to which an officer or director may be entitled under any corporation&rsquo;s by-law, agreement, vote or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that we will indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending
or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the
right of our company) by reason of the fact that he is or was a director, officer, employee or agent of ours, or is or was serving at
our request as a director, officer, employee, trustee or agent of one of our subsidiaries or another corporation, partnership, joint
venture, trust or other enterprise (all such persons being referred to hereinafter as an agent), against expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action,
suit or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to our best
interests, and with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
our bylaws provide that we will indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending
or completed action or suit by or in the right of our company to procure a judgment in our favor by reason of the fact that he is or
was an agent against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by him or her in connection with the
defense or settlement of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in
or not opposed to our best interests, except that no indemnification will be made in respect of any claim, issue or matter as to which
such person shall have been adjudged to be liable to us by a court of competent jurisdiction, after exhaustion of all appeals therefrom,
unless and only to the extent that the court in which such action or suit was brought shall determine upon application that, despite
the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity
for such expenses which such court shall deem proper.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 39; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation provides that none of its directors shall be liable to us or our stockholders for monetary damages for breach
of fiduciary duty as a director, except for liability (a) for any breach of the director&rsquo;s duty of loyalty to us or our stockholders,
(b) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (c) under Section
174 of the DGCL, or (d) for any transaction from which the director derived an improper personal benefit. To the extent the DGCL is amended
to authorize the further elimination or limitation of the liability of directors, then the liability of one of our directors, in addition
to the limitation on personal liability provided by our certificate of incorporation, shall be limited to the fullest extent permitted
by the amended DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have obtained and maintains insurance policies insuring our directors and officers and the directors and officers of our subsidiaries
against certain liabilities they may incur in their capacity as directors and officers. Under such policies, the insurer, on our behalf,
may also pay amounts for which we have granted indemnification to the directors or officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we have entered into indemnification agreements with all of our directors and officers to provide them with the maximum indemnification
allowed under our bylaws and applicable law, including indemnification for all judgments and expenses incurred as the result of any lawsuit
in which such person is named as a defendant by reason of being a director, officer or employee of our company, to the extent indemnification
is permitted by the laws of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us
pursuant to the foregoing provisions, we understand that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
16. Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.7in; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    Number</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Underwriting Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Placement Agent Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex3-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation, as amended</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1506983/000114420411048873/v232648_ex3-3.htm" STYLE="-sec-extract: exhibit">Bylaws</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Certificate of Designation for Preferred Stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
    +</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex4-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indenture.</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Debt Security.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Warrant Agreement with Form of Warrant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Unit Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
    +</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex5-1.htm">Opinion of Jolie Kahn, Esq.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1
    +</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex23-1.htm">Consent of Fahn Kanne &amp; Co.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2
    +</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex5-1.htm">Consent of Jolie Kahn, Esq. (included in opinion filed as Exhibit 5.1 hereto)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statement
    of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed, if necessary, by amendment, as an exhibit to a document to be incorporated by reference herein or as an exhibit to a current
    report on Form 8-K.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&rsquo;s Registration Statement on Form S-1, as filed with the SEC on August 22, 2011.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17. Undertakings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The undersigned registrant hereby undertakes as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering
range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the
&ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided,
however</I>, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission
by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in
the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the
date the filed prospectus was deemed part of and included in the registration statement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on
Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required
by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier
of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the
offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date
an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the
registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof. <I>Provided, however,</I> that no statement made in a registration statement or prospectus that is part of
the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:
the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold
to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant&rsquo;s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that
is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of
the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the
registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Exchange Act and
will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The undersigned registrant hereby undertakes that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed
as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant
to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time
it was declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to
act under subsection (a) of Section 310 of the Trust Indenture Act (the &ldquo;Act&rdquo;) in accordance with the rules and regulations
prescribed by the SEC under Section 305(b)(2) of the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Or Yehuda, Country of Israel on September 20, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTEGRITY
    APPLICATIONS, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jolie Kahn&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jolie
    Kahn</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer (Principal Executive and Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jolie Kahn</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    20, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jolie
    Kahn</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive and Financial Officer and Principal Accounting Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert Fischell</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    20, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Robert Fischell</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Allen Danzig</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    20, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allen
    Danzig</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Shimon Rapps</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    20, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shimon
    Rapps</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Andrew Sycoff</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    20, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Sycoff</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Paul V.Goode</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    20, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    V.Goode</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Luis Malave</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    20, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luis
    Malave</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>























</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 3.1</B></FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_001.jpg" ALT="" STYLE="height: 933px; width: 660px">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_002.jpg" ALT="" STYLE="height: 933px; width: 660px">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex3-1_003.jpg" ALT="" STYLE="height: 933px; width: 660px"></FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex3-1_004.jpg" ALT="" STYLE="height: 933px; width: 660px"></FONT></P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_005.jpg" ALT="" STYLE="height: 933px; width: 660px"></FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex3-1_006.jpg" ALT="" STYLE="height: 855px; width: 660px"></FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex3-1_007.jpg" ALT="" STYLE="height: 855px; width: 660px"></FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex3-1_008.jpg" ALT="" STYLE="height: 855px; width: 660px"></FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex3-1_009.jpg" ALT="" STYLE="height: 855px; width: 660px"></FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>

    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Indenture</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTEGRITY
APPLICATIONS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDENTURE
TRUSTEE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDENTURE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
as of ______, _____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.8in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    1.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Terms Defined; Rules of Construction</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forms
    Generally</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Trustee&rsquo;s Certification of Authentication</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    Unlimited; Issuable in Series</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authentication
    and Delivery of Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execution
    of Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.06.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Authentication</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.07.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denomination
    and Date of Securities; Payments of Interest</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.08.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration,
    Transfer and Exchange</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.09.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mutilated,
    Defaced, Destroyed, Lost and Stolen Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancellation
    of Securities; Destruction Thereof</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temporary
    Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authenticating
    Agent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
    Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2.14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP
    Numbers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenants
    of the Issuer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of Principal and Interest</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offices
    for Payments, etc</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paying
    Agents</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of the Issuer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports
    by the Issuer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    3.06.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existence</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remedies
    of the Trustee and Holders on Event of Default</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Event
    of Default; Acceleration of Maturity; Waiver of Default</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collection
    of Indebtedness by Trustee; Trustee May Prove Debt</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
    of Proceeds</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suits
    for Enforcement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restoration
    of Rights on Abandonment of Proceedings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.06.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations
    on Suits by Holder</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.07.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unconditional
    Right of Holders to Institute Certain Suits</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.08.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers
    and Remedies Cumulative; Delay or Omission Not Waiver of Default</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.09.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Control
    by Holders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver
    of Past Defaults</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee
    to Give Notice of Default, But May Withhold in Certain Circumstances</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    4.12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of Court to Require Filing of Undertaking to Pay Costs</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(continued)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.8in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concerning
    the Trustee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duties
    and Responsibilities of the Trustee; During Default; Prior to Default</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee&rsquo;s
    Obligations with Respect to the Covenants</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moneys
    Held by Trustee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports
    by the Trustee to Holders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Rights of the Trustee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.06.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee
    and Agents May Hold Securities; Collections, etc</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.07.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    and Indemnification of Trustee and Its Prior Claim</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.08.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of Trustee to Rely on Officer&rsquo;s Certificate, etc</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.09.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disqualification;
    Conflicting Interests</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
    Eligible for Appointment as Trustee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation
    and Removal; Appointment of Successor Trustee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acceptance
    of Appointment by Successor</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger,
    Conversion, Consolidation or Succession to Business of Trustee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferential
    Collection of Claims Against the Issuer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    5.15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee&rsquo;s
    Disclaimer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concerning
    the Holders</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evidence
    of Action Taken by Holders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof
    of Execution of Instruments and of Holding of Securities; Record Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
    to Be Treated as Owners</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
    Owned by Issuer Deemed Not Outstanding</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    6.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    of Revocation of Action Taken</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    7</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments,
    Supplements and Waivers</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
    Indentures without Consent of Holders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
    Indentures with Consent of Holders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execution
    of Amendments or Supplemental Indentures or Waivers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of Amendment, Supplemental Indenture or Waiver</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of Consent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.06.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notation
    on Securities in Respect of Amendments, Supplemental Indentures or Waivers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7.07.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conformity
    with the Trust Indenture Act</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidation,
    Merger, Sale or Conveyance</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidation,
    Merger or Sale of Assets by the Issuer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    8.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successor
    Substituted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(continued)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.8in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defeasance
    and Discharge; Unclaimed Moneys</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Satisfaction
    and Discharge of Indenture</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    Defeasance</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenant
    Defeasance</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
    by Trustee of Funds Deposited for Payment of Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    of Moneys Held by Paying Agent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    9.06.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Return
    of Moneys Held by Trustee and Paying Agent Unclaimed for Two Years</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous
    Provisions</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporators,
    Stockholders, Employees, Officers and Directors of Issuer Exempt from Individual Liability</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
    of Indenture for the Sole Benefit of Parties and Holders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successors
    and Assigns of Issuer Bound by Indenture</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices
    and Demands on Issuer, Trustee and Holders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer&rsquo;s
    Certificates and Opinions of Counsel; Statements to Be Contained Therein</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.06.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
    Due on Saturdays, Sundays and Holidays</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.07.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trust
    Indenture Act of 1939</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.08.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York Law to Govern</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.09.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of Headings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10.11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separability</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
    11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
    of Securities and Sinking Fund Provisions</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.01.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicability
    of Article</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.02.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of Redemption; Partial Redemptions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.03.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of Securities Called for Redemption</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.04.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusion
    of Certain Securities from Eligibility for Selection for Redemption</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    11.05.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mandatory
    and Optional Sinking Funds</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
INDENTURE, dated as of [&nbsp;&nbsp;] between INTEGRITY APPLICATIONS, INC., a Delaware corporation (the &ldquo;<B>Issuer</B>&rdquo;), and [&nbsp;&nbsp;], a
national banking association (the &ldquo;<B>Trustee</B>&rdquo;),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>W
I T N E S S E T H:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
for its lawful corporate purposes, the Issuer has duly authorized the execution and delivery of the Indenture to provide for the issuance
of unsecured debt securities in one or more series (the &ldquo;<B>Securities</B>&rdquo;) up to such principal amount or amounts as may
from time to time be authorized in accordance with the terms of the Indenture and to provide, among other things, for the authentication,
delivery and administration thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
all things necessary to make the Indenture a valid indenture and agreement according to its terms have been done;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Indenture is subject to, and will be governed by, the provisions of the Trust Indenture Act of 1939 (the &ldquo;<B>Trust Indenture
Act</B>&rdquo;) that are required to be a part of and govern indentures qualified under the Trust Indenture Act; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the premises and the purchases of the Securities by the holders thereof, the Issuer and the Trustee mutually
covenant and agree for the equal and proportionate benefit of the respective holders from time to time of the Securities as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
1</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Definitions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.01. <I>Certain Terms Defined; Rules of Construction. </I>The following terms (except as otherwise expressly provided or unless the
context otherwise clearly requires) for all purposes of the Indenture and of any indenture supplemental hereto shall have the respective
meanings specified in this Section. All other terms used in the Indenture that are defined in the Trust Indenture Act, or the definitions
of which are referred to in the Trust Indenture Act, including terms defined therein by reference to the Securities Act (except as herein
otherwise expressly provided or unless the context otherwise clearly requires), shall have the meanings assigned to such terms in the
Trust Indenture Act and in the Securities Act as in force at the date of the Indenture. All accounting terms used herein and not expressly
defined shall have the meanings assigned to such terms in accordance with generally accepted accounting principles, and the term &ldquo;<B>generally
accepted accounting principles</B>&rdquo; means such accounting principles as are generally accepted at the time of any computation.
The word &ldquo;<B>principal</B>&rdquo; whenever used with reference to the Securities or any Security or any portion thereof, shall
be deemed to include &ldquo;and premium, if any&rdquo;. The words &ldquo;<B>herein</B>&rdquo;, &ldquo;<B>hereof</B>&rdquo; and &ldquo;<B>hereunder</B>&rdquo;
and other words of similar import refer to the Indenture as a whole and not to any particular Article, Section or other subdivision.
The terms defined in this Article have the meanings assigned to them in this Article and include the plural as well as the singular.
Except as otherwise expressly provided or unless the context otherwise clearly requires, references to agreements or instruments, or
to statutes or regulations, are to such agreements or instruments, or statutes or regulations, as amended from time to time (or to successor
statutes and regulations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Agent
Member</B>&rdquo; means a member of, or a participant in, the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Authenticating
Agent</B>&rdquo; means an authenticating agent with respect to any of the series of Securities appointed with respect to all or any series
of the Securities by the Trustee pursuant to Section 2.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bankruptcy
Law</B>&rdquo; means Title 11 of the United States Code or any similar Federal or State law for the relief of debtors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board
of Directors</B>&rdquo; means either the Board of Directors of the Issuer or any committee of such Board duly authorized to act hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means, with respect to any Security, a day that in the Borough of Manhattan, City of New York is not a day on which banking
institutions are authorized by law or regulation to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Capital
Stock</B>&rdquo; means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
with respect to any Person that is a corporation, any and all shares, interests, participations or other equivalents (however designated
and whether or not voting) of corporate stock, including each class of Common Stock and Preferred Stock of such Person, and all options,
warrants or other rights to purchase or acquire any of the foregoing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
with respect to any Person that is not a corporation, any and all partnership, membership or other equity interests of such Person, and
all options, warrants or other rights to purchase or acquire any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commission</B>&rdquo;
means the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or if at any time after
the execution and delivery of the Indenture such Commission is not existing and performing the duties now assigned to it under the Trust
Indenture Act, then the body performing such duties on such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock</B>&rdquo; of any Person means any and all shares, interests or other participations in, and other equivalents (however designated
and whether voting or non-voting) of, such Person&rsquo;s common stock, whether outstanding on the Issue Date or issued after the Issue
Date, and includes, without limitation, all series and classes of such common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>company</B>&rdquo;
means a corporation or a limited liability company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Corporate
Trust Office</B>&rdquo; means the office of the Trustee (i) for bond transfer purposes and for purposes of presentment and surrender
of the Securities for the final distributions thereon is [&nbsp;&nbsp;], [&nbsp;&nbsp;], Attention: [&nbsp;&nbsp;], and (ii) for all other purposes is [&nbsp;&nbsp;], [&nbsp;&nbsp;], Attention:
[&nbsp;&nbsp;].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Depositary</B>&rdquo;
means, with respect to Securities of any series, for which the Issuer shall determine that such Securities will be issued as a Global
Security, the Depository Trust Company, New York, New York, another clearing agency, or any successor registered as a clearing agency
under the Exchange Act, or other applicable statute or regulation, which, in each case, shall be designated by the Issuer pursuant to
either Section 2.01 or Section 2.13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Event
of Default</B>&rdquo; has the meaning assigned to such term in Section 4.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934 and any successor thereto, in each case as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Global
Security</B>&rdquo; means, with respect to any series of Securities, a Security executed by the Issuer and delivered by the Trustee to
the Depositary or pursuant to a safekeeping agreement with the Depositary, all in accordance with the Indenture, which shall be registered
in global form without interest coupons in the name of the Depositary or its nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
Obligations</B>&rdquo; means securities that are (i) direct obligations of the United States of America for the payment of which its
full faith and credit is pledged or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality
of the United States of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United
States of America that, in either case, are not callable or redeemable at the option of the issuer thereof, and shall also include a
depositary receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act) as custodian with respect to any such Governmental
Obligation or a specific payment of principal of or interest on any such Governmental Obligation held by such custodian for the account
of the holder of such depositary receipt; <U>provided however,</U> that (except as required by law) such custodian is not authorized
to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect
of the Governmental Obligation or the specific payment of principal of or interest on the Governmental Obligation evidenced by such depositary
receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Holder</B>&rdquo;
means the registered holder of any Security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Holding
Company Reorganization</B>&rdquo; shall mean a merger of the Issuer with and into a newly formed wholly-owned, indirect Subsidiary (&ldquo;<B>MergerCo</B>&rdquo;)
of the Issuer, all of the equity interest of which shall be held by a newly formed, wholly-owned, direct Subsidiary of the Issuer (&ldquo;<B>New
HoldCo</B>&rdquo;). Such merger shall be effected pursuant to Section 251(g) of the General Corporation Law of the State of Delaware
(or comparable provisions of the laws of the Issuer&rsquo;s state of incorporation) and shall not require the vote of the Issuer&rsquo;s
stockholders. Each share of Common Stock of the Issuer shall be converted in such merger into a right to receive one share of the Common
Stock of New HoldCo, with identical terms and rights as the Issuer&rsquo;s Common Stock immediately prior to such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indebtedness</B>&rdquo;
means with respect to any Person, without duplication:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
all obligations of such person for borrowed money; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
all obligations of such person evidenced by bonds, debentures, notes or other similar instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indenture</B>&rdquo;
means this instrument as originally executed and delivered or, if amended or supplemented as herein provided, as so amended or supplemented
or both, and shall include the forms and terms of particular series of Securities established as contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Interest
Payment Date</B>&rdquo;, when used with respect to any installment of interest on a Security of a particular series, means the date specified
in such Security or in a Resolution of the Board of Directors or in an indenture supplemental hereto with respect to such series as the
fixed date on which an installment of interest with respect to Securities of that series is due and payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issue
Date</B>&rdquo; means the date of original issuance of Securities of any series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer</B>&rdquo;
means the Person named as the &ldquo;Issuer&rdquo; in the first paragraph of this instrument until a successor Person shall have become
such pursuant to the applicable provisions of this Indenture, and thereafter &ldquo;<B>Issuer</B>&rdquo; shall mean such successor Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
Order</B>&rdquo; has the meaning assigned to such term in Section 2.04.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Lien</B>&rdquo;
means any lien, mortgage, deed of trust, hypothecation, pledge, security interest, charge or encumbrance of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Officer</B>&rdquo;
means the Chairman of the Board, the Chief Executive Officer, the Chief Financial Officer, the Chief Accounting Officer, the Chief Legal
Officer, the Chief Administrative Officer, any President, any Vice President, the Controller, the Secretary or any Assistant Secretary,
of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Officer&rsquo;s
Certificate</B>&rdquo; means a certificate signed on behalf of the Issuer by an Officer of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Opinion
of Counsel</B>&rdquo; means an opinion in writing signed by legal counsel who may be an employee of or counsel to the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Original
Issue Discount Security</B>&rdquo; means any Security that provides for an amount less than the principal amount thereof to be due and
payable upon a declaration of acceleration of the maturity thereof pursuant to Section 4.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Outstanding</B>&rdquo;,
when used with reference to Securities, shall, subject to the provisions of Section 6.04, mean, as of any particular time, all Securities
authenticated and delivered by the Trustee under the Indenture, except:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Securities cancelled by the Trustee or accepted by the Trustee for cancellation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Securities, or portions thereof, for the payment or redemption of which moneys in the necessary amount to pay all amounts then due shall
have been deposited in trust with the Trustee or with any paying agent (other than the Issuer) or shall have been set aside, segregated
and held in trust by the Issuer for the holders of such Securities (if the Issuer shall act as its own paying agent), <U>provided</U>
that if such Securities, or portions thereof, are to be redeemed prior to the maturity thereof, notice of such redemption shall have
been given as herein provided, or provision satisfactory to the Trustee shall have been made for giving such notice; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Securities in substitution for which other Securities shall have been authenticated and delivered, or which shall have been paid, pursuant
to the terms of Section 2.09 unless and until the Trustee and the Issuer receive proof satisfactory to them that the substituted Security
is held by a <I>bona fide </I>purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining whether the holders of the requisite principal amount of Outstanding Securities of any or all series have given any request,
demand, authorization, direction, notice, consent or waiver hereunder, the principal amount of an Original Issue Discount Security that
shall be Outstanding for such purposes shall be the amount of the principal thereof that would be due and payable as of the date of such
determination upon a declaration of acceleration of the maturity thereof pursuant to Section 4.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means any individual, corporation, limited liability company, partnership, joint venture, association, joint stock company, trust, unincorporated
organization, or any other entity, including any government or any agency or political subdivision thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Preferred
Stock</B>&rdquo; of any Person means any Capital Stock of such Person that has preferential rights to any other Capital Stock of such
Person with respect to dividends or redemptions or upon liquidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Register</B>&rdquo;
has the meaning assigned to it in Section 2.08.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registrar</B>&rdquo;
means a Person engaged to maintain the Register.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Resolution
of the Board of Directors</B>&rdquo; means a copy of the resolution certified by the secretary or an assistant secretary of the Issuer
to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Responsible
Officer</B>&rdquo; when used with respect to the Trustee means any officer of the Trustee within the Corporate Trust Office of the Trustee
with direct responsibility for the administration of the Indenture and also, with respect to a particular matter, any other officer of
the Trustee to whom such matter is referred because of such officer&rsquo;s knowledge and familiarity with the particular subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933 and any statute successor thereto, in each case as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Security</B>&rdquo;
or &ldquo;<B>Securities</B>&rdquo; has the meaning stated in the first recital of the Indenture, or, as the case may be, Securities that
have been authenticated and delivered under the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Significant
Subsidiary</B>&rdquo;, with respect to any Person, means any Subsidiary of such Person that satisfies the criteria for a &ldquo;significant
subsidiary&rdquo; as set forth in Rule 1-02(w) of Regulation S-X under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo;
means any corporation, limited liability company, limited partnership or other similar type of business entity in which the Issuer and/or
one or more of its Subsidiaries together own more than 50% of the total voting power of shares of Capital Stock entitled (without regard
to the occurrence of any contingency) to vote in the election of the Board of Directors or similar governing body of such corporation,
limited liability company, limited partnership or other similar type of business entity, directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trustee</B>&rdquo;
means the Person identified as &ldquo;Trustee&rdquo; in the first paragraph hereof and any successor trustee under the Indenture pursuant
to Article 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trust
Indenture Act</B>&rdquo; means the Trust Indenture Act of 1939 and any statute successor thereto, in each case as amended from time to
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>vice
president</B>&rdquo; when used with respect to the Issuer, means any vice president, whether or not designated by a number or a word
or words added before or after the title of &ldquo;vice president&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Yield
to Maturity</B>&rdquo; means the yield to maturity on a series of securities, calculated at the time of issuance of such series, or,
if applicable, at the most recent redetermination of interest on such series, and calculated in accordance with accepted financial practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
2</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.01. <I>Forms Generally. </I>The Securities of each series shall be substantially in such form as shall be established by or pursuant
to a Resolution of the Board of Directors and set forth in an Officer&rsquo;s Certificate, or in one or more indentures supplemental
hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by
the Indenture and may have imprinted or otherwise reproduced thereon such legends, notations or endorsements as may be required to comply
with any law or with any rules or regulations pursuant thereto, or with any rules of any securities exchange or to conform to general
usage, all as may be determined by the officer executing such Securities, as evidenced by such officer&rsquo;s execution of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
definitive Securities shall be printed, lithographed or engraved on steel engraved borders or may be produced in any other manner, all
as determined by the officer executing such Securities, as evidenced by such officer&rsquo;s execution of such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.02. <I>Form of Trustee&rsquo;s Certification of Authentication. </I>The Trustee&rsquo;s certificate of authentication on all Securities
shall be in substantially the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is one of the Securities of the series designated herein and referred to in the within-mentioned Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;],</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    Trustee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.03. <I>Amount Unlimited; Issuable in Series. </I>Subject to compliance with the representations, warranties and covenants set forth
herein, in an Officer&rsquo;s Certificate, in any indenture supplemental hereto and in any amendment hereto or thereto, the aggregate
principal amount of Securities which may be authenticated and delivered under the Indenture is unlimited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities may be issued in one or more series. There shall be established in or pursuant to a Resolution of the Board of Directors and
set forth in an Officer&rsquo;s Certificate, or established in one or more indentures supplemental hereto, prior to the issuance of Securities
of any series:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the title of the Securities of the series (which shall distinguish the Securities of the series from all other Securities);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any limit upon the aggregate principal amount of the Securities of the series that may be authenticated and delivered under the Indenture
(except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities
of the series pursuant to Section 2.08, 2.09 or 2.11);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
the date or dates on which the principal of the Securities of the series is payable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
the rate or rates (which may be fixed or variable) at which the Securities of the series shall bear interest, if any, or the method by
which such rate shall be determined (including, but not limited to, any commodity, commodity index, stock exchange index or financial
index), the date or dates from which such interest shall accrue, the Interest Payment Dates on which such interest shall be payable and
the record dates for the determination of Holders to whom interest is payable on such Interest Payment Dates;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
the right, if any, to extend the interest payment periods and the duration of such extension;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
the place or places where the principal of and any interest on Securities of the series shall be payable (if other than as provided in
Section 3.02);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
the price or prices at which, the period or periods within which and the terms and conditions upon which Securities of the series may
be redeemed, in whole or in part, at the option of the Issuer, pursuant to any sinking fund or otherwise;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
the obligation, if any, of the Issuer to redeem, purchase or repay Securities of the series pursuant to any sinking fund or otherwise
or at the option of a Holder thereof and the price or prices at which and the period or periods within which and the terms and conditions
upon which Securities of the series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
if other than denominations of $2,000 and any multiple of $1,000 in excess thereof, the denominations in which Securities of the series
shall be issuable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
the percentage of the principal amount at which the Securities will be issued, and, if other than the principal amount thereof, the portion
of the principal amount of Securities of the series which shall be payable upon declaration of acceleration of the maturity thereof pursuant
to Section 4.01 or provable in bankruptcy pursuant to Section 4.02;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
whether the Securities are issuable under Rule 144A, Regulation S and/or any exemption from registration under the Securities Act and,
in such case, any provisions unique to such form of issuance including any transfer restrictions or exchange and registration rights;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
whether the Securities are issuable as a Global Security and, in such case, the identity for the depositary for such series, if other
than the Depositary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
any deletion from, modification of or addition to the Events of Default or covenants provided for with respect to the Securities of the
series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
any provisions granting special rights to holders when a specified event occurs;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
whether and under what circumstances the Issuer will pay additional amounts on the Securities of the series held by a person who is not
a U.S. person in respect of any tax, assessment or governmental charge withheld or deducted and, if so, whether the Issuer will have
the option to redeem the securities of the series rather than pay such additional amounts;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
any special tax implications of the notes, including provisions for Original Issue Discount Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
any trustees, authenticating or paying agents, transfer agents or registrars or any other agents with respect to the Securities of such
series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
any guarantor or co-issuer of the Securities of the series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
any special interest premium or other premium;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
whether the Securities are convertible or exchangeable into common stock or other equity securities of the Issuer or a combination thereof
and the terms and conditions upon which such conversion or exchange shall be effected;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
the currency in which payments shall be made, if other than U.S. dollars; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
any and all other terms of the Securities of any series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Securities of any one series shall be substantially identical except as to denomination and except as may otherwise be provided in or
pursuant to such Resolution of the Board of Directors and set forth in an Officer&rsquo;s Certificate, or in any indenture supplemental
hereto. All Securities of any one series need not be issued at the same time, and unless otherwise provided, a series may be reopened
for issuance of additional Securities of such series. Additional Securities of such series will be consolidated with, and form a single
series with, Securities then Outstanding of such series; provided, however, that if such additional Securities of such series are not
fungible with the Securities of such series for U.S. federal income tax purposes, the additional Securities of such series will have
a separate CUSIP number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
additional Securities shall be established in or pursuant to a Resolution of the Board of Directors and set forth in an Officer&rsquo;s
Certificate, or established in one or more indentures supplemental hereto, prior to the issuance of Securities of any series the following
information:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the aggregate principal amount of such additional Securities to be authenticated and delivered pursuant to the Indenture</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the issue price, issue date and CUSIP number, if any, of such additional Securities; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
whether such additional Securities shall be transfer restricted Securities or have any registration or exchange rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.04. <I>Authentication and Delivery of Securities. </I>At any time and from time to time after the execution and delivery of the Indenture,
the Issuer may deliver Securities of any series executed by the Issuer to the Trustee for authentication, together with a written order
of the Issuer, signed in the name of the Issuer by its Chairman of the Board, its President, any Vice President, its Controller, its
Secretary or any Assistant Secretary, and delivered to the Trustee (an &ldquo;<B>Issuer Order</B>&rdquo;). The Trustee, in accordance
with such written order, shall authenticate and deliver such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
authenticating such Securities and accepting the additional responsibilities under the Indenture in relation to such Securities, the
Trustee shall be entitled to receive and (subject to Section 5.01) shall be fully protected in relying upon:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
a certified copy of any resolution or resolutions of the Board of Directors authorizing the action taken pursuant to the resolution or
resolutions delivered under clause 2.04(b) below;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
a copy of any resolution or resolutions of the Board of Directors relating to such series, in each case certified by the secretary or
an assistant secretary of the Issuer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
an executed supplemental indenture, if any;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
in lieu of a supplemental indenture, an Officer&rsquo;s Certificate setting forth the form and terms of the Securities as required pursuant
to Section 2.01 and 2.03, respectively, and prepared in accordance with Section 10.05;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
an Opinion of Counsel, prepared in accordance with Section 10.05, to the effect that</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the form or forms and terms of such Securities have been established by or pursuant to a Resolution of the Board of Directors and set
forth in an Officer&rsquo;s Certificate, or by a supplemental indenture as permitted by Section 2.01 and 2.03 in conformity with the
provisions of the Indenture; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Securities, when authenticated and delivered by the Trustee and issued by the Issuer in the manner and subject to any conditions
specified in such Opinion of Counsel, will constitute valid and binding obligations of the Issuer entitled to the benefits of the Indenture,
and enforceable against the Issuer in accordance with their terms, except to the extent that enforcement thereof may be limited by bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance or similar laws now or hereafter in effect relating to creditor&rsquo;s
rights generally, and general principles of equity (regardless of whether enforceability is considered in a proceeding in equity or at
law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee shall have the right to decline to authenticate and deliver any Securities under this section if the Trustee, being advised by
counsel, determines that such action may not lawfully be taken by the Issuer or if the Trustee in good faith by its board of directors
or board of trustees, executive committee, or a trust committee of directors or trustees or Responsible Officers shall determine that
such action would expose the Trustee to personal liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.05. <I>Execution of Securities. </I>The Securities shall be signed in the name of the Issuer by any one of the following officers:
the chairman of the Board of Directors, the chief executive officer, the chief financial officer, any president, any executive vice president,
the treasurer or the secretary of the Issuer. Such signature may be the manual or facsimile signature of the present or any future such
officer. Typographical and other minor errors or defects in any such signature shall not affect the validity or enforceability of any
Security that has been duly authenticated and delivered by the Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case any officer of the Issuer who shall have signed any of the Securities shall cease to be such officer before the Security so signed
shall be authenticated and delivered by the Trustee or disposed of by the Issuer, such Security nevertheless may be authenticated and
delivered or disposed of as though the person who signed such Security had not ceased to be such officer of the Issuer; and any Security
may be signed on behalf of the Issuer by such person as, at the actual date of the execution of such Security, shall be the proper officer
of the Issuer, although at the date of the execution and delivery of the Indenture any such person was not such an officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.06. <I>Certificate of Authentication. </I>Only such Securities as shall bear thereon a certificate of authentication substantially
in the form set forth herein, executed by the Trustee by the manual signature of one of its authorized officers, shall be entitled to
the benefits of the Indenture. Such certificate by the Trustee upon any Security executed by the Issuer shall be conclusive evidence
that the Security so authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to the benefits
of the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.07. <I>Denomination and Date of Securities; Payments of Interest. </I>The Securities shall be issuable as registered securities without
coupons and in denominations as shall be specified as contemplated by Section 2.03. In the absence of any such specification with respect
to the Securities of any series, the Securities of such series shall be issuable in denominations of $2,000 and any multiple of $1,000
in excess thereof. The Securities shall be numbered, lettered, or otherwise distinguished in such manner or in accordance with such plan
as the officer of the Issuer executing the same may determine with the approval of the Trustee as evidenced by the execution and authentication
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the absence of any such specification with respect to the Securities of any series, the principal of and the interest on the Securities
of such series, shall be payable in the coin or currency of the United States of America that at the time is legal tender for public
and private debt, at the office or agency of the Issuer maintained for that purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Security shall be dated the date of its authentication, shall bear interest, if any, from the date and shall be payable on the dates,
in each case, established as contemplated by Section 2.03.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
person in whose name any Security of any series is registered at the close of business on any record date applicable to a particular
series with respect to any interest payment date for such series shall be entitled to receive the interest, if any, payable on such interest
payment date notwithstanding any transfer or exchange of such Security subsequent to the record date and prior to such interest payment
date, except if and to the extent the Issuer shall default in the payment of the interest due on such interest payment date for such
series, in which case such defaulted interest shall be paid to the persons in whose names Outstanding Securities for such series are
registered at the close of business on a subsequent record date (which shall be not less than five Business Days prior to the date of
payment of such defaulted interest) established by notice given by mail by or on behalf of the Issuer to the Holders not less than 15
days preceding such subsequent record date. The term &ldquo;<B>record date</B>&rdquo; as used with respect to any interest payment date
(except a date for payment of defaulted interest) shall mean the date specified as such in the terms of the Securities of any particular
series, or, if no such date is so specified, if such interest payment date is the first day of a calendar month, the fifteenth day of
the next preceding calendar month or, if such interest payment date is the fifteenth day of a calendar month, the first day of such calendar
month, whether or not such record date is a Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.08. <I>Registration, Transfer and Exchange. </I>The Issuer may appoint one or more Registrars. The Issuer initially appoints the Trustee
as Registrar. The Issuer will keep or cause to be kept at each office or agency to be maintained for the purpose as provided in Section
3.02 a register or registers (the &ldquo;<B>Register</B>&rdquo;) in which, subject to such reasonable regulations as it may prescribe,
it will register, and will register the transfer of, Securities as in this Article provided. The Register shall be in written form in
the English language or in any other form capable of being converted into such form within a reasonable time. At all reasonable times
the Register shall be open for inspection by the Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
due presentation for registration of transfer of any Security of any series at any such office or agency to be maintained for the purpose
as provided in Section 3.02, the Issuer shall execute and the Trustee shall authenticate and deliver in the name of the transferee or
transferees a new Security or Securities of the same series in authorized denominations for a like aggregate principal amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
Security or Securities of any series may be exchanged for a Security or Securities of the same series in other authorized denominations,
in an equal aggregate principal amount. Securities of any series to be exchanged shall be surrendered at any office or agency to be maintained
by the Issuer for the purpose as provided in Section 3.02, and the Issuer shall execute and the Trustee shall authenticate and deliver
in exchange therefor the Security or Securities of the same series which the Holder making the exchange shall be entitled to receive,
bearing numbers not contemporaneously Outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Securities presented for registration of transfer, exchange, redemption or payment shall (if so required by the Issuer or the Trustee)
be duly endorsed by, or be accompanied by a written instrument or instruments of transfer in form satisfactory to the Issuer and the
Trustee duly executed by, the holder or his attorney duly authorized in writing, together with signature guarantees for such holder or
attorney.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer or the Trustee may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection
with any exchange or registration of transfer of Securities. No service charge shall be made for any such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer nor the Trustee shall be required to exchange or register a transfer of (a) any Securities of any series for a period of 15
days preceding the first mailing of notice of redemption of Securities of such series to be redeemed, or (b) any Securities selected,
called or being called for redemption except, in the case of any Security where public notice has been given that such Security is to
be redeemed in part, the portion thereof not so to be redeemed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the transfer requirements provided in this Section 2.08, any Security or Securities will be subject to such further transfer
restrictions as may be contained in an Officer&rsquo;s Certificate or indenture supplemental hereto applicable to such series of Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Securities issued upon any transfer or exchange of Securities shall be valid obligations of the Issuer, evidencing the same debt, and
entitled to the same benefits under the Indenture, as the Securities surrendered upon such transfer or exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.09. <I>Mutilated, Defaced, Destroyed, Lost and Stolen Securities. </I>In case any temporary or definitive Security shall become mutilated,
defaced or be destroyed, lost or stolen, the Issuer in its discretion may execute, and upon the receipt of an Issuer Order, the Trustee
shall authenticate and deliver, a new Security of the same series, bearing a number not contemporaneously Outstanding, in exchange and
substitution for the mutilated or defaced Security, or in lieu of and substitution for the Security so destroyed, lost or stolen. In
every case the applicant for a substitute Security shall furnish to the Issuer and to the Trustee and any agent of the Issuer or the
Trustee such security or indemnity as may be required by them to indemnify and defend and to save each of them harmless and, in every
case of destruction, loss or theft, evidence to their satisfaction of the destruction, loss or theft of such Security and of the ownership
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the issuance of any substitute Security, the Issuer or the Trustee may require the payment of a sum sufficient to cover any tax or other
governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected
therewith. In case any Security which has matured or is about to mature or has been called for redemption in full shall become mutilated
or defaced or be destroyed, lost or stolen, the Issuer may instead of issuing a substitute Security, pay or authorize the payment of
the same (without surrender thereof except in the case of a mutilated or defaced Security), if the applicant for such payment shall furnish
to the Issuer and to the Trustee and any agent of the Issuer or the Trustee such security or indemnity as any of them may require to
save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Issuer and the
Trustee and any agent of the Issuer or the Trustee evidence to their satisfaction of the destruction, loss or theft of such Security
and of the ownership thereof. In case the mutilated, deleted, destroyed, or lost or stolen Security has become or is about to become
due and payable, the Issuer in its discretion may pay the Security instead of issuing a substitute Security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
substitute Security of any series issued pursuant to the provisions of this section by virtue of the fact that any such Security is destroyed,
lost or stolen shall constitute an additional contractual obligation of the Issuer, whether or not the destroyed, lost or stolen Security
shall be at any time enforceable by anyone and shall be entitled to all the benefits of (but shall be subject to all the limitations
of rights set forth in) the Indenture equally and proportionately with any and all other Securities of such series duly authenticated
and delivered hereunder. All Securities shall be held and owned upon the express condition that, to the extent permitted by law, the
foregoing provisions are exclusive with respect to the replacement or payment of mutilated, defaced or destroyed, lost or stolen Securities
and shall preclude any and all other rights or remedies notwithstanding any law or statute existing or hereafter enacted to the contrary
with respect to the replacement or payment of negotiable instruments or other securities without their surrender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.10. <I>Cancellation of Securities; Destruction Thereof. </I>All Securities surrendered for payment, redemption, registration of transfer
or exchange, or for credit against any payment in respect of a sinking or analogous fund, if surrendered to the Issuer or any agent of
the Issuer or the Trustee, shall be delivered to the Trustee for cancellation or, if surrendered to the Trustee, shall be cancelled by
it; and no Securities shall be issued in lieu thereof except as expressly permitted by any of the provisions of the Indenture. On written
request of the Issuer at the time of such surrender, the Trustee shall deliver to the Issuer the Securities cancelled by the Trustee.
In the absence of such request, the Trustee shall cancel Securities held by it in accordance with its customary procedures and deliver
a certificate of destruction to the Issuer. If the Issuer shall acquire any of the Securities, such acquisition shall not operate as
a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered to the Trustee
for cancellation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.11. <I>Temporary Securities. </I>Pending the preparation of definitive Securities for any series, the Issuer may execute and the Trustee
shall, upon receipt of an Issuer Order, authenticate and deliver temporary Securities for such series (printed, lithographed, typewritten
or otherwise reproduced, in each case in form satisfactory to the Trustee). Temporary Securities of any series shall be issuable as registered
Securities without coupons, of any authorized denomination, and substantially in the form of the definitive Securities of such series
but with such omissions, insertions and variations as may be appropriate for temporary Securities, all as may be determined by the Issuer
with the concurrence of the Trustee. Temporary Securities may contain such reference to any provisions of the Indenture as may be appropriate.
Every temporary Security shall be executed by the Issuer and be authenticated by the Trustee upon the same conditions and in substantially
the same manner, and with like effect, as the definitive Securities. Without unreasonable delay the Issuer shall execute and shall furnish
definitive Securities of such series and thereupon temporary Securities of such series may be surrendered in exchange therefor without
charge at each office or agency to be maintained by the Issuer for that purpose pursuant to Section 3.02, and the Trustee shall, upon
receipt of an Issuer Order, authenticate and deliver in exchange for such temporary Securities of such series a like aggregate principal
amount of definitive Securities of the same series of authorized denominations. Until so exchanged, the temporary Securities of any series
shall be entitled to the same benefits under the Indenture as definitive Securities of such series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.12. <I>Authenticating Agent</I>. So long as any of the Securities of any series remain Outstanding there may be an Authenticating Agent
for any or all such series of Securities which the Trustee shall have the right to appoint. Said Authenticating Agent shall be authorized
to act on behalf of the Trustee to authenticate Securities of such series issued upon exchange, transfer or partial redemption thereof,
and Securities so authenticated shall be entitled to the benefits of the Indenture and shall be valid and binding for all purposes as
if authenticated by the Trustee hereunder. All references in the Indenture to the authentication of Securities by the Trustee shall be
deemed to include authentication by an Authenticating Agent for such series. Each Authenticating Agent shall be acceptable to the Issuer
and shall be a corporation that has a combined capital and surplus, as most recently reported or determined by it, sufficient under the
laws of any jurisdiction under which it is organized or in which it is doing business to conduct a trust business, and that is otherwise
authorized under such laws to conduct such business and is subject to supervision or examination by Federal or State authorities. If
at any time any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately. Any
Authenticating Agent may at any time resign by giving written notice of resignation to the Trustee and to the Issuer. The Trustee may
at any time (and upon written request by the Issuer shall) terminate the agency of any Authenticating Agent by giving written notice
of termination to such Authenticating Agent and to the Issuer. Upon resignation, termination or cessation of eligibility of any Authenticating
Agent, the Trustee may appoint an eligible successor Authenticating Agent acceptable to the Issuer. Any successor Authenticating Agent,
upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder
as if originally named as an Authenticating Agent pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.13. <I>Global Securities. </I>If the Issuer shall establish pursuant to Section 2.01 that the Securities of a particular series are
to be issued as a Global Security, then the Issuer shall execute and the Trustee shall, in accordance with Section 2.04, authenticate
and deliver, a Global Security that shall (i) represent, and be issued in a denomination or aggregate denominations equal to the aggregate
principal amount of all the Securities to be represented by a Global Security, (ii) be registered in the name of the Depositary or its
nominee, (iii) be delivered by the Trustee to the Depositary or pursuant to the Depositary&rsquo;s instruction and (iv) bear a legend
substantially to the following effect: &ldquo;Except as otherwise provided in Section 2.13 of the Indenture, this Security may be transferred,
in whole but not in part, only to another nominee of the Depositary or to a successor Depositary or to a nominee of such successor Depositary.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the provisions of Section 2.08, the Global Security of a series may be transferred, in whole but not in part and in the manner provided
in Section 2.08, only to another nominee of the Depositary for such series, or to a successor Depositary for such series selected or
approved by the Issuer or to a nominee of such successor Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
of beneficial interests in a registered global security will be limited to Agent Members that have accounts with the Depositary or persons
that may hold interests through Agent Members. Upon the issuance of a registered Global Security, the Depositary will credit, on its
book-entry registration and transfer system, the Agent Members accounts with the respective principal or face amounts of the securities
beneficially owned by the participants. Any dealers, underwriters or agents participating in the distribution of the Securities will
designate the accounts to be credited. Ownership of beneficial interests in a Global Security will be shown on, and the transfer of ownership
interests will be effected only through, records maintained by the Depositary, with respect to interests of Agent Members, and on the
records of Agent Members, with respect to interests of persons holding through Agent Members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Depositary, or its nominee, is the registered owner of a registered Global Security, that Depositary or its nominee, as the
case may be, will be considered the sole owner or Holder of the Securities represented by the Global Security for all purposes under
the Indenture. Except as described in this Section 2.13, Agent Members will not be entitled to have the Securities represented by the
Global Security registered in their names, will not receive or be entitled to receive physical delivery of the Securities in definitive
form and will not be considered the owners or Holders of the Securities under the Indenture. Accordingly, each Agent Member owning a
beneficial interest in a registered Global Security must rely on the procedures of the Depositary for that registered Global Security
and, if that person is not an Agent Member, on the procedures of the Agent Member through which the person owns its interest, to exercise
any rights of a Holder under the Indenture. Notwithstanding the foregoing, the Depositary or its nominee may grant proxies and otherwise
authorize any Person (including any Agent Member and any Person that holds a beneficial interest in a Global Security through an Agent
Member) to take any action which a Holder is entitled to take under the Indenture or the Securities, and nothing herein will impair,
as between the Depositary and its Agent Members, the operation of customary practices governing the exercise of the rights of a Holder
of any Security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal,
premium, if any, and interest payments on Securities represented by a Global Security registered in the name of the Depositary or its
nominee will be made to the Depositary or its nominee, as the case may be, as the registered owner of the registered Global Security.
None of the Issuer, the Trustee or any other agent of the Issuer, or any agent of the Trustee will have any responsibility or liability
for any aspect of the records relating to payments made on account of beneficial ownership interests in the registered Global Security
or for maintaining, supervising or reviewing any records relating to those beneficial ownership interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time the Depositary for a series of the Securities notifies the Issuer that it is unwilling or unable to continue as Depositary
for such series or if at any time the Depositary for such series shall no longer be registered or in good standing under the Exchange
Act, or other applicable statute or regulation, and a successor Depositary for such series is not appointed by the Issuer within 90 days
after the Issuer receives such notice or becomes aware of such condition, as the case may be, this Section 2.13 shall no longer be applicable
to the Securities of such series and the Issuer will execute, and subject to Section 2.08, the Trustee will authenticate and deliver
the Securities of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal
amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. In addition, the Issuer
may at any time determine that the Securities of any series shall no longer be represented by a Global Security and that the provisions
of this Section 2.13 shall no longer apply to the Securities of such series. In such event the Issuer will execute and subject to Section
2.08, the Trustee, upon receipt of an Officer&rsquo;s Certificate evidencing such determination by the Issuer, will authenticate and
deliver the Securities of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate
principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the exchange
of the Global Security for such Securities in definitive registered form without coupons, in authorized denominations, the Global Security
shall be cancelled by the Trustee. Such Securities in definitive registered form issued in exchange for the Global Security pursuant
to this Section 2.13 shall be registered in such names and in such authorized denominations as the Depositary, pursuant to instructions
from its direct or indirect participants or otherwise, shall instruct the Trustee in writing. The Issuer and the Trustee shall be entitled
to conclusively rely on such instructions from the Depositary. The Trustee shall deliver such Securities to the Depositary for delivery
to the Persons in whose names such Securities are so registered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.14. <I>CUSIP Numbers</I>. The Issuer in issuing the Securities may use &ldquo;CUSIP&rdquo; numbers (if then generally in use), and,
if so, the Trustee shall use &ldquo;CUSIP&rdquo; numbers in notices of redemption as a convenience to Holders; provided that any such
notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained
in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities, and
any such redemption shall not be affected by any defect in or omission of such numbers. The Issuer will promptly notify the Trustee in
writing of any change in the &ldquo;CUSIP&rdquo; numbers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
3</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Covenants of the Issuer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.01. <I>Payment of Principal and Interest. </I>(a) The Issuer covenants and agrees for the benefit of each series of Securities that
it will duly and punctually pay or cause to be paid the principal of, and interest on, each of the Securities of such series at the place
or places, at the respective times and in the manner provided in such Securities. The Issuer shall pay interest (including post-petition
interest in any proceeding under any Bankruptcy Law) on overdue principal on each series of Securities at the rate specified in the terms
of such series of Securities to the extent lawful; it shall pay interest (including post-petition interest in any proceeding under any
Bankruptcy Law) on overdue installments of interest (without regard to any applicable grace period) at the same rate to the extent lawful.
Unless otherwise provided in the Securities of any series, not later than 11:00 A.M. (New York City time) on the due date of any principal
of or interest on any Securities, the Issuer will deposit with the Trustee (or paying agent) money in immediately available funds sufficient
to pay such amounts, <U>provided</U> that if the Issuer or any affiliate of the Issuer is acting as paying agent, it will, on or before
each due date, segregate and hold in a separate trust fund for the benefit of the Holders a sum of money sufficient to pay such amounts
until paid to such Holders or otherwise disposed of as provided in the Indenture. In each case the Issuer will promptly notify the Trustee
of its compliance with this paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
An installment of principal or interest will be considered paid on the date due if the Trustee (or paying agent, other than the Issuer
or any affiliate of the Issuer) holds on that date money designated for and sufficient to pay the installment. If the Issuer or any affiliate
of the Issuer acts as paying agent, an installment of principal or interest will be considered paid on the due date only if paid to the
Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Payments in respect of the Securities represented by the Global Security are to be made by wire transfer of immediately available funds
to the accounts specified by the Depositary with respect to the Global Security. With respect to certificated Securities, the Issuer
will make all payments by wire transfer of immediately available funds to the accounts specified by the Holders thereof or, if no such
account is specified, by mailing a check to each Holder&rsquo;s registered address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.02. <I>Offices for Payments, etc. </I>So long as any of the Securities remain Outstanding, the Issuer will maintain in New York City,
the following for each series: an office or agency (a) where the Securities may be presented for payment, (b) where the Securities may
be presented for registration of transfer and for exchange as in the Indenture provided and (c) where notices and demands to or upon
the Issuer in respect of the Securities or of the Indenture may be given or served. The Issuer will give to the Trustee written notice
of the location of any such office or agency and of any change of location thereof. Unless otherwise specified in accordance with Section
2.03, the Issuer hereby initially designates the Corporate Trust Office of [&nbsp;&nbsp;] at [&nbsp;&nbsp;], Attention: [&nbsp;&nbsp;], as the office to be maintained
by it for each such purpose. In case the Issuer shall fail to so designate or maintain any such office or agency or shall fail to give
such notice of the location or of any change in the location thereof, presentations and demands may be made and notices may be served
at the applicable Corporate Trust Office of the Trustee and the Issuer hereby appoints the Trustee as its agent to receive all such presentations,
notices and demands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.03. <I>Paying Agents. </I>Whenever the Issuer shall appoint a paying agent other than the Trustee with respect to the Securities of
any series, it will cause such paying agent to execute and deliver to the Trustee an instrument in which such agent shall agree with
the Trustee, subject to the provisions of this Section,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
that it will hold all sums received by it as such agent for the payment of the principal of or interest on the Securities of such series
(whether such sums have been paid to it by the Issuer or by any other obligor on the Securities of such series) in trust for the benefit
of the holders of the Securities of such series or of the Trustee,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
that it will give the Trustee notice of any failure by the Issuer (or by any other obligor on the Securities of such series) to make
any payment of the principal of or interest on the Securities of such series when the same shall be due and payable,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
pay any such sums so held in trust by it to the Trustee upon the Trustee&rsquo;s written request at any time during the continuance of
the failure referred to in clause 3.03(b) above, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
that it will perform all other duties of paying agent as set forth in the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer shall, on or prior to each due date of the principal of or interest on the Securities of such series, deposit with the paying
agent a sum sufficient to pay such principal or interest so becoming due, and (unless such paying agent is the Trustee) the Issuer shall
promptly notify the Trustee of any failure to take such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Issuer shall act as its own paying agent with respect to the Securities of any series, it will, on or before each due date of the
principal of or interest on the Securities of such series, set aside, segregate and hold in trust for the benefit of the holders of the
Securities of such series a sum sufficient to pay such principal or interest so becoming due. The Issuer will promptly notify the Trustee
of any failure to take such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anything
in this section to the contrary notwithstanding, the Issuer may at any time, for the purpose of obtaining a satisfaction and discharge
with respect to one or more or all series of Securities hereunder, or for any other reason, pay or cause to be paid to the Trustee all
sums held in trust for any such series by the Issuer or any paying agent hereunder, as required by this Section, such sums to be held
by the Trustee upon the trusts herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anything
in this section to the contrary notwithstanding, the agreement to hold sums in trust as provided in this section is subject to the provisions
of Section 9.05 and 9.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.04. <I>Certificate of the Issuer. </I>The Issuer will furnish to the Trustee on or before 120 days after the end of each fiscal year
(beginning with the fiscal year ended December 31, [__]) a brief certificate (which need not comply with Section 10.05) from the principal
executive, financial or accounting officer or the Treasurer of the Issuer as to his or her knowledge of the Issuer&rsquo;s compliance
with all conditions and covenants under the Indenture (such compliance to be determined without regard to any period of grace or requirement
of notice provided under the Indenture), or if there has been a default, specifying the default and its nature and status.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.05. <I>Reports by the Issuer. </I>The Issuer will furnish to the Trustee any document or report the Issuer is required to file with
the Commission pursuant to Section 13 or 15(d) of the Exchange Act within 15 days after such document or report is filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.06. <I>Existence</I>. Except as permitted under Article 8, the Issuer covenants to do or cause to be done all things necessary to preserve
and keep in full force and effect its existence, rights and franchises; <U>provided</U>, <U>however</U>, that the Issuer shall not be
required to preserve any right or franchise if it determines that its preservation is no longer desirable in the conduct of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
4</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Remedies of the Trustee and Holders on Event of Default</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.01. <I>Event of Default; Acceleration of Maturity; Waiver of Default. </I>An &ldquo;<B>Event of Default</B>&rdquo; with respect to
Securities of any series means the occurrence of one or more of the following events (whatever the reason for such Event of Default and
whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court
or any order, rule or regulation of any administrative or governmental body):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the failure to pay interest on any Security of such series when the same becomes due and payable and the default continues for a period
of 60 days or more;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the failure to pay the principal or premium, if any, of any Security of such series, when the same becomes due and payable, at maturity,
upon acceleration, upon redemption or otherwise;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
a default in the performance, or breach, of the obligations of the Issuer under Section 8.01 of this Indenture;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
a default in the observance or performance of any other covenant or agreement contained in this Indenture which default continues for
a period of 60 days after the Issuer receives written notice specifying the default (and demanding that such default be remedied) from
the Trustee or the Holders of at least a majority of the Outstanding aggregate principal amount of each series of Securities affected,
voting together as a single class;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
(i) a failure by the Issuer to make any payment, at the stated maturity, on any Indebtedness of the Issuer (other than Indebtedness owing
to any of its Subsidiaries) in an amount in excess of $50.0 million or its foreign currency equivalent at the time outstanding under
or evidenced by any single indenture or instrument, whether such Indebtedness now exists or shall hereafter be created, and such failure
shall have continued after any applicable grace period or (ii) a default on any Indebtedness of the Issuer (other than Indebtedness owing
to any of its Subsidiaries), whether such Indebtedness now exists or shall hereafter be created, which default results in such Indebtedness
being accelerated or otherwise declared due and payable prior to the stated maturity thereof in an amount in excess of $50.0 million
or its foreign currency equivalent at the time, in the case of each of clauses (i) and (ii) above, without such Indebtedness having been
discharged or the acceleration having been cured, waived, rescinded or annulled; <U>provided</U>, <U>however</U>, that if any failure,
default or acceleration referred to in clauses (i) or (ii) ceases or is cured, waived, rescinded or annulled, then the Event of Default
shall be deemed cured;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
the Issuer or any Significant Subsidiary of the Issuer:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
commences a voluntary case under any Bankruptcy Law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
consents to the entry of an order for relief against it in an involuntary case under any Bankruptcy Law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
consents to the appointment of a custodian or receiver of it or for all or substantially all of its property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
makes a general assignment for the benefit of its creditors; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
admits in writing its inability to pay its debts as they become due;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
is for relief in an involuntary case against the Issuer or any Significant Subsidiary of the Issuer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
appoints a custodian or receiver of the Issuer or any Significant Subsidiary or for all or substantially all of the property of any of
the foregoing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
orders the liquidation of the Issuer or any of its Significant Subsidiaries; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
and the order or decree remains unstayed and in effect for 60 consecutive days; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
any other Event of Default provided in the Officer&rsquo;s Certificate, supplemental indenture or Resolution of the Board of Directors
under which such series of Securities is issued or in the form of Security for such series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Event of Default described in clauses 4.01(a), (b), (c), (d), (e), or (h) above (if the Event of Default under clause (d), (e) or
(h) above is with respect to less than all series of Securities then Outstanding) occurs and is continuing, then, and in each and every
such case, unless the principal of all of the Securities of such series shall have already become due and payable, the Trustee may, and
at the direction of the holders of not less than 25% in aggregate principal amount of the Securities of each such series affected that
is then Outstanding hereunder (voting together as a single class) by notice in writing to the Issuer (and to the Trustee if given by
Holders), shall declare the entire principal (or, if the Securities of such series are Original Issue Discount Securities, such portion
of the principal amount as may be specified in the terms of such series) of all Outstanding Securities of each such series, together
with all accrued and unpaid interest and premium, if any, to be due and payable immediately, and upon any such declaration the same shall
become immediately due and payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Event of Default described in clauses Section 4.01(f) or Section 4.01(g) above occurs and is continuing, then the entire principal
amount of the Outstanding Securities will automatically become due immediately and payable without any declaration or other act on the
part of the Trustee or any Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the Holders of a majority in principal amount of the Outstanding Securities of one or more series (voting together as
a single class) by written notice to the Issuer and to the Trustee may on behalf of the Holders of all Securities of each such series
affected waive all past defaults and rescind and annul a declaration of acceleration and its consequences if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the rescission would not conflict with any judgment or decree;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all existing Events of Default have been cured or waived except nonpayment of principal or interest that has become due solely because
of the acceleration;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
to the extent the payment of such interest is lawful, if interest on overdue installments of interest and overdue principal (and premium,
if any), which has become due otherwise than by such declaration of acceleration, has been paid;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Issuer has paid the Trustee its reasonable compensation and reimbursed the Trustee for its expenses, disbursements and advances;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
in the event of the cure or waiver of an Event of Default of the type described in Sections 4.01(f) or 4.01(g), the Trustee shall have
received an Officer&rsquo;s Certificate and an Opinion of Counsel that such Event of Default has been cured or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
such rescission shall affect any subsequent Event of Default or impair any right consequent thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
all purposes under the Indenture, if a portion of the principal of any Original Issue Discount Securities shall have been accelerated
and declared due and payable pursuant to the provisions hereof, then, from and after such declaration, unless such declaration has been
rescinded and annulled, the principal amount of such Original Issue Discount Securities shall be deemed, for all purposes hereunder,
to be such portion of the principal thereof as shall be due and payable as a result of such acceleration, and payment of such portion
of the principal thereof as shall be due and payable as a result of such acceleration, together with interest, if any, thereon and all
other amounts owing thereunder, shall constitute payment in full of such Original Issue Discount Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.02. <I>Collection of Indebtedness by Trustee; Trustee May Prove Debt. </I>The Issuer covenants that (a) in case default shall be made
in the payment of any installment of interest on any of the Securities of any series when such interest shall have become due and payable,
and such default shall have continued for a period of 30 days or (b) in case default shall be made in the payment of all or any part
of the principal of any of the Securities of any series when the same shall have become due and payable, whether upon maturity of the
Securities of such series or upon any redemption or by declaration or otherwise&mdash;then upon demand of the Trustee, the Issuer will
pay to the Trustee for the benefit of the Holders of the Securities of such series the whole amount that then shall have become due and
payable on all Securities of such series for principal or interest, as the case may be (with interest to the date of such payment upon
the overdue principal and, to the extent that payment of such interest is enforceable under applicable law, on overdue installments of
interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities) specified
in the Securities of such series); and in addition thereto, such further amount as shall be sufficient to cover the costs and expenses
of collection, including reasonable compensation to the Trustee and each predecessor Trustee, their respective agents, attorneys and
counsel, and any expenses and liabilities incurred by the Trustee and each predecessor Trustee except as a result of its negligence or
willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
such demand is made by the Trustee, the Issuer may pay the principal of and interest on the Securities of any series to the registered
holders, whether or not the principal of and interest on the Securities of such series be overdue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case the Issuer shall fail forthwith to pay such amounts upon such demand, the Trustee, in its own name and as trustee of an express
trust, shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of the sums so due
and unpaid, and may prosecute any such action or proceedings to judgment or final decree, and may enforce any such judgment or final
decree against the Issuer or other obligor upon such Securities and collect in the manner provided by law out of the property of the
Issuer or other obligor upon such Securities, wherever situated, the moneys adjudged or decreed to be payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case there shall be pending proceedings relative to the Issuer or any other obligor upon the Securities under Bankruptcy Law, or in case
a receiver, assignee or trustee in bankruptcy or reorganization, liquidator, sequestrator or similar official shall have been appointed
for or taken possession of the Issuer or its property or such other obligor, or in case of any other comparable judicial proceedings
relative to the Issuer or other obligor upon the Securities of any series, or to the creditors or property of the Issuer or such other
obligor, the Trustee, irrespective of whether the principal of any Securities shall then be due and payable as therein expressed or by
declaration or otherwise and irrespective of whether the Trustee shall have made any demand pursuant to the provisions of this Section,
shall be entitled and empowered, by intervention in such proceedings or otherwise:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
to file and prove a claim or claims for the whole amount of principal and interest (or, if the Securities of any series are Original
Issue Discount Securities, such portion of the principal amount as may be specified in the terms of such series) owing and unpaid in
respect of the Securities of any series, and to file such other papers or documents as may be necessary or advisable in order to have
the claims of the Trustee (including any claim for reasonable compensation to the Trustee and each predecessor Trustee, and their respective
agents, attorneys and counsel, and for reimbursement of all expenses and liabilities incurred, and all advances made, by the Trustee
and each predecessor Trustee, except as a result of negligence or bad faith) and of the Holders allowed in any judicial proceedings relative
to the Issuer or other obligor upon the Securities of any series, or to the creditors or property of the Issuer or such other obligor,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
unless prohibited by applicable law and regulations, to vote on behalf of the holders of the Securities of any series in any election
of a trustee or a standby trustee in arrangement, reorganization, liquidation or other bankruptcy or insolvency proceedings or person
performing similar functions in comparable proceedings, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
to collect and receive any moneys or other property payable or deliverable on any such claims, and to distribute all amounts received
with respect to the claims of the Holders and of the Trustee on their behalf; and any trustee, receiver, or liquidator, custodian or
other similar official is hereby authorized by each of the Holders to make payments to the Trustee, and, in the event that the Trustee
shall consent to the making of payments directly to the Holders, to pay to the Trustee such amounts as shall be sufficient to cover reasonable
compensation to the Trustee, each predecessor Trustee and their respective agents, attorneys and counsel, and all other expenses and
liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee except as a result of negligence or bad faith
and all other amounts due to the Trustee or any predecessor Trustee pursuant to Section 5.07.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
herein contained shall be deemed to authorize the Trustee to authorize or consent to or vote for or accept or adopt on behalf of any
Holder any plan or reorganization, arrangement, adjustment or composition affecting the Securities of any series or the rights of any
Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding except, as aforesaid,
to vote for the election of a trustee in bankruptcy or similar person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
rights of action and of asserting claims under the Indenture, or under any of the Securities, may be enforced by the Trustee without
the possession of any of the Securities or the production thereof on any trial or other proceedings relative thereto, and any such action
or proceedings instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment,
subject to the payment of the reasonable expenses, disbursements and compensation of the Trustee, each predecessor Trustee and their
respective agents and attorneys, shall be for the ratable benefit of the holders of the Securities in respect of which such action was
taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
any proceedings brought by the Trustee (and also any proceedings involving the interpretation of any provision of the Indenture to which
the Trustee shall be a party) the Trustee shall be held to represent all the holders of the Securities in respect to which such action
was taken, and it shall not be necessary to make any holders of such Securities parties to any such proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.03. <I>Application of Proceeds. </I>Any moneys collected by the Trustee pursuant to this Article in respect of any series shall be
applied in the following order at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account of
principal or interest, upon presentation of the several Securities in respect of which moneys have been collected and stamping (or otherwise
noting) thereon the payment, or issuing Securities of such series in reduced principal amounts in exchange for the presented Securities
of like series if only partially paid, or upon surrender thereof if fully paid:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
To the payment of costs and expenses applicable to such series in respect of which moneys have been collected, including reasonable compensation
to the Trustee and each predecessor Trustee and their respective agents and attorneys and of all expenses and liabilities incurred by
the Trustee and each predecessor Trustee except as a result of negligence or bad faith, and all other amounts due to the Trustee or any
predecessor Trustee pursuant to Section 5.07;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
In case the principal of the Securities of such series in respect of which moneys have been collected shall not have become and be then
due and payable, to the payment of interest on the Securities of such series in default in the order of the maturity of the installments
of such interest, with interest (to the extent that such interest has been collected by the Trustee) upon the overdue installments of
interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities) specified
in such Securities, such payments to be made ratably to the persons entitled thereto, without discrimination or preference;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
In case the principal of the Securities of such series in respect of which moneys have been collected shall have become and shall be
then due and payable, to the payment of the whole amount then owing and unpaid upon all the Securities of such series for principal and
interest, with interest upon the overdue principal, and (to the extent that such interest has been collected by the Trustee) upon overdue
installments of interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities)
specified in the Securities of such series; and in case such moneys shall be insufficient to pay in full the whole amount so due and
unpaid upon the Securities of such series, then to the payment of such principal and interest or yield to maturity, without preference
or priority of principal over interest or yield to maturity, or of interest or yield to maturity over principal, or of any installment
of interest over any other installment of interest, or of any Security of such series over any other Security of such series, ratably
to the aggregate of such principal and accrued and unpaid interest or yield to maturity; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOURTH:
To the payment of the remainder, if any, to the Issuer or any other person lawfully entitled thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.04. <I>Suits for Enforcement. </I>In case an Event of Default has occurred, has not been waived and is continuing, the Trustee may
in its discretion proceed to protect and enforce the rights vested in it by the Indenture by such appropriate judicial proceedings as
the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise,
whether for the specific enforcement of any covenant or agreement contained in the Indenture or in aid of the exercise of any power granted
in the Indenture or to enforce any other legal or equitable right vested in the Trustee by the Indenture or by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.05. <I>Restoration of Rights on Abandonment of Proceedings. </I>In case the Trustee shall have proceeded to enforce any right under
the Indenture and such proceedings shall have been discontinued or abandoned for any reason, or shall have been determined adversely
to the Trustee, then and in every such case the Issuer and the Trustee shall be restored respectively to their former positions and rights
hereunder, and all rights, remedies and powers of the Issuer, the Trustee and the Holders shall continue as though no such proceedings
had been taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.06. <I>Limitations on Suits by Holder. </I>No Holder of any Security of any series shall have any right by virtue or by availing of
any provision of the Indenture to institute any action or proceeding at law or in equity or in bankruptcy or otherwise upon or under
or with respect to the Indenture, or for the appointment of a trustee, receiver, liquidator, custodian or other similar official or for
any other remedy hereunder, unless (i) such holder previously shall have given to the Trustee written notice of default and of the continuance
thereof, as hereinbefore provided; (ii) the Holders of not less than 25% in aggregate principal amount of the Securities of each such
series affected that is then Outstanding (voting together as a single class) shall have made written request upon the Trustee to institute
such action or proceedings in its own name as trustee hereunder; (iii) such Holder or Holders shall have offered to the Trustee such
indemnity as it may reasonably require against the costs, expenses and liabilities to be incurred in compliance with such request; (iv)
the Trustee for 60 days after its receipt of such notice, request and offer of indemnity shall have failed to institute any such action
or proceeding; and (v) no direction inconsistent with such written request shall have been given to the Trustee during such 60-day period
by the Holders of a majority in aggregate principal amount of the Securities of each series affected then Outstanding. It is understood
and intended, and expressly covenanted by the taker and Holder of every Security with every other taker and Holder and the Trustee, that
no one or more Holders of any series shall have any right in any manner whatever by virtue or by availing of any provision of the Indenture
to affect, disturb or prejudice the rights of any other such Holder, or to obtain or seek to obtain priority over or preference to any
other such Holder or to enforce any right under the Indenture, except in the manner herein provided and for the equal, ratable and common
benefit of all Holders of the applicable series. For the protection and enforcement of the provisions of this Section, each and every
Holder and the Trustee shall be entitled to such relief as can be given either at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.07. <I>Unconditional Right of Holders to Institute Certain Suits. </I>Notwithstanding any other provision in the Indenture and any
provision of any Security, the right of any Holder of any Security to receive payment of principal, premium, if any, and interest on
such Security on or after the respective due dates expressed in such Security, or to institute suit for the enforcement of any such payment
on or after such respective dates, shall not be impaired or affected without the consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.08. <I>Powers and Remedies Cumulative; Delay or Omission Not Waiver of Default. </I>Except as provided in Section 4.06, no right or
remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and
every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder
or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise,
shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
delay or omission of the Trustee or of any Holder to exercise any right or power accruing upon any Event of Default occurring and continuing
as aforesaid shall impair any such right or power or shall be construed to be a waiver of any such Event of Default or an acquiescence
therein; and, subject to Section 4.06, every power and remedy given by the Indenture or by law to the Trustee or to the Holders may be
exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.09. <I>Control by Holders. </I>The Holders of a majority in aggregate principal amount of the Securities of each series affected (voting
together as a single class) at the time Outstanding shall have the right to direct the time, method, and place of conducting any proceeding
for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with respect to the Securities of
each such series by the Indenture; <U>provided</U>, <U>however</U>, that such direction shall not be otherwise than in accordance with
law and the provisions of the Indenture. Subject to the provisions of Section 5.01, the Trustee shall have the right to decline to follow
any such direction if the Trustee, being advised by counsel, shall determine that the action or proceeding so directed may not lawfully
be taken or if the Trustee in good faith shall determine that the action or proceedings so directed would involve the Trustee in personal
liability or if the Trustee in good faith shall determine that the actions or forbearances specified in or pursuant to such direction
would be unduly prejudicial to the interests of Holders of the Securities of all series so affected not joining in the giving of said
direction, it being understood that (subject to Section 5.01) the Trustee shall have no duty to ascertain whether or not such actions
or forbearances are unduly prejudicial to such Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in the Indenture shall impair the right of the Trustee in its discretion to take any action deemed proper by the Trustee and which is
not inconsistent with such direction or directions by Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.10. <I>Waiver of Past Defaults. </I>Except as otherwise provided in Sections 4.01, 4.07 and Section 7.02, the Holders of a majority
in aggregate principal amount of the Outstanding Securities of one or more series (voting together as a single class) may, by notice
to the Trustee, on behalf of the Holders of all Securities of each such series waive an existing default and its consequences. Upon such
waiver, the default will cease to exist, and any Event of Default arising therefrom will be deemed to have been cured, but no such waiver
will extend to any subsequent or other default or impair any right consequent thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.11. <I>Trustee to Give Notice of Default, But May Withhold in Certain Circumstances. </I>The Trustee shall give to the Holders of any
series, as the names and addresses of such Holders appear on the registry books, notice by mail of all defaults known to the Trustee
which have occurred with respect to such series, such notice to be transmitted within 45 days after the occurrence thereof, unless such
defaults shall have been cured before the giving of such notice (the term &ldquo;default&rdquo; or &ldquo;defaults&rdquo; for the purposes
of this section being hereby defined to mean any event or condition which is, or with notice or lapse of time or both would become, an
Event of Default); provided that, except in the case of default in the payment of the principal of or interest on any of the Securities
of such series, or in the payment of any sinking or purchase fund installment with respect to the Securities of such series, the Trustee
shall be protected in withholding such notice if and so long as the board of directors, the executive committee, or a trust committee
of directors or trustees and/or responsible officers of the Trustee in good faith determines that the withholding of such notice is in
the interests of the Holders of such series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.12. <I>Right of Court to Require Filing of Undertaking to Pay Costs. </I>In any suit for the enforcement of any right or remedy under
the Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court may require any party litigant
in such suit (other than the Trustee) to file an undertaking to pay the costs of the suit, and the court may assess reasonable costs,
including reasonable attorneys&rsquo; fees, against any party litigant (other than the Trustee) in the suit having due regard to the
merits and good faith of the claims or defenses made by the party litigant. This Section does not apply to a suit by a Holder to enforce
payment of principal of or interest on any Security on the respective due dates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
5</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Concerning the Trustee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.01. <I>Duties and Responsibilities of the Trustee; During Default; Prior to Default</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The duties and responsibilities of the Trustee are as provided by the Trust Indenture Act and as set forth herein. Whether or not expressly
so provided, every provision of the Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee
is subject to this Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except during the continuance of an Event of Default, the Trustee need perform only those duties that are specifically set forth in the
Indenture and no others, and no implied covenants or obligations will be read into the Indenture against the Trustee. In case an Event
of Default of which a Responsible Officer shall have actual knowledge or shall have received written notice from the Issuer or any holder
of Securities of any series has occurred and is continuing, the Trustee shall exercise those rights and powers vested in it by the Indenture,
and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct
of his own affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No provision of the Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent
failure to act or its own willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.02. <I>Trustee&rsquo;s Obligations with Respect to the Covenants. </I>The Trustee shall not be obligated to monitor or confirm, on
a continuing basis or otherwise, the Issuer&rsquo;s compliance with the covenants contained in Article 4 or with respect to any reports
or other documents filed under the Indenture; <U>provided</U>, <U>however</U>, that nothing herein shall relieve the Trustee of any obligations
to monitor the Issuer&rsquo;s timely delivery of all reports and certificates required under Section 3.04 and Section 3.05 of the Indenture
and to fulfill its obligations under Article 5 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.03. <I>Moneys Held by Trustee. </I>Subject to the provisions of Section 9.06 hereof, all moneys received by the Trustee shall, until
used or applied as herein provided, be held in trust for the purposes for which they were received, but need not be segregated from other
funds except to the extent required by law. Neither the Trustee nor any agent of the Issuer or the Trustee shall be liable for interest
on any money received by it hereunder except such as it may agree with the Issuer in writing to pay thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.04. <I>Reports by the Trustee to Holders. </I>Within 60 days after each May 15, beginning with May 15, [___], the Trustee will mail
to each Holder, as provided in Trust Indenture Act Section 313(c), a brief report dated as of such May 15, if required by Trust Indenture
Act Section 313(a), and file such reports with each stock exchange upon which its Securities are listed and with the Commission if, and
to the extent, required by Trust Indenture Act Section 313(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee shall comply with Section 313(b) and 313(c) of the Trust Indenture Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of each such report shall, at the time of such transmission to Holders, be filed by the Trustee with the Issuer, with each stock
exchange upon which any Securities are listed (if so listed) and also with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.05. <I>Certain Rights of the Trustee. </I>Subject to Trust Indenture Act Sections 315(a) through (d):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In the absence of bad faith on its part, the Trustee may rely, and will be protected in acting or refraining from acting, upon any resolution,
certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence
of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper Person. The
Trustee need not investigate any fact or matter stated in the document, but, in the case of any document which is specifically required
to be furnished to the Trustee pursuant to any provision hereof, the Trustee shall examine the document to determine whether it conforms
to the requirements of the Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated
therein). The Trustee, in its discretion, may make further inquiry or investigation into such facts or matters as it sees fit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Before the Trustee acts or refrains from acting, it may require an Officer&rsquo;s Certificate or an Opinion of Counsel conforming to
Section 10.05 and the Trustee will not be liable for any action it takes or omits to take in good faith in reliance on the certificate
or opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Trustee may act through its attorneys and agents and will not be responsible for the misconduct or negligence of any attorney or
agent appointed by the Trustee with due care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Trustee will be under no obligation to exercise any of the rights or powers vested in it by the Indenture or to institute, conduct
or defend any litigation hereunder or in relation hereto at the request or direction of any of the Holders, unless such Holders have
offered to the Trustee security or indemnity as it may reasonably require against the costs, expenses and liabilities that might be incurred
by it in compliance with such request or direction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Trustee will not be liable in its individual capacity for any action it takes, suffers or omits to take in good faith that it believes
to be authorized or within its rights or powers or for any action it takes or omits to take in accordance with the direction of the Holders
in accordance with Section 4.09 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee,
or exercising any trust or power conferred upon the Trustee, under the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Trustee may consult with counsel, and any advice of such counsel or any Opinion of Counsel will be full and complete authorization
and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
No provision of the Indenture will require the Trustee to expend or risk its own funds or otherwise incur any financial liability in
the performance of its duties hereunder, or in the exercise of its rights or powers, unless it receives indemnity satisfactory to it
against any loss, liability or expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Trustee shall not be liable in its individual capacity for an error in judgment made in good faith by a Responsible Officer or other
officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Trustee shall not be personally liable for any action taken, suffered or omitted by it in good faith and believed by it to be authorized
or within the discretion or rights or powers conferred upon it by the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Trustee shall have no duty to see to any recording, filing or depositing of the Indenture or any agreement referred to herein or
any financing statement or continuation statement evidencing a security interest, or to see to the maintenance of any such re-recording
or re-filing or re-depositing thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
The Trustee shall not be required to take notice or be deemed to have notice or knowledge of any default or Event of Default unless a
Responsible Officer of the Trustee shall have received written notice from the Issuer or any holder of the Securities or obtained actual
knowledge thereof. In the absence of receipt of such notice or actual knowledge, the Trustee may conclusively assume that there is no
default or Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.06. <I>Trustee and Agents May Hold Securities; Collections, etc. </I>The Trustee or any agent of the Issuer or the Trustee, in its
individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not the
Trustee or such agent and may otherwise deal with the Issuer and receive, collect, hold and retain collections from the Issuer with the
same rights it would have if it were not the Trustee or such agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.07. <I>Compensation and Indemnification of Trustee and Its Prior Claim. </I>(a) The Issuer will pay the Trustee compensation as agreed
upon in writing for its services. The compensation of the Trustee is not limited by any law on compensation of a Trustee of an express
trust. The Issuer will reimburse the Trustee upon request for all reasonable out-of-pocket expenses, disbursements and advances incurred
or made by the Trustee, (including the reasonable compensation and the expenses and disbursements of its counsel and of all agents and
other persons not regularly in its employ) except to the extent any such expense, disbursement or advance may arise from its negligence
or bad faith. The Issuer also covenants to indemnify the Trustee, its directors, officers, employees and agents and each predecessor
Trustee, its directors, officers, employees and agents for, and to hold each of them harmless against, any loss, liability or expense
arising out of or in connection with the acceptance or administration of the Indenture or the trusts hereunder and the performance of
its duties hereunder and under the Securities, including the costs and expenses of defending itself against or investigating any claim
of liability in the premises and the costs and expenses of defending itself against any claim or liability and of complying with any
process served upon it or any of its officers and the enforcement of the Indenture (including this section), except to the extent such
loss liability or expense is due to the negligence or willful misconduct of the Trustee or such predecessor Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anything
in the Indenture to the contrary notwithstanding, in no event shall the Trustee be liable for special, indirect or consequential loss
or damage of any kind whatsoever (including but not limited to lost profits) unless it shall be proved that the Trustee was grossly negligent
in acting or failing to act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
To secure the Issuer&rsquo;s payment obligations in this Section, the Trustee will have a lien prior to the Securities on all money or
property held or collected by the Trustee, in its capacity as Trustee, except money or property held in trust to pay principal of, and
interest on particular Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Issuer under this Section 5.07 shall survive the resignation and removal of the Trustee and payment of the Securities,
and shall extend to any co-trustee or separate trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.08. <I>Right of Trustee to Rely on Officer&rsquo;s Certificate, etc. </I>Subject to Sections 5.01 and Section 5.05, whenever in the
administration of the trusts of the Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established
prior to taking or suffering or omitting any action hereunder, such matter (unless other evidence in respect thereof be herein specifically
prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed to be conclusively proved and established
by an Officer&rsquo;s Certificate delivered to the Trustee, and such certificate, in the absence of negligence or bad faith on the part
of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted by it under the provisions of the Indenture
upon the faith thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.09. <I>Disqualification; Conflicting Interests</I>. If the Trustee has or shall acquire any &ldquo;conflicting interest&rdquo; within
the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Issuer shall in all respects comply with the provisions
of Section 310(b) of the Trust Indenture Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.10. <I>Persons Eligible for Appointment as Trustee. </I>The Indenture must always have a Trustee that satisfies the requirements of
Trust Indenture Act Section 310(a) and has a combined capital and surplus of at least $25,000,000 as set forth in its most recent published
annual report of condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.11. <I>Resignation and Removal; Appointment of Successor Trustee</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Trustee, or any trustee or trustees hereafter appointed, may at any time resign with respect to one or more or all series of Securities
by giving written notice of resignation to the Issuer and by mailing notice thereof by first class mail to Holders of the applicable
series of Securities at their last addresses as they shall appear on the Register. Upon receiving such notice of resignation, the Issuer
shall promptly appoint a successor trustee or trustees with respect to the applicable series by written instrument in duplicate, executed
by authority of the Board of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the
successor trustee or trustees. If no successor trustee shall have been so appointed with respect to any series and have accepted appointment
within 30 days after the mailing of such notice of resignation, the resigning Trustee may petition any court of competent jurisdiction
for the appointment of a successor trustee, or any Holder who has been a <I>bona fide </I>Holder of a Security or Securities of the applicable
series for at least six months may, subject to the provisions of Section 4.12, on behalf of himself and all others similarly situated,
petition any such court for the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem
proper and prescribe, appoint a successor trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In case at any time any of the following shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Trustee shall fail to comply with the provisions of Section 310(b) of the Trust Indenture Act with respect to any series of Securities
after written request therefor by the Issuer or by any Holder who has been a <I>bona fide </I>Holder of a Security or Securities of such
series for at least six months; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Trustee shall cease to be eligible in accordance with the provisions of Section 310(a) of the Trust Indenture Act and shall fail
to resign after written request therefor by the Issuer or by any Holder; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Trustee shall become incapable of acting with respect to any series of Securities, or shall be adjudged a bankrupt or insolvent,
or a receiver or liquidator of the Trustee or of its property shall be appointed, or any public officer shall take charge or control
of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">then,
in any such case, the Issuer may remove the Trustee with respect to the applicable series of Securities and appoint a successor trustee
for such series by written instrument, in duplicate, executed by order of the Board of Directors of the Issuer, one copy of which instrument
shall be delivered to the Trustee so removed and one copy to the successor trustee, or any Holder who has been a <I>bona fide </I>Holder
of a Security or Securities of such series for at least six months may on behalf of himself and all others similarly situated, petition
any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee with respect to such series.
Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, remove the Trustee and appoint a successor
trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Holders of a majority in aggregate principal amount of the Securities of each series at the time Outstanding may at any time remove
the Trustee with respect to Securities of such series and appoint a successor trustee with respect to the Securities of such series with
the consent of the Issuer by delivering to the Trustee so removed, to the successor trustee so appointed and to the Issuer the evidence
provided for in Section 6.01 of the action in that regard taken by the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Any resignation or removal of the Trustee with respect to any series and any appointment of a successor trustee with respect to such
series pursuant to any of the provisions of this Section 5.11 shall become effective upon acceptance of appointment by the successor
trustee as provided in Section 5.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Any successor trustee appointed pursuant to this Section may be appointed with respect to the Securities of one or more series or all
of such series, and at any time there shall be only one Trustee with respect to the Securities of any particular series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.12. <I>Acceptance of Appointment by Successor. </I>Any successor trustee appointed as provided in Section 5.11 shall execute and deliver
to the Issuer and to its predecessor trustee an instrument accepting such appointment hereunder, and thereupon the resignation or removal
of the predecessor trustee with respect to all or any applicable series shall become effective and such successor trustee, without any
further act, deed or conveyance, shall become vested with all rights, powers, duties and obligations with respect to such series of its
predecessor hereunder, with like effect as if originally named as trustee for such series hereunder; but, nevertheless, on the written
request of the Issuer or of the successor trustee, upon payment of its charges then unpaid, the trustee ceasing to act shall, subject
to Section 9.06, pay over to the successor trustee all moneys at the time held by it hereunder and shall execute and deliver an instrument
transferring to such successor trustee all such rights, powers, duties and obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a successor trustee is appointed with respect to the Securities of one or more (but not all) series, the Issuer, the predecessor Trustee
and each successor trustee with respect to the Securities of any applicable series shall execute and deliver an indenture supplemental
hereto prepared by and at the expense of the Issuer which (1) shall contain such provisions as shall be deemed necessary or desirable
to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and duties of the retiring Trustee
with respect to the Securities of that or those series to which the appointment of such successor trustee relates, (2) shall contain
such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the predecessor
Trustee with respect to the Securities of any series as to which the predecessor Trustee is not retiring shall continue to be vested
in the predecessor Trustee, and (3) shall add to or change any of the provisions of the Indenture as shall be necessary to provide for
or facilitate the administration of the trusts hereunder by more than one trustee, it being understood that nothing herein or in such
supplemental indenture shall constitute such trustees co-trustees of the same trust and that each such trustee shall be trustee of a
trust or trusts under separate indentures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acceptance of appointment by any successor trustee as provided in this Section 5.12, the Issuer shall mail notice thereof by first-class
mail to the Holders of any series for which such successor trustee is acting as trustee at their last addresses as they shall appear
in the Register. If the acceptance of appointment is substantially contemporaneous with the resignation, then the notice called for by
the preceding sentence may be combined with the notice called for by Section 5.11. If the Issuer fails to mail such notice within ten
days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be mailed at the expense
of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.13. <I>Merger, Conversion, Consolidation or Succession to Business of Trustee. </I>If the Trustee consolidates with, merges or converts
into, or transfers all or substantially all of its corporate trust business to, another corporation or national banking association,
the resulting, surviving or transferee corporation or national banking association without any further act will be the successor Trustee
with the same effect as if the successor Trustee had been named as the Trustee in the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case at the time such successor to the Trustee shall succeed to the trusts created by the Indenture any of the Securities of any series
shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any
predecessor Trustee and deliver such Securities so authenticated; and, in case at that time any of the Securities of any series shall
not have been authenticated, any successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder
or in the name of the successor Trustee; and in all such cases such certificate shall have the full force which it is anywhere in the
Securities of such series or in the Indenture provided that the certificate of the Trustee shall have; <U>provided</U>, that the right
to adopt the certificate of authentication of any predecessor Trustee or to authenticate Securities of any series in the name of any
predecessor Trustee shall apply only to its successor or successors by merger, conversion or consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.14. <I>Preferential Collection of Claims Against the Issuer. </I>The Trustees shall comply with Section 311(a) of the Trust Indenture
Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act. A Trustee who has resigned or been removed
shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.15. <I>Trustee&rsquo;s Disclaimer. </I>The Trustee (i) makes no representation as to the validity or adequacy of the Indenture or the
Securities, (ii) is not accountable for the Issuer&rsquo;s use or application of the proceeds from the Securities and (iii) is not responsible
for any statement in the Securities other than its certificate of authentication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
6</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Concerning the Holders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.01. <I>Evidence of Action Taken by Holders. </I>Any request, demand, authorization, direction, notice, consent, waiver or other action
provided by the Indenture to be given or taken by a specified percentage in principal amount of the Holders of any or all series may
be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such specified percentage of Holders
in person or by agent duly appointed in writing; and, except as herein otherwise expressly provided, such action shall become effective
when such instrument or instruments are delivered to the Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Issuer shall solicit from the Holders of any series any request, demand, authorization, direction, notice, consent, waiver or other
action, the Issuer may, at its option, as evidenced by an Officer&rsquo;s Certificate, fix in advance a record date for such series for
the determination of Holders entitled to give such request, demand, authorization, direction, notice, consent, waiver or other action,
but the Issuer shall have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice,
consent, waiver or other action, may be given before or after the record date, but only the Holders of the requisite proportion of Outstanding
Securities of that series who have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent,
waiver or other action, and for that purpose the Outstanding Securities of that series shall be computed as of the record date; <U>provided</U>,
<U>however</U>, that no such authorization, agreement or consent by such Holders on the record date shall be deemed effective unless
it shall become effective pursuant to the provisions of the Indenture not later than six months after the record date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof
of execution of any instrument or of a writing appointing any such agent shall be sufficient for any purpose of the Indenture and (subject
to Section 5.01 and Section 5.05) conclusive in favor of the Trustee and the Issuer, if made in the manner provided in this Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.02. <I>Proof of Execution of Instruments and of Holding of Securities; Record Date. </I>Subject to Section 5.01 and Section 5.05, the
execution of any instrument by a Holder or his agent or proxy may be proved in accordance with such reasonable rules and regulations
as may be prescribed by the Trustee or in such manner as shall be satisfactory to the Trustee. The holding of Securities shall be proved
by the Register or by a certificate of the registrar thereof. The Issuer may set a record date for purposes of determining the identity
of Holders of any series entitled to vote or consent to any action referred to in Section 6.01, which record date may be set at any time
or from time to time by notice to the Trustee, for any date or dates (in the case of any adjournment or reconsideration) not more than
60 days nor less than five days prior to the proposed date of such vote or consent, and thereafter, notwithstanding any other provisions
hereof, only Holders of such series of record on such record date shall be entitled to so vote or give such consent or revoke such vote
or consent. Notice of such record date may be given before or after any request for any action referred to in Section 6.01 is made by
the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.03. <I>Holders to Be Treated as Owners. </I>Prior to the due presentment for registration of transfer of any Security, the Issuer,
the Trustee and any agent of the Issuer or the Trustee may deem and treat the person in whose name any Security shall be registered upon
the Register for such series as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding
any notation of ownership or other writing thereon) for the purpose of receiving payment of or on account of the principal of, and, subject
to the provisions of the Indenture, interest on such Security and for all other purposes; and neither the Issuer, the Trustee, nor any
agent of the Issuer or the Trustee shall be affected by any notice to the contrary. All such payments so made to any such person, or
upon his order, shall be valid, and, to the extent of the sum or sums so paid, effectual to satisfy and discharge the liability for moneys
payable upon any such Security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.04. <I>Securities Owned by Issuer Deemed Not Outstanding. </I>In determining whether the Holders of the requisite aggregate principal
amount of Outstanding Securities of any or all series have concurred in any direction, consent or waiver under the Indenture, Securities
which are owned by the Issuer or any other obligor on the Securities with respect to which such determination is being made or by any
person directly or indirectly controlling or controlled by or under direct or indirect common control with the Issuer or any other obligor
on the Securities with respect to which such determination is being made shall be disregarded and deemed not to be Outstanding for the
purpose of any such determination, except that for the purpose of determining whether the Trustee shall be protected in relying on any
such direction, consent or waiver only Securities which a Responsible Officer of the Trustee actually knows are so owned, or has received
written notice that such Securities are so owned, shall be so disregarded. Securities so owned which have been pledged in good faith
may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee&rsquo;s right so to act with
respect to such Securities and that the pledgee is not the Issuer or any other obligor upon the Securities or any person directly or
indirectly controlling or controlled by or under direct or indirect common control with the Issuer or any other obligor on the Securities.
In case of a dispute as to such right, the advice of counsel shall be full protection in respect of any decision made by the Trustee
in accordance with such advice. Upon request of the Trustee, the Issuer shall furnish to the Trustee promptly an Officer&rsquo;s Certificate
listing and identifying all Securities, if any, known by the Issuer to be owned or held by or for the account of any of the above-described
persons; and, subject to Section 5.01 and Section 5.05, the Trustee shall be entitled to accept such Officer&rsquo;s Certificate as conclusive
evidence of the facts therein set forth and of the fact that all Securities not listed therein are Outstanding for the purpose of any
such determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.05. <I>Right of Revocation of Action Taken. </I>At any time prior to (but not after) the evidencing to the Trustee, as provided in
Section 6.01, of the taking of any action by the Holders of the percentage in aggregate principal amount of the Securities of any or
all series, as the case may be, specified in the Indenture in connection with such action, any Holder of a Security the serial number
of which is shown by the evidence to be included among the serial numbers of the Securities the Holders of which have consented to such
action may, by filing written notice at the applicable Corporate Trust Office and upon proof of holding as provided in this Article,
revoke such action so far as concerns such Security. Except as aforesaid any such action taken by the Holder of any Security shall be
conclusive and binding upon such Holder and upon all future Holders and owners of such Security and of any Securities issued in exchange
or substitution therefor, irrespective of whether or not any notation in regard thereto is made upon any such Security. Any action taken
by the Holders of the percentage in aggregate principal amount of the Securities of any or all series, as the case may be, specified
in the Indenture in connection with such action shall be conclusively binding upon the Issuer, the Trustee and the Holders of all the
Securities affected by such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
7</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Amendments, Supplements and Waivers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.01. <I>Supplemental Indentures without Consent of Holders. </I>The Issuer and the Trustee may amend the Indenture or the Securities
or enter into an indenture supplemental hereto without notice to or the consent of any Holder to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
to cure any ambiguity, defect or inconsistency;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
to provide for uncertificated Securities of any series in addition to or in place of certificated Securities of the applicable series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
to comply with Article 8 in the case of a merger or consolidation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
to maintain the qualification of the Indenture under the Trust Indenture Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
to evidence and provide for the acceptance of appointment by a successor Trustee;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
to conform the text of this Indenture or the terms of the Securities of any series to any prospectus, offering memorandum, offering circular
or any other document pursuant to which the Securities of such series were offered;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
to establish the form or terms of Securities of any series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
to provide for the assumption by a successor corporation, partnership, trust or limited liability company of the Issuer&rsquo;s obligations
to the Holders of the Securities of any series, in each case in compliance with the applicable provisions of the Indenture; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
to make any change that would provide any additional rights or benefits to the Holders of Securities of any series (including to secure
Securities of any series, add guarantees with respect thereto, to add to the covenants of the Issuer for the benefit of the Holders of
all or any series of Securities (and if such covenants are to be for the benefit of less than all series of Securities, stating that
such covenants are expressly being included solely for the benefit of the applicable series), or to surrender any right or power herein
conferred upon the Issuer, or that does not adversely affect the legal rights under this Indenture of any Holder of Securities of any
series in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee is hereby authorized to join with the Issuer in the execution of any such amendment or supplemental indenture, to make any further
appropriate agreements and stipulations which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or
pledge of any property thereunder, but the Trustee shall not be obligated to enter into any such amendment or supplemental indenture
which affects the Trustee&rsquo;s own rights, duties or immunities under the Indenture or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
amendment or supplemental indenture authorized by the provisions of this section may be executed without notice to and without the consent
of the Holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 7.02.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.02. <I>Supplemental Indentures with Consent of Holders</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
With the consent (evidenced as provided in Article 6) of either (i) the Holders of not less than a majority in aggregate principal amount
of the Securities at the time Outstanding of that series or (ii) the Holders of not less than a majority in aggregate principal amount
of the Securities at the time Outstanding of all series affected by such amendment or supplemental indenture (voting together as a single
class), the Issuer, when authorized by a resolution of its Board of Directors, and the Trustee may, from time to time and at any time,
enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any manner or eliminating
any of the provisions of the Indenture or of any supplemental indenture or of modifying in any manner the rights of the Holders of the
Securities of each such series. Except as otherwise provided herein, the Holders of at least a majority in aggregate principal amount
of the Securities at the time Outstanding of all series affected by such waiver (voting together as a single class), by notice to the
Trustee may waive compliance by the Company with any provision of this Indenture or the Securities with respect to such series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the provisions of paragraph (a), without the consent of each affected Holder of a particular series, an amendment, supplement
or waiver may not (with respect to any non-consenting Holder):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
reduce the aggregate principal amount of Securities of any series at maturity whose Holders must consent to an amendment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
reduce the rate of or change or have the effect of changing the time for payment of interest, including defaulted interest, on Securities
of any series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
reduce the principal of or change or have the effect of changing the fixed maturity of Securities of any series, or change the date on
which Securities of any series may be subject to redemption or repurchase or reduce the redemption price therefor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
make Securities of any series payable in money other than that stated in the Securities of the applicable series or change the place
of payment of the Securities of any series from that stated in the Securities of such series or in the Indenture;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
make any change in provisions of the Indenture protecting the right of each Holder to receive payment of principal of and interest on
such Holder&rsquo;s Security or Securities on or after the due date thereof or to bring suit to enforce such payment, or permitting Holders
of a majority in aggregate principal amount of Securities of each series affected (voting together as a single class) to waive defaults
or Events of Default;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
make any change in these amendment and waiver provisions; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
make any change or modification to the ranking of the Securities of any series that would adversely affect the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
supplemental indenture which changes or eliminates any covenant or other provision of this Indenture which has expressly been included
solely for the benefit of one or more particular series of Securities, or which modifies the rights of the Holders of Securities of such
series with respect to such covenant or other provision, shall be deemed not to affect the rights under this Indenture of the Holders
of Securities of any other series. It shall not be necessary for the consent of the Holders under this section to approve the particular
form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.03. <I>Execution of Amendments or Supplemental Indentures or Waivers. </I>Upon the request of the Issuer, accompanied by a copy of
a Resolution of the Board of Directors certified by the secretary or an assistant secretary of the Issuer authorizing the execution of
any such amendment, supplemental indenture or waiver and upon the filing with the Trustee of evidence of the consent of Holders as aforesaid
and other documents, if any, required by Section 6.01, the Trustee shall join with the Issuer in the execution of such amendment, supplemental
indenture or waiver unless such supplemental indenture or waiver affects the Trustee&rsquo;s own rights, duties or immunities under the
Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such amendment, supplemental
indenture or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee, subject to the provisions of Sections 5.01 and 5.05, may receive an Officer&rsquo;s Certificate and an Opinion of Counsel as
conclusive evidence that any amendment, supplemental indenture or waiver executed pursuant to this Article 7 complies with the applicable
provisions of the Indenture; <U>provided, however</U>, that such Officer&rsquo;s Certificate and Opinion of Counsel need not be provided
in connection with the execution of an amendment, supplemental indenture or waiver that establishes the terms of a series of Securities
pursuant to Section 2.01 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
after the execution by the Issuer and the Trustee of any amendment, supplemental indenture or waiver pursuant to the provisions of this
Section, the Issuer shall deliver a notice thereof to the Holders of each series affected thereby at their addresses as they shall appear
on the registry books of the Issuer, setting forth in general terms the substance of such amendment, supplemental indenture or waiver.
Any failure of the Issuer to deliver such notice, or any defect therein, shall not, however, in any way impair or affect the validity
of any such amendment, supplemental indenture or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.04. <I>Effect of Amendment, Supplemental Indenture or Waiver. </I>Upon the execution of any amendment, supplemental indenture or waiver
pursuant to the provisions hereof, the Indenture shall be and be deemed to be modified and amended in accordance therewith and the respective
rights, limitations of rights, obligations, duties and immunities under the Indenture of the Trustee, the Issuer and the Holders of each
series affected thereby shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications
and amendments, and all the terms and conditions of any such amendment, supplemental indenture or waiver shall be and be deemed to be
part of the terms and conditions of the Indenture for any and all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.05. <I>Effect of Consent. </I>After an amendment, supplement or waiver becomes effective, it will bind every Holder unless it is of
the type requiring the consent of each Holder affected. If the amendment, supplement or waiver is of the type requiring the consent of
each Holder affected, the amendment, supplement or waiver will bind each Holder that has consented to it and every subsequent Holder
of a Security that evidences the same debt as the Security of the consenting Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.06. <I>Notation on Securities in Respect of Amendments, Supplemental Indentures or Waivers. </I>Securities of any series authenticated
and delivered after the execution of any amendment, supplemental indenture or waiver pursuant to the provisions of this Article may,
but need not, bear a notation in form approved by the Trustee for such series, as to any matter provided for by such amendment, supplemental
indenture or waiver or as to any action taken at any such meeting. If the Trustee shall so determine, new Securities of any series so
modified as to conform, in the opinion of the Trustee and the Board of Directors of the Issuer, to any modification of the Indenture
contained in any such amendment, supplemental indenture or waiver may be prepared by the Issuer, authenticated by the Trustee and delivered
in exchange for the Securities of such series then Outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.07. <I>Conformity with the Trust Indenture Act. </I>Every amendment, supplemental indenture or waiver executed pursuant to this Article
shall conform to the requirements of the Trust Indenture Act as then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
8</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Consolidation, Merger, Sale or Conveyance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.01. <I>Consolidation, Merger or Sale of Assets by the Issuer</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Issuer shall not merge into or consolidate with any other Person or Persons (whether or not affiliated with the Issuer) or sell,
convey, transfer, lease or otherwise dispose of all or substantially all of its property or assets to any other Person or Persons (whether
or not affiliated with the Issuer), unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
either (a) the transaction is a merger or consolidation and the Issuer is the surviving entity; or (b) the successor Person (or the Person
which acquires by sale, conveyance, transfer or lease all or substantially all of the property or assets of the Issuer) is organized
under the laws of the United States, any state thereof or the District of Columbia and expressly assumes, by an indenture supplemental
hereto, executed and delivered to the Trustee, in form satisfactory to the Trustee, the Issuer&rsquo;s obligation for the due and punctual
payment of the principal of (and premium, if any, on) and interest on all the Outstanding Securities of any series and the performance
and observance of every covenant of the Outstanding Securities of such series and this Indenture on the part of the Issuer to be performed
or observed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
immediately after giving effect to such transaction and treating any Indebtedness which becomes an obligation of the Issuer or any Subsidiary
as a result of such transaction as having been incurred by the Issuer or such Subsidiary at the time of such transaction, no Event of
Default shall have occurred and be continuing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Issuer has delivered to the Trustee an Officer&rsquo;s Certificate and an Opinion of Counsel, each stating that such consolidation,
merger, conveyance, transfer or lease and, if a supplemental indenture is required in connection with such transaction, such supplemental
indenture comply with this Article and that all conditions precedent herein provided for relating to such transaction have been complied
with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The restrictions in Sections 8.01(ii) and 8.01(iii) hereof shall not be applicable to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the merger or consolidation of the Issuer with an affiliate of the Issuer if the Board of Directors determines in good faith that the
purpose of such transaction is principally to change the state of incorporation of the Issuer or convert the form of organization of
the Issuer to another form; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the merger of the Issuer with or into a single direct or indirect wholly owned subsidiary of the Issuer pursuant to Section 251(g) (or
any successor provision) of the General Corporation Law of the State of Delaware (or similar provision of the Issuer&rsquo;s state of
incorporation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.02. <I>Successor Substituted. </I>Upon any consolidation of the Issuer with, or merger of the Issuer into, any other Person or any
sale, transfer or other conveyance of substantially all of the properties and assets of the Issuer in accordance with Section 8.01, but
not in the case of a lease, the successor Person formed by such consolidation or into which the Issuer is merged or to which such sale,
transfer or other conveyance is made shall succeed to, and be substituted for, and may exercise every right and power of, the Issuer
under the Indenture with the same effect as if such successor Person had been named as the Issuer herein, and thereafter, the predecessor
Person shall be released of all obligations to pay principal and interest on the Securities and all other obligations and covenants under
the Indenture and the Securities. For purposes of the foregoing, if the Issuer consummates a Holding Company Reorganization, New HoldCo
shall be treated as the &ldquo;successor Person&rdquo; and the Holding Company Reorganization shall constitute the transfer to New HoldCo
of substantially all of the Issuer&rsquo;s assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
9</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Defeasance and Discharge; Unclaimed Moneys</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.01. <I>Satisfaction and Discharge of Indenture. </I>The Issuer may terminate its obligations under the Indenture, when:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
either (i) all the Securities of any series issued that have been authenticated and delivered have been delivered to the Trustee for
cancellation (other than any Securities of such series which shall have been destroyed, lost or stolen and which shall have been replaced
or paid as provided in Section 2.09); or (ii) all the Securities of any series issued that have not been delivered to the Trustee for
cancellation shall have (A) become due and payable, or (B) are by their terms to become due and payable within one year, or are to be
called for redemption within one year and the Issuer shall have made irrevocable arrangements satisfactory to the Trustee for the giving
of notice of redemption by such Trustee in the Issuer&rsquo;s name, and at the Issuer&rsquo;s expense and the Issuer have irrevocably
deposited or caused to be deposited with the Trustee sufficient funds to pay and discharge the entire indebtedness on the applicable
series of Securities not theretofore delivered to the Trustee for cancellation, for principal, premium, if any, and interest to the date
of such deposit (in the case of Securities that have become due and payable) or to the applicable maturity or redemption date, as the
case may be, together with irrevocable instructions from the Issuer directing the Trustee to apply such funds to the payment thereof
at the applicable maturity or redemption date, as the case may be;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Issuer shall have paid or caused to be paid all other sums then due and payable under the Indenture; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Issuer shall have delivered to the Trustee an Officer&rsquo;s Certificate and an Opinion of Counsel each stating that all conditions
precedent under the Indenture relating to the satisfaction and discharge of the indenture have been complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing conditions are met, the Trustee, on demand of the Issuer accompanied by an Officer&rsquo;s Certificate and an Opinion of
counsel and at the cost and expense of the Issuer, shall execute proper instruments prepared by the Issuer acknowledging such satisfaction
of and discharging the Indenture with respect to such series except as to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
rights of Holders to receive payments when due of principal thereof and interest thereon, and remaining rights of the holders to receive
mandatory sinking fund payments, if any;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
obligations of the Issuer in respect of issuing temporary Securities, registration of Securities, substitution of mutilated, defaced,
destroyed, lost or stolen Securities and the maintenance of an office or agency for payment on Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
rights of registration of transfer and exchange of Securities of such series, and the Issuer&rsquo;s right of optional redemption, if
any;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
the rights, powers, trusts, duties and immunities of the Trustee hereunder and the obligations of the Issuer in connection therewith;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
the rights of the Holders of such series as beneficiaries hereof with respect to the property so deposited with the Trustee payable to
all or any of them;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
the defeasance provisions of Section 9.02; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
the rights of the Issuer to be repaid any money pursuant to Sections 9.05 and 9.06.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.02. <I>Legal Defeasance. </I>Upon the Issuer&rsquo;s exercise of the option applicable to this Section 9.02, the Issuer will be deemed
to have paid the entire indebtedness represented by, and will be discharged from its obligations in respect of, the Securities of any
series and the Indenture, other than its obligations in Article 2 and Section 3.01, Section 3.02, Section 5.07, Section 5.11, and listed
in clauses (1), (2), (3), (4), (5), (6) and (7) of Section 9.01, <U>provided</U> the following conditions have been satisfied:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Issuer has irrevocably deposited or caused to be deposited with the Trustee as trust funds for the purpose of making the following
payments, specifically pledged as security for, and dedicated solely to the benefits of the holders of the Securities of a series in
cash or Governmental Obligations or a combination thereof (other than moneys repaid by the Trustee or any paying agent to the Issuer
in accordance with Section 9.06) in each case sufficient without reinvestment, in the written opinion of a nationally recognized investment
bank, appraisal firm, or firm of independent public accountants to pay and discharge, and which shall be applied by the Trustee to pay
and discharge, all of the principal, interest and any premium at due date or maturity or if the Issuer has made irrevocable arrangements
satisfactory to the Trustee for the giving of notice of redemption by the trustee in the Issuer&rsquo;s name and at the Issuer&rsquo;s
expense, the redemption date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Issuer has delivered to the Trustee an Opinion of Counsel stating that, as a result of an IRS ruling or a change in applicable federal
income tax law, the holders of the Securities of that series will not recognize gain or loss for federal income tax purposes as a result
of the deposit, defeasance and discharge to be effected and will be subject to the same federal income tax as would be the case if the
deposit, defeasance and discharge did not occur;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No default with respect to the outstanding Securities of that series has occurred and is continuing at the time of such deposit after
giving effect to the deposit or, in the case of legal defeasance, no default relating to bankruptcy or insolvency has occurred and is
continuing at any time on or before the date of such deposit (other than an Event of Default resulting from the borrowing of funds to
be applied to such deposit and the grant of any Lien securing such borrowings);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The defeasance will not cause the Trustee to have a conflicting interest within the meaning of the Trust Indenture Act, assuming all
Securities of a series were in default within the meaning of such Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The defeasance will not result in a breach or violation of, or constitute a default under the Indenture (other than an Event of Default
resulting from the borrowing of funds to be applied to such deposit and the grant of any Lien securing such borrowings), or any other
material agreement or instrument to which the Issuer or any of its Subsidiaries is a party or by which it or any of its Subsidiaries
is bound; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Issuer has delivered to the Trustee an Officer&rsquo;s Certificate and an Opinion of Counsel, in each case stating that all conditions
precedent provided for herein relating to the defeasance have been complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to compliance with this Article 9, the Issuer may exercise its option under this Section 9.02 notwithstanding the prior exercise of its
option under Section 9.03 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.03. <I>Covenant Defeasance. </I>Upon the Issuer&rsquo;s exercise of the option applicable to this Section 9.03, the Issuer&rsquo;s
obligations set forth in Section 3.04, Section 3.05 and Section 8.01 will terminate and Section 4.01(d) will no longer constitute an
Event of Default, <U>provided</U> the following conditions have been satisfied:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Issuer has complied with clauses (a), (c), (d), (e), (f) and (g) of Section 9.02; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the Issuer has delivered to the Trustee an Opinion of Counsel to the effect that the holders of the Securities of that series will not
recognize gain or loss for U.S. federal income tax purposes as a result of the deposit and covenant defeasance to be effected and will
be subject to the same federal income tax as would be the case if the deposit and covenant defeasance did not occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as specifically stated above, none of the Issuer&rsquo;s obligations under the Indenture will be discharged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.04. <I>Application by Trustee of Funds Deposited for Payment of Securities. </I>Subject to Section 9.06, all moneys deposited with
the Trustee pursuant to Section 9.01 shall be held in trust and applied by it to the payment, either directly or through any paying agent
(including the Issuer acting as its own paying agent), to the Holders of the particular Securities of such series for the payment or
redemption of which such moneys or Governmental Obligations have been deposited with the Trustee, of all sums due and to become due thereon
for principal and interest. Such money need not be segregated from other funds except to the extent required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.05. <I>Repayment of Moneys Held by Paying Agent. </I>In connection with the satisfaction and discharge of the Indenture with respect
to Securities of any series, all moneys then held by any paying agent under the provisions of the Indenture with respect to such series
of Securities shall, upon demand of the Issuer, be repaid to the Issuer or paid to the Trustee and thereupon such paying agent shall
be released from all further liability with respect to such moneys or Governmental Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.06. <I>Return of Moneys Held by Trustee and Paying Agent Unclaimed for Two Years. </I>Any moneys or Governmental Obligations deposited
with or paid to the Trustee or any paying agent for the payment of the principal of or interest on any Security of any series and not
applied but remaining unclaimed for two years after the date upon which such principal or interest shall have become due and payable,
shall, upon the written request of the Issuer and unless otherwise required by mandatory provisions of applicable escheat or abandoned
or unclaimed property law, be repaid to the Issuer by the Trustee for such series or such paying agent, and the Holder of the Security
of such series shall, unless otherwise required by mandatory provisions of applicable escheat or abandoned or unclaimed property laws,
thereafter look only to the Issuer for any payment which such Holder may be entitled to collect, and all liability of the Trustee or
any paying agent with respect to such moneys shall thereupon cease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
10</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Miscellaneous Provisions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.01. <I>Incorporators, Stockholders, Employees, Officers and Directors of Issuer Exempt from Individual Liability. </I>No past, present
or future director, officer, employee, incorporator, agent, stockholder or Affiliate of the Issuer or any of its Subsidiaries, as applicable,
shall have any liability for any obligations of the Issuer or any of its Subsidiaries under the Securities, this Indenture or for any
claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Security waives and releases
all such liabilities. The waiver and release are part of the consideration for issuance of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.02. <I>Provisions of Indenture for the Sole Benefit of Parties and Holders. </I>Nothing in the Indenture or in the Securities, expressed
or implied, shall give or be construed to give to any person, firm or corporation, other than the parties hereto and their successors
and the Holders, any legal or equitable right, remedy or claim under the Indenture or under any covenant or provision herein contained,
all such covenants and provisions being for the sole benefit of the parties hereto and their successors and of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.03. <I>Successors and Assigns of Issuer Bound by Indenture. </I>All the agreements of the Issuer in the Indenture and the Securities
shall bind its successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.04. <I>Notices and Demands on Issuer, Trustee and Holders. </I>Any notice or demand which by any provision of the Indenture is required
or permitted to be given or served by the Trustee or by the Holders to or on the Issuer may be given or served by being deposited postage
prepaid, first-class mail (except as otherwise specifically provided herein) addressed (until another address of the Issuer is filed
by the Issuer with the Trustee) to Integrity Applications, Inc., Attention:
Chief Financial Officer and a copy of such notice or demand shall be sent to the Issuer&rsquo;s General Counsel at the same address.
Any notice, direction, request or demand by the Issuer or any Holder to or upon the Trustee shall be deemed to have been sufficiently
given or made, for all purposes, if given or made at the applicable Corporate Trust Office of the Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
the Indenture provides for notice to Holders, such notice shall be sufficiently given (unless otherwise herein expressly provided) if
in writing and mailed, first-class postage prepaid, to each Holder entitled thereto, at his last address as it appears in the Register.
In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed,
to any particular Holder shall affect the sufficiency of such notice with respect to other Holders. Where the Indenture provides for
notice in any manner, such notice may be waived in writing by the person entitled to receive such notice, either before or after the
event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such
filing shall not be a condition precedent to the validity of any action taken in reliance upon such waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case, by reason of the suspension of or irregularities in regular mail service, it shall be impracticable to mail notice to the Issuer
and Holders when such notice is required to be given pursuant to any provision of the Indenture, then any manner of giving such notice
as shall be satisfactory to the Trustee shall be deemed to be a sufficient giving of such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.05. <I>Officer&rsquo;s Certificates and Opinions of Counsel; Statements to Be Contained Therein. </I>Upon any application or demand
by the Issuer to the Trustee to take any action under any of the provisions of the Indenture, the Issuer shall furnish to the Trustee
an Officer&rsquo;s Certificate stating that all conditions precedent, if any, provided for in the Indenture relating to the proposed
action have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have
been complied with, except that in the case of any such application or demand as to which the furnishing of such documents is specifically
required by any provision of the Indenture relating to such particular application or demand, no additional certificate or opinion need
be furnished.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
certificate or opinion provided for in the Indenture and delivered to the Trustee with respect to compliance with a condition or covenant
provided for in the Indenture shall include (a) a statement that the person making such certificate or opinion has read such covenant
or condition, (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
contained in such certificate or opinion are based, (c) a statement that, in the opinion of such person, he has made such examination
or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been
complied with and (d) a statement as to whether or not, in the opinion of such person, such condition or covenant has been complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
certificate, statement or opinion of an officer of the Issuer may be based, insofar as it relates to legal matters, upon a certificate
or opinion of or representations by counsel, unless such officer knows that the certificate or opinion or representations with respect
to the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable
care should know that the same are erroneous. Any certificate, statement or opinion of counsel may be based, insofar as it relates to
factual matters, information with respect to which is in the possession of the Issuer, upon the certificate, statement or opinion of
or representations by an officer or officers of the Issuer, unless such counsel knows that the certificate, statement or opinion or representations
with respect to the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise
of reasonable care should know that the same are erroneous.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
certificate, statement or opinion of an officer of the Issuer or of counsel may be based, insofar as it relates to accounting matters,
upon a certificate or opinion of or representations by an accountant or firm of accountants in the employ of the Issuer, unless such
officer or counsel, as the case may be, knows that the certificate or opinion or representations with respect to the accounting matters
upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should
know that the same are erroneous.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
certificate or opinion of any independent firm of public accountants filed with the Trustee shall contain a statement that such firm
is independent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.06. <I>Payments Due on Saturdays, Sundays and Holidays. </I>Except as provided pursuant to Section 2.01 pursuant to a Resolution of
the Board of Directors, and as set forth in an Officer&rsquo;s Certificate, or established in one or more indentures supplemental to
the Indenture, if the date of maturity of interest on or principal of the Securities of any series or the date fixed for redemption or
repayment of any such Security shall not be a Business Day, then payment of interest or principal need not be made on such date, but
may be made on the next succeeding Business Day with the same force and effect as if made on the date of maturity or the date fixed for
redemption, and no interest shall accrue for the period after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.07. <I>Trust Indenture Act of 1939. </I>The Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act
that are required to be part of and to govern indentures qualified under the Trust Indenture Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.08. <I>New York Law to Govern. </I>The Indenture and each Security shall be governed by and construed in accordance with the laws
of the State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.09. <I>Counterparts. </I>The Indenture may be executed in counterparts, each of which shall be an original, but such counterparts
shall together constitute but one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.10. <I>Effect of Headings. </I>The Article and Section headings herein and the Table of Contents are for convenience only and shall
not affect the construction hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10.11. <I>Separability. </I>In case any one or more of the provisions contained in the Indenture or in the Securities of any series shall
for any reason be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality or unenforceability shall
not affect or impair any other provisions of the Indenture or of such Securities, but the Indenture and such Securities shall be construed
as if such invalid or illegal or unenforceable provision had never been contained herein or therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ARTICLE
11</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><BR>
Redemption of Securities and Sinking Fund Provisions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11.01. <I>Applicability of Article. </I>The provisions of this Article shall be applicable to the Securities of any series which are
redeemable before their maturity or to any sinking fund for the retirement of Securities of a series except as otherwise specified as
contemplated by Section 2.03 for Securities of such series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11.02. <I>Notice of Redemption; Partial Redemptions. </I>Unless otherwise indicated for Securities of a particular series by a Resolution
of the Board of Directors and set forth in an Officer&rsquo;s Certificate or a supplemental indenture hereto, notice of redemption to
the Holders of any series to be redeemed as a whole or in part at the option of the Issuer shall be given at least 10 days and not more
than 60 days prior to the date fixed for redemption to such Holders of such series at their last addresses as they shall appear upon
the registry books. Any notice of redemption shall be mailed or caused to be mailed, by first class mail, or, in the case of the Depositary
with respect to any Global Note, sent electronically, to each Holder whose Notes are to be redeemed at its registered address. Any notice
redemption that is delivered in the manner herein provided shall be conclusively presumed to have been duly given, whether or not the
Holder receives the notice. Failure to give notice, or any defect in the notice to the Holder of any Security of a series designated
for redemption as a whole or in part shall not affect the validity of the proceedings for the redemption of any other Security of such
series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notice of redemption to each such Holder shall specify the principal amount of each Security of such series held by such Holder to be
redeemed, the date fixed for redemption, the redemption price, the place or places of payment, that payment will be made upon presentation
and surrender of such Securities, the conditions precedent, if any, to the redemption, that such redemption is pursuant to the mandatory
or optional sinking fund, or both, if such be the case, that interest accrued to the date fixed for redemption will be paid as specified
in such notice and that on, after said date interest thereon or on the portions thereof to be redeemed will cease to accrue and any other
information as may be required by the terms of the particular Security of such series or the Security of a series being redeemed. In
case any Security of a series is to be redeemed in part only the notice of redemption shall state the portion of the principal amount
thereof to be redeemed and shall state that on and after the date fixed for redemption, upon surrender of such Security, a new Security
or Securities of such series in principal amount equal to the unredeemed portion thereof will be issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notice of redemption of Securities of any series to be redeemed shall be prepared and given by the Issuer or, at the Issuer&rsquo;s request,
prepared by the Issuer and given by the Trustee in the name and at the expense of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
less than all the Securities of any series are to be redeemed, the Trustee shall select Securities of such series to be redeemed in whole
or in part in compliance with the requirements of the principal national securities exchange, if any, on which the Securities of the
applicable series are listed or, if the Securities of such series are not so listed, on a <I>pro rata </I>basis, by lot or by such method
as it shall deem fair and appropriate, or in the case of Global Notes, in accordance with the procedures of the Depositary. Securities
may be redeemed in part in multiples equal to the minimum authorized denomination for Securities of such series or any multiple thereof.
The Trustee shall promptly notify the Issuer in writing of the Securities of such series selected for redemption and, in the case of
any Securities of such series selected for partial redemption, the principal amount thereof to be redeemed. For all purposes of the Indenture,
unless the context otherwise requires, all provisions relating to the redemption of Securities of any series shall relate, in the case
of any Security redeemed or to be redeemed only in part, to the portion of the principal amount of such Security which has been or is
to be redeemed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
least one Business Day prior to the redemption date specified in the notice of redemption given as provided in this Section, the Issuer
will deposit with the Trustee or with one or more paying agents (or, if the Issuer is acting as its own paying agent, set aside, segregate
and hold in trust as provided in Section 3.03) an amount of money sufficient to redeem on the redemption date all the Securities of such
series so called for redemption at the appropriate redemption price, together with accrued interest to the date fixed for redemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11.03. <I>Payment of Securities Called for Redemption. </I>If notice of redemption has been given as above provided, the Securities or
portions of Securities specified in such notice shall become due and payable on the date and at the place stated in such notice at the
applicable redemption price, together with interest accrued to the date fixed for redemption, and on and after said date (unless the
Issuer shall default in the payment of such Securities at the redemption price, together with interest accrued to said date) interest
on the Securities or portions of Securities so called for redemption shall cease to accrue and such Securities shall cease from and after
the date fixed for redemption to be entitled to any benefit or security under the Indenture, and the Holders thereof shall have no right
in respect of such Securities except the right to receive the redemption price thereof and unpaid interest to the date fixed for redemption.
On presentation and surrender of such Securities at a place of payment specified in said notice, said Securities or the specified portions
thereof shall be paid and redeemed by the Issuer at the applicable redemption price, together with interest accrued thereon to the date
fixed for redemption; provided that any payment of interest becoming due on or before the date fixed for redemption shall be payable
to the Holders of such Securities registered as such on the relevant record date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any Security called for redemption shall not be so paid upon surrender thereof for redemption, the principal shall, until paid or duly
provided for, bear interest from the date fixed for redemption at the rate of interest or Yield to Maturity (in the case of an Original
Issue Discount Security) borne by the Security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
presentation of any Security redeemed in part only, the Issuer shall execute and the Trustee shall authenticate and deliver to or on
the order of the Holder thereof, at the expense of the Issuer, a new Security or Securities of such series, of authorized denominations,
in principal amount equal to the unredeemed portion of the Security so presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11.04. <I>Exclusion of Certain Securities from Eligibility for Selection for Redemption. </I>Securities shall be excluded from eligibility
for selection for redemption if they are identified by registration and certificate number in a written statement signed by an authorized
officer of the Issuer and delivered to the Trustee at least 15 days prior to the last date on which notice of redemption may be given
as being owned of record and beneficially by, and not pledged or hypothecated by either (a) the Issuer or (b) an entity specifically
identified in such written statement directly or indirectly controlling or controlled by or under direct or indirect common control with
the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11.05. <I>Mandatory and Optional Sinking Funds. </I>The minimum amount of any sinking fund payment provided for by the terms of Securities
of any series is herein referred to as a &ldquo;<B>mandatory sinking fund payment</B>&rdquo;, and any payment in excess of such minimum
amount provided for by the terms of Securities of any series is herein referred to as an &ldquo;<B>optional sinking fund payment</B>&rdquo;.
The date on which a sinking fund payment is to be made is herein referred to as the &ldquo;<B>sinking fund payment date</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
lieu of making all or any part of any mandatory sinking fund payment with respect to any series of Securities in cash, the Issuer may
at its option (a) deliver to the Trustee Securities of such series theretofore purchased or otherwise acquired (except upon redemption
pursuant to the mandatory sinking fund) by the Issuer or receive credit for Securities of such series (not previously so credited) theretofore
purchased or otherwise acquired (except as aforesaid) by the Issuer and delivered to the Trustee for cancellation pursuant to Section
2.10, (b) receive credit for optional sinking fund payments (not previously so credited) made pursuant to this Section, or (c) receive
credit for Securities of such series (not previously so credited) redeemed by the Issuer through any optional redemption provision contained
in the terms of such series. Securities so delivered or credited shall be received or credited by the Trustee at the sinking fund redemption
price specified in such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
less than 60 days prior to each sinking fund payment date for any series, the Issuer will deliver to the Trustee a written statement
(which need not contain the statements required by Section 10.05) signed by an authorized officer of the Issuer (a) specifying the portion
of the mandatory sinking fund payment to be satisfied by payment of cash and the portion to be satisfied by credit of Securities of such
series, (b) stating that none of the Securities of such series has theretofore been so credited, (c) stating that no defaults in the
payment of interest or Events of Default with respect to such series have occurred (which have not been waived or cured) and are continuing
and (d) stating whether or not the Issuer intends to exercise its right to make an optional sinking fund payment with respect to such
series and, if so, specifying the amount of such optional sinking fund payment which the Issuer intends to pay on or before the next
succeeding sinking fund payment date. Any Securities of such series to be credited and required to be delivered to the Trustee in order
for the Issuer to be entitled to credit therefor as aforesaid which have not theretofore been delivered to the Trustee shall be delivered
for cancellation pursuant to Section 2.10 to the Trustee with such written statement (or reasonably promptly thereafter if acceptable
to the Trustee). Such written statement shall be irrevocable and upon its receipt by the Trustee the Issuer shall become unconditionally
obligated to make all the cash payments or payments therein referred to, if any, on or before the next succeeding sinking fund payment
date. Failure of the Issuer, at least 60 days prior to such sinking fund payment date, to deliver such written statement and Securities
specified in this paragraph, if any, shall not constitute a default but shall constitute, on and as of such date, the irrevocable election
of the Issuer (i) that the mandatory sinking fund payment for such series due on the next succeeding sinking fund payment date shall
be paid entirely in cash without the option to deliver or credit Securities of such series in respect thereof and (ii) that the Issuer
will make no optional sinking fund payment with respect to such series as provided in this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee shall select, in the manner provided in Section 11.02, for redemption on such sinking fund payment date a sufficient principal
amount of Securities of such series to absorb said cash, as nearly as may be, and shall (if requested in writing by the Issuer) inform
the Issuer of the serial numbers of the Securities of such series (or portions thereof) so selected. Securities of any series which are
(a) owned by the Issuer or an entity known by the Trustee to be directly or indirectly controlling or controlled by or under direct or
indirect common control with the Issuer, as shown by the Register, and not known to the Trustee to have been pledged or hypothecated
by the Issuer or any such entity or (b) identified in an Officer&rsquo;s Certificate at least 60 days prior to the sinking fund payment
date as being beneficially owned by, and not pledged or hypothecated by, the Issuer or an entity directly or indirectly controlling or
controlled by or under direct or indirect common control with the Issuer shall be excluded from Securities of such series eligible for
selection for redemption. The notice of redemption of the Securities of such series to be redeemed shall be prepared and given by the
Issuer or, at the Issuer&rsquo;s request, prepared by the Issuer and given by the Trustee in the name and at the expense of the Issuer
in substantially the manner provided in Section 11.02 (and with the effect provided in Section 11.03) for the redemption of Securities
of such series in part at the option of the Issuer. The amount of any sinking fund payments not so applied or allocated to the redemption
of Securities of such series shall be added to the next cash sinking fund payment for such series and, together with such payment, shall
be applied in accordance with the provisions of this Section. Any and all sinking fund moneys held on the stated maturity date of the
Securities of any particular series (or earlier, if such maturity is accelerated), which are not held for the payment or redemption of
particular Securities of such series, shall be applied, together with other moneys, if necessary, sufficient for the purpose, to the
payment of the principal of, and interest on, the Securities of such series at maturity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
least one Business Day before each sinking fund payment date, the Issuer shall pay to the Trustee in cash or shall otherwise provide
for the payment of all interest accrued to the date fixed for redemption on Securities to be redeemed on the next following sinking fund
payment date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee shall not redeem or cause to be redeemed any Securities of a series with sinking fund moneys or mail any notice of redemption
of Securities for such series by operation of the sinking fund during the continuance of a default in payment of interest on such Securities
or of any Event of Default except that, where the mailing of notice of redemption of any Securities shall theretofore have been made,
the Trustee shall redeem or cause to be redeemed such Securities, provided that it shall have received from the Issuer a sum sufficient
for such redemption. Except as aforesaid, any moneys in the sinking fund for such series at the time when any such default or Event of
Default shall occur, and any moneys thereafter paid into the sinking fund, shall, during the continuance of such default or Event of
Default, be deemed to have been collected under Article 4 and held for the payment of all such Securities. In case such Event of Default
shall have been waived as provided in Section 4.09 or the default cured on or before the 60th day preceding the sinking fund payment
date in any year, such moneys shall thereafter be applied on the next succeeding sinking fund payment date in accordance with this section
to the redemption of such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page Follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused the Indenture to be duly executed as of the date set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTEGRITY
    APPLICATIONS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;], as Trustee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STATE
    OF ___________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ss.:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COUNTY
    OF _____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
this ___ day of ___________ before me personally came ___________ to me personally known, who, being by me duly sworn, did depose and
say that s/he resides at ___________ that s/he is a ___________ of Integrity Applications, Inc., one of the corporations described in
and which executed the above instrument and that s/he signed his name thereto by like authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NOTARIAL
SEAL]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STATE
    OF ___________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ss.:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COUNTY
    OF _____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
this ___ day of __________ before me personally came ___________ to me personally known, who, being by me duly sworn, did depose and
say that s/he resides at ___________ that s/he is a ___________ of [&nbsp;&nbsp;], one of the corporations described in and which executed the above
instrument and that s/he signed his name thereto by like authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NOTARIAL
SEAL]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><B>Exhibit
5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jolie
Kahn, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
E. 49th Street, 11th floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
20, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integrity
Applications, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white; color: #26282A"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8
Ariel Sharon Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white; color: #26282A"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Or
Yehuda 6037607</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white; color: #26282A"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white; color: #1D2228"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:
REGISTRATION STATEMENT ON FORM S-3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Integrity Applications, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the preparation
and filing with the Securities and Exchange Commission of a Registration Statement on Form S-3 to which this opinion has been filed as
an exhibit (the &ldquo;Registration Statement&rdquo;), pursuant to which the Company is registering under the Securities Act of 1933,
as amended (the &ldquo;Securities Act&rdquo;), the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">common
    stock, $0.0001 par value per share (the &ldquo;Common Stock&rdquo;);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preferred
    stock, $0.0001 par value per share (the &ldquo;Preferred Stock&rdquo;);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">debt
    securities (the &ldquo;Debt Securities&rdquo;);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
    to purchase Common Stock, Preferred Stock, or Debt Securities (the &ldquo;Warrants&rdquo;); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    combination of the above, separately or as units (the &ldquo;Units&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">some
or all of which may be issued from time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, at an
aggregate public offering price not to exceed $100,000,000. The Common Stock, the Preferred Stock, the Debt Securities, the Warrants
and the Units are collectively referred to herein as the &ldquo;Offered Securities.&rdquo; The offering of the Offered Securities will
be as set forth in the prospectus (the &ldquo;Prospectus&rdquo;) contained in the Registration Statement, as supplemented by one or more
supplements to the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Debt Securities may be issued pursuant to an Indenture between the Company and a trustee to be named in such Indenture (the &ldquo;Indentures&rdquo;).
Warrants may be issued pursuant to a Warrant Agreement between the Company and a bank or trust company as Warrant Agent (the &ldquo;Warrant
Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined the Company&rsquo;s Amended and Restated Certificate of Incorporation, as amended (the
&ldquo;Certificate of Incorporation&rdquo;), and Amended and Restated Bylaws (the &ldquo;Bylaws&rdquo;), both as currently in effect,
certain resolutions adopted on April 6, 2020 by the Company&rsquo;s Board of Directors (the &ldquo;Board of Directors&rdquo;) relating
to the registration of the Offered Securities and such other documents or records of the corporate proceedings of the Company as we have
deemed relevant, and the Registration Statement and the exhibits thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents
submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, photostatic or facsimile
copies and the authenticity of the originals of such copies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing, we are of the opinion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
With respect to the Common Stock, including those duly issued upon due conversion, exchange or exercise of any Preferred Stock, Debt
Securities, Warrants or Units, when (i) specifically authorized for issuance by the Board of Directors or an authorized committee thereof
(the &ldquo;Common Stock Authorizing Resolutions&rdquo;), (ii) the Registration Statement has become effective under the Securities Act,
(iii) the terms of the sale of the Common Stock have been duly established in conformity with the Company&rsquo;s Certificate of Incorporation
and Bylaws and do not violate any applicable law or result in a default under or breach of any agreement or instrument binding on the
Company and comply with any requirement or restriction imposed by any court or governmental body having jurisdiction over the Company,
(iv) the Common Stock has been issued and sold as contemplated by the Registration Statement, and (v) the Company has received the consideration
provided for in the Common Stock Authorizing Resolutions, the Common Stock will be validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
With respect to the Preferred Stock, including those duly issued upon due conversion, exchange or exercise of any Debt Securities, Warrants
or Units, when (i) specifically authorized for issuance by the Board of Directors or an authorized committee thereof (the &ldquo;Preferred
Stock Authorizing Resolutions&rdquo;), (ii) the Registration Statement has become effective under the Securities Act, (iii) appropriate
Certificate or Certificates of Designation relating to a class or series of the Preferred Stock to be sold under the Registration Statement
have been duly authorized and adopted and filed with the Secretary of State of the State of Delaware, (iv) the terms of issuance and
sale of shares of such class or series of Preferred Stock have been duly established in conformity with the Company&rsquo;s Certificate
of Incorporation and Bylaws and do not violate any applicable law or result in a default under or breach of any agreement or instrument
binding upon the Company and comply with any requirement or restriction imposed by any court or governmental body having jurisdiction
over the Company, (v) shares of such class or series of Preferred Stock have been duly issued and sold as contemplated by the Registration
Statement, and (vi) the Company has received the consideration provided for in the Preferred Stock Authorizing Resolutions, such Preferred
Stock will be validly issued, fully paid, and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
With respect to the Debt Securities, including those duly issued upon due conversion, exchange or exercise of any Preferred Stock, other
Debt Securities or Units, when (i) specifically authorized for issuance by the Board of Directors or an authorized committee thereof
(the &ldquo;Debt Securities Authorizing Resolutions&rdquo;), (ii) the Registration Statement has become effective under the Securities
Act, (iii) the terms of the Debt Securities and of their issue and sale have been duly established in conformity with the applicable
Indenture and do not violate any applicable law or result in a default under or breach of any agreement or instrument binding upon the
Company and comply with any requirement or restriction imposed by any court or governmental body having jurisdiction over the Company,
(iv) such Debt Securities have been duly executed and authenticated in accordance with the applicable Indenture and issued and sold as
contemplated in the Registration Statement, and (v) the Company has received the consideration provided for in the Debt Securities Authorizing
Resolutions, such Debt Securities will constitute valid and legally binding obligations of the Company, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors&rsquo; rights
and to general equity principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
With respect to the Warrants, including those duly issued upon due conversion, exchange or exercise of any Preferred Stock, Debt Securities
or Units, when (i) specifically authorized for issuance by the Board of Directors or an authorized committee thereof (the &ldquo;Warrants
Authorizing Resolutions&rdquo;), (ii) the Registration Statement has become effective under the Securities Act, (iii) any Warrant Agreement
relating to the Warrants has been duly authorized, executed, and delivered, (iv) the terms of the Warrants and of their issuance and
sale have been duly established in conformity with the Warrant Agreement and do not violate any applicable law or result in a default
under or breach of any agreement or instrument binding upon the Company and comply with any requirement or restriction imposed by any
court or governmental body having jurisdiction over the Company, (v) the Warrants have been duly executed and countersigned in accordance
with the Warrant Agreement and issued and sold as contemplated by the Registration Statement, and (vi) the Company has received the consideration
provided for in the Warrants Authorizing Resolutions, the Warrants will constitute valid and legally binding obligations of the Company,
subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating
to or affecting creditors&rsquo; rights and to general equity principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have relied as to certain matters on information obtained from public officials, officers of the Company and other sources believed by
us to be responsible, and we have assumed that the Indentures will be duly authorized, executed and delivered by the respective trustees
thereunder, and the Warrant Agreement will be duly authorized, executed and delivered by the Warrant Agent thereunder, assumptions which
we have not independently verified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is understood that this opinion is to be used only in connection with the offer and sale of Common Stock, Preferred Stock, Debt Securities,
Warrants and Units while the Registration Statement is in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters.
This opinion is based upon currently existing statutes, rules, regulations, judicial decisions and facts, and we disclaim any obligation
to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters
or opinions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the filing of this opinion as an exhibit to the Registration Statement (and this consent as Exhibit 23.2 is subsumed in this
Exhibit 5.1) and to the references to this firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus which is a part of the
Registration Statement. Reference is made to the section of the Registration Statement entitled &ldquo;Legal Matters&rdquo; for a description
of ownership of the Company&rsquo;s securities by a member of this firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jolie Kahn, Esq.</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_001.jpg" ALT="" STYLE="height: 86px; width: 300px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 75%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 25%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fahn
                                            Kanne &amp; Co.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
    Office</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32
    Hamasger Street</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel-Aviv
    6721118, ISRAEL</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PO
    Box 36172, 6136101</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T
    +972 3 7106666</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F
    +972 3 7106660</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.gtfk.co.il</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTERED
PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have issued our report dated April 13, 2021, with respect to the consolidated financial statements of Integrity Applications Inc. included
in its Annual Report on Form 10-K for the year ended December 31, 2020, which is incorporated by reference in this Registration Statement.
We consent to the incorporation by reference of the aforementioned report in this Registration Statement, and to the use of our name
as it appears under the caption &ldquo;Experts.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FAHN
KANNE &amp; CO. GRANT THORNTON ISRAEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel-Aviv,
Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
20, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Certified Public Accountants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Fahn Kanne &amp; Co. is the Israeli member firm of Grant Thornton International
Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex3-1_001.jpg
<TEXT>
begin 644 ex3-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /# JD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HKF]+\376M&6[T_2A+I"RM ER;C$LK*^QF6/;C8"#R6!XX
M4U0T;QGJ.K>(KS2/[.TI);*=HIT356>8* /W@C\D?+\P'+#OC.* >AV=%<'H
M/Q"NM8UG^SGTJQ#I=RVDT=IJ1GGA*$CS'C,2[8R1C<3W''-78?%'B"7Q5)H9
M\/V"M%!'<O(-48D1.Y7@>3@L-I)&<>A-'8'I?R.OHKSJY^(^IVFD3ZC<:)ID
M44&J_P!F2-)JS*JMNV[RQ@X7)_+\JU!XOU9;[0('TC3GBU>1E2>#4V= JIOW
MK^Y&X%0<=.?;FA:[?UU_('I_78[&BN;TOQ-=:TTMW8:4)=(65H$N?M&)965]
MC,L>W&P$'DL#QPM6AXA0>+_[ >V9"UH;B*X+#;(58!T ]5#(?^!>U']?J!M4
M5R$/BCQ!+XJDT,^'[!6B@CN7D&J,2(G<KP/)P6&TDC./0FF>'/&>H:]K%S8-
MIVE1&TGD@N4AU1I9HMA(W^685^4G&,L#WQQ0M0>AV5%<[JOB6>#Q!%H.DV$5
M[J36QNY%GN3!''%NV@E@CDDG@ +VY(KG[[XGK#:Z3=6]E8I;WTLUO))J&H&V
M%M-%G<C8C<'[N 0>21QS0M0/0J*YS7_$6H:#X-FUR32[>2XMTWS6OVPA0N<?
M*_EG/8C*CKVJE+XSO;/5?[.O])MX)9H<VDPO2T,TX7<86;RP4.#D':<X/'&*
M/Z_4#L**YI?$M]<:NND66F6\]]!!'/?YNRL5N'SA5;82['!(&U1CJ1FF7/BJ
M\?6%TC2](6XU!+47=S'=7/D+"C$A5R%?<Y(/ &./O=* .HHKSZ]^)\:6NAWE
MG:Z>MIJHE7SM2U'[(()(\[D?]VXZC YY/YU:OO&^K6T>B-%X>A#ZHLO[NZOF
MA:)HU9CTB;*E5R#QG(R!0'D=O17'Q^.'U.;3;30]-%S>WE@-1:.[G-NL,)P!
MN8(Y+$\  8XSD5FWGQ06.+29K>ST^."_>:%Y-2U+[*+>:+.]&(C<=L YYSTI
MM-.W]?UH!Z%17/R>)+B+P7)KS:1.+E(&E%@7P[%<\ XZ$#(.,X[=JK>(/%=U
MIGA5?$6F:=;W]B+4W<ADO#"0F 0%Q&^XG)ZX''6DP6IU-%<A=>*M<L9]$AN=
M"L%;5+K[."FI,P0;"X8?N1G@-P<<@=CFH/\ A80^Q-K)TY1X=6[^R?;?M/[W
M=YGE[_*VXV;N^_/?;3L]OZ_K45]+_P!?UH=M17(3>,[J#6+[29-+@CO$4O8-
M)>$17BK@N-PC)5E!!V[3]<<UUJ%S&ID55? W!3D ]\' S^5+I<?6PZBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** .<T3PU=: [VEEJ:#1S*\R6S6V98
MV9BQ42[L;,D\%">?O56TGPUKNEZC=W UK39(;N\:ZE4:6XD&X*"JOYY !"C^
M$_X=910#U.%TWP#?:;-'>IK5K_:4=]-<K<)8,JM',<R0LOFDE2<$'(P0.M;4
M7A^]B\;W7B ZA;F&:T6T%K]E(90I+ [_ #,$Y8_PCC ]ST%%']?H&]_ZZW//
MS\/]9-BUL?$%AEM7&K%O[+?_ %FX-MQY_P!W(^N/SK>U?PY=ZCKVAZA;W]M;
M0:7(TGD&T+F0LI1@&$@"C:3C@X///2NBHH6EOZZ6_('K_7S.;T7PU=Z SVEC
MJ:#2#*\R6SVV98V9BQ42;L;,D\%<\_>K.F\"W+ZEI>KQ7NEV^L6MRTUU?1:6
M5>[5@5V-^]SC:<<EN0,8QBNUHH3MJ#UOYG/Q>'[V+QO=>(#J%N89K1;46OV4
MAE"DL#O\S!.6/\(XP/<T]!\-:YHUS(9-:TZ>WFNY;J54TQTD)D;<RJYF8 9Q
M_">E=910M >O]?(Y_5/#D\^O1Z[I5[%9ZD+8VCM/;>?&\98,,J&0Y!Z'=W.0
M:R8OA^]E<:&;+4H5@TV>6XF6>T,CW4DH82$L'4+D,<#:<<=1Q7;5R7C^_OK+
M3]+AM)I+>&\U*"UN[B-MK10N<$AOX23A<]1GCFA7NDOZ_JX/6]_ZT_R1H^+-
M"G\2>&KK1[>\BLQ<J$>5X#+A?0*&7GISG\*J7/A275],O[#6[NVN8KD1M$UM
M:M"\,B*!O!,C<Y (Z8Z<UQ^NW-]8VOC?2K2_U%K'3=.CNK:X^VRF6WG*L2GF
M[M[#A6P2<9QT.*[3P=IUS9Z4)[PW"SSJI,<FIS7J8 X96EY!.>0 !Q[9+6U_
M3^OP!NS7]=O\PE\-7-OX@DUG2=1CM9[F*.&\CGMC,DJIG:R@.I5L$C.2/8TE
M[X9N?[:.L:5J4=KJ$EJMI</<6WGK*BDD' 9,."3SG'/0UTE%(#AF^'$,:Z':
MV]W!_9NFI,LT%S:F5[KS@1(68.H!.3_"<'VXJ*7X>W][)HL&I:OIVH:;I$K-
M%;W6EF1I$(*A9&,V&(4C#;>H!(-=]13N]P.>U+PU+)KD6MZ1>0V.HI:FS8S6
MWG1O%N# %0R$$$<$-CDY!K%/PWC1](BBO8'LK,W#W,-S:F1KMIP1*2P=0N03
MCY3CWZ5W=%+^OZ^]@<G;^$+HV-GIFK7NGZMI5J'5+>\TW>S#&(]S&0@L@XSM
MYSV/-5(_ VHK\/+OPFVMVS+,'CBG%@P$,3'.P)YO.,D [N!C@XKMZ*+@M#E]
M4\,ZEJ4_AZ7^U;2-M)E$T@^PLPG?84./WHV##-Q\W..>,&D?A^ILSHW]H)_P
MCQN_M9LOL_[TMYGF;/-W8\O=VV9[;J[6BG=WO_7?\PMI;^OZU.<N_"HU6WGB
MU2XAE(O1=VDD$!B: C& 27;=P,$C ()&*Z.BBEY %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %<RWQ \-I'<22W=S%%;7 MIY)K"X18Y#_"S,@ ZC
MGH 03735YYI6FZH+O6(M0\,WC6FHZPTY#RVS+Y#Q!"6 ESVY !.", T+?^NZ
M#I_7F=3>>*=+L'G6?[<?(95<Q:=<2 Y4L-I5"&& 22N0.^*HCX@^'&TU-1$]
M\;21HU23^R[KYR_W"!Y>2&/ (X)XZU'I6AZCH'AS5].+2ZBB[UT]0R^:8=@"
MH2Q RIR,DC@"N?NM$UN3X3Z#HAT.^>^MWM5N((;F%'18G4LP?S0.0IVE6SDC
MIV>GY?C_ )!_P?R.U'B;2O[+?49)IH+=)!$1<6LL,A<XPHC=0Y)R, #G/&:B
MN_%^BV.E2:E<SW$5M$5$H:SF\R+=]W?'LWKG'<#MZBL&]TG4[ZQT6YM=*O+=
MM$OA,EE?W,;RW*;"I.]7==WS'!9N2.2,YJIXEL_%VO\ A37+>728S]K*1V=I
M$(XKE4#!B99//*<<@;3GG/'0)_U^'^;^X%_7X_\  ^\Z5O&NA)IM[J$EQ<QP
MV6#<K)8SK+$#R&:,IO"X_BQC@\U#/X]T"VEMXI7U$/<8$*C2;IO,)7?@8CY.
MWDCJ.]<Q=Z'KUMX5\2:)!HU]?G4;<FTNI;F%IAO7'DS.\NYC&2<-EAMX!)'.
MKJMEJ]S?^"YXM%NV6QF\V[_>P P Q-'@_O.3EL_+G@'O@%I:_=^3_5?UH*^G
MW_H;5MXRT2[O+RT@FNGGL[<7,Z?89P5C(R",I\V1T R3@X'!K5BOK>;3EOPS
M);-%YNZ6-HR%QG)5@"..Q&:Y;Q)IE^_C/0M2TW3+F9!OM]1FBEB56MVY"L&<
M%L/@\ \;NYQ6[KHO)K:&TM(KO%Q*(Y;BU,.ZW3KOQ+P1P!C#<$\&D_ATW_K_
M ('XCZZ_U_7^1#=^+M%LO#]OKLUU(=,N ACGBMI9<AONDA%)7/3D#D@=:J7_
M (R\-?V?";QYYK>\E:V$1TV>4M(.L;H(R5;_ &6 )]*XNXT#Q+#X!U;PM!HN
MHSHE\#IUPT]H&>#S!(21Y@ ((; P.J\#D#3\0>%K]+#1H=(M=4FN&U5-1OKP
M26HG1MI!8AB$+<@ *I7Y3[9'K^'XAM^/X&PEYX)E@L/#\6FVLEIJ ,UM:QZ4
MS6[X/).(]BD'KG!'?%:JZQHNDZM9^&HD>WN'B+6UO#92"((O7#*NP <9Y&,C
MU%<[<Z/=Z!X@T#^R-!O[[3]/@N1+)%-;AF>4@Y_>2)DY!)X Y&/0.N+77-4\
M9Z1?S:)=6MNMA<P32^= ?(:4KMR!(22 G)4$9(QGG#OV\_UL'K_7<Z2T\3:1
M?73V]M=&0I)Y7F")_*9\X*K)C8S YR 21@YZ58BUC3YKZ^LH[E&N;%5:YC .
M8PP)7/U /2N>\)6^KZ%X>M="N]%=SIT6P7231&*X"Y*E 6W!CQPP4 Y^8]\Z
MRTK7K#QKI^N)9ZE<1ZA;M#J44\EJ%M!NW(!L(+;6+?WSM/7/%%M;+^NP=+FY
M;>.]"N[U[.%M1-Q& 71M*NEV9!*YS&,9 .,]>V:E@\:Z!<:.-5CNYOLC3&W0
MO:3*\D@X*I&4#N<@C"@\@^AJAI%MJ=KXW\3W\VD7*VEU'!]FE\R$^<8U(( W
MY!.>-P ]<5S>D>&==@TKP_>S:5/'=Z-J5U</8M-#NGCEWD%&#E-PWCAF7H>>
MA(M?P_-_U\P[_P!=/\SM)O&F@6^FC4)KYH[7SA [O;R Q2<?+(NW,9Y'WP*L
MS^(M-MVNEE:Y!MB@<BSF(<M]T1D+^\)]$W&N5L] O_[3U34;_2)Y8=;OHS+8
MB2%OL\*PF,M)E\$G/(0MQCK3SX0O;;PQ>:+*UU?01W2O8RP70AN8H5 *!7/\
M:D%03C(QDCFET_KRO_7^0=?Z_K^O,[>"XBN81+$Q9#D<@@@C@@@\@UAW7C?0
M;*ZU"VN)[M)=/0/=?\2^X(C4]#N"8(/.""<X/I4/A^[UFS:QTK58I;B22*:5
MKF66,RQ*'Q&DBIP6*GEEXR#UZUD2VNLQ>+_$5\OAV^GM;I+2.!TFMOWGE,=Q
MPTH(&&R,XZ'IQEVUM_70.AU<7B'3)G41W#&-K878N/)?R/*_O>;C9^&[/M1I
MGB#3=8Q]BFD;=DIYD$D7F*,99-ZC>O(^9<CGK7(WO@*].B>)-$L+M8].OX ;
M")S_ ,>SDEGCX_Y9DXQZ;B*Z2UO]7;2Y)&\.R17=M"1'!+<Q?OG & C*S *?
M5MIZ<4:?U_7R_$/Z_(W:*122H)&#CD>E+2 **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=<YW1)CMTSG)Z8Y -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<\UKU4K7=MB(WY5?<****104444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1-4M/MMKJNGM9BW%Q(YNEW1*3C+K_".",D]015@^)M!7R,ZWIH\]0\.;N/\
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M/*VJV*QQRB!V-P@"R'D(3GAN1QUYJ"'Q1HUS;ZI/!?0RII;,MV8W#&/:NXY
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M%67W?D%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVT9;Y@-H..Q()[4 6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHJIJ.IVNE6OVB[=U0MM58XFD=SUPJ*"S' )P >AH MT
M5B'Q=H8FM8Q>EOM2H\;I#(R8?[FYPNU"W8,02>!57_A/?#VQ'^T7FQXVE#?V
M=<8VJ0&.?+_A)&X=5[XH Z6BL5O%FBK>M:?:V:55+ I!(R,0N\JKA=K/MYV
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M8>Q!![UN444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMZEIOB'7=!FM+Z'2X)=\;>3'/)+%<A6#,CL44JK %2-K<'OT():V.IHKSA/
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M>HK)&S1HR%B552K.&)+*1\H8 ]2!S6M8^)(K_P .G6X]/ODMS&)(XW5/,D!
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M\O\ AO\ @DZ_U\_^ 9MU\1-/L-.EO-0TZ^LA'<FT*7#VZ9E SMW>;L^Z,Y+
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M;C$Y0>8<2+@$+WR12>&-6D.OZMHQ,L@BNYI!)=7#LP3Y<+'N!W $G(W#;E<
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M9I^(-Q]GCG71T:.X2.:VQ=\M$TRQ'>-GR."X.WD'GY@0:>M[=P:_#^OT'?\
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M&H.!)"J*R.I\K/S%BOMM)!-)O1_UYCMM_7D:)\+W:-((;ZS2'R@L4)M9&42
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M3W4<RM)F-(HC&D2  !0&9CV]<>@%:E%%( HHHH **** "BBB@ HHHH ****
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M%69-<\0OHU]#!)KSWHN$%K<'2_*X:$-AMUNPV!PRY"$CC)&<TEM<=CL[S1-
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MRR+/-=6$D;2$3$ 2(ELQ ,>#D",9_BX(IV$Y=3T2STZVL89HH(E"32O+(H4
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M)9':TC+.XZ,3CDCUJFTW>V@G<YN'XB.9=3\_0[A(+!9 UP@D,9EC<(R%VC5
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M!?D=:]/HIIV \QN-(\3%8_+L_$/V4M<&*W&KKYT*&)0BR.9_G/F@D'<V!QD
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M(  W$#OW(%<Y:^.XIXHII-"U>VADNA:K)+Y!&_S?*/W92<!\ _7(R*ZLYP<
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MOYENR@YPP.QCD#H>:0=CU2J-]J:6%YI]O)!,_P!MF,*2)MVHP1G^;)!P0IZ
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MM?\ (]#F=HH))$B>5E4D1H0&<CL,D#)]R!5'0]777=)AU%+2XM4ESMCN-F_
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MB(D(K9(XCYRORGO@#!!R2*UAOR)M4O[NSU?1H86@^S7=P\,RO&2_$3NI5@P
MY3!!!SGMBLRR\0:G>:AL$5H+>Z:YBLP0P9'A;;ESD[@V"> ,8 YSQKZGHXU*
M]TZY-[=6YL)S,B0B/;(2I7#;E)QM9AP1U^F*L7A>W@O+BY@O;R)I!+Y*J4VV
MK2'=(T8*]6//S;L=L D4NGW_ -?UL-B:7>ZO=:?J<5RUFM[:S/#%<QP-Y,N%
M#!O++YX+;2-_53R*YW0?&6J:O=Z!"S1K]KMGGO VC74() # 0N[;3]X#C?G&
M>_'4V&B2V.E36/\ ;-_.T@*I<2K")(N,?*%C">^64Y)YS5&W\');II*+K6J%
M=,@>WB&81O5ACYB(P<@  %2.@[Y);_K[G_P!=/Z\B[;:R-7C632"Q\FY$5U'
M=6LD+JN,D;7VLIP00<'/ISD0G6KD>*TL#'#_ &>Z-$)>=_V@*'V^F-A/XJ:?
MX>\-6WAR*Y2VN+B8W+K)*TPC!9PH7=\BKDD*,GN>?6LUO &F&6*[6XG358[H
MW)U58+873DY^1G\KE<'&,= !G%&E_P"OZ\PZ/^OZ[&DOBO2&A:8S7$<:-*CO
M+9S($,>-^[<@QU&">IX&35/4/&6G+H5Q=V-T5N5#I''-93%TD5=W[R+"NH (
M))V@ @Y -6[CPO873ZH97N"FH@>8@DPL;  ;DXRK':I/NHJA)X$LY0TK:IJ?
MVZ0N)KX/$)9E=55D;"; -J(/E4$;<@YR3+V&K7U-.P\06MU<6ME+YR7LUNLV
M#;2+&WR@G;(5V-C/0,36?+K]]%XN?39GL[6VR@MTN(G#W0*[F:.0':6&&'EX
MSQG..*?I_@VVL-7M]3.HW]S<6Z>6AG\H_+L"%<B,$ [0V 0,C.!S5N\\.QWU
M_'<3ZA?-"DZW'V3>IB+KC:>5W  J#A6 )SD&J=K_ 'DJ_+9^10L/'VAWL*.[
MW5LSK)(%GLYD'EH^UGR4 P,@GGC//0U:/C/0ELC=FZF$8D,90VDWF*0 QS'M
MW@!2&W$8P0<XYJJG@:P#@2WU]/;?9KBU-M(8]ACF;<XR$#=<8.>W?G-$_"W0
M&TJ&P(RL,QFC?[%:<$@*04\GRVX Y92WO2&=!I'B&TUF^U*UMDG!L)EB9WA=
M4?*!LJQ !Z]B>QZ$9YW6_%FHZ3XNDTU;W2FC\N"6"P>!Q<W(=F1E1O,P2NW=
M]S&#SC&:W+/P^VEWS36%[,D,\ZRW$#"/8=L0CPH"9&=JG@C!''&0;,&C"#Q#
M=:O]ONG:YA2$VS"/RE"$E2,(&SEFZL?O'VP]+H.C*6JZMJ#:];Z%I)MHKJ2V
M:ZDN+J)I4C0,% "*REB2?[PQCOTJ"+7[^[\)ZI>0K;0:EI[3Q2;T:6(O$3D@
M!E.& R.>,]\<WK_PZE]/%=C4;VVOX=ZQ7D'E"1(W()CPR%2O ^\I/ .<\TR3
MPS#_ &-)I=K?7EI#*L@F>(QL\C2'+.Q=&^8\^WS'CIB7?E?<:MS*^QB^'O&<
MMP]ZNKW$/EV]O'<&4:?/9,-Y(V^5*S._.,,O!)P.:UF\:Z"D<;M<W $F\!?L
M4^X,N-R%=F0_(^0@,>PJN/ ]I*DOV_4]1OYFA6&.>=HU:!58.NP1HJ@AE4Y(
M)XI)_ ]M<6[1OJVI^8[M-).IA#O,0H$O^KP'4* "H  )XJF2KV-#Q'K4FD>'
MKF^M(1-=+ \L,4@*@[5+$MW  '/Y=35:YUJ^@U?1H2UNMM?##JT#Y)VYXESL
M4YP A!+9)&,&K6L>&-*\0:4+'5[6*^VQ-&EQ/#&\J$C!=25PK=\@#GM2)X<@
MCELU2ZG2QLU006")$L*,OW7X3=D>F[;[4NHWL-TN]U9M;O;#41:2)'#'/');
M(R[-Q8>6VXG<1MSN&,Y^Z*D\1:A>Z?I;-ID,4U^Y(ACESM8@%CG'/W5/XXJO
M%H%]9K<M;^(-0EEG<./M"P8C^8$XVQ MP-OS9XX!7J)M6\,Z?KM_!/JB+>6\
M,;*ME<0Q2P;C_P M,,A.[L#GIGCDT/96_K^MAZ7)O[>L2M@!*Y>_C$D CA>0
M8('S-M!VCYAR<#GK7,IXUN)O"4]VDMJ-7M%$DZ/:2K"R>:4)7+#.=IY#-M/7
MTK4M?!T5KIEEIZZOJ+06<@>+*P!@H.0F1$-JC'&W!QQG'%46^'4+63VA\0ZR
M87A,# BVY4R>8?\ ECZG\J;WT_K7^D39V_K^O,V9_%FC6J0O-<R*LS,$/V:4
MY (!<X7B/)'[P_+R.>:JQ>*8+*WN6UB=0Z7DT,?V:VD<LB8.XJN\X (W-T[\
M51N/AMH]U#91W$\\WV)W,!G@MI0B,03&%>(J%! Q@;AT!QQ5MO!4#.\PU?4U
MN&FED6=?)#(LF-\8_=XV':.H+#'!%+T_K^OZZ#+MOXLT6[U-=.@NG>X9]B_Z
M/($+%/, #E=IRO(YY&<9P:C\6ZCJ6EZ3%<Z7+:)*UW!"WVJ!I5*R2+'P%=,$
M;@>O;'?(I1>!+:TNTN+/5=1@6*:.>*W3R?+4I%Y2KS$6QLXZD]ZOZEX?FUG0
M[6PO=6O(I8GBEDGMA%ND="&&=T97[P!X49QV'%5I=?UU!>8Z;Q7I%J'\^XF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL_4]9M=(\K[3%?2>;
MG;]DL)[G&,9SY2-MZ]\9YQT- &A17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\
MSZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_
M .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/
M_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZ
MZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?
M_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\
MSZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_
M .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/
M_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZ
MZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?
M_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\
MSZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_
M .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/
M_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZ
MZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?
M_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\
MSZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_
M .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/
M_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZ
MZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?
M_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\
MSZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_
M .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/
M_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZ
MZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?
M_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\
MSZZY_P""*]_^,T =!17/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_
M .,T =!17/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,T =!17/
M_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,T =!17/\ _"9:7_SZ
MZY_X(KW_ .,UH:9K-KJ_F_9HKZ/RL;OM=A/;9SG&/-1=W3MG'&>HH T****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M//#;6=I>JJP71:=+&4QQ-*@"%V"X4D@YR<COBMK_ (03P?\ ]"IH?_@NA_\
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M()]6L8I;:/S)XWN45HD_O,"?E'N:0&A16<OB#1F@6==7L#"TI@607*;3(.J
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MN6O;?S8;@6OG!;UW$#O$Q_=JR@$$J,@;.N<&CFWO_6@FM$3_ /" 3?8(K/\
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M79G()DR' Z@';CUYYXJ:?X]U'4ULA!X=,;7D[0PFYEF@1OW1E5@7A!(^4AB
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M?EYYK%T'3];@\6K=ZC8WI!@N(IKM[M)(2QD1D,:;R47:N,!1R.1_$<[6]/\
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M,*.<5:SM_6Y%[QNOZT.AU@>$K"WN+S5=-LU6]?;<-)IY=IRAX+@(2RKC.XC
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M.Y+>3869=RKN (5F'(0G<>P-5KOPD+ZWA2YUO5))HH9H!<$0!V250&!Q%M[
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MOZ'::I;QS1Q7,8D5)HV1AGV8 _CT/49%95KX(LK:>-S?W\T2LDK02-'LDF5
M@E.$!W;0. 0N1G;GFM71](&C6%M917ES/;V\"P1K-LX"YP<JH.<8'I@#C.2:
M=M2%>R-&BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"_-E_\CUN01M#;Q1/-).Z(%:60*&<@?>.T 9/7@ >@%"^&W];)?H-ZN_\
M6[9)1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **IZKJ']EZ9/?&UGN5A7>T<&S?M'4C<RC@9/7/'&3Q5
M*#Q';W>H:?;6MK<SPWUNUQ'=H8_*55QD,"P<'+*,!3U]C@6H&S116='JPEU2
M\T];.Y\VU\IBQV;763.&7YLX&ULY /' /&0#1HHJ*YN(;2VEN;B18X8D+N[=
M%4#)- $M%("" 1T-+0 45F:UK<6BPPN]K=7<LSE([>U0-(^%+-@$C.%4G'4]
M "<"F:EX@M-,:%)$EE>26"-DC"[HA,^Q&8,1QN&.,GVH2N!K445E:EKL5A?1
M6$-I=7U]*AE%O:A-RQ@@%V+LJ@9/<Y/. <4 :M%16TYN(%E,4L1)(V2C##!Q
M_2I: "BBB@ HJO%=QSOB#,JJ[1NZD81EZ@Y.>O'&:L4 %%%4+'58K^]U"T6&
M:.2QF$4ADVX<E X*X)XPPZX/M0!?HJCJ.IKIS6@>WFE%S.( 8MN$8@D%LL..
M,<9Z^G-4SXD@&A6FK?8[OR;B6.(Q_)OB+N$!;YL8#$9VD^V:%J!M4450GU1(
M-8@TTV\[23P23I(NW8=A4%>6SGYQVQ[T 7Z*JWEZ;+3)KUK::3RHC*84*[S@
M9(&6"Y_''O4$VLQ0PZ=-]GG>._D2-&7;^[+*2"V6''&.,\G\: -&BBHK>XAN
M[=)[>021.,JZ]"* ):*S]8UFVT6QFN9U>0QPR3"&+&]U09;;D@<#U(J[#*LT
M,<J@A74,,]<$9H ?16=JVLV^D1P>9'+/<7$GE6]M  9)GP3A<D#H"<D@#N:G
ML;Q[R%GELKFS=2 8K@+NZ ]59E/7&03R#0!:HHHH ***KM>1^?)!$#+-'L,D
M:$90,2 3D@8X)]<#ITH L4444 %%%5[F[CLT>:X!2WCC:22<D;4"^O.>F3T[
M'VR 6**0$$ CH:CN+F&TB$D\BQH75 3W9B%4?B2!0!+115 :K&=>;2#;SK*+
M?[0LIV^6R[MI YW9!QU '/4T 7Z*HZ9JD>J+=%()H6MKE[9UEVY++CD;21@@
M@COZ@47VIQV%W86\D,S_ &V8PHZ;=J,$9_FR0<$*>@- %ZBJ,6II+K5SI?D3
M)+!#'-YC;=CJY8#;@YR"ASD#\:O4 %%5M0OH-,T^XOKEBL$$9D<@9.!Z4S3+
M\ZE8K<M9W5FQ9E:"Z0*ZD$CG!((XX()!'0T 7**** "BB@D $DX H **BMKB
M&\MHKFWD$D,JAT<=&4\@U+0 453U74%TG2;K49()9X[:)I7CAV[RH&3C<0.G
MO5I'$D:N,X8 C- #J*** "BBFNZQQL[G"J"23V%&P#J*S-$UJ/7+1KF*SN[:
M/(V&YC"^:I4,KJ02"I!'N.A (Q6G0U;< HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBL3Q)>W=@FG3VC3L3>)&]O"L9,ZL"-OS].QSE>G)Q0!
MMT5RC>/M.CA::6ROXX4M7NI9&2,")4<HX;Y\Y5A@XR#G@GFHD^(VDRZ -:B@
MGDM%N#;S%)[=O);CJ1+M?.1@(6//3/%.UQ71V%%<=X@\4RG2=1.F1:A"UMDQ
MWRPQM%(T<@5XQG=@YR/F49YVGC(VHO$5H=$O-4N8KBTBLS(L\<RJ70IU^Z2#
MGM@GJ*0^MBQK<%W=:)>VUBD+W,T+1H)Y#&GS#&2P5B.N>AKG;OPC?W$]Q-;7
ML=B+K3YHGBC8N(;F39ET; )4[.>G/( )-1:OXMO+BTBM-.L-3LK^6]CM)E*V
MYEMPZE@X#.8VR!QR>^<$8IGBK6M:TRZT[3;=[TL+*6[N;VS@MSYGE;-PV2N,
M [CG'.67!.#1_7X#5WHC1\.^';O2M.U*'99Z:;O_ %5MI[%X;8[-NY<JO)/S
M$;0,^IR3S*^!]=@*F#2O#V4EM)@!=R+N>%G+.?W)^9PW)Z\G);J=[4/$\CW>
MFPZ:+^14GB6YD1(=C[X]PB?<<AR"K97 '&6&<5/;>.[&[C!BT_4#+)!!/#"5
MBW3>;N"JOSX##8V=Q &.N*>M[DVNOZZG+W7PVU&YT#2[55L;:6V>7SX+:<*C
M;FRCK(]N^&0<#" C/##OJ7?@:YO;378+BTTZ:XOH)HX=0DF<ROO.Y4E39@A"
M %;)P!P!DULIXI1IKP_V?J:R6UG#<M;3"&+Y79QP7<88%2#N8#@8SG)@@\=0
M7D2O8:+JE[NM$O L'D<QL6'!,H!(*$8!YXQD4MOZ_KL4K_U_7F8<W@&^:XF:
M*RT=$*2;6#L&9&A,8M6'EX\E6((/L/D!YK=G\,W+^!;?1X8[.*Z186GBW$PW
M#*5+H[;<E7P025Z'D'I6A8^)K*]TVZU(QS06-O$LS3RE"I!C$AQM8GY01GWZ
M9K(L?%5PFHW?VRSU,PS7<$,$,J0!H/,3(SM894D>K$$\X[-WV?\ 7]?UYRK)
M<W]?U_7I3@\%7<5WH$KZ=H\D=A>37+1-(Q%HCCY8X,Q<A3AAG9RHP!QA?$O@
MJ[U+Q#<:E9V&D3?:!9AWN9&CD AE+NN1&V0PVCJ/NC/05,WQ#'F^:F@:G)8K
M9)>22H8-T2L[*=P,HX&PYQG\JZ6'5Q<:==7L5G<,D+R*B[HP9MA(W(2^W!(.
M"Q7WQ1=[]OZ_0=M;=_Z_4X*#X?ZV=1TFYF>TAAL7^2VM;L;;=1,T@\MGMR>5
M8(57R\A0,D' ZS4M*U6'Q*NNZ.MG/(]J+6>VNYGB5E#%E9757P02P(V\YZC%
M)8>,K/4K>PFM[2Z9+R1XL[HL1,C[#N8/M/S=-A;/7I5S4?$,&F:SI^FW%O-F
M^?RXI@\6W?@G:5+ASTZA2/4T:Z(.Y@ZWX4U/5M;AOF-@[&.)5G9G62Q9'+,T
M'RG.\$*<E>G.1\M<]<>$/[/CT:WE\-:5=ZA)?76[;#)) ('$A5))1"=B@R+A
M2,9&?4CK/%/B&6SFBLK#[6+B.XM6GEA2-HXTDF"!7W\_,-WW02,9)'=(?&MJ
MHC#66IMYC71+.L/[H02;) </T7.1UR!U+<$6U^G]?U_5QM-F1%X#U*"ZM#)-
M9WAA6#%[.[">-8T"M"HVG,<F#G+?Q'(8XJO'X!U*/2M!MX[+0XKFP,<DLZ',
MA='3&V0PEMK(N#C:1P,D<5MZ?\1=)U>Q>?3;>ZO)A-Y*VMN\+R.=F_((DV8V
M@G!8$8P1GBE3QSG4KNT.B:BSI+'%;1J(A).S1>:1AI!M(7D[L=,=>*=W>_S_
M %%O_7R,>+P#>VNK33V%II-D9WO@]_;N4N DW*' CY*GL6QQD'M41^']^?LS
M'2M"\I+I)9+ 3N("%C='<?NC\TF\%AC'RC);.:ZS3?%EKJVH16EG9WKB2W2Y
M\XJBHJ,6'.6W AD*D8SGU&2&>*?&FD>$%MCJ;L#<;BJJZ*=JXW-\[*#C(^49
M8]@:FUK+^OZ_KS'JW<KIH%\_@2RTB]M;*XO+:-$,;7+&%BGW26:(Y' ."AQ[
MXK&3PAK\>O)J7V/0WF6>-_/\^13Y8MO)= GE'"EL-MW8. ,]ZWV\9VD>HW-I
M+87T8M8VGFF81;%A"Y$O#Y*-R!@9R#D#%4]4^(^E:';Q2:M9WUB\CL%BN?*1
MBBA274F3:XPPX4ECR-N00'JW?O\ \,"O_7W_ -?+R,_2O">O:39B."UT<%M2
MBO3#%<&&*,",*ZH$@ ^\,CCOR<\G5_X1_4KCP*NDW4=BMZCK)L69GA?;*) I
M8H" <8)VG&>AJ.]\?06MK=2_V1J \H3B)G\K9+)$I<J")">5!8$@# ]>*D\0
MZ]J5OX6L+JTL;R*[OIH(66+R#)!YC $C>Q0GL.6&2,\9HU?X?\ 5[._J<_J'
MPZU*ZM]-6"6V@CMY99#903+'%;%V5@87>"3!7! (5#\QP5'%=#XIT/4]8N5%
MM;:?-;G3[FU<74[*2\H7'RB-@0"@SSWZ<<UE\=6^G::YO8-0NS;Q2'[8D,2+
M>-"=LI1=_!!R<-C.#MS6MK%_=KIUA=6YGLV>_@C>-U0EXVD"$-][ (.>""..
MG(H:NK=/\] ORN_7^F<_;>$-7?6H[ZZATFW(LVM)'M6R[JT07+$Q!G(<<98#
M!Z CEEIX.UBR@C^RV^EVSO<0/+%!<.J 1JRF4'R_FD;()&!]T?,>M:P\:VD%
MO:S36M_Y5U?26>^5K=3%()3'M*AP6&[IM#'')JA#XQDTW3-035(]3G:![TQW
MD<<'[Q(I&!"C(&Y5 /S* <=SFC?^O._ZCY+:?UV_0F\#>$;SPW:7]OJ$D<_V
MG:&*RHRRX!!<HL,>&;/.2Y/=CCG'B^'5]!IMC9Q0Z2GDVX@61&93:2!RWVB'
M$?,C C(.WH/F(SGH!KDUKKDUM/+>SPS75O'!L2$>5OC+;6S@[25]SD]0.D&G
M>/6N;=&N_#^I6\DRRO!\T!6?;($"(1+]_P"8<-@=>U";;O\ UH3TL.\9^%+C
M7I[>YL[73I[B*SN;8->,4*&50%=6",<@@\<?>/-8%Y\/]:O-+GLEBTRT@:\2
MY%K!<[HY?W(C<-YENRJ=PW@[&R3V/-=MJ&HSC6K#3+<M&\L4EU*0JEC'&4!0
M9X!8N!GT!Z'!%/2M=DNKK2Y/,F:SU2&1HH[A$$L,B<D'9\I!&?7!7J<TEV_K
M^KIE-Z#;_0-0-KH5Q8S1OJ.D#A;N4E)P8RC*SJN0>^X)U'3FJ_B#P_JVOP6<
MEU:Z5.T8D62PFF<P*6 "R!]F6=""0=B_>/0\U7NO$VH0^,;F$Q7PM;:1+>&S
MBCMV%Z[QE_E9G#*PP3DD+A3GDBM?3_%MKJE];VMK8WK&:$R[RJ!8PKE'5OFR
M"K#!&/IGFCXE?O\ U_7Z,GX?R.+U7P?)IFEZA<WVEVNJ7+7=D]K-'#)<3,4\
MI9'=5B)3<(R25W9!Y[9N7'@#49;*.*.+2PK+,([<R.(],9V#+);D)DLO;A/8
MJ.*Z75O&-KHVHW%E<6-VSQ6LEVIC>$^:B %MJF0," ?X@![U&GC:V)3S-+U&
M%#<"WDDE$06%B@="_P"\Z,&&,9YX(!II]2K=.W_ ,&Z\!WMSI>I6AT_0R]Y?
MR2^;)B1EB9>&7="0LF_YL;2.3SGFBY\"WS:O#J<6F:))>A[*5KF25EE0Q?ZP
M*WE$G< !G(SW Q71:MJUXNFZ/J-K#>PF:YC#V6V(R2*P/R-DE0>AX8>YQFJZ
M^/\ 3O+GEDL=0BAM[8W5Q)(D8$2@NK!OGSD-&5(&>2",C) M'Z$M)JW<YZ]^
M'VJ3PWZK#I+RRHZF5YG5KTM*KK)-^[.UHPI"XW=>"HXKH;#P]J,?A?6-)VV>
MF-<O,;0V4S2+"KCC^!,<D\#UZU%!\1M)N=)AU*&"=[9[K[)(R3VS>2Y*@9(E
MP^=P_P!67/M3=<\5SMIT\FFP:A (+F()=^3&T5R//6.1%))QU(^8*3U4XYHM
MT_KH-:N_]=3-M? =VNH:=/+IFBPVD5VTTME#*QBB0PF-A&#$,[R0S*0H^4=3
MDUH>*_"=YKVHWC0VVG&"YTB6Q,D[G?YA8,F5"$%5(Z[LC<2!Z[<7B2T;P_-K
M$T-Q;Q0LZ20R*ID5T<H5PI()W# P2#ZUS^L>++Z\6QT_2[34;"]N+_[%<$I;
MM+:'RC(#AG*-D8/!/RANC8%&K=OZU&EK_70T]!\/S:3J\D\>GZ;96KP!66V?
M>Y?@  ^6FU !@#)[8"XYRM2\$SW\5_%_9VD&&6]@NECF<R&<I+O<R-Y61E<J
M!\_'&<<5+XG\2:G8&]TZVBN$FM+&*[-_&L15F,FTKL8DX.UA]WOU'!J74/B3
MHNDK -0CN+66662-H9FB5H]C!68YDPP^8'"%F(/3@X$[O3^M?\R=M'_6AF)X
M#U1)+MD?3XG9'5I4=\ZCF57 N!MX 52G!;ACC ^6B;P=K U'3YK+3=&MK*UB
M -B;V22)B9=[+@P_='5<8VL%P !6]XRU]]*T>ZBLOM1U!K26XC>U2-C"J#)D
M8/QMR5& "3G@=PQ?%\4,\D+66I7$WVQ;+8JPX\PPB4;?F'RL.YZ$\X%"ONNA
M35T8EQX-UV?5-0N(H],M'NWNA]MBNI#,L<B*$&/*&<%02-PQV.:GLO"6KV36
MC6UKI5E$M\+A[2VN'$5NHA:,M'^Z&68MN(PHR.IR35VR^)&B:E-=6]DD]Q<P
MLJ)!$\+/,22N%'F?*<J>'V>O3FGS^.!;ZF+>;1M12(VL4R[EC60R22%$BVEP
M0Q(QZ=R0.2ELDOZ_K^M17W.9?X>:Z]I<6X&DP"2"!)6AF)-V\;N6:4/"R_O
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M%R54_*'(QC [=:Z*BJ<F[^865DNP4445(PHHHH **** "BBB@ HHHH ****
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MK+-"^6OIVPT7^K(R_&,=L9[YKAD^)IN;*%[J^\/.)5LIS'G(17FV2*<R?>7
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M,9_O<@X]"/44DMG<W@TPW BC\AQ-/&CEP7"D  D#(#'.2!]T<5E:=X6N]/\
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M[>6()+&@$2@8;++\O. 3R34UW\/[Z;PDFEK!HSWLA/GW+QC<NR/RXG1C&WS
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M0/<>4T)^9OFX8\8QQ\W:M/\ X32QWVLDD&H0++;32^6R1D;HY%C:-L,3O#,
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MQ&<9&2,@$\\U%>^$M'U#4#?3Q7(N#(LI:&]FB&]5*!MJ.!G:<9QTJGO=>?\
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M([[36FL+*VN(Y'TNYO%O$\H^2T87&58G/)P?E/4>Y%]?!FA(DB+:S 2%6/\
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M7\\8#2C#D!7 &?;U)[FK%AX9TO2[I+FS2ZB=4"$?;9F1\#:"R%RKM@ ;F!/
MYXI1\QO=V->BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex3-1_002.jpg
<TEXT>
begin 644 ex3-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /# JD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **8DBR,Z@."C;3N0@$X!XR.1SU''Y
M4^@ HHHH ***:[K&A=V"J.I8X H =114<D\<0.YN0A?:H+,0.N%')ZCIZT 2
M44@.0",\^HQ2T %%%% !13(I%EC#J& .?O*5/Y'FE=TC +LJ@D $G'). /SH
M =15.75+6'4#8NTOVD0&XV+"YW(#@D$#!.2/E'/(XYIU_J%MIFG37]TSI;0(
M9)&6)G*J.IVJ"?TH#R+5%0RW4<4*RL)&1N1Y<3.>A/0 GH/Z=34-IJMG?6<%
MW!*QMYX1-'(T;(I0],E@,'GH>?:@/,N444A(4$DX Y)H 6BN?C\;^'I3&$OV
M)DF$"C[/(/F.W!/R\*=Z8<_*=RX/(KH*+ %%55U"V;4Y-.#/]J2(3%3&P782
M1D,1M/(Z Y'>B_U&UTR&.:[=TCDE2$,L;/\ ,[!5SM!P"2!D\<]: +5%-+H'
M"%E#L"0N>2!U_F*=0 452BU6TGNKBVC,IFMI%BE7R'&"PR.<8(Q_$./>KM !
M137=(T9W9511DLQP *=0 4444 %%!.!FJNG:C;:K9)>6CNT+E@"\;1L"I*D%
M6 ((((Y% %JBCI5.TU6SOKJYMK:4O+;;/-&Q@,,-RD$C# CN"10!<HIKN(T9
MR"0H).U23^ ')K#T[QGH>JW$$%O<7"27!(@^TV<UN)2,Y"&1%#$8/ R>*/(#
M>HJK>ZA;:<(#<NZ">98$*QLPWL<*#@':">,G Z<U:H **** "BFRR1PQ/+*Z
MI&BEF9C@*!U)-9VFZ_IVK/MLY)B2"R&6VDB$BC&60NH#KR.5R.: -.BBB@ H
MI&(52QS@#/ S5&/6=/DT8:O]I$=B4\PRS*8]J^X8 CZ$9H OT50T[6+/5,_9
MOM"D+NVSVLL#$9QD"15)''6K] !1110 44QY4C.&8;MI8*.20.N!U/4?G2HP
M=%< @,,C<"#^(/(H =12$[02<\<\#-9^CZW8Z]:R7.GM.T4<K1,9K:2$AU.&
M&)%4G!X/N".HH T:*** "BF12+-$LBA@K#(#H5/X@X(_&GT %%,ED6&)Y&#%
M4!)"(6/X 9)^@I7=(T+NP51U+' % #J*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "N<\80:C-9V)TVVU&=X[R-Y4L+I8',0SN!+2(
M"".,9ZD'C&1T=5[V_L]-M7NK^[@M;=,;IIY B+]2>!28'GNG6OBJ&VF2XTG7
M)O,L2CI/JJ F02_+M99\JWE]P5W$<MGFFC2O%,=M8F6TURXEMU*7*Q:J(Q<Q
M^?E0N9R5<+AMQ))7Y223D=CJ/BS1=*WO>:G81PIY()^TKN4R'"EE[*1R&ST!
M]*9HOBFRU..[6>>SMKJUEF66 70<K&CE/,.0"%.,Y(Q[U2=M0MI_74X[4++Q
M2^I70BTKQ(UM]JN6C:'5HE#1O&H0#-P" ) 6 XP#QU(JQ:V/BG9YDMEK8,4]
MI.4DU),RG;MG"[9L;><[3A>,J,UVL/B'1+AH5@UC3Y6G4/$$N4;S%+;05P>1
MNXX[\5)_;>E?VC_9W]IV7V[=L^S?:%\S=MW8VYSG'/TYI6Z":3/-1I_C-$A'
M]F^(S)'!;IN75HBN])F+L=T_S9B('(Y/49 (V;V6^TSX::VVJR7^G/;O.;66
MXOQYNS?F']ZLA)ZJOS-D]#D=>L?Q)H4?G;]:TY?(E$,N;I!Y<AZ*W/#'T/-2
M6>N:1J$D<=EJEE<O(&9%AN$<L%.&( /."0#Z4)Z:?UU*;.+MM-UVYNM.F1=8
M739KZ27:=4#-%;M!CYV$IW@R?,NTL5'0CI52X\.^)[W3;F&YCU)VVQFX7^TN
M+J99D8O!B0>4NP.-IV#)''&:[V7Q!HL$MU%+J]A'): &Y5[E 80>!O&?ESD=
M?6JVK>(H--M;*\C:VFLY[M;>6<W 58@206S@@X(P02._/&*=_P"OZ]!>O]?U
M<Y!=(\:QZKJTAN+QX&W>3&LH"RQ>8I55<SDI((PRY$:<G)8\-2:GX<U=DDN;
M"U\0FX.DSP6_FZL!+#,7RBLPFPV,\-EN%&23BN[;6])4V@;5+(&\&ZUS<)^_
M&,Y3GYACGBHE\2Z"R0NNMZ:5G=4B8728D8] O/)/8"A7'?K_ %_6AR@L/$\V
MJM<20:H@;>SD7ZB-H#"0L*QB3"S!\?.,=,[\<5<\$VVO6:2PZM::HN;*WR][
M>I.&N I$FTB1RH/R]@.">O79U'Q7H>FV>ISR:G9N^FQ&2YA2=#)'Z!ESD$G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYKHOAT\LWP^T6XGN+BXGGMEEDEN)GE=F/))9B3^'04[;_P!=6OT)OM_71/\
M4ZBBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO R2<>YKNZ* .:MO"EY96T=M:^+-8@MXE"QQ16UBJH/0 6V *KW/@7[9I_\
M9]UXAU&>RSG[-+9:>T><Y^Z;;'7FNMHHW X9?A?IJ.SKJ$P9H_*8C3--R4QC
M:?\ 1>F.,=,5TGA[0H?#FF?8+>=I80Y==T$$(3.. L,:+C.3TSDGGI6K10 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 5K^^@TVRDN[DR"*/&?+B:1CDX "J"Q.2. #6+;>.= N]ACFO
M%#S+ K2Z=<1@N7V8RT8'WOE)Z X!Q71-]T_+NQSBO/#I>L3^#$M'T&^CNAK/
MV@Q"> 2"$W7G%@PEP/EXZYR/3FFM]?+\P>W]=CT2L_4M;L-*DABNI9#--DQP
MP0O-(X&,D(@+8&1DXP,\UP,&F>-I-1TEV.IVUE;OM*23)-( )F.92+E0X:,H
MN3YI&"< \GIM2M=2T_Q>NNVFFRZG!+9"TDA@DC66(ARP9?,95(.2#\V>!P:.
MP'1VUS%=P+-"Q:-B0"5(/!P>#SU%2UQ6MV7B6[UN&>VCNXT,<7V=K>]"Q6SA
MR9/.3</,#)M P'P0<;?O5SUQ%=Z='HT6I/KBZC>7UU"ME_;A26:#$C1[?W^W
M(S'SG=QC/0% ]#U:BO/8M)\7)=6@NY;VXF18,W,%Z%@$80":-X]Z[I&.[#[>
MI!RN*A.E>*%\-Z-''::N=30"2YEDU4LRNA4;2HG",&4'!)89Y*Y)-.P/0]$-
MQ'O5 2Q9RGR*6 (&>2/N].^.WK4E>;+H7B.PN2-,M]3CEDOKYS/)J D@"2*W
ME,T;2\@,5X"Y!5N.>6G2?$I^S?Z)KXL_M2&6W&K@S!?+<2MYGG#*,Q0JN[(P
M2 O2ET#K8]+JI::E:WMS>6\#LTMG((IU:-EVL5##J!D8(.1D5@)!K$_@2RBN
M[?4UU..-!-%%<1B9V7U=95&"0#PX)SSW%84%AXDM_$37XT74P9+F(RB/48_)
M>/[,$;<#*"V) OS%=V!D>A=K-H?0[V]U&VT]K=;EI%-Q)Y4>V)G!;!(!V@XZ
M'KCTZTEKJ=K>Z8FHV[2/;.A=2(7#D#_8(W9]L9KAM/L_$EM9QBZTG4K@#5(K
MF.)KR.5H8O+&Y2\L[$X;=_%SG@ <#1DM-9/PTDM8-/O[?5@K"*"*YCCE#>9D
M'>LFW'<_-R,C':E_7Y">^AV=5;34;6^FNX8'<R6DODS*T;)M;:&XW 9&&!R,
MCGK7GT5KXO\ M-W-::?K5M+<-=>4;S48I(H59 8\KYS@8<'& <9].*IW&A^+
MS#=KIMIJUC#+=K*1)>)/<,ODH@^<7*$E74DAI,$$<,. (#U>BO-+G3_$YUUR
MUCXAFM7ND9Y(=2BC0PF#;(%3SP5)DP1CI@[2,\U]/M/&27%O<W6E^(3+$MFK
M*=4A*,R,PG8KY^TAD*CD<GG&>::0/17/0-1U_3=)M4N;Z9X8G<H"8')R#@D@
M+D*,9W=,<YQS6GU&:\R31=0G_L276[/6[:&S%X+F[;6!&8(V;,;.Z3[B N,G
MD\<\5U'A&UO(]):YN[J6ZE9?)A<W3R+)%'E4D^8D;G^\6'7(Y.!2Z-@=+56_
MU&UTR&.:[=TCDE2$,L;/\SL%7.T' )(&3QSUKSI-+\4L8Q-I^NK;O>I,\,&K
M_-'$8G5TWM<DM\^TC!'7("G-.N=.\67=AIIO-,U.XDAAM#Y:W\2[9(Y@TIE'
MF;9"RJI4Y;I_"<Y:5[ >ENXCC9VSA02=H)/X <FH-/O[;5-/@OK.0R6UP@DC
M<J5)4]." 1^(K(U6'4/[?LKJUM[Z>)5VNB7"QPH.225\P;F/ Y5ATY7+&N-T
MG2?$MEHYT]M&UA4DM+=&!U15$4JNP=D\NX# ;2AVJR@[3WZH>AW]WX@TVQN+
MB"XEE62W6)I0+>1@%D8JAR%((R""1TQSBM.O-_L/B7[!*EUHE]=73:7:6[RB
M>W_>2QR,7Y:7/1LY/H>_7<\86^M7?V#^R+2[+QGS6EAO#'L(93L9!*BON&X9
M.X ]N<T[=!/]#HGU&UCU2+36=Q=2Q-,B^6VUE4@-\V-N06'&<\]*M5YP_A_7
MM0UV3[;#JL7F17D1U"'4@J)O9&A:-5D#( J!2 !D]0P)-6M8TWQ%=>&4^RV=
M_%JUR2[B/57Q:.L>%Z2J&4D#(!(RV2K<TNB';6R.]HKS=;+Q<NK74UM::Q$T
MUQ+Y4EQ?QR011M;@ F/SCP)AN&%) Z8SBC5-(\43:%;II7]MVK&=GN(+B\6>
M9<J #&XN$R@8%L-)W^Z1\M CTBBN(\8Z=XIO;721I-U<IL0BZ-N LOF87:^W
MSXU(!#94NPY'RMVSKRUU2QNM3N[Z/68=+:&Y83R:OL6U;8/WAQ-G8Q!V@?ZL
MYZ9X'HF^U_P&E>WF>D45Y0;'Q9JF@17>CW&H+97!AD,;WWGS2?NV#21N+A,(
M6*$+YJ_=/R\[3?MK#Q5;ZRLTEMKLR_:(PTHO8A&8S;[781&<J#YN&Q@X[=3E
MM6=B4[JYZ117FFK:3XQGT^TATXZC:Q13RJV;GS;AN%\N4YN5! (?Y3(P.1E#
MG ZO1;?48-9OC<Q7I@D&\37,X(+Y^[&BR,%4#'9>WWB2:+#9T%5M0O[?2]/G
MOKMG6W@0O(R1LY51U.U02?P%>>7ND^+VAO\ RX]7:<HXD:+4E"W$GFJ8V@!D
M'E!4#!@=@.<8?K6_:6&J7?A+7-,GM;R"6;[1%:?;[E969'4[<NKN<9)ZG(I=
M+C5N9)['6*P= RG*L,@U5LM3M-1DNTMI&9[28P3!HV0JX ./F R,,#D9!SP:
M\[U#1?&,NFC^SCJ=I \^XVLEV)KF/Y -P87"#;OR0GFXQ_"?NB:VL/$MIKUU
M>+I&J2>?=.TA%]%%%+']F1 2@F.TF1 00"P'?M3TU_K^OZ]"=;'?W6HVUG<V
MEO.[+)=R&*'$;,&8*6P2!A>%/7&<5#IVMZ?JMQ=064YDDM6"R@QLN,YP02 &
M'!&1D<'GBN+L=/\ $4-M8QWFE:E<+%JC3@->([Q0- 5QO>=F)#.1]XG@D8&!
M5W2-(UBR^&RZ?:VUY9ZDI^:*XNP\A&\%@L@=@NY<@'<,$YXHV_KT'V_KN=1J
M^M:?H5H+K49S%$6V@K&SGH2>%!.  23C  )/ JS]IAR<L0H0/O*D+@]/FZ?A
MG/YUP,.AZQ)JV@SW-AJ[VUM?S2H'U$&2UA,855E;SOWAWY/!?Y<@DYP9_%&C
MZSJ>I:O##::E)8RP6;P^5?B-6DCF+2!!YH*$H1SA02O7H:+?U]W^?X M;G>T
MR::.W@DGF=4BC4N[L<!0.236%H%K?VM]J"30WZV[$-%+>W/FECD\*HD<!0,#
M^'..AZGDKK0O%%UX?UJTN+?49I;C3Y(9$:_4K<W)8;9(<R?NH\9RIV@CC:>Z
M'%7:OW.MM_&V@75Q%;PWDKS2L46/[),&##/RL"F5)VL0#@D D9 KH*\P?0M8
MM[G5+JQT;Q!'+);62P$ZNI+&-@9%.;@C@<<\'#==W-R^TOQ3-9:H;8:K%J+R
M??:]5K>>+S<@1()5:-Q'\O!CYS\Q.&IM(E.YZ'17GVGZ1XA:6"._;7-BZ8R-
M.EVD?[[S#L&S[0_SA3C<20>,L3TVUBU0>"I83IUX]YAE2V-^5G*[N/WHD)#;
M>?\ 6>VZD]!K4Z:JLNH6T.HV]A(SBXN%9XAY;%6"XS\V-H//0G)KS<:;XO@6
M O9Z]/-;VY4-%J:*CNMQE"5:X.?W?7<3D'!+$5MV=CKH\9P7E[I]Z\:S3AKC
M[6A@6)A^ZVQ%\J0!M8A<D\_,.0[:BZ,ZVXU&VM;ZTLYF=9[LL(0(F*L5&X@L
M!@'&3@D9P<=*GBD6:)9%#!6&0'0J?Q!P1^-<->Z=KC^*TNI=/U&ZACN9"LT%
M\BQ"%H61 D9D4JX8\L #SG)Z+F:9I7C*73+P2Q:M9WZZ9;QP/=Z@LB/<*&65
M@$F;[RD8)QDC/!P:2VN/J>GTU'20$HRL 2"0<\C@BO/]-TKQ(L&G1ZE_;<L2
M,Y'D720RP-O!'F9N)/-3;E>7<^H[BHOASQ#96)M[>#5BAN;U@(-4VL)7DW03
M$M)S&%SE/4DE&)I_U_7]?\ 6O]?U_7X^FTUG1"H9E4L<*"<9/7 _(UP,>DZ_
MY.JR72:W).+P/;)#J "2IY:YP/.7:AD4G&00"!C!85K^(-(OM1G\-W"0S^99
MW/F3K#=LHCS$RY/S+O <KGJ2,\$$@E@1U-4AJUD=573!,3=M$TRJ$;:55@K?
M-C;D$@$9SSTKG?!]AKMK<2MJ@O8T,"+,+J\$XEN 3NEBPQV1D?P_+_NC'/)O
MX9\06,LAL]*UIIHEOC%/%J:?-))<*\1!:<';M7+*0 3G())H25[-_P!?UJ#V
M9ZW6?_;>G_VU_9'GG[=L+[/+;;P 2-^-N[!!VYS@YQBN9\.6/BB+Q??7>K2W
M0LI1(8XR5:+:6!C'^O;:RKD';$H/.6;@U0.@ZO#KFLZA;:?K"%]6AN$"ZGM6
MY@V*C@+YVWLQPP'&T#H $-[,[*]\0:=IUQ)!=2RI)&B2-BWD8!7;8#D*0>>O
MIU.!6G7F8LO$O]F)#/X?U2XN%L%@:1[NW<LXGW<LTV3\HSD_SJQ#I/BQ];U>
M2^N-3-I,'\I+615#(74H%8W(V,%!4[43.3\Q.#0A'H6]#(8PR[P 2N>0#WQ^
M!IU<?X<TC48/$\^IW]I=Q>?IT$8+WQE175GW*R^8?FP4.<$#YL-R<]A3:L 4
M444@"BBB@ HHHH **** "BBB@ HHHH **** "J6IZM9Z/;+<7LCJC-L18XGE
M=VP3A40%F. 3P#P">U7:QO$GAG3_ !3I\=GJ"G;%*)HV"1OM< C.V161N"1A
ME(YI/R&K=1G_  E^BFYBMTN)Y))EC:(16<SB19 2K*0A!& <D<+CG%5=.\=Z
M)J$=N2]S!)/(8T26TE7'SE%+$IA0Q& 3@$Y )(-*?!EN+BRFAU2_MVLEC2 0
M) BQHN=R "+ 5\C<!@':N,8JI_PKC1O[0L[YI)I)[5B8VFAMY?E\PR!?GB.T
M!F."N&]2<"JTN(L7'C_0XM-N[R![J<VR,YC%E,K-A_+(&4YPW!QG&1GJ*T=0
M\2Z9I:VYNVNT^T1&6,+93.2H )R%0D$ Y(.#UXX-8R_#ZV$<D;ZWJTD;QS)M
M;R./-D\QF&(@<[P".W'3%7=>T34]4U'2OLUV8+: 2"YN4F"SD,N,*IB93GO]
MW';%+II_6G^8=7V_K]"=O&&A"5XUO&D*0F8M%!)(I4+O(5E4AFVD-M!+8.<5
M!_PG?AWS?+-W.IVQL&>RG52KG",&*8*D\;LXSQG-4D^&^AV^H37EEOM))+?R
M/W<$#,@\OR]RN\;.#M XW;?;DY6Z\ 0W/DC^W]7B6.W@MB$%O\ZPMO0G,)YW
M<G&,^E/2XE?J6[KQII,%FMXD\S1"&>8Q_8IM["+AUY V,#U##/MWJ&#Q_H\L
MTT<L=_ 8XXG >PN-SLX)VJNS+$ 9P!G&3C -,_X0*V8%9=9U25&:Z9T;R '^
MT#YP<1 ^XQC'O1J7P]TS5HBE[=74Y*P\RI XWQ*RA]K1E22&(((*^@!YI%:%
MB]\66S7VDP:9=13"ZFC\S_1Y'4QNI*XD&%5NA .21GCO3KKQ*FF>*)[#4942
MS:"!X'2VD)5W=U(D<94#*C!(4<XR:AB\"V5O/!)::A?6J1212F" 0I$\D:A0
MQ41X&5 4A<#'0 @&M#4O#=MJ>I)>2W-U&"BQSP1LHCN%5BRA\J3@$D_*5SG!
MR.*>EQ=_3\22R\1Z;J%PMO;/<&5I)(]KVDJ8:/&[=N4;1\R\G .>,U13Q,M@
MFJ2ZNS"&TO6@62ULY7"Q^6K@OMWXP&.6.%X[5<TS23;ZOJ&JSPQ17-V53;%*
MTB[5X#<J,,PVYP/X5&3C-9E_X%M-3CO8KO5-1DAO+AYY8CY.SYDV;<>7T "X
M)R05!SUROZ_(.I9?QOH,=T]L]S<K*DDD1!L9\;T3S&&=F#\GS#GYATS5Z[UJ
MUMH+"9I9(EO)%6+?:2L6RI;:5 RA(!^]CGC&>*S+SP1IM]=M=37%YYK"')5U
M',?!/W>"R_*WL,#%:.N:)_;<5J@U&\L6MIQ.DEJ(BVX @9\Q&&.3VH>V@!HW
MB32M?#'3;B23;&DAWP2191L[6&]1D<$9'<$=159O&6A*9,W<I$<BQLPM92OS
M,5# A<%-P(WCY0>":9H'A*+P_.LD6JZA=*MJEH([GR=H16+*?DC4Y&YN_>J-
MK\.M(LOMBVDLL$5VX::-+>W&]-VXQL_E;W1NA#,W'&10]] -%/%NE2N)%N94
MA^RM<[9+&=&= X7<I*C//&T D[E(X(S')XTTJ'47M)?M<82U6Y,KVDP&&8JJ
M_<^\2,!>I/ !-1VG@T6D\$QUW59V@MGM4$_D.-C,&Y_=<XP /85%/X TR[LY
M+6ZNKR>.6V%O()3&0^)#(K$;,9#$X4 )@XVD8% +?4MCQMH!DB074^Z50RYL
MYAM&_P L[CL^7#<$-C:>N*F?Q9HB37437C!K49<F"3#?-L(0[<2'<0N$R<D#
MK6./AU9QP+#;ZOJ%K&L'D;+:"TB7'F"0G:L 4$D#H!_6KL_@JRNM+OM+N;V\
MGTZZ;?\ 99/*9(GW[]R_)D_-SM8LO;&.* 6^IH_\)#I9T8:M]H;[(6V ^2^\
MONV[/+QOW[N-N,YXQ69J'CC2K*T:\CFFGC6T-R(4LYB[C>$X..,,<,I&X9&<
M8Y?)X)TJ;PG_ ,(Y*NZS#!P5MX$PP;<#L6,1GGL4P>X-5C\/[ P10)J%Y%#'
M9O:"."*WB3#.'+;5B #;@#P ..G)R]+B=[:#M+\96\FHZG::G.D!@N'^SN;:
M6)3"(4E^<MD!P&.02#A2=HP:NP^,=$N)(8XY[@RS.T:1FRF#;E )!4ID'#!A
MG&0<C(YJA<> ;6[N;B2ZU?4YHKB9YIH&\@(Y>+RB#B(,!LXX(]>M.T?P%8:'
M<6,ME>7$:VDCR"*.WMHDD++M._RX5S@#KU]2:- ?6QJ7GB?2;#51IES/*ET?
M+X^S2%0)&*H2X7: 6&,D]<#N*K3>-] M_M/F7<V+<$N5M)F# ,%+(0AWJ&(!
M*Y /7%,U?PC'J^I2WK:OJ-LTD<,9C@\G:!%)YBD;XV.=WO3(_ ^FHMQ')<7D
M]O)!-;Q02.NVVCE.9!'A0>2!]XMC&!@<4EMJ4[7T-"P\2Z7J5W]EM9+AIM\B
M%6M)4VM'MW EE 'WEZ]<\9J.Z\6:+9WLUI-=2":%6+;;>5E)5=S*K!2&<+SL
M!+8[4:+X8LM"N;BXMI;B22=$$AF<'+* "_ 'S-@%CW('2JMWX+L[N[N)OMU]
M%',[S"!&C\N.9T*&5<H3NVD\$E<G.W-#\A+S':QXD\GPRNLZ6Z/%Y\*[IK>3
M#QO(JDJ/E/1L@\CV-3#QAH92V?[7)BX8HH-M*"A#[#Y@VYC^;Y<OCGBEN_#<
M5WX:M]$.H7L<< B"W">7YI\L@KG*%>JC.%K(?X;:5-=0W5S=W-U<13R3+)<P
M6TI^=]Y7#0D ;LG( ;GKC%/2_E?\!:\J[FD_C708XY)&N;C;'(\;8LIB0RDA
MQC9GY=I)/88)P""7W_BS3;);Q?\ 2GGMK5[H(+27$J* 28VV[7^\N=I.,\UG
M7OP[TO4;+[->7-S<%;R6\CDGBMY2C2'+J%>(H5Z]5)'K4DG@.RDN[BY&HW\<
MLUN]L&00_NXG55*KF/@?("!R 2< #BI=[>?_  /\RM.;R_X/^13T/QXLOVB+
M6E:.2.&*Y22&PN45DE)")M92?,R,  G=V'4#>LO%&D:C>1VEI/-)/)&LJK]F
ME&%.X9)*X'*,#G&",'!(%9EYX!TW4+62WO;N[N%DM8+=_-6%MWDL6C<KY>TL
M"QX(VD=5-3Z5X.M]&E:2RU&[B)M!:*L<-M&B ,S!U5(@H;+-VQSTJW:_]?UV
M)5[?UY?\$Z2B@=**D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M':JGP]UOP=9>'[G3H[W1E>ZU"[#6T4D67C\Q\%E!^X(QU/&T#VKL/^$-TO\
MY^M<_P#![>__ !ZC_A#=+_Y^M<_\'M[_ /'J;=[^8'#?"A?#<>QH+KPZ^HR/
M,MO%91QI=(GF2$^80Q++MVX.   ..YGU8^#A\6=2&M-HHC.BJ+G[28@=_F<[
ML\[MFWWQCVKLO^$-TO\ Y^M<_P#![>__ !ZC_A#=+_Y^M<_\'M[_ /'J3UM_
M72P+KY_YW.2\ _V'I>NGP_<+ISZE9P[](N5$9DELI,LH##G<,G=ZCGG)KTVL
M.#PGIUM<13I<ZR7C<.HDUJ\=20<\JTI##V((/>MRFW<04444AA1110 4444
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M\,<T /HHJDNI(VM2:88)ED6 3B4[=C@L1@8.<@^H YXS0!=HIB.S[MT;)M;
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MRV>W)Y5@A5?+R% R0<#K-2TK58?$JZ[HZV<\CVHM9[:[F>)64,65E=5?!!+
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M5@^5RORG;C(X.:YG3-3UYY;%9M4UJ[0V-Q-<M'I83]\D@*Q@O F&*[EPP&<
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MRW$0E0.%.>)(V0\''1@#1;05]3'3PEI$?E^4EY%Y<(@_=7\Z;T P ^'&\@'
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M6E(& 6(Y)QZU8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M?S74%E))8VR7-R,!(I)
M?+5B2!RV&P!UZ'ITKD8?&VJKIR:A?Z)8V]FUZ+1I$U)GV?O_ "68YA4<'D<\
MC.2.E=L<X." >Q(S7()X0U0>'%TN36+)I5U(7PF&GL%QYWG%-GG'^/OGIQC/
M--6OKY?F#V_KM_F="NN:0YLPNJV)-Z,VN+A/W_\ N<_-^&:K>(=?AT&TCD9[
M5KB1U6.WFN1$THR VS@EB <XQ^(ZUS$7PXF_M"UO;G5HIGBDW21I#/%&X$S3
M+A4G R&<\MO' X'.=CQ#X5NM8O)+FSU.*U,T"02I-:^>,(^]2OSKM.3SUR,=
M" :.W]=@[FFOB'2?/DBDU735<2M&BB[0L2N P(XPP+8(YQD>N*>?$&BBWNK@
MZO8"&T?9<R?:4VPMZ.<X4^QK MO"&IQ^)!J=QJ]E+;_:Y;KR%T]E?+QB/ <R
MD# 4'.WKG\*6F?#B32$#6FK(;B&2-K6:>*:;"H' 216G*L,2-]P1X)SBD!T?
M_"7>'Q=W=NVLV*-:1)-,SW"*J(_0DD].G/\ M#UJTVO:.CJCZM8*S1B50;E
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M9PQSRV3T&%&*[*F)7"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"LKQ#JTNC:6UU!#!/-G"0S2NGF<$D+L1V9L X 4YK5JK?V=A>P+'J%M;3Q"1
M65;A%=0^?E(![YZ=Z3\AJW4XS4O%$NJ-I1M(7@C6>QFF<7C1N/.8$)L4?O%V
ME@<G&>@..)/^$_N6AAFCT>$I<K'-;$WI&8FE6(E_W?R."ZG;R.OS9&*VK+3?
M"^NV-O=P:183P0Y@A,MB%,01\%0KJ"N&7I@<BEU7PAI6I6-U:QPI8?:Y4FN9
M;2"(/,58,-^Y&#<@9R*K2_\ 7];?UJ2EW_K?]3,TWQ3JNH^*+/3SI]K##Y=T
M+O%T7P\3HN4/EC</F'7;U.<%<&0^,KB'5KRVN=+1;6VN);?SXKDN[%(1,#L*
M#JN1][@^O4:FF)H4PMC86$2?8GDMH,6)C^SD<.JY4; ?; /&,U*/#6@B_P#M
MXT33?MGF&7[1]D3S-YZMNQG/OUI=!G*P_$/4)].AOAX>$,$DOE"2ZFF@4[HR
M\9&^ %@2-IP, D8+ YK>\/:U/XHTN::>R6T@:-4(BNF,@<H#(I(52I4G;D'.
M03Q5V/0]#LH'BBTK3H(9)EE9%MT56E# JQ&,%LXP>N:M)I]E':2VB6=NMM*7
M,D(B 1]Q);*XP<DG/KDT.UF@70\V\-7.LZ=?Z7D22F_M)C D^M3W(NI%P5WB
M13Y' /*!AS@]JVW\07.MZ59WJPFS2._M$8PW;Y\TR!9HF 5057)4YR"<\#%=
M#9^&=%TM9CI&EV.ESRH4,]E:Q1N/?[N#CKR"/:GMH6ER:?%:WMI;WL44AGS=
MQ(_[S))DP1@-DDY '7C%-.V_035[^9S3^/+M/M3?V99-#;7$$;W OI!%Y4K%
M5D#&$;L$<XRO/WC@U8TOQAJ>JZ=)=0:'#NBPDL?VMR8Y-[*RD>5G 50V<9.X
M#'>KND)X2U&SNVTVQT_[.SB&X'V,1!R3N (91N!+[@>0=V1G-6[6#0=<T^Y$
M5C;3VLEQ(MQ'+:;0\JG8^Y649/&,D<_2CH/J5M9\22Z;I.GZE;V]I<6MTR+)
M*]V8TCWCY&!"-N!; SQU!K*M_&5YJ.G6MVVD11Q/=V]M*HOW62*9GPRD",9V
MG;D$C<"?H>LNX+ :<T=Y#;?8HE#,LJKY:!>0<'@ 8!]L5CVI\,Z\HMDTV&:/
MS6ND6YTUD1Y 1F5/,0!C\P^<9SGK0K78G>QR</BG7([RRUBZM8WS87DDUK%?
MN(C''/& X!3&\ L!QSW8=MF_\>3V@NY8M)CEMXVN8H6:Z*N\D"EG#KL.Q2%.
M&RV>,@9%;LWA/PW<DF?P_I4I.[)DLHVSN.X]1W/)]^:M1:)I,%Q)<1:991SR
M1B%Y4MU#,@& I.,E<=NE*^@^M_Z_JQS$GC#4[B\@M[+3[53_ &K'92%[HX:-
MH!-N&(S@X.,>W7G(U-7\23:;KMEIT5K;W"W+!&83N)(F8-M+*(RH4[2,EA[
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M=\E8?[ TKRED$JI]CCVAP  P&.N !GT%6/["TC^T?[1_LJQ^W;@WVG[.GFY
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ME!<-+<(HCW#*Y)/N*MW&L6$+P0"^LOM5TA:TADN%4SX&?EZDCW -#>G]=/\
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ME?F2+498G^TAVCO@L5Q"RD11Q)Y@\N0';EL+T/S'/'80:WI-S<I;0:G92SR
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M(NI6,]U*+MC)*MQ<22&*3.&C =CLVG(VC &*WJ;5M 3N%%%%( HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%95SKL=IK%MI\UE>*EP_E1W>Q?),FTML
M^]NS@'G;M[9SQ6K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!B7<&L3^(+9Q9Z>^FP$,DCW;B56((9O+$9!."0/G'4GTK;HHHZ %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<[HDQVZ9SD],<Z%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M9^O-.F@7\EM<R6T\<#NDT:J64@9Z,".W<5PT.L>)[?PYH&O1W\^I)]@6[U&S
M:"(-,C8+-&412&7=D#H0N.O)[[4;:TU&VDTV[=MERA!CCG:)V48S@J0W<9P>
M_O5/3/#.F:.UL;);I%MH/L\2/>S2(L><XVLY!^I&0 !T%"Z_UW!_U^!GQ'4-
M2\"S7&E:]<RW<\3S6=\\4)8\DH-HC"D$ #[N<'KFN6T7Q%K&H:GIV=;O7L]7
MTC-O^ZM\PWB[-XSY74!LX/&=W'0#TNVMH;2W6"WC6.)/NHHP!WXK/@\-:-;?
M8_)L(D^QSR7%O@G]W))NWL.>^YOS]A35K^0:V\SG+'^VKOQEK^D'Q+?K;VMO
M;/"WD6VY"Y8L1^ZY.$P,Y W'@\8H^'Y?$>J>$KN_?Q5>_:C<S6L1>UMBL96<
MQJV!$,\#D'KVQ786WAO3+36+W5H4N1>WJ;)Y#>3,&4= %+;5QSC &,G&,U!:
M^#]&L='DTJVCO(K.2;SV5=0N-V_.XD/OW#)Y(!P3DGK0MM>WZ_Y!_7X?YG*-
MK^M7FBZ\\NJ7>FZSHUBPN;6**$Q>:H++*N^-B5<#CG&"1@$9J[87?B5/!=WJ
MGG:M=7K0H\=M=16QE P"[1"%0K$J3M#;N0,]Q74ZCH.G:K;W,%W Q6ZB6&=H
MY7B>1 20I9"&QR>_<CO56U\(Z/:020+'=S0N@0I=7T]P%4= HD=MOX8Z#TI=
MQ]CGKCQ1>OHME=6/]MW$45WY.H"*P3[=!A </$5VXSRQ5>C#;V-7O%&IWTGP
M^;7-!U61'AA6[\V&%#Y\8Y==KJVW*Y[9! ]Q6L?"NCFS6V\B;:I+"474HFW'
M&3YN[?D[0,[LX&.E6[@:9IFDB"Y:VM=/5%@ E<)&%/RA<GCG( %-OMO_ %_7
MS$M+7.-TC4]5O?$VJ:8^NWDD$ZP7>FS+';C$!)\P#]U@X*D<Y.".AYK UWQ)
MXHT\>)UMM0UATLM1A@@NUBL?*@1Q&2K!E#D_O#R%/1>>N?3+/P_I5A-9S6ME
M'')96OV2W8$YCAX.WK_LCD\UB:KX1\)6UCJ$VJR36]I>3+/=R7&K3QQM(/ND
MDR #MCIT7T&!M)^7_!7Z KV\_P#@?YF9#/XAE\?WVD+K6L/96ZP2"58;/RX]
MRLQ$G[L.0=H VXZGD<5ES>(O$$7CS4-+36+\1+J4-O:M-!;?9 'C$C1R,$$N
M2-P7'4X!-==!X0\.WD\FI6TU]*UR%WS0ZS=%90H^4'$N& ST/')]:G?P3H,C
M:D9+6=SJ3K)=;[V8[G4@JPR_R$8&"N", #BA:-7Z"W3,#[3K]Q\1=1TN+5M6
M%A#Y,JM%%:&&'<KL5?='YA!V@#'J<MTJO?>)-;N(/%VK6VH-9Q>'I7BAL_)C
M,=QLC#DR,REOFSQM*XXZUTI\#Z(;V:\_XF8GFVB5AJUT/,"] P$F"!SP>.3Z
MT_5= \.37J76I)'')=2+&4:Z:*.Z?'RJ\88+*<#@,#TI+9+^OZZ#ZMLY*;6?
M$&I^,K.TL]0UBVL[W2X+TPVT-H?LC.VTEO,C+%1UP,G/H.G>:QJ#Z/H%YJ'E
M/<O:6[2E%PI?:N>Y '2J%YI_AW1M:/B2_NEL[N1!;^?<Z@Z1E>R!&?9UYP!U
MYZU>@L;:ZL;V.2<WEK?,Y8&5F7:PVE5.XX'!X! R3@"AZJR\_P _\@CI)<WE
M^ESF=%\77)U>ZM]5@O4BFG00ETBVVQ-NLIC8HV3T<@_-Z$]*U/#?C;2O%=O>
MRZ5OE-J 3&)(F9PP)4C:Y S@\,5([@4L7@?0H;E+A8KTR)*DP+ZC<,"ZIL!(
M,A!^7Y<'J.#6EI>BV6C1/%9"=8F/$<ES)*J#T178A![+@4W8#!7XA6+PQ2II
M>IL)$M9% 6+.+AF1/^6G9EP?J,9'-0ZMXQ^T:2ITR._AN_DDFVI"3;+YOED2
M[B1@LKK\FX\$@@<U>/P_\.;PRVMVA4I@)J%PH&QRZ# DQA6)('0=J23P/X9V
M1VTD-P"^\*#J,X>3+;R"WF;FPV6&2<$DC!HT!^13'Q-T*2\O+6!+BXDM)%C<
M0M$Q.91$3MW[@ [ $, 3G(!%7=0\6QVUI?F73M3@-K"))&7R-ZYVYV@N02NX
M9."IP<%B,5/+X,T2:.>)H[P0S.)'B34+A$WA@VX*' 4[ADD 9/)J+Q'I7AGR
M)KKQ#=_9X)U^SM)<ZE)#& 2#M7YP%)V\[<$@<Y%+32X>A!J'CRTL==FT=-+U
M"ZN88VE?R&@&%";B=KRJV,<;MNTG@'-07?Q)T>PTP7MY;7=MN=%CBG:&-I T
M?F!@S2! -N>"P.1C&<9?'X,\_5KF\?5II--NE_X]X+BYC+ H$^9A/L;('WM@
M;H=V>:N)X&T&-"J0WH/R;7_M*YWIL7:NQO,RGRDCY2,CKF@11D\6+J>LZ*ND
M/=&REN1'/.J1F&7= T@0DY<,!L.0 .<9)XK6\47EW86%I<V<DP<7L"/%$J$S
M(SA2GSCC(;J".0.<9IDW@[1IKY+[R;A;I'619%O)E^=5VAR XW-MX)/)'!)J
M2YM=)^P6F@:G>K)),H$*RW3)/*R8.Y&W;RPP#D$D=<]Z>G0?3Y&._P 3-"BO
M;*RG6X@NKE_+:&4Q*\+^88L,"^6^=2/DW@=3@<TY?'EK!!"[Z=JT@EBFN&9E
M@S$D<NR0-AQ]TD=,Y'0L:T#H7AZVU"QA5C:WJHWD)%?2123*IW-N"N#* 6).
M[=RQ/>H&^'_AUH1$8+[8(Y(L?VG<_==MSC_6=V )H5@?D2P^,+6X\6/X=BL;
MQ[A,F28-#L0  [F7S/, .0 =F">F<$UD:MXLU*/Q$MI;6%ZL-IJ*6TBQ^0WV
ML- TFT;FR#G:0?E]SVJ?3='MM+\82[_$<9E?,T>G"YF63:WRY9&G9&&?XA&"
M3R23G.O>^$M'U#4#?3Q7(N#(LI:&]FB&]5*!MJ.!G:<9QTI=$QKK<SH/B)H5
MQK&G:8CR+<7\<;QAVC4J77<JE2V\D@=54@'J13-7UFYT/Q'J%Y/=WUQIEKIH
MNVL88X< [RI()"L< 9P7]?85J:?X2T?2Y+>2RCNX6MU"+B^G(91G <%\28S@
M;LX' XI-1\):/JUU=7-Y'=O)=0?9Y@M].BM'_=VJX4#Z =3ZFA[JWF)=2L?&
M=OL94TK4Y+M))%>SCCC:550*6? ?!&)$. 2QW8QGBH[OQWI]I]H9K*_>"+S@
MDR+'LF>($R1IEP=P"M]X*#M.":/^$?\ "MO?O;FZD2_!-Z5;5IA.HP%+Y,FX
M)@ '^$X&>@J"UL_ OB&[O$L=0LK^:X1_.BM-49\!AAV"H^$9AP6 !/<T>@+3
M<G?QO##</'/HNJPQ1K%(\[B$HL4C%5D($A;;D<C&X>G6F3>/]/@221M/U$PA
M6DAD5(]MRBN$=D^?.%+#AMI(Y -)=>&M/M]>@U'4M0A73TA@L[:UFED0EU8E
M-[F7$I);A64G(!ZCF[-X)T"=;I7LY0MSG>$NYE"@L'8)AQY8+ $A, D<YIZ?
MU_78'_7]>I%J'C&+3KQ+.?2[U;F6VDGA0R09DV*6*X$FX' ZD;>1SFH-.\=0
M74-G]HTV]A:7R8YY,1F.&:104C8AR<MN7! (&X9(/%:DOA?2)]1:_DMY6N&(
M+'[3+M8A#'DKNVD[6()QSWZ"HX/"&B6\]O-':RAX%14W74K [!A"P+89E'1F
MR1V-('Y#8/%,,_AJZUW^S;]+>WC>0QN(_,8)G<%&_&1@]2 >V:J7/CJSM-(N
MM2FTV_2*TE$<Z.T"-&"@</\ -( 058< EN<;<UJ1>'-,A\/R:&D4_P#9\BNC
MQM=2LQ#$EAO+;^<GOWK*M_"'A6]-SY!ENBDICGQJD\A5Q'Y91OWAP=A (/MG
MH*/Z_P QJUM0D\=6J7LUJND:I))'.]NNQ8L22+&)0%)D'5#D$X'!!P< Q'XD
M^'1J5E9-<,K7<"3J[LB[%="ZY4MO.5'4*0.A(JTW@+P^UTUR8]0$ID,F1JET
M!O*;"P DP#M^7/IQ5FU\(:+9&#[-!<1K!$(0@O)MKH!@+(N_$F <#?G XH>V
M@BMX=UFZU76]4\Q;R*T$-O-;P721J5#[^5V9.U@H.&)(R>G04;SQ<]S=>38P
MWL-S8W\4-S:*;=S.KAL#(=@N<9Y9".,X!K9T7P]HVE337&EK)N=1!(3=R2KA
M"<+AF(&TDCV''3BHH_!>A0V\D$=M<*CA!Q>3;EVLS+L;?E,%FQM(P#CIQ3=N
MG]?TA*]G<J#Q[IS*CK97[( ING")BS+.T8$GS9^\K#Y-P&,GCFI6\:6L.FRZ
MA=Z=?6D$ F\\S&']R8V"8;$A^\3P1D8Y) J6[\-^&[5([ZZ@CMH;*,9D:X:.
M/8IW#S?F"N 26^?."2>M6WT;1GAU"=X(C%J($ETYD.V0!0 V<X' !R,>M)[#
M0>'O$%EXFTE=1L"?*+M&P+HY5E."-R,RGZ@D5S/_  E6HIXMU"-[?4&M[:Y^
MQ6^GPQV[?:F\H2;U8N"I R?F(7:0,;LBNAT^TT^VBM+ZSU.62P$9$;R7\DZ2
M[R,'>[L&[ =3SP><&.;P;HD\UW-)!<^;=3BXDD%].&60#:&0A\QG;\OR8XXZ
M<4^H+;433?%EKJVH16EG9WKB2W2Y\XJBHJ,6'.6W AD*D8SGU&2,'4/&.I)X
MD6&'3[Y;:TU&2TDBB\AOM:_93+QN;(((!ZJ,$9R<@;EE;^&-.U\QVEW;1:FE
MLEM]E%Z<K$#\H\HM@<D\XSR>>:DO/!VBWU\][-#="=Y#*6AOIXAO*>66PC@
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MALK1"EO"NV-"Y;:/3))--VNQ+9%BBBBD,**** "BBB@ HHHH **** "BBB@
MHHHH *Q/%%S?6NGPM9M=1HTP6XFL[?SYHHR#\R1[6W'=M!^4\$G%;=8WB;6+
MS0]-BN[.R@NV:XB@9)KDP@>8X0$$(^?F8<8Z9^A+7T&CG;O4/$L6J6D,4]]*
M-MOY?EZ;MANE)Q.\I*DPLHR0NY>W#9P,G^U_$:VFG/)J^N+<7=M<X@&DIO\
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MF,VVY%DP11(Q8YC\TDGYFQ\P[>G-:;P;=F99K;58(Y/ML=VZR6A=%*\LJ*)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BLZ;6$@UFWTY[.Z_TC(2X"KY>X*6V_>W=!U"[>V<\5HT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 85YI5U>^)[.^-M9PQ6G*W:3,;
MB52I!B*[  F2#]X_=' /(W:**.E@"BBB@ HHHH **** "BBB@ HHHH ****
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M7_S]:Y_X/;W_ ./4?\(;I?\ S]:Y_P"#V]_^/5T%% '/_P#"&Z7_ ,_6N?\
M@]O?_CU'_"&Z7_S]:Y_X/;W_ ./5T%% '/\ _"&Z7_S]:Y_X/;W_ ./4?\(;
MI?\ S]:Y_P"#V]_^/5T%% '/_P#"&Z7_ ,_6N?\ @]O?_CU'_"&Z7_S]:Y_X
M/;W_ ./5T%% '/\ _"&Z7_S]:Y_X/;W_ ./4?\(;I?\ S]:Y_P"#V]_^/5T%
M% '/_P#"&Z7_ ,_6N?\ @]O?_CU'_"&Z7_S]:Y_X/;W_ ./5T%% '/\ _"&Z
M7_S]:Y_X/;W_ ./4?\(;I?\ S]:Y_P"#V]_^/5T%% '/_P#"&Z7_ ,_6N?\
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M.E/:20_896EM;G<OS^5MWG(!7<H/Y&A+]/Q!_P"?X'9R>&=!BM3=2:GJR6X
M)E;Q#>! #[^=CO574],\):*T:ZKXAO; R@F,77B:ZBWXZXW3C/44SQ18C7-&
M?P_:0-8QWL4L\KS:9+-&!S_<*A9"3O )SD?=)K%U>]O];^#;FXTG4AJ[1QVT
MD/\ 9\WFLZNI)"[-VT@;LXQSCK2_X'^7YA_7Z_D:3GP%%%%+)XOD2.4$QNWB
MRY < X.#Y_//%:T'AG0KJT2[M]2U>:V==Z31^(;QD9?4,)L$>]8?C-C-JWAJ
M6U&LVJ*9IY;FPTN65X@T14;AY38). 00&'MUK2\7V5UXE^'%[;Z-#/%+.@*0
MRQ&!Y%#@LI5\$;@#PV.O-'3Y_K_7W M6AL&G^$+JRN+VW\1WDUI;9\^>/Q/=
M,D6/[S"?"_C2:;8^#]9G:#2_$EW?2HNYH[7Q1=2L!TR0LYXK/<2WOBP:W96%
M_:Z;9:1+:W(>QEC>9R041(RNY]N"<J".< GFK_PQTZYLO!6F_;9+XSK;K'Y%
M[;>2]MCAD4;%.W(')R3CJ>*:7]??_P .)_U]U_\ @&A_PBNB_:?LW]H:Q]HV
M>9Y7_"07N[;G&['G9QGC-0V6@>'-2$QL=8U.Z$#F.4P>([Q_+<=5;$W!'H:Y
M_4Y]0A\8:5XLAM[N:V,\FGRVL>CW N%@/5W;G*AE##Y!]XX)HMX[FT\6:M?6
MEC?G3=5BF2])LIE9)8C\K!2H9M\;%05!R5&*GI?U_P"!]Z*MK;T_X/W&A*/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %8_B'0(O$%I;(TI@N+2Y2ZMI@H;RY$/!(/4=01QP>HK8HH XJ_\
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M9WEW,8R3ALL-O )(YU=5LM7N;_P7/%HMVRV,WFW?[V & &)H\']YR<MGY<\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%G]^2<IE<EF((!)X##T&$8@C&UUPH^5VW,..A.3D^^33Z*&[B"BBBD 4444
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M$,7V"2[:.\!WL4=1M!\Q?O!B!P<%2>>E9FK?$>:SN]4%KJ.CR6T$1D@DFCV
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MB=ZX/H3@_*,4[$IG3T444AA1110 4444 %%%% !1110 4444 %%%% !1110
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M2!0K8R"N[:V<#D@G@>E7Z* "BBB@ HHHH *CA@CMT*Q@@%BQR222>IR:DHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#D^6I:3 (;=P,$<CU%8-TVOZE92R/J>N0K!K21A8=.56$.X'< T.74$\-@C
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MYU&PM;JYUF.)[F96DDTW[T/EH\9=S;HJMN)7HHZCDC-)+0;TU.G7P5H*6]I
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MK,9CYD;*("RX4CCAO<XIK0.C.HU3POX:CCDO-0:6UB$DDC2'4IH$5I?E<\2
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MJ>?3[6RGF\JQG-_&WVDY(*[>"KC ^7G@CGJ!.OB2X_M)+22PB53J3V#.+DG
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MJ&"\M;IYDM[F&9H'\N58W#&-\ [6QT."#@^M34 %%%0&\M5O5LC<PB[:,RK
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M.N17<7]D6][;0O");6**R#K<3ESN2<[28E*X.<H>3DY&*RY-5UV,0S7.L:Y
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M\<'/(-1+K'BGRH2UUK@A:XMUED.CCS8V;?YT841',:@*0^#S_$U=R/$FA,9
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MNS.?FSC'-4[:SN%ELM072[R'3[!+*.XM_LK[V>)9@Q6/&7"L\9RH.<9&<5Z
MFIZ>VH?V<E]:F]$8D^S+*OF!/[VW.<>]9AUZ\NM7O++2=.BNDL&$=U+-<F'$
MA4,$0!&W'!7.=H&>IYIK3;^OZ_/S#?\ KO\ U]QB-%*OA*#3I+:X-Q%/'?/:
MB%R?LXN=^P<89@F 4&3T&.167=Z?=O;WLPTN[9=3M[R&Q06[[H7ED#*7&,Q;
ML;LMC&,'!XKNGUG1K:[FCN=0T^WO8X/-GC>=!)'&.=S<Y"C)Y/%1KXJ\.M<?
M9UU[2S/N5/+%Y'NW-]T8SG)[#O0M_P"OZZ?F'3^O7]3G]*L;N+Q#;P/:SB>W
MO;FYN+IHF$<D<BD( ^,,>4& 21LYQQ4/BZ?4I+3Q'9*-2NXIM/D$,,%@Y2-B
M J@$1Y=B2>C-@=0 ,GK)?$&BP2W44NKV$<EH ;E7N4!A!X&\9^7.1U]::/$F
MAM.]NNLZ>TZ1M*T2W2%E1<[F(SG P<GVI7V?]?UH"T?]?UU.&O->\1)IEQ'8
MG7Y;J"Z<V\K:48UEC"*VUP;<DC)<+M"YV@%@2"9+_5?%G]EW]QI\NI2%-3:$
M"6Q,3QV^,AT'V=V?YL+D(_'O\U=7I?B_0M8M);ZSU;3I+.&%99G%VA:'.?\
M6+_!P.Y]>.*LGQ-H*^1G6]-'GJ'AS=Q_O%+;05YY!/&1WXIOM_7]: M/D86F
MZOJMO=0RZO+>3(;,23I;Z?*(8F5 6/S1!V))/R@YZ#8,$UV".KHKJ<JPR#[5
M3OKRTBG@L[F6S!N Y\J>4*SHHRQ52/FQQGI@'/UFL[VTU"V2YLKF&Y@?[LL,
M@=6^A'%#=Q$]%%%(84444 %%%% !1110 4444 %%%% !1110 5S_ (M@U*YM
M=/32[8RSK>QR&0JC)"HS\[*TB%@/13FN@K*\0ZM+HVEM=00P3S9PD,TKIYG!
M)"[$=F; . %.:3MNQI7T,.3P3>"+3X(-;"06DHN3$UNVUYO.,A;"R*-IR1M.
MX#@CD<[.A:&^E^'AI5Y/#=DF3S'C@,2N'8D_*6;UQUK$7QS</<PHNEP^7,+%
MT9KLAMESN )7R^JLO3/(YR.E8VG^)];748M4O+6-UDM7\Z"._?RU07.P.JE,
M;P"1C R!RW:J:?PLCF2LS?O?!]_>>&4T8Z\X#*T=S,8"#,A38H^5U((&WN0<
M'(YI'\(:B]Q+.=8M1*;V*[B*V+84K%Y3*P\WYLKT/&#Z]*AO_'DUH;N2/2DE
MMXFN8H6-T5=Y(%+.'78=BD*<-EL\9 R*<_BK489]2,FDVL<UO:V]Q&'U-_+>
M.1W W?NOE<;3PH<G(&:6ZN6KK1%72/AR^F:AIEW)JJW'V..)'0QS(KF-2J,J
MK,$!VG!W*_?&,XK9UKPY=:QKFFW3WL*V5I()O*,&95<%2-D@(V@X(.03@D=#
MQDQ^/[Q=5M-.NO#\RSM&DEX+9I;@6P<L%^98MO&W+;BF.V[%6/"VL7&L^([V
MZ=3%;W&G6UQ#"+QIE"LTN&VX 1B ,@ CCJ:K5Z^K%O<OZ7X:N-+F$B7\4GD1
M?9K-6MSB& N&96P_SMP &X P.#SFO)X,\][B.;4&-IB<VL218>!Y6WLQ8L=V
M&^Z,# .#GK67:^.=62S8W&EV<MSOO9MJWI1?L\$NQL$Q\OS@+T(&2RYQ707V
MM,EYHGE6;RQ7PD=")C&ZL(BX!3&&R,CDC!P<'LM?Z^_^O,'I>_\ 73^O(J3^
M%K^;3)8UU6V&H7%]#>W%PUFQC8QE-JK&) 5'[M1]X]_7B7Q9:ZK=/HPTJWWR
MQ7PEDF9$=(5\MUW,C2(6&7'"G/!_%(_$UZ1 9M-MXOWWE7;&Z?;;L=NU3^Z!
MW'>#R%&.YR,X\GQ'EMK1YKK2$!6*4[(+EI3YB7(M]N!'G:20<@$]1MR.34=_
MZ]1X^'"0ZE87=MJ1Q;1QJ\<PFVNT;,RL%CF11RQX8..PQ6[I7A^33O"5OHDE
MQ;7#PQ[/--L51L'()3?G/_ NO/M52;Q)<2>!;C6Y=)G@E1&\RTFDEMVP&VDJ
MQ0.,CE254GCIVT[#59[G4[JSN;1+;R\M#F4L\J XWXV@ 9]&;@C."< L]5_7
M<FZ_K[CG)_!&L3S><VOVC2&*%"TNG,QS'.9A@^<#C)VX.3@#))YI;CP-J=U=
MS74VO0RRS30.YELW8%89FD10/-P.NTX '&<9-37US<V-KXM>WNKA6C=&1WE:
M3R-T:[BH8G:!DG X'I35O;O3O#OBI+2YGF&FEUM)IG:9Q^X1SEF)+89FZY].
MU$6]T4]78M:?X.6P\77&MK>&2.5I)%AD,Q,;. &V_O?+P<#_ )9Y]ZT],LI]
M/U/4D\L-:74WVJ.4-RK$*&0CKU&01ZD<8YY/?)_:G]B_VO??V8MSDW'VM_,+
M?9_,V>;G=C/SXS[?=XJ&VU;4KJ*RU&XO;A;R./31';JY5)!,X$C,@X8D9ZYV
M[>,<T16R7I_7S)??^MO\CJ)= OH->N=3TC4X;47NS[9#/:^<'*C:&0AUVMMX
MR=PX''K6D\(3-K3WBZDIMVNEO?+DMLR"=8Q&#Y@8?)@ E=N>HR <53\17EU'
MKMRZWD\)LHK1[6&.0JLKR3,CAEZ/D +@YQG(P<&LF35=1MK6:YBU&Y:>[M+R
M6YW.76V9)D12BGA-JEA@#G;DY/-)*^G]?U^13\_Z_K\2:'X<ZO#:+ ->TWY+
M>"!&&DN"!%+YH)_?\DDG/2D?X<:O);SPOK^FXE@NX=RZ2X(^T2"1S_K^H(P/
M;KFNBT*>>UAURWB-Q?16%QLMA),9)''DHY3>Q)8[F(R3WQVK!O\ Q-J%KKMM
MJ"VRL8M.N3>V2WT@C3RY(LD!D&7 =L95201R!5*][(3;M=FA<>"+J>>5_P"U
MH1&TDERBFS)9;AXC$26\S)CP2=G7H-V!BM'PWX?OM#,XN-0M;A)(88D$-F82
MOEIMR<R-G/T%9NH^.+BQOM0MX]-M[E+6+SHY([M\.!(J.I)BVAQN^Z&;I@E<
MBG'QM>?\)'-HZ^'[F>2 ;9I+?S'59#'YBC=Y83:1A<EP=Q^[CFI6HK=.PMSX
M*NKU[^:YU6 W-S:"V6:.Q$9;#!@\V'_>$$<8V !B.^:2[\"M?W<WVG4@;.66
M2Y\N.#;*LTD1B8B3<?DP20N,]/F(&*Z+2-0DU&R\V>**&=',<L4<C.$8=1EE
M4_F!U%8,GC&ZM]5EMKK3K6*W2\DM!<?;B<,L7G*S*8QM4KU.3M/8CFF-;W14
MU'P/JFI+9,^L:?!/:NTOG6^F-&SR;0J.<3=5VKUR#C& .*Z^1KJ#3]P1;JZ5
M!PF(P[^O).T9YZG ]:Y?3?&=_J%U:VRZ/ LLMS+;N?M;A5*(K[ANA5F4JW7
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MBTVA(X9!(GF /^\;(P2"HZX R:?=^#=7N;B_N#K\+3W2>4&ELW<(@E#J HF
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex3-1_003.jpg
<TEXT>
begin 644 ex3-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /# JD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\;(0RL58%6 ((((Y':@"W115#5]:T_0K076HSF*(MM!6-G/0D\*"<  DG&
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M4QJ5G/%896817"':_0(3GY6)XP:?;ZU<OX:_M2:RB6=E)B@@NEE28DXCV2
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MR4T/6)-3T*>YL-8DMK:^FE16U(&2VA:/:JRMYW[P[\G@O\N02>A[:/6])EU
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M:I+RLO&X_<5!STK)TGQ7<Z+;:DNI6TDUO"]_<)-]K:9\0RX,>''"@, #GMT
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MR6\D%\66>)U;B0 +@@=5(90<8)QQ):>,+V\M;R2+289'M9T4M%<R-$T3)O\
M,#&(,1CCY5()(YQDA;707O\ U_78ST\ :I%''''KECLB@MX(]^F,Q"PS>:I)
M\X<GH>GX5J>'O!@T#7+O4!>FX2;S/+5S,6C#OO8<RF/&[^[&I]SSENI>*9X8
M)]]A"8L1O"5OG1YHRZ*SJ0G0;QC!.>,[<UCC4=4/CJZGNUD-I!J26$20:G(J
M!6A60%H=FUCGGJ#\Q'( RTV#]Y79Z)17!Z?\0Y=7MAY6ASQ&ZE2*R>X:6&*;
M>'/,C1#:P"'.S>.5P3GBY8ZK-9_#FSOG22[;Y%?S+QPY4R[<^;RS$ _CCK2L
M#T_'\#L**X>?QOJ0M=3(TFVBDMX+UH'^V%P[V[!3N'EC .01U[CW-C3O&-Y-
M>V]K=:;"$\^.SGEBNBS+.T0D&$*#*8(^;(.<_+@9H2N-IK<["BBB@04444 %
M%%% !1110 4444 %%%% !1110 4444 %4-9NM/M=-D.IQF:UD&QHA;M.9,CD
M>6H8MP"<8/ -7ZS]9NKVTT]GL-/GOK@D*(X6C!4'JW[QU!QZ9YI/8:W* LO"
M_P#PB>8M,L)=!,?V@0060DB9?O;A$JG)[\#-4=<M/#-WIZAA]C?5;=+9;VSL
M@91"V,*S&-@B'@?. .>QJ_;1S6OA@65OH]Y&4LF$<+20E]V,!"0^W>>N<[?>
MLNXL=1N_#NAV TJ_AO(4B;S?M$0BMI$ '[U1(?,'!( 5QT/!Y%/?YHF[_,O2
M6OA6U6W\.SV5C*(E^T"W-DK)'C)\UPJ;(\D'D[<G.*GL+7PWK,-]);Z7:.)Y
M0EXLUAY;2.N"OF*Z@G (()'0@BL2+1-4L?&=UJ,%O>LDMRUS-,MV/*GB\D(L
M/E%Q^\#!<$J !_%R16QX<L;RUM-09H;BT6YG,L$%Y*LTL65&=[*S9^8$CYFP
M,#/8*^E_Z_K_ "]!VZ?U_7];W)M0T3PW#I\LE]I&FFUCC(</:(P"%MQ&-O(+
M8..Y]Z;8:=X:UBS:_M=*L)8KN+R9&>R56=%.WRW#*#@$8VL.,=*XJXT#Q-=>
M'KRVNK/5YW=(!+"=34M-<+("\L3>:-D94?=RO;"#'/1^,;/6;G2K.'1+6],Z
M*666.^*-$R@%0X\U!)GD98N >2",T[=/Z_K^O(/3^OZ_KN=!I^BZ5I)E.FZ9
M9V1EV^8;:!8]^.!G:!G':HY;73=%L+^Z@MH[)&1I9Y;2V!<X7[VU5)8@>QZ=
M*H^(;"_N'TZ^T\733P2%)+=+QHE:-U*DL P4E20W<_*<<U@WNF:];ZS<?8['
M4IK!+.2V ;43*+G,0V/B6;"D,"#\H))SN(S4RO9_,:MI\C7T7PMX<LM$BL4L
M(KZ% ESYUS8H6E.#L<E8U#.!QD#<.,]>;.FW'AS5-7%]96<)U*6V$OVE[%HY
M6B)*XWLH/4$%<Y'<"N7^Q^)_-D5=,U9+%H[/S8%U"-'8*C"18B)OW9W&,G!4
M$*W//,5OIM]'IAM]7AOM$ACTYH/[2;4(XPDWFDI\\<NXYR.P!S@]<54MW_7?
M^O,E7:5_ZV_X)W3Z)HX6U9M*LC]A!-MBV4F#/7RQCY<^U-AT+1/[--I'H]BE
ME*PE:W^RJJ,V<[BF/O9P>1G-945GJ;^"+UY%NVU:]MWE,,-VX:.1E^5(V9AL
MQQT*C.3WJE;V>M2M+YUMK,?GV2K*[7J9C?"C;&%F(SPQ+84\_>/&$]&T/>S_
M *_K4Z!?#'A]  NAZ8 %= !:1\*^=XZ=#DY'?-26FBVEC<QO;CRX(8_+M[2.
M-$AMP?O% J@Y/?)/MC)SQ%UIWBM6AGM[+5?G6V<Q)JF3&8[@EPP:;&6B(R 6
M!((). 2VTTKQM%%J_P!JFO9FD=#Y<<P02H),OY,AG8HQC^7[D0SCH>:8,[.&
M'0_$6S4OL-M=/$[0K+<6F)$*/ROSJ&&'7/U -43:>$&UV72SI>G'4)XW,JFP
M!$@)#,&?;M)/RL5)R>#CO4/A!KO3K<Z7>Z;>6TLEQ=3HTT\<OR&7<NYE=F)(
M<#)'4')Z9P6\/ZQ#XDU74K;3]959=463":KM2X@:'RV(3SMH(<!OF (7&WIM
M ]'_ %_6X][Z_P!?\,=!+;>#=#U%B=&L;:[A42&2'2^565MA(94[GAL'@=<"
MM:'PWH5NMNL.BZ=&MLYD@"6J#RF/5EP/E)[D5P_V/Q,=(M8KG0-2N;M=*AMY
MI&NK=BTJR@MEFFR>!G/OZ\5NZ+9R2>)[UH=1N+C38)#,H.H22E)V&UX6&XC:
MFTG9R 7' P*+:V$S3/@WPL1&#X:T<B(DQ@V,7R$G)Q\O'/-32Z#H(>X\S1;%
MFOSMN"+-6\[O^\(7D<=6XKC].DO;_P 7ZF-*N;RYBL=0E$['5-\.PPC]SL+D
MJWF'(.T!<$ \;:AL]/\ &-N;4I::FA%^95634!*L,3VY7;)OG8R!92#U/3(
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MUTZ7[1.K6@BCC<9(E&5 /*GYQGD'G(J734\-:D+R*UTN%1>@M<K-IK0_:0,
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M73Q*74  E@J'" !06/ &,GI6GI>FZ+:.T^EV%C;O/%&7:W@6-G3&$W8 .,#
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M&3U !(Q5M:V(7PW9T]%%%2,**** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ98X4$XSD5M7FK6=A-;0SO)YER3Y2Q0O(2!C).T' Y')P,D#N*PY/ EB]NL
MU#4439+#)L>,>;#(Y9HF^3[N2<$889^]6MJ>BQZG#!";F>WBA8'; $RP!'&6
M4E>G52#[T=!E6#QCH5PA9+J4 1-+^\M94)"R>6P 91E@_P NW[V2..16>/&U
MI_;D*FX']EW%MN1OLDPDCE$OED2?W!D@'<JX(Y/-*W@"P:XDE_M'4@K>:4C#
MQ[8B\HERIV9R)%##)/H<CBI+_P &'49/-G\1:OYOV<6[.JVP+*'#Y/[G&<@=
M./:C30'UL=112*"J@%BQ QD]32T@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L#Q3K4^BPZ:8+FQA:[OH[4_:P2&#Y'RX9>1P>_0CW&_
M10!YN/B!K":MJ]I-9V:1V6Y269 \0$BIYK()C(T94L_W%P!C<V<T^3Q%:6^L
M0:C<ZQH;7XT>Y8W=H/,C=!*A1MF_<5QN.-V!\WS<$UVUCJL5_>ZA:+#-')8S
M"*0R;<.2@<%<$\88=<'VI;_5$T^YL8'MYI#>2F%&CVX5@C/\V2#R%/3//7%"
MV7]=QM7_ *]#DM)\:7EW'IK7=SID;37,EK+&B@R2N)"JE$$K;05&XD&3@YZ
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M8U&R)XX)T8RWQ=RK+"0P *  GANHSM'-=9<W$-I;2W-Q(L<,2%W=NBJ!DFI
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M[P[25(;!W8&>N01Z!67=:]:6M];6FV29Y[K[(S1;2(I/+,@#Y(/*CL#U%$=
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MQ0W]K^NGZ?UO>D[-(J:%X1U6Q\9S:Y?3QN)D;=Y=PI(W!?W9!@#NJD<$R?\
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MXY\/H(B]U<+YJ,XW64XVA7V/N^3Y=K'#!L8ZG YIS>(EE\66NE6DJ21%95N
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MTZ6WO(HYO.WQQ+,LA/\ JV>8$[!MSM5]V>BY%;FE^(KFZ\/:E>YMM0N[+?\
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M3)=[EBU!!(R,8"6X^10X!WY#@=/FI/AEKUM?6+:7;3V2PVB,8((<,7C,C_O
MRMC;_#MV@C&<X(HMT_KL-M]33B\!P12B9=;U7ST2%(9?W&Z$Q*RJR_NL$E6<
M'<"#N/'3%J[\(P7NKV^J3:G?FZMPOE-B$[&"LI89C."0YR!@' XXKE+GQ]):
M221V^J^'(7^UWT<I=#R8EW*2!*.2  <]<@\=*DC\::A]HU"Y&J:6+.26U6*6
M2,M%9Q20[_-<B0;D+97/RC/?C%*]]?Z_K4$K:+^OZL;J>#FL+-8K:]N-05;+
M^S_L]_)&D31%N23'#N+ '@< X&<=:V/[#B'AL:+'<W,,8@$/GQ/B7IRVX@Y8
MGDYSG)SFL2Y\1ZJO@>'7T6T@>-P]UYD3NC0!]K2( RD97YQG/''O7,ZKXAO]
M4\,7;ZS-I</V&[MD?=;M&!-]H5D8%I"%'E;6*\GYCR*>]U_7]:@M;/\ K^M#
MHF^'%CY)A@U?4[:(PS0^7"MN%"S.'DP/*XR0/IVK0L_"$-CJD-]#JFHXBEDE
M%NQB\HM(/WAQLS\Q^;@\'I@$BN8@^(+27D8\[1K^ZBMK_"VH_>-)#(H&SYV(
M5T^8KR?ER":HZQXI-M?:=K(UOPU<7D-E?-%<PG]W-&OE,$V^9E6.&&-QP><=
MJ-=!\MW8[;5_!FFZU?S7MQ-=)+*D2'RI  IC<L&&0<-R5)]#CBB]\(6]]?7E
MV^HW\;7)MV")Y6V(P-N0KE">N<[B1R?;%/Q'J\V[PU-:ZC90Z=?7.VX>9?,C
MEC,+L!NW 8.,#KR0><8/%Z)X]FT?PE;V=G/I5UY%E;/#Y)7-NC,R.9 TJJ0I
M5>=T8&X ^YJOD*R:N=DGP]LP LVL:K.@$FU7, VL\HF+@K$#N#@,.<<=,5)=
M^ ;"]M7BEU'4?/E$PN+I6B$DXE14?=\FT<(F-JC&T>^5F\2WB^"[#67ETRTE
ME"M.TTR/$!@D["L@5B<<8?C.><8/-VGBJUTKQEJ(BU#2XK>^OXEGB==LV]K0
M,' W CYEP5()).,@CDV=AK^9'=Z3HD>D27CQW5S.;MTDD$VS[ZHJ;AM4=0HS
MVST K"'P\MT14CUW5XT6**)%'V<A5BD\Q!S$3PQ[]1US6-IOC_4-0O;&S2_T
M8O=7S6R2&$KYL9@\U)%03MCYOEP3SD#Y3Q3K#Q]JMX=5\\:78+:,.;J6(-"
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M#'E#."H)&X8['-'4.OS_  .VOM3CL+NPMY(9G^VS&%'3;M1@C/\ -D@X(4]
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MT<$H$8CN)H@2\:DOD,-I^\%!P<$XK5AT:S@OUOE%P]PD?E*TUU+(%7C.%9B
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M@.X%55P%^;G  &>>M:.G:/9Z3#'#9K,D4:E$C:XD=5!.>C,>_3T' P.*O44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM!/&3@9[T 7:*89%$RQ8?<RE@=AVX&.^, \].IY]#3Z "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***Q_$.L2Z3!9QVL4<EY?726L E)"*S D
MLV.<!58X'7&..M &Q16+)JDVAV@DUZ[MY2Y"1&QLY=\C\D@1 R,>!G@G@$G
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M\=:+MZ^OXDI))Q\OR.'T_1O&D>P:E)JUP[7T)E-O<K$@0%A(ZL;DDJ01\H5
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MS$MY,ZPA%)/8I&K' &!DG K6HHI#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"BFDV<>LRZLJS?;)8EA=C/(
M4* Y V;MHP2>0,\GU-7J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BLJYUV.TUBVT^:RO%2X?RH[O8ODF3:6V?>W9P#SMV]LYXK5H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#V]_^/5T%% '/_\ "&Z7_P _6N?^#V]_^/4?\(;I?_/UKG_@]O?_ (]7044
M<_\ \(;I?_/UKG_@]O?_ (]1_P (;I?_ #]:Y_X/;W_X]7044 <__P (;I?_
M #]:Y_X/;W_X]1_PANE_\_6N?^#V]_\ CU=!10!S_P#PANE_\_6N?^#V]_\
MCU'_  ANE_\ /UKG_@]O?_CU=!10!S__  ANE_\ /UKG_@]O?_CU'_"&Z7_S
M]:Y_X/;W_P"/5T%% '/_ /"&Z7_S]:Y_X/;W_P"/4?\ "&Z7_P _6N?^#V]_
M^/5T%% '/_\ "&Z7_P _6N?^#V]_^/4?\(;I?_/UKG_@]O?_ (]7044 <_\
M\(;I?_/UKG_@]O?_ (]1_P (;I?_ #]:Y_X/;W_X]7044 <__P (;I?_ #]:
MY_X/;W_X]1_PANE_\_6N?^#V]_\ CU=!10!S_P#PANE_\_6N?^#V]_\ CU'_
M  ANE_\ /UKG_@]O?_CU=!10!S__  ANE_\ /UKG_@]O?_CU'_"&Z7_S]:Y_
MX/;W_P"/5T%% '/_ /"&Z7_S]:Y_X/;W_P"/4?\ "&Z7_P _6N?^#V]_^/5T
M%% '/_\ "&Z7_P _6N?^#V]_^/4?\(;I?_/UKG_@]O?_ (]7044 <_\ \(;I
M?_/UKG_@]O?_ (]1_P (;I?_ #]:Y_X/;W_X]7044 <__P (;I?_ #]:Y_X/
M;W_X]1_PANE_\_6N?^#V]_\ CU=!10!S_P#PANE_\_6N?^#V]_\ CU'_  AN
ME_\ /UKG_@]O?_CU=!10!S__  ANE_\ /UKG_@]O?_CU'_"&Z7_S]:Y_X/;W
M_P"/5T%% '/_ /"&Z7_S]:Y_X/;W_P"/4?\ "&Z7_P _6N?^#V]_^/5T%% '
M/_\ "&Z7_P _6N?^#V]_^/4?\(;I?_/UKG_@]O?_ (]7044 <_\ \(;I?_/U
MKG_@]O?_ (]1_P (;I?_ #]:Y_X/;W_X]7044 <__P (;I?_ #]:Y_X/;W_X
M]1_PANE_\_6N?^#V]_\ CU=!10!S_P#PANE_\_6N?^#V]_\ CU:&F:-:Z1YO
MV:6^D\W&[[7?SW.,9QCS7;;U[8SQGH*T** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HJ"[O+73[62ZO;F&VMHQEYIG"(H]R>!
M52T\0Z)?RPQ6>L:?<23(7B6&Y1S(H)!*@'D @\CTH TJ*SO^$@T4Z6^I_P!K
MV']GHVUKK[2GE*<XP7S@'/'6HD\4^'I7E2/7M+=HHO/D5;R,E(\ [SSPN"#G
MIR* -:BL;_A+O#69A_PD.DY@7?,/ML?[M<@9;YN!DCD^HIL7C'PO/'+)#XDT
M>1(AND9+Z(A!ZDAN* -NBLR[\1Z'I\C1WNM:=;.L0F*S72(1&3@/@G[I) ST
MHLO$FA:E#<36.M:==16Z[IW@ND=8ASRQ!X'!Z^E &G15)]8TR.SBO'U*S6UE
M*K'.9U".6^Z V<'.1CUS1?ZOIFE6Z7&HZC:6<#L$22XG6-68]@6(!/!H NT5
ME+XG\/N+@IKFF,+9Q'/B[C/E,3M ;GY23P >]1/XP\,1B8OXCTA1 _ER[KZ(
M>6W/RM\W!X/!]#0!M45B_P#"8^&#=+:CQ'I'VAF"K%]NBWDGH -V<G-/3Q5X
M=DU'^STU[2VOMYC^S"\C,F\=5VYSGVH UZ*QY/%GAR&_-A+X@TI+P/Y9MVO(
MQ('Z;=N<Y]JM7.LZ79WT-C=:E9P7D_\ JK>6=5DD_P!U2<G\* +U%8][XL\-
MZ;=O:7WB#2K6Y3&^&>]C1UR,C*DY'!K75@RAE(((R".] "T5!!>6MU)/';W,
M,SP/Y<RQN&,;8SM8#H<$'!]:GH ***@NKRUL81-=W,-O$65 \SA 6)P!D]R3
M@"@">BBF2RQP1/+-(L<: LSN<!0.Y)Z4 /HHHH **@FO+6WN(()KF&*:X)6&
M-Y K2$#)"@\D@<\55G\0:+:ZFFFW&L:?%?OC;:R7*+*V>F$)R<_2@#1HHIDL
ML<$3RS2+'&@+,[G 4#N2>E #Z*@DO;6&Z@M9;F%+B<,886D >0+RVT=3COCI
M4] !1137=8T9W8*BC+,QP /4T .HJK#J=A<:=_:$%[;2V.PO]I256CVCJ=P.
M,#!YJ:">&Y@CGMY4EAD4.DD;!E93R""."* )**;)(D4;22.J(HRS,< #U)JK
MI^JZ=JT7FZ;J%K>1_P!^VF60=2.JD]P?R- %RBBB@ HHIDLL<$3RS2+'&@+,
M[G 4#N2>E #Z**9--%;PR332)%%&I9W=@JJHY))/04 /HJ.">&Y@CGMY4EAD
M4.DD;!E93R""."*DH **** "BBB@ HILDB0Q/+*ZI&@+,[' 4#J2>PIEO<07
M=M'<VTT<T$JAXY8V#*ZGH01P1[T 2T56AU*QN;'[=!>V\MF 3]H256CP#@_,
M#C@@Y^E6: "BJ4VLZ7;WZV$VI6<=XR[EMWG42$=,A2<XJ[0 44QY8XR@DD5"
M[;4#'&XXS@>IP#^55[?5=.N[F6VMK^UFN(F*R11S*S(1C((!R",C\Q0!;HHH
MH ***KMJ%DE^E@UW MXZ&1+<R 2,HZL%SDCWH L4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445'//';6\L\K;8XT+L?0 9- $E%4=(U2
M'6=+AOX(YHDDR#',H5T8$J58 G!!!'6KU#5@"BBJ4^I);ZM:6#03$W2NR3#;
ML4K@D'G=D@\8!''44 1>(9/+\.:B?+FD)MW4)#$TKL2I  502>3V%<%8:/\
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M4BON9&D9",$<_*PYXR>177:W-)>^&=:@TI[B.[A@EA3RXBKB0)D!0R\YR,$
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MXANHI7OI;9XO-C\RT,,4/( 7+(I+'D_>;OD+QGH**+_U\@:UN<7X;9M+DO\
M2=2TR]EOI[^:?SQ:.\4Z-(61C+C8-J[1AF!&W@=*PDUKQKYMQ]K-Y 1>P((X
M+"2;:AEP^#]G"E/+YR'<@C[PSBO4:*2W3_KH-ZW_ *[GFJR:]I/BJ97U+Q!/
M;2ZF(Y!_9RRQF VHQ(&2#@B0 <'''(ZU4T&;6]+L[(6,.JSW,^FW1E%WI7EG
MST<&(,_E(1P9,!FP<^XKU6BFF,\]OM5UR#3;)M/O->O)6F:3?+I/E$Q@INCE
M7R"<X+;2HCSC&<CG-O+KQEIL<RZ=-?OYFI71DEN+1CL&X>2 ([=V:-E)R0.V
M-Z=*]4HHOK<2_K\?\SD?%E_KENUF+!KV&-X)&,EE9_:"UP-OEQNI4E8SELMA
M>@^9>\7ARVGG\8:S=:BMXTRB!HEGM,0QMY>'\J0QC."67ACP379T4NMP>JL%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9/B*SU#4=-%G
MI[1Q^=(JSRM+L:.+.6* QNK-QC##'/-:U% 'GM]X1U^2PNM/Q8:E -3AO[::
M^NO+E.&5I PC@"J20P^4='.?>C:^ ->2":%$TK3O-M+BW:6TNG=L/,)(DP80
M"J*"@SP QP.Q]0HHZ6 \I;X<:NEM"D5CI$DD5I/"C3WG,4CR*Z%/+M4 5"I(
M 48+''K6E<>#=:FO[FX>RT6Y:X6Y62::X<22K*A"H_[H@JA^4>HYP#D'T2BA
MZJS!:'E]CX%UZVFMY%T_1+>2*6V830W\K.@1"DC#, ^9QC//.,$\4VP^'&J6
M6G);3PZ=?N+Z&X?[3<@)($#!GVI;##N#@Y+DCJQ[^I44[B44E8XKPOX2N])U
M>WU"]L=*21-/%IOMY"[Q[9&*A28URI5@.V-H&".F)?\ PZU!Y+M+72]!:&5[
MYT=YFC8M,5:-RHA/S(5]3T!!%>H44O,I-HX&?PGJ]S-J4LNF:,SW,D,\8-VS
M*)5BV,SJ8,,0>1W.!RIY'2:]!J]QI\=K86MC<K)\MTMQ=/;ADQR%*QOU[^V?
MK6U10):&%]AU0^)+>\,5FMHM@UN[).P=9"P/RKLP5&WKN!YZ<51\.>']6T^Z
MN9]1NEDEEM5@61+R:7;M>0@E9."=K+\W7(/&*ZNB@$K'FEOX%UF&&YMWT_P]
M+%<V\$$Y=V?SV21BTS*\3+YC!]V2&PPYW9R-&U\";%T07,-F\D5LMKJ;>6'%
MS''M:/)(!)W(O;&"P]*[JBG=[@]3D/%_A:\U^ZBDMULI4$#0K]J=E-I(2"+B
M+:IS(,=/E_WASF?PYX?N='UGQ!>R66G(;^=989H9#YD@"!<2?NQC)!;@MRY^
MIZBBDG960'G^I>"=0O[;[0UMI37\\ET9XY9&9$2:/9M5_+RP!"G!49]L"I)/
M">J7EA>?;[+3!=Q);2Z=)',9S'<0K@$AHTP,C'!Y!/2N\HH6FP6,S2K)]*2+
M3X;2%;-(MYGC8 M*6R^4"C&2=V<G))R!WR+C2-;U5M42^M].MQ/$8[>>*Z>9
ME ;* H8U &>6^8YZ= ,=511YAY''W6@ZW+IMS*L>GMJ-WJ5O>2Q-<NL4:Q&/
MY5?RR6)$0ZJ/O'TYLOH&H'7GE5[;^SWO%U!B7;S?,6(((\;<;<@-NSGMCO73
MT4[_ -?UZ!ON1PF5H(S.B),5!=(W+JK=P"0,CWP/I4E%%( HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT"BD,\__ .%6?]3[XY_\''_V%'_"K/\ J??'/_@X_P#L*] HH \__P"%6?\
M4^^.?_!Q_P#84?\ "K/^I]\<_P#@X_\ L*] HH \_P#^%6?]3[XY_P#!Q_\
M85L>&_!?_".:C)>?\)-XCU3?$8O)U._\^-<D'<%VC#<8SZ$^M=110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex3-1_004.jpg
<TEXT>
begin 644 ex3-1_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /# JD# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]P)MCZ<QBP8EB=64R\Y"C!R,<]0<4S4O!%[J5Y//)K4:AH'MX(Q:MLA1O+(
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M1KXATDN0I"B]CR0V-O&>^1CUR*Q[GP3-/<;DO[6""0P//#'8X'F0MN0QG?\
MNQGJ/FSS@J2364_@[5A_9FA!T:QCTR>SNM0%JFQE=E.U4,VY7POWL,,GIZ-6
M'T.TG\0:+:SSP7&KV$,MNH>:.2Y16B4G + G@$D=?6J]QXL\/6PG\S6].WP1
M--)&+E"X1<Y.W.< @CZUSNI?#N:]MKFTBU>.*V9IW@$EJ9)(WF!5]S^8-ZX)
MP,#!QDG %6]7\&7NL7:R3ZTJP)"T,<"VS!4#PM&^!YFWDL&&02,$9P:70:WU
M_K;_ ()JVWBW0KJPEU%-:TO^SXRJM<"]0JC$?=<YPIZ<9YJV-?T8WJ60U:P-
MTY4+ +E-[%AN7"YR<@$CU'-<W_PA>J_;?MW]MV?VJ.2*6'_B7-Y8983$V]3-
M\P*L2,%2#W-0Q> +VTGC-GK%JD*+:*%EL&=L0.TG#"50,LQXQ@# [9IZ7)UM
MYG7W&J:?9W=O:7-_:P7-QD00RS*KRXZ[5)R?PKG+;QK)J=CK5]I-E9WEIIX<
M1RB_&)6C)#JP5"4X&Y3A@01TS5C6?";ZKJTETE^L5O<I#'=0O!O9A$Y=#&^X
M;#DG)PWM@\T6GAO4K;POJ>DMJEH\]Y+/(DXLF"QB5BS IYN6QN;!W#MP<<R_
MA=MRU:ZOY?\ !+5EXJTN6VA%]J.FVM\T0>6U%ZKM&=F\CG:3A>?NCCFI=,\4
MZ%J\-F]GJMG(UY&98(A.GF.HZX7.>.0?3'-<^G@K5_M2S/K>GM\UL6QIC@D1
M*5P#YYQG<?7'O4%I\.Y;"ZL;O^TA<M:01QF(I*BNT2%$95$P0':<'>K]^@.*
MIVU?]=?^ 0KVUW_X8Z-?&7A=YV@3Q)H[3+NW1B^B+#:"3D;NP!SZ8JNWCOPS
M#);K<Z]I,:W*R20RB]0QNBL%SO) R2>G/(;KBN8\->$=;_T.2]6&Q6UNXKAD
MN+8R22[$9=H(NI%50'.,;0#T0"M:V\(W>FN]W/<)J:@7JO:0VHC:9+B19"H+
MR[00P/)."#C /-%DAJQUEO?6EXTJVUU!.T1 D$4@8H2 PSCID$'Z&LG3_%-K
M<6]_<7_E:=!:S!!+<3J$DC8 QR9.  V< >O%)9Z)>VGA(Z;;W_EW[Q8:[GC\
MXAB,9(!7<0, '(Z USVK>"[W3=.U)M$FFNDNM.%H]C)))-)(XR%99)Y\(HW'
MY?3/4XHTN"V.I/BOPXH4MK^E -G!-Y'SAMI[_P!X@?7BH[3Q L][-:7'V2WF
M2]:VC1KKF91&)-R J"6PPRO;GDXKE9_"FM2:U#(-N[4(9_[0N_LL?E0[TB0(
M(O.W!ML6-P+C)[C@7V\"WK/&AUBW%LEZ;D(+-M^PP>1LW^;][9SNQUYQVH#L
M="?$_A\(KG7=,"/,;=6^UQX,HZH.?O>W6H+7Q;HNH:K)IMGJFGRW<,S130&Z
M42C:N253DM@\'IT/ISCWO@O4[[1AISZW:Q(4,<KP6#1F90H$9<K*"2N!WVD9
M&W'0O? ]W?7+[]7A6TDN)YI(UM&$F)8?*8!_,P.I(.T]NN.06INGQ5X=6$3'
M7]+$1+J'-Y'M)4989SU Z^E78=2L+B[:T@O;:6Y1!(T*2JSA3T8@'.#ZUR#^
M!-1>^M[_ /MJR^UQ,,DZ<WEL%B>)/E$HPP$C$G/.!@*!BKFF>'-:T.TC^SZC
M932PVPA5([%HUE<;5#N#,?X5 XP>_/"T:!J:&N:_-HNI:;$T%G]BNF<3W5Q=
MF'R B%RV-A!&U3U8?UJT?$6ABQEOCK.G?9(G"27'VI/+1CC +9P#R./>L_Q-
MX?U+6Y[*2RU.TLQ;"3*S633[BZ%#R)4P &/KSCZ5EVW@C5+8Q2#6; RP>3Y/
M_$M;R_DB,3!U\[YLJQZ%<'U'%)!K<[965T5T8,K#((.012U6L;>6V@\F1K?R
MTPL200F)44*!C&X]P<8Q@8';)LT,:"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3[%C97=U?6Z%A<Z?<)#-%+@+E Y"L#DY#'&!T/ KEYM*^(<FK>>]\ZN;4!3
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4<A\R*.<!\@9K:HHN 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRLJM=SJS*S%6LIP4"L%;>-GR;2PR&Q@$$X'-58_ %BD8B;4]2DA6V6VCC8Q
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MF\')7&TKSN^[TYY%6-2UW3M)F@BO9V1YB H6)W R0,L5!"+D@;FP,GK5/3-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJMJ$0FTZYB
M9I%#1,"T<C1L..S*00?<'-)NRN-*[L6:*\CL].U%O ^GZE>W>J02SOIX62'7
M[N7SEDD0.S99=A(8C:.!GJ<#&GI<=U:^.I(3?7UO:B]E2&:?4Y[A)P(P3 8Y
M&*H06WAN20I'&*MQL[>OX$WT3[GI-%<%H=L]T[:-J>H:DUQ/#]I%W:ZF[17:
M"09>-@P>(GY057"@,0N>35_P593P:3;WD=S>71N'=+C[;J$TVU5=P&0.6YZ
M@;<CG.1@JPV];'745S<\<(\> 37=T@DTUF6+[9*L9PX#,$#;<@,.<9'6L2R\
M37&AV:6Z61O+**&&Y:YFU*269XY9&4%0ZL6((&!NY!XP< I?U]]@_K\#OZ*X
M1OB%=%;1XM%B=+TQO:_Z:03&\JQ9<>7\CAG7Y>1C/S9&*T-0\2:B/!@U:SLK
M=+XW"V[0R3G8K>?Y38?9DC.<':..<=J=G:X=;'5T5YUI_B^ZT&SU :A:2W$,
M<U[)%(+IYG)CG"^7@KG:-ZX(). ?E'&=:\\2ZE<?#K5=9@T][&_MX)BL5P)(
MP"H/SKOC5B,<C*#/3CK2Z717*^91[G7T5YWITE[;F*UE>[6YMM2M\EM6FN%<
M21EMA+*IVC)&"&['L,6K/QO>$6J_V-&('BMY97.H,[()IFBP-T?S889Y(X],
M %[NQ"U.ZHKFO#_B/4M;U6ZADT5;:PA!V79FD/F'<0  8E5N!G*.P&0,GG&=
M-X[NX[JZMXM*M9S#<6\:21WC[)$FE:(,&,(&0R\@9'7YLC%):VL/OY';45YY
MJ?BZYU.VMX(;;[+-!=6INVCOV0H3=>5M3"CS5.Q\YVC!'!/ V]:\82:7XFM=
M%M])N;UY$CDE>))&\M'<H#\D;# ().XK@=,GBG8/,ZBBO''OM>,<>I:A<W<=
MM<&]GN4L]7DR@MV;!B4Q  XXV9VMM!(R376V'CC4=1MXD@\.RB_E,C1PW$DE
MNDT:*A)C>6)2S'>  5 R&^; S0E<#MJ*X.S\5:_/>2)+HUG(_G7BVH34G7<8
M3C8ZB+'(Z'+<]A2W_P 1)[2.R>WT4WXO(_-A%G)+,S!41I!A(2<@N ,X!P<E
M.E):A9WL=W17$7/C^XL%O)KS1@MO;R31*T5PSN[)M(RGE@@$.,]2"",'K5NS
M\77]S:6MS-H4EJDCM'*;AI(L/NVH$#Q*6W9&"P3J!UH ZRBN=E\17,?A35-3
M>TB2]L8I&>V25I-KJFX DJI[@].G/>N9U34-;MYIK%9"\=E>:<8IQ>NLDSRR
MC>' 7&Q@S#&2  ,+Z-*[L#T5STBBN'M/B#-=:S9Z:-"N&D<A;MH?-E6 F1X\
MAEBVE04))<IQT!Y Z*\TR^N;R1QJ6RT<KF%5=6"A6# .LBXSD$$#((YSP GH
MK@FC6HKRJR;6-'\'WVM+(XN!ILK6SW&NW%SYS#DLT<H(1E"Y 7/<$@55;5M9
M\.:ZHNA?72Q" 6UNFJ7%P&DF61F1P(&9T^0X.UF7:N."<-(;5CU^BN)NO&FJ
M2Z5>WFGZ%C[):F2=;R<PRP2&'S0&C*9*]%SG.>V,D%IXKU.%BVH:99Q;)[>&
M[F&I.R(LB@JX!B SE@"..HY-+K83VN=M17'V_C6ZE\1VVCR:)+O94-Q+!YLJ
M0[P64[A$%VX R692"> 1S3->T-+CQ5IH;4M7C6^>;S$@U.XA10L7RA51PHP1
MGIR2<YH[!=:G9T5PDOC.^TY9D71TG,7VQY&;4&/_ ![E=Q&8^-RG( X!XZ?-
M4=]\2+BRN39?\(_//>AR1#;-)-NC"(^1LB8[\2*,$!<@_/C!(M=AV9W]%<U?
MZ5/;Z?=:A;ZG>QRQQ2SQJ\TA56SO 968@@8(QCH2!@  +J/B._MH=->TTRWF
M-[;/-BXNS 4*H'*GY&[9Y]1^(&[;_P!?U9B]/Z_JZ.DHKA/^%AW+HKPZ/$?,
MD"1B2\*$@VIN%)'EG' VD<XZ\U??Q5J:6<-TVC6T<4]KY\1EO6 =BA<)D1$
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M87D5  0%)P6]3S5G3_B%J&J6UK+;>''7[7<)% ;F66!'5XW=2&>$9(V8;;N
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MR"WL[VV0-<,0GG.6CVY@X"<C_@1QZ'43PAJ@-Q-/INAW5Y);".*XN)Y&\O\
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M#S?NSAE52HQN^\<%1Q79^%-,N]'TF2RNK>SMU6YF>"*TE+HD3.651E%QC.,
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M+QD2>>)!)@0':VT 9!)[9Q6_X,\)ZCX>U74;J^N%F-T.9$F4^8=Q(+*(4.X
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M44 %%%% !1110!S]_?:E=:U<Z;I<L<4EI:I._F<"5I"RJN[:VT (QSM/)7J
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MB86RRYG?S)'FG>5F.,?><DXP, 9P.U8I\ >'2,"WO578B!5U*Y4!5?>H $F
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MK1Z:FKZS<:;!9/$)WBCB<- I7.-Y8ASG'15^E%W]W]?C8'K?S_K]3)U6TO\
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M7US-;022/+#Q(WD.J9XZ,1M/7H"<5>H8D%%%%(84444 %%%% !1110 4444
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MW)C8*J9V8P@.0&(Y)SWR>:W**!61R\O@6PN68W5[?3;Q,L@)C0,DBJK+A$
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MH **** "BBB@"G=:1IM];Q6]WIUI<0PN)(XYH5=48=& (P#R>:N444 %%%%
M!1110 4444 %%%% %6RTRPTWSOL-E;6OGR&67R(E3S'/5FP.2?4U:HHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKV2PE9YG";'9(/GW;64D[N#SU STQ7K^H7T&F:?<7URQ6"",R.0,G ]*H?\
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MVD99%@P^%*8W$'=][G:.:V/!GC237[U;6ZU'1[B62V:=$L3M9=LC(<@NV00
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M(+U?$,US)*S(5\TAE+ '<R-Y\AVGCC$8'91G%"0V=;--';P23S.J11J7=V.
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MO8KN"Z$KV\LUONE3RI(PL964K\N_)+$9R<=A2ZE'2?\ "2:2;NTMA=[FNP#
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MJS)&LL;1MNVL,':Q4_F.13J*'KN U$6*-8T4*B@*JCH *=110 4444 %%%%
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M2WXA_P#1,/\ ROV_^% 'H%%>?_\ "6_$/_HF'_E?M_\ "C_A+?B'_P!$P_\
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M_A0!Z!17G_\ PEOQ#_Z)A_Y7[?\ PH_X2WXA_P#1,/\ ROV_^% 'H%%>?_\
M"6_$/_HF'_E?M_\ "C_A+?B'_P!$P_\ *_;_ .% 'H%%>?\ _"6_$/\ Z)A_
MY7[?_"C_ (2WXA_]$P_\K]O_ (4 >@45Y_\ \);\0_\ HF'_ )7[?_"C_A+?
MB'_T3#_ROV_^% 'H%%>?_P#"6_$/_HF'_E?M_P#"C_A+?B'_ -$P_P#*_;_X
M4 >@45Y__P );\0_^B8?^5^W_P */^$M^(?_ $3#_P K]O\ X4 >@45Y_P#\
M);\0_P#HF'_E?M_\*/\ A+?B'_T3#_ROV_\ A0!Z!17G_P#PEOQ#_P"B8?\
ME?M_\*/^$M^(?_1,/_*_;_X4 >@45Y__ ,);\0_^B8?^5^W_ ,*/^$M^(?\
MT3#_ ,K]O_A0!Z!17G__  EOQ#_Z)A_Y7[?_  H_X2WXA_\ 1,/_ "OV_P#A
M0!Z!17G_ /PEOQ#_ .B8?^5^W_PH_P"$M^(?_1,/_*_;_P"% 'H%%>?_ /"6
M_$/_ *)A_P"5^W_PH_X2WXA_]$P_\K]O_A0!Z!17G_\ PEOQ#_Z)A_Y7[?\
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MPN$;)^<GG'3WXP=8\&76J>(KR];3M'FM9+BSG59W):0Q;@Y8>60"5; .3]T
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MHU"HB#"J!T  Z"GT4+16#K<**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex3-1_005.jpg
<TEXT>
begin 644 ex3-1_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /# JD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2:-I;N::)+&., NTY;@#\-V?;-9'P"\4?VOX,?1YW'VK2GV 'J8FR5_([A^
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M'KJ2Z,GVB$W,R!P[;C@^4<<X[&O0?'7A"7QUX)DTFX:*TOCMF0HYDCCE7MG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K@_&NJ_$BQUF&+P?X?TW4-/-NK22W4@5A+N;*C,J<;0I
MZ=SSZ=Y10!X__P )#\<_^A,T/_O\O_R11_PD/QS_ .A,T/\ [_+_ /)%>P44
M >/_ /"0_'/_ *$S0_\ O\O_ ,D4?\)#\<_^A,T/_O\ +_\ )%>P44 >/_\
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M-#_[_+_\D5Z^&4D@$$C@@'I2D@#)X% 'C_\ PD/QS_Z$S0_^_P O_P D4?\
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M@=0#U J>B7E^C175O^MT<QHFI^*-2\!PZ]'=F\O)[?FTBAC0Y$I#/&3QNV9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7OTLK5KU;AX3.BW&GW$ :,$#<#(B@C+#H>]:5]?VNF6C75Y,L,*D LW<DX
MZDDD  <DT/0%KL6:*Y6?XC>&+:WFFN+R[A$,GE2))IURKHVS><H8]P 7DG&
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MKESX9U>\O+?REM#%?6\-O.4C92TB^:< L[,#L+ 'ZBMK3[;6--FU>RN?#_\
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M(CAB@)XR<<9P,CG%<SXHTG7=92^U%-#N3+=V8TV*S2XA$D<+.&E>1C(%R0,
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M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS;VLT9(R,G;@,20<8SSUS7+^./%>J>';NS_LP6<T2@3:A%-"S-%;[PK2!PX
M/. "IS@GL:75(.ESM:*X?6M;\6Q>*X],TU-+BMKA)'MC<6[322B.-69OEF0
M%F" ''<U0EU_X@#5H=--MHL%W+927$<)MVE,C1I%N (G4 -)(RC/0+DYS0M4
M.VMCT>BN"D\7:Y:^,],TR==/ETZ4QVU])'"RM;W+Q,X0/YA#9*Y^Z,!EY.<U
M?CUKQ)K&F/JNAV^GM:R2>7:P3AB\B"3:9B^X #&Y@F"2,<Y.*=OZ^=OZ\M1?
MU^IUU%>76OCGQ'>WEI8PSV"W-SJLUDKOHET(?+CWY<2&4(Q_=GY0W?V-6_#/
MBGQ3XBO)X8[O25-I*?M(?29XE\K?(JLCF8AB0F[ &.<;LBETN#T/1J*X30_$
M_B"6+P]>:F^F3VNM2M$B6MM)"\7R.ZMEI'# A.1@8SU-=Q,)6AD$+HDI4[&=
M2RANQ(!&1[9'UIM6#K8?17#6'B'Q(ND:[JMU]@U"+3I)X(+:QL9(Y)WC(&[)
ME? SN& I/&<]JT/"FN7NMW=V[:OHM_91(HV64$D4\,I)RDBN[8P,=@2<\#%)
M:@]#J:*R?$NI2:1X?N[V&6*.=% B\V(RAW) 5 H92Q8G &X<D54\%ZUJ&N^'
MA<:M#!!J<,\MM=10 [%D1RO&23TP>O>A:W\@>ECH:*Y;QWK.N:%HAO\ 18;-
MA"KO.]VA=0 /E4*'4Y9B!GG'/%<_JGB;Q=H6HVD.L:IX:T^TNKIH8[NXLW52
MBQ;S)_Q\\?-\@4D'O[4+4#TFBN L?$_B34[_ $6TA?3(/MJW+O))92L)(XF
M65%\U2JN&7 .<9SDUBQ^/O$_VNQBFNM+$=Y)-'&\.C3R\K<"%,XN,*')+9)
M&,<DT[/8'HKGK-%4]+&HC381JSVKWV#YIM%98LYXVAB3TQU-<IXP\6:IH.N6
M$.GBSGLPT3:DDD+%X(GE$8<.' !);@%3]UCGC%*VJ0=&SMZ*\PUSXB:OI>M^
M(]-06(%G%OT^>2V<K+*JJ[P,!(-S8=<$8[\'%7)?$?BVSAU^ZGNM$FBT2-))
MHDL)8S,3&)&0.9F"D @ X;KTH6JN.SO8]#HJ-)E:V6=OD4H'.[L,9YKDEU_Q
M!?:&FOZ=#IXTZ5D>.&96\Q;?=\TS/N ^YE@@7\3TH>FXEJKH[&BN'D\4ZZMI
MI&KF&QBT[59T@BMFC=IXA)GRY&;< W8L@48&?FXK'T;Q]K6J6D$L.I:#>R2P
MSR3QVEJ^;!45BKR_OCD$J!M^4_-P>#0]+WZ!OL>H45YEI'CS6=1TLW27^AWI
M_LM[V>2SMG*6$BJ&$<G[XAB<L,94C;G&*FTGQKKTND-K5XUC-9QL+9[==/FM
M)FNFV!$0O(V5W.5+%5^[P".:=G>W]=A7OJ>CT5Q^J7?CNS\H6MOHUPC(6FG\
MMU6W^=>-ID!<!"YR,9P.!2^"]6\3ZS!:W^JKIQTZ[L$N8WMH&B82,?N?-*Y(
M"X.<#J/>A*XV=?1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH #R.N*Y2U\"PVZR)+KFJW43W#70CF\@*L['=YG
MRQ#<0W(#97(''%=710%SE-/\$R:;%#!!XIUWR(9'E6+-LJEWW$EML(+<L6P2
M1G&0<8K.N/A?;W5@;&7Q/K_V<W,ET55K9297W;FR(0>=S<9P,\=!7>44!<X=
M?A=HT,LKVEU=62SV+6,\=G!;0K,C+@LVV$9;.#GL>@ )!C7X3Z)!!=0V5]J5
MG'=006\PB:([HXA@*=\;<-U;U^F0>\HHN!PLGPMTI;BZDL=1OM-BNA$);>Q@
MM(HCY;;D.WR>N[G/?..G%7=1\ VU_/<2IK.J6@N989[B.W$&R6:(@K(0T38;
M*KG& <#BNMHHN!S[:#J4&FZA%;Z_?W-[>!4%S>,G^CKT)C6-%4$ D].3C)K:
MM+<6EG#;+)+((D"!YG+NV!C+,>2?<U-10!B:[X<_MR[T^Y&K7]C)8R-+#]E$
M)&\J5W'S(W_A9AZ<_2JG_"$V,=Q#=V=]J%G?IO$MY#(AEN Y!82;U93D@= ,
M8XP*Z:B@"IINF6ND6*6=G&4B4ECEBS,Q.69B>22222:Q=4\&IJFIW]\VM:I
MU[:"R>.'R-J19)PNZ(D$Y;DD_>]ACI:*'KN--K8X^W\!/:SO-;^*]=CD>V2T
M+*MH"(DSM4?N.,;CR.??@5(_@&TG74DN]7U2Z2_A2)Q,T1,9C_U;JPC#;UZ@
MDGGDY-=913N]Q6.2A\#2P27;IXLU\&]E66YVFV0R,%51\RPAEX4#Y2/UIT7@
M:)9+@7&NZM=6UU<BZN+67[.$E<;<9*1*V/E7@,!QSWKJZ*5PM<Q(?#AB\42Z
M[_;&H/))&(6MF$/DB,$D*,1[P 6)SNR>Y(XK7FACN()()D#Q2*4=3T((P14E
M%'2P7UN<Q'X,\G3Q81>(=;2UCC\JWB$L6(%QC _=Y<8X_>;\=>H!JO\ \($?
M[+&FMXIUXV:VILTB!ME58R ",+" QVC&6R1DXP>:Z^BAZ[@M-CG8?"4=M<I=
MVVK:A#>"S%G).@@W3*#E&<&/:67)P0 .3D&G:5X7?1]%FTRUU[4]KR&1)V6W
M,D19BS;?W6TY).=P/7C%=!10))(XY?A]&OA]M$'B/6OL1E$N,6N[.\N1GR>0
M6.3GTQTR#O7>D37FA-IDFKWRNZ;'O$6$3,#U_P"6>P9''"CVP>:TZ*'JK,:T
M=RCH^F_V/I5OIXNY[I($")).$#;1P!\BJ.!QTJIXC\/CQ'8K9R:G>V<&X,ZV
MHB_>8(89\Q&Z$#ICWS6S10W=W8+161SUWX6>\U*PU!]>U1+FRMW@C9%M\-O&
M&=@8B-QP.F!QTZYS+#X>#3)+>2S\4:Y$]O UO$=MH=L;,&8<P=V .>M=I10#
MU*VG6?\ 9^G6]G]IN+GR4">=<OODDQW9NYKD]6^&6DZY/J<^I7EU=3W^%$TT
M%L[VRC^&%FA)08X[GOUYKM:*.MPV.9B\'R)K%CJ;^(]8FFLXC#&LBVVTH=NY
M3B$'YMBY.0?0BIYO##R^)!K?]NZFDRQM"D*K;^6L;$$J,Q%L94'.[/'7'%;]
M%%P.$;X5Z2VR9M0OCJ"W?VS^T3#:FZ9\Y ,GDY*@]O?'3 K8L/"":8B06FM:
MM%8Q9,-FLD8CB/7@A-Y /.UF*]L8XKHZ*/(#C8?A[';PZ='#XDUI#I\LLMN^
M+4D/)G<3F$@_>;\ZFLO [V%G;V</BG7A;6ZNL46ZW4#<",G;"-^-Q(#9&<''
M%=910!SNA^$+71!9@W]]?BQB\FS%V8\0+@ [1&B@G QN;)Z\\FMR[@DN;62&
M*ZFM7<8$T(0NGN ZLOY@U-10W?<%H<C:^ +:#3OL$FMZO<6XO!?*LC0J5EWF
M0G<D:DY8YP2>@Q@5M:5H<&ESW5U]HGN[VZ*^?=7!7>X7.T8554  G  %:E%.
MX&#XA\*VOB::R^WW5Q]EM9/--F$B>"<_]-%=&W#!/<8ZCG!I/#/A.T\*+>QV
M-U</;W4WG?9W2%(XFQ@[%CC7 ( XYZ>I)._126FP/4QO$?A\>([%;.34[VS@
MW!G6U$7[S!##/F(W0@=,>^:AG\+_ &K5=/U"YUC4)GLX6A\IU@V3!L;RX$6<
MM@9VD#C@#G._10!RD/@.TM4L!::KJ=O)8K)#!+&\>Y8'()AY0C8-HP<;A@?-
M38_ <5I>"XTW7M6T\+;+:I%;BW94C!S@%XF;)8EB2223UKK:* *]C:BQL+>T
M$\\XAC6/S;A]\CX&,LW<GN:X_4OA?I&KOJ,VH7MY<W5[(K_:I8;5IH . L3F
M'*+C'TQD8))/<447UN'2QQ3_  STRYB\O4-3U*_QJ":BK3^0&$R]>4B7A@ "
M/0#&*NQ^"+?[;?37&KZG<V]]<"YN+20PB*1@% !*1J^T!5&W=@XYSDUU%%.]
MOZ_KL@L-=%>-D90588(/<5S]AX/M["%+1=3U*73(D,<6GR2((44C&W*J'88/
M1F8?D*Z*BD!S$'@BU@M8K?\ M34Y%MD*6)E>-OL8(V_("F&(7@,X<@$\\U4D
M^'-BVEVEDFKZI"UM9O8?:(_($DMNV/W;_NMI QP0 1Z\UV5%#UW!.VQR-_\
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M ;,8'[PX'SL1U)P.:U*'N)!1112&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<I#XQF;Q\_A
MJ73HA!L8QWL=R6!D"AO+92@ ;:=V S<8]>.FN5G>VE6VECBG*D1R21EU5NQ*
M@C(]LCZUY_;_  VU&SN=.O[;Q#%_:5K<2W,T\UO/)'.[@J3Y1N=B9#'.T#.!
MC X(M]=@>WF7[+QOJ<UU"MUHMG%;3:C)IT;P:@TDC2(2"P0Q+E 5.3G(P>*3
M2_&^J7D]D+K0[2&*]NY[.!H=0:5R\6_+%3"N(\H?F!)&1QS5CPWX,F\.V-WY
M<VCOJLVXKJ,>E>7(2S%B9?WI,G)Z!EZ4[PQX-E\,Z/-!;R:.=39=JZA'I?EL
M_?,H$N9#G)^\M"TW#T+?A;7]3\0Z?<WEQIEI:(DLD,(CO6E\QHW9&)S$NU<K
MP1G@]!5&Q\8:AC6;C5]*LK.QTF1HIYK>^>=G<*K813"N?O@=0<\8J/1?"7B#
M1[:SMQXDM'ALUF,:)I\B"223)W2_OSO +$[1M^O%%MX(OWT?5--U/68+B.^N
M3>"2VLFA>.8N'!RTK@J"H 7'0<DT_P"OR_X/X!_G_G_P/Q+LOB'6[=H_M'A^
M."*2":?SGO3Y<"HH($S",[6).,+N P2"<50TKQU?:OX5N-3A\/N-1ANUM6L/
M/;C<5(=G\O*KL<.<KP*?K/A3Q+K]B+*^\367V1R!<00Z8\:S("#C(GWJ3@Y(
M8<'H.[=/\%ZKI!UM=/URV6'4V#*MS:S7#187;DN]P6<[0!R0,@8 '%)[/\/Z
M_ .W]?UW%T/Q=XAUNS6Y3PW:0QRV27D$KZC)Y3!FQL9_(X;:"V &[9QFI-,\
M:7EWH6G:C=Z1#%-JK*NGVMO>&5Y<@L2Y:- @"@L3SQ[X!M6WA_6;+P;;Z%:Z
MM81S0PBV%S_9[E?*"[1A/.R'Z'=NQ_LU5@\':C!I6BQ+K%JM_HORV<Z6+"(Q
M^7L*R1F4EB1W#+SC\:=KNVW_  __  /Q%K9&7JOQ/ET#4(K+5M&BBF2[C@NO
M)O3((HY%++*G[L;E 5MV=I&.]6A\0+J.>6WN=+L89'U!M/M'.I'RI9%3>Q9S
M$-@Z 8#$MD8[DN/A[/=ZY_:-SJMO<),DBWD<UD29O,4(=I$@" (-JC!QEB2Q
M-,TKX=76CZ/;:=#KB7,,4$L<D-]9^=#.\DFXR.F\9('RCGU]<4EMK_7]?J-[
MZ'6:+=ZC>V'G:GI\5C/YC*(XKH7"L@/RN'"KP1SC&?6M&N9MM O-$T;2=#T*
MX,%M%-NN+EE0E8\EF55(P-Q.!QA1GT%=-0_(2.=\3:[JNBS6*V.EV=['=SI;
M*9KYH6$C$_PB)P5 &2<YZ\5D7WC^YTWQ)<:#=Z7:)=II_P!LBD6^8Q.P!+1,
MWE J<*Y!P<A<X';3\0>']9U?5M.N[76+&V@L)_M$,,NGO*6?8R?,PF7(PQ(
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M;&,5TK;@'5S$"%)1@#M/2E\,^-+[Q1<VXM='A2V6$&_F:[;-K-D@P@>4-[C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[XQU""SL;:*34+B!IY@HMK-2;F\&#^ZC((923@EAT /(ZCF[*;4H[71=%O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(O7;+ISJ!^*S?T-<]'\1I)OM5K!9075T+J.QM9[:5FM[B=]WRABHP$"DMC<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(".4#E2X .>-WTK?T'5/L'V;P]JD1MM0BAVPOC]W=11\!T;IG;@E>",],<T
M<-X-\06D5YI%AX@EC2[TJWFTXB886VFCD548D\*9(\88]=I ZXKUV-ED17&&
M!Y!SG\JH1Z+IGVR]O!8PF>\54N6*9\U5' 8'@C!K$&A:KX<<?\(P]J]@6W-I
M5TQ1$]?*D )3_=((^E '8#H**P/^$IM8;B*VU".?39I" GVI,1L?02 E/PSF
MMQ6+<\8[8YH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 UEW$')&.E<)+?K\.[YK>XM''A>XE:5+R/+?8I'
M;<8W4#B,L20W09P:[VF-$CA@RA@PP01D&@#AO#5S'XC\?:KXDL9/,TR"TCTN
M&8?=F=7,CLOJ!E1GOS7>5'%#'"@2-0JCHH& *DH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQT3ZF$NWM8K:>=XD5W,>W"[B0!R1S\I.!VQZUS'BG59M0CCM;"V=G@9;@B2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXO&%K.K"8)Y6"P,2E6)<C"MM'?.>-36/%FL:%8Q2WND:>;F3>XM;>]GF<QJ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex3-1_006.jpg
<TEXT>
begin 644 ex3-1_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .* KL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,ZB[Q+O\R7]VV'V_)_%PQYQ\M(&>D45Q?A#POJFB7R37D=BBBV$#^3.92=N
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MZ72ET^&0L6MFC$2/]XG*\ ]S1YC*FH2:F6@FM-2,9$ZJMOY2%94# 2%R1D
M,05(P<=<@5E6&JZG?O(LFKRP)<6[W!:."(M:%92@C4%3DGI\P8Y5L=>-N=?"
MNI2Z=/<+HUU))_QX22")RV.?W1/7'7Y:CG7P?<6E_+.-#EMFG"WKR>2R&8'
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MDPN,#.]AUX)H>FXMK';T5AZ)XHM]?N&6RLKO[.(4F%T_E^6P=0R@8<MG!/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.><@C\#ZY]ETR&?^S)1HUA+96BB=P+H.%0M+F,[,*OW1OR3U HWUZ_U_7_#
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MBVXG9O+%F9B=W5CVP!T=%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/<+/% +F036<T2I$1D,6= H'7OV/H:Q_$,.LZHWA2YCT.Y,MM?)=7D:S0?N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB\B11*JNQZD@#DGO0WN/_,\@M3K!CT?S+J]%E+XDEM3<?V[=--)&))%$;(>
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M&WTRRAM%<2"".!5C#@@AMH&,Y .?45-?7L&G6<EU<L5BC'. 222<  #DDG
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M8M/O.7NO!=W>^()=2M](T>6QN[U;V073O%,Z_9S$8G3R3_$S-R>YR.34-CX
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MRA(FD4^=(25 !"2)NB/S9P>5&.<-T)NZ9XTTK4;#3;IA=6YOU#1++:R@ DX
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M. #7$Q6GB6]M-0^UZ?KMN[I;NB+?Q_/(J$.%V7"E%+8.%9,_F*V+^PU6/4=
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M:6SY_M%&9[A582@,+A653E/NLH)4^ISKZU/J=]I%M8P:%>37=I=64LZ1W$+
M!661L.\@+8VD<X).#T.:JVMKB3TN=F#D C//J,4M><V]CXKCO7>UM-8@>66\
M59+R_CFBB1ES"2AF;HWH"0,CIQ72^&XKNTM]MQ9:Q&\SYD%]>1W B8+R5;S&
M;:2.GJ?NJ,XE:C>AT-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW7R[D3<!E58$'D9SQZ&DTSQAHU]I$-[<:C86DGV6*YN()+M,VPD (WYQ@?,
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MX)$8-8NKJHAF_><L^X[3\O(X#"DM1OJ>ET5P$WB_5[777L&OM%NF\VV,%M#
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MCA61O-*M$#).N'4#/ ;J!M'6NHU7Q5>V7B/[!$UDNV6&-+*96\^[5\;I(FW
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M,/+/R(6&#EON+@"F]-@6NYZ%17FK>!]::TN+%;'0XK.Y\@R(MPSX=8BK2 -
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MUE;5KFQ%G- DMM>"[4K.S,5V 8QG(XP3FK\FO:/"UPLNK6*-;,%G#7" Q$G
M#<_*22,9H T**H)K>DR7,=LFJ633R!F2);A"S!202!G) (.?H:=:ZQIE]9RW
M=IJ-I<6T1(DFBG5T0@9.6!P,"@"[17-:QXUTJPTVTN;._P!-NVOIO)M-U\B1
M2,.O[P!L 8QG!Y('>M:/5[036MI=W%O:ZE<1AULI)T,O3)  /S8YY''% %^B
MLL>)-"9'==:TXJDPMV872864]$//WN#QUII\4>'Q'YAUW3!'Y?G;OM<>-F=N
M[.?NYXSTSQ0!K45G0Z_HUQ/'!#JUA)-*[1QQI<H6=U^\H /)'<=J:?$>A@3$
MZUIV()!%,?M2?NW)P%;G@D\8/- &G15$ZWI(TTZD=3LOL"G!NOM">4#G&-^<
M=>.O6JD?BS09;RYMEU:SW6T"7,KF= @C;HV<],8.>GS+ZT ;-%4'US2$M[:X
M?5;%8+I@MO(;A LQ/0(<X8_2LW3_ !;8RVD\NJSV6F20W$\!66[7#")MK,"P
M7CIVXS0!T-%9,OB/2?)E^S:IILLZLL:QF[0 RL,HA(R06[<$XZ U3TOQ?I^I
MZ#:WXNM/AN)EA\RVDO5'E/( 0A.,[B#P,#-%@Z7.BHK"UOQ/::98Z@]I+9WE
M[8()9[/[4$=4R,D@!B.#QD<^HZU8N_$NCV>B7&L/J%N]C;Y$DL4JL P."N0<
M;L\8]:.EPZV-6BN?T?Q79:IJ-Y9/-912QS[+81W8D-U'Y:2"11@?PN,XR!ZF
MKK>(=(_LR]U&+4+:XM;(.;A[>59/+*C)!VD\^U#TW"VMC3HK'TW4M5O$BN+K
M2H;6TE =6^U[I$4J3EUV  ]!@,W7VJ5/$>AR0I,FM:<T3N45UND*LP&2 <\D
M#DBAZ;@M33HK-L_$.B:C*(K+6-/N9"AD"07*.=H."V >GO35\3: \:R)KFFM
M&Y8*PNXR&*C+8.>PY/I0!J45CWOBK0["SNKJ;5+0QVK!)@DRL48G !YX//>G
MIXBTK[)<7LNJZ8EE%+Y0N%O%*9P.&/ 5LGID\8/?  -6BLXZ_HPNEM3JU@+A
MBH6+[2F\EAE0!G/(Y'K2SZS86ES<I<W]A#':Q+).9+E5:(,3@NI^ZIQP2>>:
M -"BJ4FL:9#IT>H2ZC:)8R8*7+3J(VSTPV<'/:F?V]HX./[6L<^9Y./M"?ZS
M&=O7[V.<=<4 :%%<M9^.M*O=0@6.ZLQIT\#217C72C,BR!/+*D8!.X$?-GV%
M;4VMZ3;W,UM-JEE'/!&998GN$#1H.K,"<@>YXH OT5DCQ)I#7#JFK:6T44)F
MF;[:FZ-?EPQ7^[@_>)&..N>%3Q/H$MNEQ'KFF/"\ODK(MW&5:3^Z#G!;VZT
M:M%8E[XDM[7Q%IVCQ-:SRW3LDRBY E@Q&SJ3'@Y!VD9)';K2P^+O#\RW#_VQ
M91I!<&V=I;A$'F#MR?KCUP: -JBJEY?PVAME>>U1[B58XQ-,(_,)Y(3@[FP"
M0._M51_%/AZ.*21]>TM8XI?)D8WD8"2<_(3GAN#QUXH UJ*H1:[I$\L<46JV
M,DDKND:)<(2[)]\ 9Y*]QV[TS^W=+ETNXU"VU/3Y;:#<'G^U*(E8=F<9"\XS
MZ4 :5%4HM7TZ6^&GK?V;7XC$K6J3JT@7^]MZXYZXJ[0 4444 %%%% !1110
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MB[L,2>9D$S9]ADD\#))ZQWO@34[U[R237H#)=02VS%K)RJQO('P%\[ (P1D
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M41$@@[0!\N03T]:XI-2\6^;9K=B\AO=MOB"&R#V\RD+YS22!3Y;+\Q W+T&
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M9],L+J\M[RXL;::ZML^1/)$K/%GKM8C*_A5JB@ HHHH **** "BBB@ HHHH
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MW,VU=H)8Q;E.,#Y"O2L>3QS>QM JZKH,L,MU%"+X(RPL'5B5 \WAT*C/)SN
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M9</E)E\PG<I50?F7[XR%[YUIXD@L_B!=$7ND+=7UK8I=75N1)#OW2C. X;+
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M\&IF5$CFAFB"L\,Z[6"MRK<$@@X/(]".H(J74KT:;IES?-#+,MO&TC1Q;=S
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M&.#BD!Z'?W?V#3[B[,,DP@C:0QQ;=S #.!N(&?J14*:M;/8V=UEA]L4&WB;
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M.XN ;>["JRDNJ6Z;6)8,<B3)49/&:5KK4+V9W&AW\-SX=LKBQM+L0D")89I
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MTVIF]-BT[M%*&B"$O^Z&&#+O'!R3V(S2Z!U.DT3Q/:Z[*D<%K=0E[2*\4S!
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 8J^+-&;4WTXW,B7*3-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'GNH^-]4M?[?:VETRZ73+U;;$:#=$CJIWR;IE4!274Y*@D=5P:
MFL?%>NW5MITLQTV(ZG"\5H(XO/4W*MU+QS%2I3+8!XP1N..>\HH6@/5Z'EEY
M\2=9M9]966+2K1;%9-HNI(PZE'"J"@GWD2#)!V+MR/OCFMO4/%FJ:9>RH9M.
MOR;22>VM;.+,DQ";QD^:2HQ@9V$'CY@6"UU.CZK%K6G"\BAFA7S)(C'-MW*R
M.48':2.JGH:OT=+?UL'7^NYQ&@^+-5UCPKJ-^QTM+B"0+#/YT1A92!RRI,X4
MC)&TR#.!RN>,[_A,-3%['>)J-G<0-IGFK ML4WMYVQY% E;*J,,<%@5'!YS7
M=W^I1Z;;75S<Q2K;V\8D,@VD/U^51G.>!U 'S#GKA-*U&34K=I9--O; JQ3R
M[M4#$CJ1M9ACWSSVR.:-W=!ZG&?\)MJ!C6(7^B+&\SQQ:TZ,+*<A48*!YGRL
M2Q7.\C*'J?EJCX;\0VUMXNURPLKG3(A<ZBTK,I#1R2?9XR44JPVDL';<0<[&
M&,YQZ<S*B%V8*JC))/ %06UXEXD<L"L]O+$LL<XQM8'H!SG.,'ICFG?<&< ?
M&^I1I;>=K6@0*\\UO/<2VQ\F)U0,H#+<%6YR.H/(X4C!S'\56UMJ&HZE<G2;
M6]N+72WN[6ZP>3(X;(+*0RJRD$YP N17IEUI%G>ZE9ZA.LQN;,L8"MQ(BKN&
M#E58*W'J#5ZA.W]>@'(>'-7N[B]OH;S7=-D<:G-#' 8MLA4*2J+^\ZXPW3H#
MQSD<]-\0=8M],OIS>Z%)/:QW7FQK ZF!H9&5"X\TX$F  .#DC!;I7I<UO',8
MVD4L8SN4!B.<>F<'\:QO""Z<-!W:7;7EM UQ-NANYVED602,KY)=^K GAL<Y
M[TE^5A[:^9AW7C#4;>]@B6ZTIS)'%+# (VWWZR-T@;?C*#&3AL]<**9J7B35
M[?3=:BN;C21<:7%-)=":Q<0R1E<P@9E_BYSR>A&!W[VBABCHU<\MUGQ1#?ZG
MI>^;2DM[.^M'MXBO[V170'S8W+;1&2Q3@=C\W:GZ;\1M6O;.X>[ATVS7S8HS
M<2NC+9;MVX3QI,S87 &6\O);D+BN[M=<BN]8GT^*TNRL.5:[V#R=XP2F0<AA
MN'4 'G!.#6I3_42.)^']_I3>%6L/M>G%XYKPR6\3J%6,3OD[,Y"8(Z]B*YWP
M]XU&EZ#;6%I=Z5-&+-9(!%R;9?.\MFD ?YE4'=P%P%(SWKTN>>V2](56GOHX
M&=8$8;BF>P)"@D@#)(^M71THW=QG -XLUTVT,\,^E3VTMQ)9Q7<-L[QW$NS=
M$Z8EX0ME",GYA]ZJNH>.]<M=#AU*.&Q$<\@@+R1JB02*G[P.TDZ+S)E!\PQM
M/WCQ7I-41JD9UTZ28)A+]F^T"4[=C+NVD#G.0<=1CGK2#8YK3?$>N75Y':7
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M=TFT8Y&:H:QXLGMK'5I;.SOOM5O:P2K$Q@**)2P#J0_)!!!!)'RC (.2KO\
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MG:<]NL;6$MG,TGD.J[2NTQH-AY! /(].S+'QZLND17MUH]\C^4UQ<)%Y3>1
M&($C?O.1\IX7+?*?EK:U/Q##ISP1QVEU?331-.L5J$W")<;G.]E&!N7@$DYX
M!I/;7^M M=G)KX OI-=L;N]FANK>.&&.1/-5=@6/8\8#0LSQMR2N] <\CO4V
MG> )+2\MS,FG/:+B&:,1Y,D,3!K<G*\N,8;/;'/%:L/CK3Y[E46SOA;-)$@N
MRL?E?O$WHWW]V"/]G(/4#K3-$^(.B^((=0DT_P Z4V4(G9$*2-)&<X*A&."<
M'Y6VL.,@9IZWN&Y3N?!][>75ZQ@TVUBNK>9+@02.4NW=< O"5VJ5.#ORS'':
MJT/@>^2:RQ:Z5!Y0MREQ#(WFV/EXWI#^[&Y7P<\I]\Y#5/=^,9X-3L=0$%\=
M-DT^YFFLD-M(R^4\?[S<KD<*S9 <\ <9K4O/&MA97TUFUK=22QVSW2",Q9E1
M0&;:"X(P".6"@]B:7PJ_]=?Z_IC:;^?]?U_PQSMQX(U@:0UM:VFE+?FX@>74
M1>2))=+%*) \B^4P\PXQD[NO7'%:TOA*XG\,6EL]KI(U6QN?/@DV9C<[\LS?
M+D,ZYW8!Y)ZTMS\2-$LM1L[&[2>":Z$;*)&B4JLAPC%=^X@G^Z"1U8 5K:CX
MFM=-O7MWMKJ5(0AN;B)5*6X<X7=E@QS_ +(;'?%/6UOZT$WU_K4Y9_ %U;Z6
M]I:P:9*T=Q"ML\C&(K;)-Y[*2L9P2V5P., '.>*AA\%>(%G\N*'2+"%8KV&&
M>UNI#)"D[!D55\I<!2,8##J2,8K6M+[6]8GUZ?[7?:;;VCR011^5;L,J 0RM
M\QSUR&!&&&,$&H++7-3ECTR+5K^6POK5\WRPI&8[J+RF<2C<A(4[,';@@[AZ
M&A/^OZ_K\1W>R_K^OZZ$$W@V]DM[&&+0-!@@CDFEN;1;V0PNS1&,;5,. #D$
MC';/).:TIO"][=^#](M+J/3Y-:TP1&.60F2,LF WS%0V'4$'COWQ3=/^).D:
MH0+*VNIOWT<3%'@8)YF?+9B). Q!&/O \$"K]EXE?7;&8Z193)<FU>2-KDQ[
M$D#,BH^UR<[D)XR,#K0[V_$2M<PX_ $MMIL]O%'ITIB=8[5)$VK+;"0R-#(0
MORJS,00 PPJ\'D56N?A_?-;2?9[;25:YLKJTD@=V,=NLA5HU0[,LJ,IP"%QN
M)&,8JW%XIU#2M-E-RNH7NHQO;1R65U!%%(ADDVE@ZE4=23@8Z$<GKC7D\;:;
M 6>Y@NX+0&5$NG13'(\>=Z*%8MD;6ZJ =IP31J"TU_K^OZV,1_">O7+SM=VN
MCRPO=03M9O=2/%<*D'E%')B&,$!QPV2!D#K6E;>&M23P(FAR&S2XBDR%61GA
MF02[]C$J"%8?*>#P3UJO>^+;BV\0Z<9H;^QMY(YXWL;E(5,TBB,Q[&R02=^.
M'QG@X(-=I&Q>-'9&C9@"4;&5]C@D?D:-U<-FC@CX(O(WMKJ'3]',L3W#1VC2
ML(K4.BA5B?RB<!E+?=7ECBL\_#_6VL6M%&FVT!AM1)'#/N%S)$K*Q</ RX;<
M#DJWW%X]-35+G7W\6:C965]K)@2.!H_LD=F8X"Y8$OYB[V4;<X7)Z\]*V;CQ
MEIMEJESIUTLZ36\)FW?(WFJ"%.U58L#N8 ;@,]LX-+IZAU_K^NIS^G?#P-)=
M0:M8V$]G+I\=LLCS^?,LB;\.?W*#(#[0PP0$'KP+X!NI(+@7MKH]T;B#S7A9
M,1_; AC#CY#\I4Y)QG<,XYK2OO$]Y;ZE8W!L-4AA\NX%QI[Q0[V**K!PV[!&
M">0^#TZ\5KW/B.""?38H[6XG&H*&B=&C10#@C)=UR<'.%W' /%#U_+\PO8YQ
M_!FI3)&46PL[IM/^R37L<GFRJ1%L'EDQ!E&>>& Z_*2<B72O!5W;>#-9T2:6
M.%[]'5=DJR11EDVY54AB"@]2 .O.<FK-CXX,^G^?<:-?";=.[0P^4Q2&-RID
M/[SD=L#YB0<*1@T:OXK^T:-J3Z0E^HBMI7BU**)&A61$W[3NR?;)7;VSFARW
M?]=PBM5%?UT,+4OAYJ5_82+&MA9K+<"5],MY1]G/R;2VYX'&XGYL^5U[Y^:M
MVZ\-7TDN@;8K:X6QM9;>XFN+MA.P>/9@.L7S<\D_+TSBKUCXHMY- _M&597B
MC$<?G)L87$K84J@5NN\[>0O/MS5'4_B'I.BK -4MKNRFEW%H)_*1XU#;2W+X
M<9/&PL2.@XIM6?+Y_P# $M5?^NC,]/!-S'9V<2:7HBO:W320*0ICA0E?F*B
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MU)%*,>6;R9E0>B L1&/9<5I44 <[+X&T"8DR07C,T<D3,=0N,NLF-X8[\G.
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M%V)[<XP.^,Y)NT47 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFH'0ZMJL>DVR2M!-<22R"**"#;OD8@G W$#H">2.E2:;J-OJNGQ7MJ7\J3.
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M10 4444 %%%% !1110 4444 %%%% '-:IXUL=)O[JRFM+J2:"W>Y C,1,B(
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MO;BWG*,R-N:[F,B;#E CEMR!23@*0!D\<U)8>%](TRZAN;.WEBDA\W9_I,I
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M;AI+%MT!6ZE7!QC) 8;N,CYL\$CN:/Z_#_,#$7QW:0V]J9[#46^T+&T,HCC
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M%8XZXY].XP3HU4TO3+71M-@T^Q1TM8%VQH\K2%1Z;F)./QXJW3=KZ %%%%(
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M*W0XSGTS_O#UK3IIV2&]V_Z_K4\[T::0Z[IP-AJ: :IJ#EY-/G155RQ1BQ0
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M[O6H1,[P2Q&VMI8 CQJRY)6<,00S<!E(XY/>(_#R>&Q%K8ZI;6Z,D&]7LWF
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MP-%)N&SY?]DX.2,9-8FG?#J?37MS#JENQAN(92TMO/*TD<08(AWW# $!CRH
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MTWH#.Q?PYIDE[)=M%/YDJ[)4%U*(Y1MV_/&&V.<<98$U2N- \/6=I:V5Q/-
MC3!;4R:G,D@<@X2)S)N'&1M4].U<JOB#7[V]TL2W]_IT7DVYO0--?"2$?.IS
M;N 2<<L\>T'.&!!J;7HK]/$-^#)K$B27]B\ CL6EBC12"S*RQD?+AN"?J#FB
MUG;^M!7TN=:/"VD_\3#=%<2C4(A#<B:[FD#H!@#YF.#CN,&I)?#FF2O:N(YX
M7M8UBB:WNI83L'16*,-RCT;(KAO[>\9RM8B!+I(E=D::YL)4,Q$Q \Q%MV(!
MCV'(\L98\\$#4\4ZKK=CK5U]@GU;R8K2*6.&WTLSQO)YF&7>(B3E3R V1U&,
M&CM_7];@]+_U_6QTK:!:W&G-97KSW$9G,ZL;B0/&V[<-K[MXQ[-[# XK#;P#
MI\>L"Z,VS2DAD5K+S)AEG?>Y9_-P4)ZH5*]:QK[6_$EM"R>=KQ=)+R/?%I/F
M;@06MV^6$Y/W1D#'4-S3(O$7B*.X4M)KDR)-9MM;0Y%619,"=3B'(5!DC!!!
MX);I2C=O0'IN=;#X?\.ZH&U&U FBNE8B2UO)/*)8%2Z!&VAB,C>H#=>:GT[P
MKI.DRR2V4=U&\ENEL2U[,^(T^Z!N<XQS@CGD^IKB+6;Q;I>FSV^E17DKPQ3>
M;!<VH1(7,P*F%]A,A*,YX\P9 X!^4W?"^I^)KW7+:VU.\U 0&%W8_P!FNB$J
MZE TDEM'ABI8'  ( Q@FFM=@>BNSI9?!FA3PB*6UF<8E5F:[F+N)  X=M^YP
M<#AB<;1CH*HP>%O"DCWFDPSS23^9%<W, U>=Y59,>6S?O-PQ@8_W5]!B/5K_
M %Z/Q)Y-L;U$$L(MX8[026\\1(\UI)=AV,OS8&Y>@X;.*H>'+:[71-:N5N=3
M74/MD_DW%YINV5(VDSE!Y()#  ]& ...,4D^I5C<O?#OAW5KZ]M)I9C<31@W
M=I!J<T6Y6XW/&D@'.,9(YZ<T\>"M"$KR^1=&5Y$D,AOYRP95V@@[\K\O!QC(
MX.:Y*YU+6([I=0ACUQ;J/3T!+:8TAG83G*MB$  J<X"JP&,A2"*DU'Q#XE\[
M5&M$UF.$PR-:_P#$K9V25)%"J%\G[C*<Y)8GGE2,4)="6SJ[7P;HMDL"VD=Y
M;B%-BB+4+A,KS@-A_F R<;LXZ#%7;+0].L-&_LB&!FL=K(8IY7FRK9R"7))'
M)XS7)37_ (LB\50V\<TITT[2DDMH["1&7+%@D!VLK' #.G"@$$G-7[2]UU?"
MVH.IO[K4(9MJRSVX1G7*[FC3RH\X&X@%3D\984=/Z[CZEJ_\-^&K/2F_M"22
MWLXY$E>>?4YD(*_<S(9 <*>@)P#T%7)1H6KZA' U]%<7-J$G^S)>MP!@J[1A
ML,.006!['TKC;V35KYM)6>[UV2T35LQ3_P!E8EDA\KEID\G"X=BHRJY!)P<;
MAMZOI8N/$MF--2>TO=/M,V<BVTBV^,\Q,P79M8 #&<C@CI3]?ZT!JW]>9-8>
M'/"&JV[RZ<8KR  P%K>_>14^8/M&'(4@X(QC;VQ5NZ\&Z+>@BY2^ES;FV)?4
M;@DQD@E2?,YR0,]S7*W6H>+X)K);*TELK>6221EDA>3YVN')1_+AD(7;C!R@
MYSN/2K;S^+8+Y[876HS(DTEH9S:Q8/F#=#,,1X(3[K=LXXZT+R!G1WT&@Q7U
MA#?WJI<1KFV@GOW&_:/O;"^'(Z[B"1US38_!VA1QV\:6LH2!/+5?M4N&0'(1
M_F^=02<*V0.PK&\26L]I?R7=C#>7-]);Q0/%+8^?;WVTDA6*C]VPR?F.U1N[
MXP*?F:W8ZAJH:ZUN.WEU+,LT-B)GBC,0V&(>4=X+#:<!L!1TR30NXGV.CO?"
M>A26U\+E)XK6X)EN46^FBBSG<6VJX5<GDD 9[TZVT+0+K1'AM@)]/N9/M(DC
MNW<%\YWI)NRIR,Y4CG)ZDUB6NI>(#>6HU66^M L2.$MM-,\=R.=XD*JQC? &
M "N"?XN@J^"[K4XO#DEK=PZK8FVT_P#<J+)L=6RP#1;C*#_!R"-I .32V3*W
M:.ICT'2;H6MY!+=/MC41W$.H39E3JNYU?]X.21N)Z^]-C\)Z1#:6]M'%=+';
M2O-"1>S;T=@0QW[]W.X\9QS7$1>(O%'EQ7#R:[N2UL7D@.B-AI2VVX7_ %.<
M!?FX/7H<<5-9S^(+&WEA>\UZ.)KV\+3KIHED#^9F%0OE',3*22P& >-RCBJ:
MM?\ K^OZ[A:ZN=4G@?0HTA5(KU5A@>VC U*Y&V-OO+_K.A_H/082?P_X;TU(
M_M#FU29%L@)-0E19\C:J,"^)&QP,Y..!3-6FUV/P[IVH(UQ%>Q&)KZTLXDD,
M@; D"AE8Y7)(QZ=ZYG4?^$BFT-H]3DU.::VO+:';'9"02L+@2&8".+) C"C(
MPN01C-*UW9_U_5Q+77^OZT.M3POH%O-#&$E$QE6XC#WTI=G1-F[E\GY2%/8C
MKFD&D:1IUQ;V%M?RV<\T@EAMCJ$I+*AR5CC,F N#R -N.HZ5RT/B+Q-Y_D6\
M>KW,\<5ZBBZTEXHY65@;=F?RE4$KGHR@\=":+VXOYFTB5;[7IV6>>47+:&Z3
M6Z^0PPRB+:3N.!E><XYQFB_4&NAV5]X;TJ^O6O[F.83_ "$NEW+& 4SM.%8#
M(R>>N#6=I_A/PM=V<-Q8>9=6IA,44L>I32ILW[OE/F$9##((Y!'!&*H:A<:G
MJ7A;PU?R-JEI<?:()+Z.WLV,@.#NW1F-FP&]L=_0US]EJOB73]/:#2K74W::
M*YE2&YTV2)(&^TY!#&+.XQL[8;=RJX7G!+6;785[V\ST3_A'].9+198II_LC
MEX6GN9)6!(P<LS$L/8DCIZ"GZ6NEV,9T?3I80;-0&MUEWO$&Y&X$EAGD\]:Y
M[3+SQ!<>")IKN[EBOUE.R9+20RF,,#@HUNIW8R,B+'?!Z5AS:EJ\&K/J4$6M
MK*+2R1PVF-(;C$S^8&VQ8^X^[Y0I''0@K0EK8:U5STVBO-KOQ!XD$FH-"NL)
M$=C6W_$K9V5A+M=,"'[NSGJQ/4,.@M27WBZ/Q6]J+B0:> 1')+:.XD0QY#GR
MX,!P_8R+P,;<G)2U [^J][?V>FVQN;Z[@M8%(!EGD"*">G)XKF(;_6QX3N9$
M_M&:\BN AFFMU$IBW+O>-/*3.%+8!3DC^(8SCW)U2_OM"%Y/K$EJFI2;9/[,
MYD@,14-.ODX0[F*<A?E).!U#2N[!TNST96#*&4@@C(([TM-1$BC6.-51% 55
M48  [ 4ZD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '-3^)KV6[U!-(TE+Z#37\N[DDN?*8N%#%8EV
M,'(!'4J,G&?1VF>,+/49;J5S#;Z=%9V]['=RS;0T<H;[X( 0@H>Y_"FS>&+V
M&\U&32=66RM]3?S;J.2V\U@Y4*6B;< A( ^\&&><50/@.2&9Q8ZE#;VT<-I'
M:1-:%_+-NQ9"Y,GS@EFR,*>F"",EJUM?Z_KH#\B<^-0/"[ZS]EMN+QK12+O,
M'$A02-+L^5.,YVG&>]:2>)K.&YL+/4GM[.]OBPMXOM"N) H^\K<9![<9/H.<
M0:9X>U#3=*N;1=4MV>:[EN0RV6$Q(2Q1E+G(W$\@@XX]ZH1>!3';00B_BC7=
M<^>D-MY<>V90K+$H?]WC&1DMR3ZTOZ_#_,.IT">(-%ELI[V/5[![6W;;-.MR
MA2(^C-G /UJA;^*K:37+RRG>TBM(H;>:WO!= K.)BRJ.0 #E<#!;.1]*SCX*
MO'FCO9-7@.I6YA%O*ED5B"QAPHDC\SYR1(V2&7M@#%-3P7J,?B1-9AU>SMRD
M<,:P6]@R1A4+9!'FD'<)''3(R".ARU:^O]?U_5P>W]?U_70Z636M*BNY+234
M[-+F/&^%IU#KE2PRN<CY03] 355O%GAQ88YF\0:4(I%+HYO(]K*#M)!SR,\?
M6L_5?",FKZEJT]Q?HMMJ%BEF(XX&62/8Q8-Y@?G)8Y  [<\<\^G@W6--U?3X
MK(QR+(+DWFH/$\L8,BQKRDURTA8B/&02.G'6E_7YCT_KY';MK^C*9@VKV ,.
M?-!N4_=X )W<\8!!Y[&@:_HS/9HNKV!:]&;4"Y3,X_V.?F_#-<R?A\3IU_8'
M4P()EM1;,D+I)$8 H3<ZR O]T$XV'T(JQ8>"IM/M[2*WU"* I(7N9(8Y]\X+
M%F7<\[\$L?O;\9)&"<A_U^?_  !&V?$N@@,3K>FX6;R&/VI.).NP\_>X/'7B
MHAXLT%M1MK%-5LWEN;=KF(K.I5HUZD'//<\=E)[5R]E\-)M.CC2VU6 ^7-;L
M'G@GF<Q0MN1#ON"HY[JJCKQS4R_#ZYEM7MKO6(GCEBNHI/(M&B)$THE^4^:<
M88>^1QP>:- 9I7M]X6LK27Q19KH$UW(K+!>>;$AN' ^X)@"23C&!GITJ67Q?
M;VEQI)U 6MG9:A9M<_:9[H((F&SY#D '.\<Y'3I61!\/)[:(M%JL(N9%GCN'
M>WFF25950,<2SNP?Y%YW8Z_+6I/X6NY++25CU*!;NPMFM6E>T+1R(ZJK?)OR
M#A1@[B.N0:6VW];_ / _K<6^O];&K_PD.B[IE_MC3]T,BQ2C[2F8W;A5;G@G
ML#UI7\0:+%=O:2:O8)<QLJ/"UR@=6;A01G()[#O61IOAU;76;4Q0W4%II]JE
ML#*Z$790 1OA23\H+CD+R>AP#2ZAX5N;U[T1ZE';P3E7CAC@8JLJR"0.P,F"
M<KSM"9R<D\8>EP1?O]1\.7FG,FHWNE3V,DWD,MQ+&T;2 _<.XX+ CIUJ+1=<
MM+BZN=*9;.SN+2=H(;6.<$O&JJ0RKA2!A@, 8'J:S$\&WJ7\MZ=4M)I9I)O-
MCGT_?$\<H3>A7S.N4&#GH<$'K3X/"6H0ZS%?G5;/:NH/>M&E@RDAHO*V9\WC
M"]\=>W:A>8G?H= =8TP7%Q;G4K,3VR;YXS.NZ)?5AG*CW-5W\3^'XX1,^N::
M(FC\T.;M,%,[=P.>1GC/KQ6-/X(:YL+W3Y+Z$VLLCR6[BV*W$)>02D&57&Y=
MP' "G '.1FFZ1X*N-+U.TN_M]LZ0I.)$%O,S2-+M+-ODG<@_(OKW]>$5H74\
M;Z'-I4NJ0ZE926<5J;E\7*^:HS@ IVR>.3UXQ2:'XLAU.TN[J[ETJV@ME5VD
MAU))P%89#,<#8,>O<'L 3F)X(U2/3Q9C6[/8-+;3%8Z>V=A/WC^^ZXX^O/M4
MS^#M2FNWNY=9M?.$=L(ME@P57A+%2P,IW [VR.#TP01FGI=B9JLWA6?5+._8
MZ-)J,Z;[6X)B,LBCNC=2/I3K+Q;H%_:QW$.KV0CEG:WCWSHI>13C:!GDG@@=
M<$'O69=^$+V\NK.8ZG:PQV\D4WD0631QF5)"Y; EZ-N.0V[!Y!]:-W\.6NTC
M634T<(TR%#',B/%))YFUA'.F2">I.#Q\O%"L)W.LO=6L[286AN[,:A*C-;VL
MUP(VE(!Z#DXXZ@&J.D>*]+U+08]3FO;.VQ!'+<QM<J?LV\ @.3C'7N!FG:CH
MMW<:A%=V5]#:,L>R0^0[M*!G:&Q( 5!/0@GDX()S6%:>!M5LHH(X==M56*TA
MM?EL'4LL;%LY$V03N(XP>X-+H5T-+6/%CZ;-*+>S@NX%M%NDE6ZQO4R!".$(
MZ'(.3GIQUJUJ7B2'2=?M;"^-M;V=Q;23"[FN0FUU9%V$$8Y\P8.[KQBN??P#
MJ8LHK.#7;1(8[/[)^\T]W8KYF_.?.'/ 'Y^M:GB+PM?:[=),FIVL &GSV3*]
MDTG,NW<X/F#'W1@<]^30OZ_$4=]?ZV_X)LS:YI%M+/%/JMC%);IYDR/<(IB3
M^\P)X'N:CD\1Z'#"TTNLZ='$D:2,[72!0C_<8G/1NQ[]JQ;/PA?1ZU;:A?:O
M#="%'C,2VKHI1T56&/-*CE<YQG!P2>M17O@22]T:VM'UB5KJUN/-@N&$BX0*
M45&$<B,<(V,AP2<D]2* 7F;.L^((M'_LV:3[.;&[F\J2Y>X"+$-C.&Z$$?*>
MX_&K?]M:5OM$_M.SWW@W6R^>N9QZIS\WX5EOX8\O0M)L+.XBMY=+=)+=C"TD
M>54K@JS[B,,?X\].:QV^&T O+>=+\LHVFXCD\X+(PE:4%1'*@7#.<!@X''OE
MZ7#H=0WB+1$,@?6-/4Q2B&0&Y0;)#G"'GAC@\=>*>=<TD6MO='5+(6]P^R"7
M[0FR5N>%.<$\'@>E<?%\-I+6)H[;5(L!XMCW$,\SB..42!"&GV?> ^ZJ]^.:
MTF\):BVF"S.JV9/]J_VB6-@V"/,\S9M\W^]_%GIV[T('IL;T.MZ3<3O!!JEE
M+-'$)GC2X1F6,C(<@'A<=^E4AXEM9[_3$L);2]L;WSA]K@N0RHT:YP, @CKG
MYACT-8-Q\-H;C4[ZY.H/Y5RTLD88S,\+R'+8!E\HKD#CR^1P36A/X8U6YFM)
MVU33H9XO.,KV^F%/-:1-@;!E."!CKG.!TI=+_P!=?^ #[+^MO^":S>)=!2Q6
M^;6]-6S=_+6X-V@C9_[H;.,\'BFW/B/28&N85U;3/M5OM$D,MXB;"Q 4/U*Y
M) ''.16#;>";ZUM[S9K$)N[FX6Y%S]GEW1/L5&VGS\X(7H20,XP1Q5C4_"6H
M7L5_#;ZQ!;0W2 >7]D=UW;PQ=AYH!8X/*A>I)SQAZ7_KR_X(/R"7QQ;-XG;1
M[1],E$4Z6\\DNI)$Z2-SA8]I+>G!SNXP.2-PZ[I"F\!U6Q!LAFZ!N$_<?[_/
MR_CBN>NO".L75Q>RG6[%1=7UO>;?[.<[3#MPN?.YSL7GZ^O%&/X9_9[Q[F#5
M )(Y/,M'E2:4QGS!)M=6F*,NX=%5#WSGFDME<);Z&G%XS:31;?4S:6OD/J1L
MI76\RBIYA02JVS##H<''!Z^NY_;NC[;1O[5L=MX<6I^T)B?_ '.?F_#-8"^#
M]072ELO[5LSC5?[1+&P."/,\S9M\W^]W].V>:S#\,YI9(Y;K5XIGWOYJ"&XB
MC=#,TP&V.X7D,QY8L, <9&2]/Z^7_!![NW];G6GQ/X?6V-R=<TP0+C,INX]H
MR2HYSCJK#Z@^E5+7Q98MJ^H:=?7%C9S6TNV$-=KF=/+63> 0,8#<XR!CK6+/
M\/KBYTI+>;5H_M,=[/=)+%#-"A$Q)=66.=6/WB =XXP"#SFU!X'%K)&L=VGV
M%7MYWMT@)<R0*JH$D9R57Y!D-N/7YN:-!OK8Z*UUO2;YH%M-3LKAKA&>$0W"
M.9%4X8K@\@'@D=*K>)=7N]#TEM0M=/%\(W420B4HY4D#Y %;<V2,*<9]:JZ'
MI-Q:)>W4:O9R74N^&VN0LGV9"=S+A&QRQ=N&.-P[#%:&M6-WJ&GB"RNH+:42
MQR>9- 9E^5@V-H=>X'>DQ+<IVWB+[9>6\MNMFVCS6ANA?-=%64 X(*%, <CD
MMQSQQ6E;:IIUY8&_M;^UGLP"?M$4RM'@=?F!QQ6)>>#8+B2]:&[DMTND!\I$
M!2.4.',@'^T5&Y>AY[DDK_PBDLVE:E#=7Z&]OYTN9)X+?RXUD39MQ&6;CY%R
M"QSST[ (U8]>T:;[-Y6K6#_:B1;[;E#YV.NSGYL>U4-2\5V-IL-I<V-X([N.
MVO MVH:VWMMW, #R#V.WH>>*S]0\'ZAJ3PM+JMG%LDCG=;>Q>-'E20/N($O.
M<8(;=V(P13[KPGJ$[D1:K;16XNX;E+?[([(NQMQ !EX)..F!_LY.::![:&ZV
MMZ2EO:W#ZI9+!=L$MY#<(%F8] ASAC["JLOBK0Q%;-!K>D.UTVVV#WR*)OFV
MG81G<0>, 'GCBJ4/A:Y7PO-I,VI1-<&Y:Z@NH[8H(G,OFJ=A<YPW^T,CCWJI
M/X(G^P7=M::JD?G3Q31F:V,@BVN)'& ZYWR#<3D=<>]&E_Z\OZ^0?U^?_ +D
M'BFXDU2VLY-/B19=1GL&=;DL5V1F16 V#.0"",C![FK \36T/B>ZT6_>TM&5
M(6M7>Z :X,F\;0I ^8%#P"V01]*SH/">J1ZM;WDFL6;I%J4E^8UL&4MOC,>S
M/G'& 3SCKCCM5G6/"C:KJLUR+Y8K>[BABNXF@WNRQ.SKY;[AL.6.20W;&#S0
MK65_ZV_X(N_]=_\ @&W;ZGI]Y=7%K;7UM/<6Q GBBE5GB)Z;@#E?QJO;^(M$
MO)FAMM8T^>549V2*Y1F"J<,2 >@(()[5B^'?!*>']:GOUN_M",LB0AS.7C5W
MWL,M*R8S_=1?YYR].\+:OJ'VV2]<Z9LO;R:R5H(WD5IMP$C,LC!EP_W2%.1R
M2,4E^A7^9UL>NZ==/9"RU'3KA;MF$96[4F0*I+>6!G>0<9'& 2<\8-;3?$EO
MJGB&]TRU>UGAMH4D^T6]R),L6961E ^4@KZGKVK$@\"W\4\3-K4+1B]DO)1]
MED+LSP^4P5VF)7@L1G.,@=!SH>'_  M>:-J8N9M2M[B);&.R$<=EY3;8V)0E
MMY&<,0>.>HQTIZ"-5O$6B(URKZSIZFU8+< W2#R6)P _/RDG@9J]!<0W40EM
MYHYHR2 \;!@2#@\CT((KB[KP#=7&G/9#5X D=M):6C-9%F2.1E9O,(D'F'Y0
M 1M[D@UVL*LD$:.5+*H!*+M!..PR<#VR:.@/?0?1112 **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex3-1_007.jpg
<TEXT>
begin 644 ex3-1_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .* KL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX\YY3&&A>)U0@@.<\GJ,]1C/.(X?&4K7NH6LFBWKS0WK6MM%"T1:?:@=B"9
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M1[BLM=?O+[5[NTTG3HKF"QE$-U<371BP^T,5C 1MY (SDJ,G&>N'?]?Z^7_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCU*PEOY+".]MGO(EW26ZRJ9$'J5SD"H;C7M'M99XKC5K&&2W4/.DERBF)20
M6!/ R1R?6DG8;5S-\6:3>7ZZ9>Z8B-J&GWJ31[F"@H?DD!/IM8G\*I^']!OO
M#^HZYB(RZ<9C<V,2,N]F=09!R0!\PXR1]XUN-XBT-+>2X;6=/6")PDDAND"H
MQ&0"<X!/I3[G7-(LYC#=:K8P2B(S%);A%;RQ_%@G[OOTHZ?U_72X;_U_7<\S
MT_PGK%GI?ATG0]5-[::H;BYC.HHT2QAF.5C,^P$[QT&>&]>=C0=/U;2_$NM:
MC+X=U5GO+YI(&6]@\D1LJKET\[&>"<A2V./:NIO_ !;H&G1[[C5K,?O(HR!.
MA*F3[I// (^;)[ FK9US2!]K']J6.;,9N?\ 2$_<#_;Y^7\:>VO]=/\ ) ]?
MZ]?\SSK3_#>OVU]/J_\ 9%VS+JTETVFW-U$T<\4C95T42%%E3&<G'U-:&E6&
MKV7C#6]8E\-ZL3=W"O;;;V 1A?+"$R)YV.O.0I./RK;7Q@S>&FUE;2V:..]^
MROLN\IL\WR_,5]G(Y!Q@<=ZUXO$6ASM"L.LZ?(TRL\02Z0EU7.XK@\@8.<=,
M&A:?+_)?Y?G\B2O_ %YO_/\ (Y#^PM:TJT\3Z7;:<^H+K5Q-/!=&>-4B\U0I
M$H8AOE_V0V1Z57MO"-]'XNT:.XL]0DT[3]*2R-]'=)&'D5E8,5$FYDXQ@J>>
MV.:Z?5O&>E6$*+;7=G=7<]K+=6L7VD*LZH,G#@'KSC .<'T-7(/$NCR:3_:,
MNIV,,";5G=[E-L+D [&;. >1P<4+3Y?\,OZ[C>NG?_@?Y"VVJW5Q/JT3:9(!
M9OMA:.9&^T_+GC) 5L\88CL<\UP(TGQ2FD6T-OI>M6\]OI1A58M1B2,W(<%&
MVB;& -V>.1P<]*]*EU&Q@%N9KVWC%RP6#?*H\TD9 7)^8XYXJDOBGP\VS;KV
MEGS &3%Y'\P+;01SS\PQ]>*2T8KZ'#WOA_Q*/[1DTZ+4K875]Y\BB[WO(C1
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MSXSL F1E90.&88Y/U/-W]YJVH:Q;Z>4U*VUJ72N;6+5$C$,P8!9F19=I3J2
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M@&.X1RZ*<$J >>>.._%+H/5Z')OI7B,I$8K;7(XOM%L9(3JH:3(8^<X;S?\
M5LN %SUYVKUJSIEEXA1M-ENK35B]O<.C1SWZ[!#YC%6<I/EV"%1\P?)7'&2U
M;FE>++'4M2GLVGLH_F3[&RW:N;I60/E1@<@'D#=]:O?\)%HA\[&LZ?\ N9!#
M+_I2?NY"<!6YX8GC!YIW)T_K^OZ^\RO$$UYK/A2)]/TJZFEEN(7\@/"K*J2A
MB22X4C"'&&.<CMS6 UEXL&HS3V-IJ\#2WDYC-S?QRQ11-#A,H9F&!+AL $@
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M04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;VNC:6(OL\MLJG6GPJ2.7.,68Z$X'M4]!G2MXRT%;TVOVQS('CC9UMY6C5I
M"@:0+M&X,,9/.:W:\_B\-^((;*YM5TC3#'<2P2N3K<F080@7'^B=#Y:Y^IZ5
MZ!3=N@!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex3-1_008.jpg
<TEXT>
begin 644 ex3-1_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .* KL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXKV-5"J%'04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/^-63K$MUX0EO;H()8KMX6 W*#Y=P4!XY&0H/XT =71FL+0M8N-0U'4[:=%
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M4NQ!!')^4@?A0!VE%5$G*2*NZ'R @^;?\V?\,4UM7TY3AKV$'_?% %VBJ/\
M;.F_\_L'_?8IPU;3VSMNXCCT:@"Y15)]5LP $N(VD;A$W8W'TJW&S-&I==K$
M<KG.* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF@#T4LJ@L2 !WIL<L4T:21NK(X#*P/!!Z&N%_LG7EN3+';7JJ6SL-RC @",
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_2G6_B;2;JYBMXKH-+*VU%*D9.,XZ>U &O1110 4444 %%%% !1110 4444
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M>VQE2!+ETD5U+R"*0K@J,8)&.GH>E++J:S7B7<GA'4VN$&%D,4>0/^^Z8M_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZGF@#I4N$GMA/;,DR.NY&1@0P[8-8T'B"XDL[>ZET_RHY;K[.<R@[/G*9/\
MP(58"RZ9IT-K8P13;1@[&2$+WR!C Y[5EI;7:Z9-I[::TD$I8D->KD%B22"
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MGI3HO%UG/*L<=M>;I)3#"3%A9G&_*JQX) C8]>F/6JZ2^&8@1&60&9)]JB4
M.BA5('0 !0,#CCI4$W_")B&1668(\WGXC\[*29)W)M^YU.=N,Y.>M %Y_%2Q
M?:-^F7A,<JPQHBAGE8PB7 7.00,CGTIJZ]/>:_IT%K#*ME(9TED=0 73;\N,
MY&#N'3M6?<7WA*1B9([O<61PT<%P"K*NU6!4<':<9')'!J:TO_#2Z@+JTM;[
M[1N9QY=G<8R1@G:%QSCTH N/XH6W-YY]E-_H[R\(RDM''MW/UZ?,..OM5K4/
M$$-A]F(MYKB.:%YS)$5Q'&FW<QR1V8'C)X-4))=#EEED?3M2+2EBY^P7/.X
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MDAD\R",I<&9$C:2,$&,)R48$'@<_ACN&R^%;@67V2UN+6.-XH4;S(6D*^7R
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M9@4D-N2I 0K@KOST)/!':@#41TDC62-E9&&58<@CUJA9ZQ;7FHW=@JR1SVK
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MZD/]9XDU!O\ =BMQ_P"TS3_['O?^AAU/_OBW_P#C5 &M16)_85_G/_"4:O\
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MZQUN3PZ)+:Z"R;8+W>Z1E2S-@QC)4#H.OK6Z?"EN;O6;C[==@ZM&L<R#R\(
M" 5^3.<$]2:DLO#-O8V&E6<=W<O%IH*Q[]A,B[2N'^7T/;% &)J'Q"AL7TR1
M(;2:QU!V6.Z-X555";@Q^0]>F.U37GC5[#6K;2;RTAM;R>(/&D\^U)FW8V1R
M;<%N^#C.0..UJ7P-I#&Q$(EMX[*626&.+;L!?.[@@\<GCWJ:Z\)6U_"8;Z]O
M+N%MNY)RC D,6!^[\IYQE<< >E %7PUXPC\0ZG=V86&&:V:19K9W(GB*O@94
MCYE8?-N' R!SUJ/Q%XLN]#U6:R6UBD9["2YL]S$&:1"-T?'?!R,5K6GANSM=
M3AU%GEGNH8VBBDFP65&.2,@ G\2<58U'1+#5;FQN+R!99+*;SH"?X7P1G]:
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ME A25=I/3[^,D=NW2NO&FV DB<6=OOB!$;>6,IGKCTS20Z7I]N (;*WC"G<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)NKF?=C_ %[[L?2@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>^NX(_,F@MWD1,$[F520,#DY([5A:)K-T^K-:7%U]IM)(B\%S(@1W==HD&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/Y5%_:&J9_Y S#_MX6N4@DO]+G@CM;2:.WGM;4W%['9YE!(F!R-O)&R(8P2
MW0=1;GU#Q!YVH;+B1/(@<PQ"P+><?+!5PW0'?D;>?3'>@#J5FU KDV<(]C.?
M_B:7S;__ )]8/_ @_P#Q-/L$ECL8$GF:>4(-\CJ%+'')(  'X"K% %3S;_\
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M5LX8 ]C@_E5ZL"W%W!?/=_V;<M+)%'"Q>9,80L1^K-^=:JS7;#/V:,>QE_\
MK4 6J*K^9=_\^\?_ ']/_P 34<DVH#_5VD#>S7!'_LIH N4506XU3/SV%N!Z
MBZ)_]DJ?S+O_ )]XO^_Q_P#B: +%%5_,N_\ GWB_[^G_ .)J*2;45/[NS@?_
M 'K@K_[(: +M%45FU(@;K*W!SR!<D_\ LE2K)>;1NMH@>X$Q_P#B: +-%5_,
MN_\ GWB_[^G_ .)J*6;45(\JSMW'^U<%?_9#0!=HJ@L^J$_-86P'M=$_^R5,
M)+S S;Q _P#78_\ Q- %FBJ_F7?_ #[Q?]_3_P#$U &U7<,I:A=PSRQX[_C0
M!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[!P-P8,#_P!] &KM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML$TJU90>";TC/X>76I10!G17.K,?WNFVZ#_9NRW_ +(*F\Z^_P"?2+_O^?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!(_+%=96+KCZ=IT/VZZLXY6D98BQ SSQR30,Q+/QVL^I-!+:E8C(R1L 0>"
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M,****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.IKE7\&WTR1I+>6Z>4]N=\:'=*L8Z/\ KTJYI_A-M/N8W22)H]DJNC G[P4
M#V 44 =-!-'<1)+"X>-AE6'0BIZJV< M;2" 8Q&@7@8Z"K5,&%%%% @HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH .M-V
MBG44 -V"C8*=10 W8*-@IU% #=@HV"G44 -V"C:*=10 W8*-@IU% #=@HV"G
M44 -VBC8*=10 @4"EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex3-1_009.jpg
<TEXT>
begin 644 ex3-1_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .* KL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ%WJT%
MG=1VTD=P9),[-D)8' R>15*7Q=I$-I]I>=]GEM(0(R2 &VG([<T ;E%5?[0@
M%C)>-O6&,$DLI!P/3UJ"/7+"5[-5EYNXS+$2." ,G)[&@!NO:JVC:4]ZL:R;
M65<,<#DXJA/XBN;>6R5[>$K>,8XG60X\P'@'C@$=ZCN]6TG7818RVL]U#)\X
M4 KG:V,C!!ZU TWAV32VG%K)-%$2CHS.71E;N"<@Y[T 2R>+2EV;40Q-,+J6
MW(#GC8F[/3WI#XN=+I8GMX\$ <.<Y*;O3IVHEDT-[Y+>33Y!=>>\A1B5P[)R
MV<X.5%+!)H+7;1&SD4^>MOEMQ7S-N%'7'3C- %V#5[V>ZM(A;08N+<3CYSD#
MC(Z>]2-KT2>)8]'*'+Q%A+GC>.=OY<U)NTVSU&WM$C NDMV\E1G[@Z@50.H:
M1<VZ7:6KRB-S.<9#1N#M.1GK0 [5-?N=+NITDM8VAB@,^X.=Q7<%Z8ZY-/\
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M B^6C[CSZDC\JU!KD::FUJNG.MY)((@<K\Y"LW+#L #U]:J1>)=,E:2)M/9
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M=R*WZ* ,.7PXD]^+V6X\R?=N.^(,OW2HP.V,TZ'P[%%<M(T[,AN!<^6% ^<
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MMR0WTX_(5JL+]9(C&EOM+#S1D_B1QSQ5!]$GDEE'G1K&;P7BD EMP P/ID4
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MX_#Z5(=!T[[/>6X@"Q7;;I5!_B]1Z5I44 9<>@VB7D=XSS27*-N,CL"7^4J
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M^5OZ@#\:JIKFMQWB3&/[0GSH\2H5 RZ ?B 30!VU%<A+K>KRI,J01E!;-*&
M8%C\N%'O\Q_*I9=?U/[4RP0QM"UP8D9T8' !)) SP2  ?6@#JJ*Y&+4]5GAU
MNYC8J\<,1AC\LD(^7W#'<\"M&WU*]N#=!T7RUA9E8 C8P) !]<CF@#=HKD(=
M?U;:B?9L_P"J&=N3@IDXYY.>W\ZDM=?U6YO((#;I&I<!Y'1L$YY48Z'&?RH
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M#"(Q5<$%P1DGG[AK:-G:MUMH3]4'KG^?-,.G6)QFRMSM(8?NEX(SST]S^9H
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M,QX5/FVE3W'W<]ZK36WBJ2.6,379$L<C(P*#:<L #W'&TCWS2W/B^ZDMX8S
M+::5HV#@DKM(!*]/O<G\JF?Q?-:??M=\0$A+NYW9'F'TQCY/U% $)7Q-+>.L
M\]W:61D!,H9"40*^><>NPUI6K:VWAJ.5I&FNC*N2A&YH@0"1VRP!;\:;+XGG
M7PW!J8MXP\TC)L#DX4$C(P,DX&<5E-XXN=.TZ%IH$N'!&X[FRRDM[8W#;TH
MT[32;R6?49[Y9GDEMHXXFW*&'W\@'L<%<^]9\%AXDM;0B))-XW*C1LB97<F&
M93QNP&X'I[U*GC2^+E)-/MT<PM/&#*1O4;NF1U&T9^HK3NO$4T5O821VH9[F
M(2%&)4]0"J\=>3UQTH S-/M_%(N;+[0UPL;$-<'?&?F"QYR,\*</T]:[2L/P
MI<7=YHQNKV5WFDN)Q@\!565E4 8] *W* "BBB@ HHHH **** "BBB@ HHHH
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MC/4?7]:</%^EF-91YVQSA6\L_,-RKGZ984OV?0+1K5X8$8SOB$0Y;<57L!Z
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M&S@^E $]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=?+*M+'/MVL. 2,<Y !^N: -+3?#4.FW4-PDVYHPP;Y -V5"_AT%..@A=/\
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MU5B\4S6Q:+4$'FQ^9(/+7B:,9P5]P1@B@"-KW7K.4QO:DS/(D1G",\;@*?G
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M\JHGPCITD*)YUR45MPQ(.><XZ=*DCTNRT73#:R7LB6+1F#;(5Y+<#D <XXH
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M,X8@D].O JU:^';.UF:8/-([0^0Q=AROO@#F@"L]_H\\]M;PV,5T;HLHQ$N
M  QSGM@#]*AN=>TQ[2&ZDT\36SL\,4A12"5)&,'H,J?RJ];:'8:<T5R'ES;!
MB&=P<#;MYX["H8-#TR]ME>*25K5BSQQ;AL0L3D@8SUS0 R&^T:\OI;>+3XI9
M(H#.S"%3Z97W/-,L]>T:6*&Y^S)"U]N4_NP2Q49(<COVP:NV7A^TL+F6:&6?
M=)&8]K."$!QG;QQT%4Y_#>DV\2R333*ZR^:)MX#;\;0<XH ?<Z[HNG6?VJ!8
M6$:](E52HS@\]NAX]JMW=UI<-C')-#$8I WEH8Q\W!)P/?FJLGA32Y(IX6,O
MDW$>R:/>-KC).2,=>3^=3S:!8W&G6]C*\KPP9*$N-P'3KC/% %>VUW0YK6UF
M00JS[4C0H 58@$*/3G]:L:9=VFLB2<V2*ZX!+JI)SGO4$GA/39# _F7 \ED=
M,2#&5&!VJW9Z1;Z?*KV]S*J#[\98%7X(&>/?- &9;ZSHD\\MM-8Q0EF*HCPC
M,NT@=,>N *L2:[X>MI5W26ZNWS B/GC/MU&T_E4A\.6!DW^9,) 25/F#*DL&
MR..N0*1O#FFLP822@X(X<=PP)Z?[1H EU'5M'M95%\\.X(65G3.!C/!^@JJ-
M0T1KFTBMK6WE::7:"L2_(1GD\<=Z=?\ AS2M1G62XED)AC"[1(,* ,9Z<<9I
MMGI&D2W[WMM/(989CYA#_*S<'GCG&[]: "_U[3+&*X6*V\Z42)%)$D77<< G
MU'6FPZ]X?E$<FR-'9$?#089=V-H/'7GI[U)_PC6F274]R)YF9Y \@$@(!!R!
MTIT7AO3H&#1S3+@QMCS>,I]TX]< #Z"@"&ZU?2;6[-JUB,[D+GR!C]YD@].3
MP:EDU?1;B.]F6.*Y>"'?)^[!+)C.,GJ.:DU"STUK^*>>61)9W5%V-P2 <9_
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MH==[R1/+"^9%]%QTQ[]:[J 2"!!,ZO)CYF48!/TJ2B@ HHHH **** "BBB@
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MLO#\%IJS:G'<2O,\8C?)&& SV'N<U030]/CED2WO@9H8W5XV"XRQ)R>.,$T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !? 4P# 2(  A$! Q$!_\0
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MR>^N'GN'+.3QD\ >@]JY^[')JWK&KVFFKB:3,AZ1KRQ_PKD)_$EQ<2[8K>,
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MLD9A_+^E;]>1/XF<KW/G/XK#_A(OCGH6@S_\>R?9X67U#ON;\P0/PKZ+4!5
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MU+08]*T73"Q\EKE=QD&?4JQ/UP!4FE_%'Q)X8\80>&?']I;[[AD$5];<##'
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MH.*6K]M/N/G9EZ3X?T_1TQ:Q9<C!D?EC^-:E%%9MMZLD****0!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
..444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
